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Abstract
Tripartite ATP-independent periplasmic (TRAP) transporters are extracytoplasmic 
solute receptor (ESR)-dependent secondary transporters that are widespread in 
bacteria, but not eukaryotes. TRAP transporters are composed of an ESR 
component and 2 unequally sized integral membrane components. The large 
membrane component has 12 predicted transmembrane helices (TMHs) and is 
thought to form the translocation channel. The small membrane component is 
composed of 4 TMHs and is o f unknown, but essential function. TRAP transporters 
combine an ESR, which is normally associated with ATP-binding cassette (ABC) 
transporters, with the utilisation of electrochemical gradients across the membrane, 
using an undefined mechanism.
Analysis of the data contained within the relational database, TRAPdb 
(www.trapdb.org), has revealed a number o f new insights into TRAP transporter 
function, including the observation that marine-dwelling organisms have a 
propensity for high numbers of TRAP transporters -  possibly indicating a role for 
Na+ in the transport cycle.
Structural and functional analysis o f TRAP transporters has been limited due to the 
recalcitrant nature of integral membrane proteins. The work presented here details 
the first overexpression and purification of the integral membrane proteins of a 
TRAP transporter. Using Escherichia coli and Lactococcus lactis expression 
systems, the integral membrane proteins from the E. coli TRAP transporter, 
YiaMNO, and the Haemophilus influenzae TRAP transporter, SiaPQM, have been 
expressed and purified.
The entire sialic acid-specific TRAP transporter, SiaPQM, has been functionally 
reconstituted into liposomes. The energetic requirements of transport by SiaPQM 
have been elucidated revealing that a Na+ gradient in combination with an applied 
membrane potential are required to achieve maximal transport rates. Under normal 
conditions, SiaPQM is a unidirectional transporter, unlike most other secondary 
transporters, however, the presence of excess unliganded ESR is able to induce 
efflux o f substrate from the proteoliposomes.
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Introduction
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Overview of introduction
All living cells require the ability to transport a multitude of molecules across their 
cell envelope without compromising their integrity- Bacteria, in particular, are able 
to colonise a huge variety of environments with vastly different concentrations of 
various compounds, both beneficial and toxic, that need to be actively transported 
against a concentration gradient. Bacteria have therefore evolved a number of 
active transport systems that have different structural components, energetic 
requirements, specificities and substrate affinities.
One particularly interesting family of bacterial active transporters is the tripartite 
ATP-independent periplasmic (TRAP) transporters. These transporters are novel in 
that they combine certain characteristics o f two other major families of transporters; 
secondary transporters and ATP-binding cassette (ABC) transporters. But in 
contrast to these two families there is very little structural and functional information 
on TRAP transporters.
To introduce TRAP transporters this chapter will be split into 4 sections. First, the 
bacterial cell envelope will be introduced along with passive versus active transport 
of solute across the membrane, diversity o f active transporters and details of the 
chemiosmotic theory of energy transducing membranes. The second section will 
describe secondary transporter structure and mechanism in more detail. The 
model secondary transporter lactose permease from Escherichia coli will be used 
to illustrate the characteristics of this transporter family. Thirdly, the structure and 
mechanism of ABC transporters will be introduced. The maltose ABC transporter 
from E. coli will be used to exemplify their general characteristics. The final section 
will describe the known structural and functional details of TRAP transporters and 
how they relate to secondary and ABC transporters. The sialic acid TRAP 
transporter from Haemophilus influenzae and the C4-dicarboxylate TRAP 
transporter from Rhodobacter capsulatus will be used to typify the characteristics 
of TRAP transporters.
19
1.1 Bacterial cell envelope
Bacteria can be divided into two large groupings depending on the nature of their 
cell envelope; Gram-positive or Gram-negative. The cell envelope of Gram­
negative bacteria consists of a cytoplasmic (inner) membrane, a periplasm, a 
peptidoglycan layer and an outer membrane (Fig. 1.1a), whereas Gram-positive 
bacteria possess a cytoplasmic membrane and a peptidoglycan layer that is 
generally much thicker than that of Gram-negative bacteria (Fig. 1.1b). The primary 
function of the bacterial cell envelope is to separate the cytoplasm from the 
environmental milieu while still maintaining the ability to readily transport molecules 
into and out of the cell.
The outer membrane of Gram-negative bacteria is an asymmetric bilayer 
consisting of an inner leaflet of phospholipids and an outer leaflet composed of 
lipopolysaccharide (LPS) (Nikaido, 2003). LPS is a glycolipid composed of the 
glucosamine-based phospholipid, lipid A attached to an oligosaccharide core 
domain followed by O-antigen which consists of repeating oligosaccharide units 
(Bos et al., 2007). The majority o f the LPS biogenesis machinery has been 
elucidated and has revealed that the LPS component parts are synthesized on the 
inner leaflet of the inner membrane, transported across the inner membrane and 
transferred to the outer membrane (for review of LPS biogenesis, see Bos et al 
(2007)). The primary function of the outer membrane is as a selective barrier and it 
is impermeable to hydrophilic compounds. However, movement of hydrophilic 
compounds of up to 600 Da across the outer membrane can be mediated by outer 
membrane proteins (OMPs) that can be non-specific, for example OmpF from 
E. coli (Nikaido & Rosenberg, 1983), or specific for a particular compound or group 
o f compounds, for example maltose and maltodextrins via LamB from E. coli 
(Schirmer eta l., 1995). The outer membrane is not energized, therefore movement 
of compounds is generally via passive diffusion (for an excellent review of outer 
membrane permeability see Nikaido (2003)).
The cytoplasmic (inner) membrane of both Gram-positive and Gram-negative 
bacteria is primarily composed of phospholipids and embedded proteins. The
20
Original in Colour
(a)
O-antigen
Core polysaccharide 
Lipid A
LPS
Outer membrane
>- Periplasm
LP LPIH
Cytoplasmic (inner) membrane
Cytoplasm
Figure 1.1 Com ponents o f a typ ica l bacterial cell envelope, (a) Gram negative 
bacterial cell envelope and (b) Gram positive bacterial cell envelope indicating the 
relative locations of the cytoplasmic (inner) membrane, periplasm, peptidoglycan, 
outer membrane and lipopolysaccharide (LPS). LP represents lipoproteins, IMP 
stands for inner membrane protein, OMP is outer membrane protein.
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phospholipid element of the membrane is composed of two leaflets of lipids with 
the centre of the leaflet composed of the hydrophobic fatty acid tails from each 
leaflet separated from the bulk solvent by the hydrophilic phosphatidyl headgroup. 
The hydrophobic character of the membrane is essential for its functions. Although 
the outer membrane functions as a molecular sieve, it is the inner membrane that 
forms the major barrier between the cytoplasm and hydrophilic compounds in the 
environment. The inner membrane is impermeable to electrolytes, which allows 
electrochemical gradients to be formed that can then be used to perform work. The 
membrane and the embedded integral membrane proteins regulate the 
concentrations of ions and hydrophilic solutes within the cell by either an uptake or 
efflux mechanism. The integral membrane proteins that perform these tasks are 
termed carriers or transporters and come in many varieties, which reflects the 
multitude and different abundance of substrates that need to be transported into, 
and out of, the cell. The integral membrane proteins of the bacterial inner 
membrane vary in size, shape and complexity, but do share some similar 
characteristics. Integral membrane proteins are predominantly composed of 
hydrophobic residues (often >70%) that span the hydrophobic lipid bilayer in a- 
helical transmembrane helices (TMHs).
1.2 Passive versus active transport
There are two general mechanisms by which molecules and ions can traverse the 
inner membrane; passive or active transport. Passive transport is diffusion of the 
substrate across the membrane down the concentration gradient, resulting 
ultimately in substrate equilibrium. Diffusion of most molecules and ions across the 
membrane is very slow, however, in most cases this process is catalyzed by 
carriers (carrier-facilitated diffusion) or pores (pore-facilitated diffusion). Pore- 
facilitated diffusion in bacteria is quite a rare occurrence. A well documented 
example is GIpF in E. coli (Sweet et a l„  1990). GIpF is a member of the 
aquaglyceroporin family o f proteins for which there is a high resolution crystal 
structure available (Fu et al., 2000). Transit of glycerol through GIpF is powered by 
the substrate gradient alone as glycerol kinase phosphorylates the transported 
glycerol as soon as it enters the cell, thus maintaining the inwardly-directed 
glycerol gradient (Fig. 1.2a). An example of carrier-facilitated diffusion is the K+-
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Figure 1.2 C om position  and energetic requirem ents o f d iffe ren t classes o f 
transporte r, (a) Facilitators represented by the aquaglyceroporin, GIpF, powered 
only the substrate gradient (Fu et al., 2000). (b) Primary transporters represented 
by the maltose ABC transporter, MalEFGK2, powered by the binding and hydrolysis 
of ATP (Oldham et al., 2007). (c) Secondary transporters represented by lactose 
permease, utilizes existing electrochemical gradients (where X is usually H+ or 
Na+) (Abramson et al., 2003). (d) Schematic of components of a typical 
phosphotransferase (PTS or group translocator) system (Saier et al., 2005). 
Phosphoenol pyruvate (PEP) is used to start a phosphorelay between Enzyme I (I), 
HPr (H), Enzyme IIA (A) and Enzyme MB (B) eventually phosphorylating the 
substrate that crossed the membrane through Enzyme IIC (C). P is the phosphate 
group. The yellow circle represents the substrate in each case.
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ionophore, valinomycin. This peptide antibiotic, produced from strains of 
Streptomyces, adopts a number of different conformations in polar and non-polar 
environments (Perkins et a/., 1990). Upon binding K+, valinomycin forms a rigid, 
lipophilic structure that screens the cation from the non-polar phospholipid 
environment and facilitates its downhill diffusion (Ovchinnikov, 1979).
The majority o f transporters in bacteria are active transport systems. Active 
transport, in contrast to passive transport systems, requires energy, which can be 
obtained from a variety o f sources. This energy is used to power transport of 
substrate across the membrane usually against its . concentration gradient. As 
opposed to passive transport, active transport ultimately results in the 
accumulation of substrate and further increase in the substrate concentration 
gradient across the membrane.
1.3 Diversity of active transport systems in bacteria
Bacterial transport systems can be broadly divided into one of three classes: 
primary, secondary and group translocation systems.
1.3.1 Primary transporters
Primary transporters are a broad class of transporters that utilize light or chemical 
energy to power transport o f substrates against the concentration gradient, which 
can in turn result in the formation o f an electrochemical gradient. Primary transport 
systems include bacteriorhodopsin, which is a small, 7 TMH containing integral 
membrane protein that upon illumination catalyses the translocation of a proton 
across the membrane (Lanyi, 1993). Bacteriorhodopsin is produced in halophilic 
archaea in the presence of low oxygen, and generates a proton motive force (pmf) 
when no respiration is taking place in order to power oxidative phosphorylation. An 
example o f a primary transporter that extrudes H+ across the membrane by a 
completely different mechanism are the proteins o f the electron transport chain, 
which uses the redox potential as an energy source. A well studied example o f a 
primary transporter that uses chemical energy are the P-type ATPases. These 
adenosine triphosphate (ATP)-driven ion pumps are multisubunit complexes found 
ubiquitously from bacteria to animal cells (Kuhlbrandt, 2004). P-type ATPase
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complexes pump a number of different substrates including H+, K+, Na+ and Ca2+ 
forming electrochemical gradients (Kuhlbrandt, 2004). The formation of these 
electrochemical gradients can power processes such as transport, or are used in a 
different capacity, for example, in inducing skeletal muscle contraction in animal 
systems (Siebers et al., 1992, Kuhlbrandt, 2004). The primary transporters most 
pertinent to this project are the ATP-binding cassette (ABC) transporters that are 
found ubiquitously (Fig. 1.2b (Davidson et al., 2008). ABC transporters are 
multisubunit complexes that are able to transport a wide range of different 
substrates, for example, sugars (MalEFGK (Davidson & Nikaido, 1991)), amino 
acids (HisPQM (Ames & Nikaido, 1978)), vitamins (BtuCDF (Hvorup et al., 2007)), 
oligopeptides (OppABCDF (Tynkkynen et al., 1993)) and phospholipids (MsbA 
(Zhou et al., 1998)). ABC transporters utilize the binding and hydrolysis of ATP to 
power transport of substrate across the lipid bilayer.
1.3.2 Secondary transporters
Secondary transporters (Fig. 1.2c) utilize the free energy present in existing ion 
gradients to power transport of a substrate across the membrane. The 
electrochemical gradient of the counter ion (usually H+ or Na+) is used to drive 
accumulation of a substrate against its concentration gradient. These transporters 
are involved in both the uptake and efflux of compounds from the cell and are 
known to transport a number of different compounds such as amino acids (almost 
all (Heyne et al., 1991)), sugars (LacY (Abramson et al., 2003)), antimicrobial 
compounds (tetracycline via TetA (Kaneko et al., 1985)) and ions (NhaA (Padan & 
Schuldiner, 1994)).
1.3.3 Group translocation systems
Group translocation systems, otherwise known as phosphotransferase systems 
(PTS), couple the chemical modification of the substrate with transport into the cell 
(Fig. 1.2d). These structurally complex, multi-protein complexes are found 
ubiquitously in eubacteria, but not in archaea or eukaryotes. There is a wide 
variation in the number of PTS transporters in different bacteria, for example E. coli 
has 38, whereas, Mycoplasma genitalium  has only two (Saier et al., 2005). The 
substrate range o f these transporters is limited to sugars, including glucose,
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ascorbate, glucosides, maltose and AZ-acetylglucosamine (Saier et al., 2005). The 
substrate is transported into the cell by an integral membrane protein in the 
complex and then phosphorylated by a complex of cytoplasmic enzymes using 
phosphoenol pyruvate (PEP) as a substrate (Saier et al., 2005).
1.4 Chemiosmotic theory and energy transducing membranes
To fully appreciate the energetic requirements and physiological relevance of the 
different classes of transporter it is necessary introduce of the energy transducing 
membrane in more detail. In the case of bacteria, the cytoplasmic membrane is the 
energy transducing membrane.
Generally, in bacteria there are two forms of potential energy used to perform work; 
the energy potential in the hydrolysis of ATP and the electric/concentrative 
potential o f the proton motive force (pmf) or sodium motive force (smf). These 
energy sources are intimately linked in the bacterial cell and this is underpinned by 
the chemiosmotic theory first postulated by Mitchell in the 1960s.
Bacteria produce this energy by a number o f different mechanisms. Fermentative 
bacteria produce ATP by substrate level phosphorylation, this can be used to 
power a number of other reactions and mechanisms such as biosynthesis and 
transport of compounds across the cell envelope. Respiratory bacteria can also 
obtain ATP from substrate level phosphorylation, but also produce a pmf by way of 
the electron transport chain, or by light-driven ion pumps in photosynthetic 
bacteria. The cytoplasmic membrane-associated electron transport chain and light 
driven ion-pumps use energy (either redox potential or light) to extrude protons 
(H+) across the membrane, thus forming the pmf (Nicholls, 2002). The pmf can 
power the production o f ATP in the cytoplasm via the F ^ o  ATP synthase and can 
also be directly coupled to the transport of compounds across the cytoplasmic 
membrane (Nicholls, 2002, Harold, 1986). The pmf can also drive the formation of 
other electrochemical gradients, most notably, the sodium gradient in E. coli is 
formed by the action of an H+-Na+ exchanger, NhaA (Padan & Schuldiner, 1994).
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The basis of the chemiosmotic theory is the formation o f the pmf (also denoted as 
Ap), which is formed by a gradient of protons (ApH+) across the bacterial 
cytoplasmic membrane that is inherently impermeable to ions. There are two 
components to the pmf that are important when considering its functions; the 
concentrative difference (potential) of protons across the membrane known as the 
pH gradient (ApH) and the electrical difference (potential) across the membrane, 
which is known as the membrane potential (AH'). The sodium motive force (smf) is 
analogous to the pmf, but instead of a ApH, sodium forms a gradient across the 
membrane (ApNa+) which acts similarly to the concentrative potential o f protons. In 
general under physiological conditions, the cytoplasm is negatively charged and 
alkaline when compared to the outside of the cell.
Mitchell defined the pmf (with units of mV) as;
Ap = AY  -  (2.3RT/F)ApH
Where R is the gas constant (J.K"1.m or1), T is the absolute temperature and F is 
the Faraday constant. At 20°C, the term 2.3RT/F is -58.8. A similar equation can 
be derived for the sodium motive force;
Asmf = A Y  -  (2.3RT/F)ApNa
The electrochemical potential can also be related to the change in Gibb’s free 
energy (AG), the membrane potential and the concentrative gradient across the 
membrane using the following equation;
AG (kJ mol'1) = -mF A Y  + 2.3RTIogio([Xm+M X m+]A)
where m is the valence of the ion, F is the Faraday constant, R is the gas constant 
and T is the absolute temperature. Xm+ is a cation moving down an electrochemical 
potential from a concentration o f [Xm+]B to [Xm+]A. For the specific cases o f the pmf 
and smf the following equations apply;
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AG (kJ mol'1) = ApH+ = -F AY + 2.3RTApH
AG (kJ mol'1) = A|jNa+ = -F A Y  + 2.3RTApNa
The free energy (AG) of ATP hydrolysis is negative, therefore it is termed 
energetically favourable (downhill) and can be used to power energetically 
unfavourable (uphill) reactions. This is the same situation as the pmf (and smf) 
because the free energy change as H+ (or Na+) moves back into the cell is 
negative, therefore can power unfavourable reactions such as the movement o f a 
compound into the cell against its concentration gradient.
1.5 Secondary active transporters in bacteria
The defining feature o f a secondary transporter is that it couples the energetically 
unfavourable transport of one substrate against its gradient with the energetically 
favourable transport of another substrate (the counter ion, usually H+ or Na+). This, 
however, is a simplified view, as secondary transport mechanisms are complex 
and variable depending on the substrate and counter ion involved.
1.5.1 Uniport, symport and antiport
Secondary transporters can be split into 3 broad categories based on the direction 
of flow of the substrate in relation to the counter ion. A  substrate can undergo 
uniport where the transport of the substrate is independent of any counter ion. An 
example of a transporter using this mechanism is the lysine transporter from 
Bacillus stearothermophilus (Heyne et al., 1991). A substrate can undergo symport 
in which transport o f the substrate is accompanied by at least one other solute in 
the same direction. An example o f this is lactose permease from E. coli (Abramson 
et al., 2003). Substrate antiport is where transport of substrate is accompanied by 
transport of at least one other solute in the opposite direction. An example of this is 
the glycerol-3-phosphate:inorganic phosphate exchanger (GIpT) from E. coli 
(Huang et a/., 2003).
1.5.2 Substrate and counter ion considerations
The mechanism of secondary transport is more complicated than simply uniport,
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symport or antiport because the transport mechanism is also dictated by the 
charge of the substrate, the charge of the counter ion and the stoichiometry of the 
two during the transport cycle. The substrate specificities for secondary 
transporters are diverse and there are many examples of substrates that are 
neutral, positively and negatively charged. This means that each transporter has 
different energetic requirements, for example, different numbers of counter ions to 
allow transport. The nature of the counter ion further complicates matters. In the 
majority of cases the counter ion is H+, N a \ Li+ or occasionally a transporter is 
capable of using all three (MelB (Pourcher et al., 1995)). The counter ion used is 
often determined by the nature of the organism and its environment. In the case of 
alkalophilic bacteria, Na+ is the preferential counter ion because in an environment 
of pH 10-11 the cytoplasm is maintained at -pH  9, therefore there is no inwardly 
directed proton gradient. To maintain this cytoplasmic pH, the Na+ that is 
symported with the substrate in secondary active transport is used to exchange for 
H+ via an H+-Na+ antiporter (Harold, 1986). Marine bacteria also prefer Na+ due the 
abundance of Na+ in its environment and the fact that seawater has a slightly 
alkaline pH (Kogure, 1998, Tsuchiya & Shinoda, 1985).
There are examples o f very similar proteins using different counter ions indicating 
that they have different mechanisms despite their similarity. A  prime example of 
this is L-glutamate transport in E. coli and B. stearotherophilus. E. coli possesses 
two secondary transporters for L-glutamate; one that uses a ApH+ (GltP) and one 
that uses a ApNa+ (GltS) (Poolman & Konings, 1993, Tolner et al., 1995a). 
B. stearothermophilus possesses only one L-glutamate transporter, GltT, which is 
-60%  identical to GltP, and has been shown to use gradients o f both ApH+ and 
ApNa+ in combination (Tolner et al., 1995b). Another interesting observation from 
this study was that GltT from B. stearothermophilus utilized a ApH+ when 
expressed in E. coli, but if homologously expressed was found to use a ApNa* to 
power L-glutamate uptake. This indicates that it is not only the environment o f the 
bacterium and the protein itself influencing the nature of the counter ion, but also 
the protein-lipid interactions that could have an effect on the transport mechanism.
1.5.3 Electroneutral and electrogenic transport mechanisms
There are a number of different combinations of substrate and counter ion with
29
different energetic consequences. For the purposes of this introduction, only the 
mechanisms of bacterial uptake systems (uniporters and symporters) will be 
described. However, it should be noted that antiporters are just as abundant. An 
excellent review of secondary transport mechanism is available by Poolman and 
Konings (1993).
Electroneutral transport is defined as transport o f a substrate that results in no net 
charge transfer across the membrane. Conversely, electrogenic transport results in 
the net transfer of charge across the membrane and the creation of electrical 
potential. This has an impact on the energetic requirements of secondary transport, 
for example, the membrane potential may have a positive or negative effect on the 
uptake o f substrate.
The simplest form of secondary transport is electroneutral substrate uniport, but 
this could really be argued to be facilitated diffusion. An example of this is glycerol 
transport by GIpF in E. coli (Fig 1.3a i, (Sweet et al., 1990)). In this situation, the 
driving force for transport is derived only from the substrate gradient itself. 
Electrogenic substrate uniport occurs when the substrate is cationic (Fig. 1.3a ii). 
An example of this is lysine and arginine transport in 8. stearothermophilus (Heyne 
et al., 1991). The driving forces for transport are the substrate gradient, the 
membrane potential and the valency of the substrate, i.e. the more positively 
charged the substrate is the stronger the effect of the membrane potential will be. 
Electroneutral substrate-cation symport (Fig. 1.3a iii) occurs when an anionic 
substrate is in a 1:1 stoichiometry with a cationic counter ion. The membrane 
potential has no effect on transport, however, the counter ion and substrate 
gradients will have a positive effect on the transport rates.
There are four different mechanisms by which electrogenic substrate-cation 
symport can occur. The first mechanism is where a neutral substrate is in a 1:1 
stoichiometry with the counter ion (Fig. 1.3a iv). Transport o f the substrate will be 
positively influenced by the membrane potential and the substrate and counter ion 
gradients. A number of neutral amino acids were found to use this mechanism in 
B. stearothermophilus (Heyne et al., 1991). The second mechanism is where a 
cationic substrate is in a 1:1 stoichiometry with the cationic counter ion (Fig. 1.3a 
v). Transport o f the substrate will be affected by the gradients as in the previous 
example, except the membrane potential will have a more pronounced effect due
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Figure 1.3 Energetic requirem ents and unique transport characteris tics  o f 
secondary transport, (a) Examples of secondary symporters showing the 
relationship between solute (S) and cationic counter ion (C); (i) electroneutral 
solute uniport, (ii) electrogenic solute uniport, (iii) electroneutral solute-cation 
symport, (iv-vii) electrogenic solute-cation symport. (b) Schematic of model 
substrate counterflow data, (c) Schematic of model “cold chase” data, (i) No 
excess substrate added, (ii) presence of a unidirectional transporter, i.e. an ABC 
transporter, (iii) presence of a bidirectional transporter, i.e. secondary transporter. 
Black arrow indicates addition of excess non-radiolabelled substrate.
31
to the increased overall charge. An example where this has been observed is 
lysine transport in Lactococcus lactis (Driessen et a!., 1989). The third mechanism 
by which electrogenic substrate-cation symport can occur is where a divalent 
anionic substrate in a 1:3 stoichiometry with the counter ion (Fig. 1.3a vi). 
Transport of the substrate is driven by the gradients as in Fig. 1.3aii, except the 
counter ion gradient will contribute to a larger degree than the membrane potential 
because the incoming counter ion concentration is greater than the net charge 
transfer. An example where this has been observed is with citrate uptake by 
Klebsiella pneumoniae (van der Rest et al., 1992). In this example, a dianionic 
species of citrate is transported with one Na+ cation and at least two H+ cations by 
the protein CitS.
In each o f these three situations the membrane potential, the substrate gradient 
and the counter ion gradient have a positive effect on transport. An example of 
where the membrane potential can have a negative effect on transport is in the 
case of a divalent anionic substrate in a 1:1 stoichiometry with the counter ion (Fig. 
1.3a vii). The driving forces in this situation are the substrate and counter ion 
gradients, which can be actively opposed by the membrane potential as seen for 
malate uptake in L. lactis (Poolman et al., 1991).
1.5.4 Classical features of secondary active transporters
Bidirectional movement of substrate is a characteristic feature of secondary 
transporters. This feature manifests itself in two notable experimentally observed 
phenomena; counterflow and exchange reactions. There are no equivalent 
phenomena in primary transporters, e.g. ABC transporters.
Substrate counterflow or counter transport was first theorized in 1952 (Widdas, 
1952) and then experimentally determined in 1957 in erythrocytes (Rosenberg & 
Wilbrandt, 1957). It has since been observed using a number of different 
secondary transporters, including lactose permease (Wong & Wilson, 1970).
In a counterflow experiment, a high concentration of cells (or membrane vesicles or 
proteoliposomes) containing a secondary transporter are pre-loaded with a high 
concentration of substrate (Substrate A), for example, 10 mM. The cells are then 
diluted into buffer containing a low concentration o f radiolabelled substrate A 
(Substrate B), for example, 0.4 mM. This results in an outwardly directed Substrate
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A gradient which exchanges with Substrate B resulting in accumulation of 
Substrate B inside the cell. Eventually, the gradient of Substrate A dissipates 
because the Substrate A concentration across the membrane reaches equilibrium, 
which is followed by equilibration of Substrate B across the membrane meaning 
the counterflow phenomenon is transient (Schematic o f “ideal” counterflow result in 
Fig. 1.3b).
Counterflow occurs because Substrate A and Substrate B compete for the same 
empty transporter. Inside the cell, where Substrate A is at a much higher 
concentration than Substrate B, Substrate A will out-compete Substrate B for the 
transporter more so than it would on the other side of the membrane. Thus there is 
an apparent net flow of Substrate B in the opposite direction of Substrate A. As 
soon as the outwardly directed gradient dissipates, Substrate A can once again 
compete for the empty transporter and reaches equilibrium across the membrane. 
Counterflow is only theoretically possible if there is a reorientation o f the 
transporter when transitioning from facing one side of the membrane to the other, 
hence counterflow is not observed in rigid channels and pores. Counterflow is also 
not observed in ABC uptake systems as conformational changes in the 
transmembrane domains are coupled to other protein components and ATP 
hydrolysis and these systems are also inherently unidirectional due to the presence 
o f an extracytoplasmic solute receptor (ESR).
Another characteristic of secondary transport is seen in exchange (or “cold chase”) 
experiments. In a cold chase experiment, transport o f radiolabelled substrate is 
allowed to proceed, leading to accumulation o f radiolabel inside the cell (or vesicle 
or proteoliposome). At an appointed time, excess unlabelled (“cold”) substrate is 
added to the outside of the cell leading to exchange of radiolabelled and 
unradiolabelled substrate, ultimately leading to apparent efflux of radiolabelled 
substrate (Fig. 1.3c). An example of this is observed for citrate uptake into 
Leuconostoc mesenteroides (Marty-Teysset et a!., 1996). Excess cold substrate on 
the outside inhibits further uptake of radiolabelled substrate, but not efflux of 
radiolabelled substrate leading to a net efflux of radiolabelled substrate from the 
cell. In transport systems incapable of exchange, like ABC transporters, addition of 
excess non-radiolabelled substrate prevent further uptake o f radiolabelled
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substrate (presumably by dilution), but does not lead to efflux from the 
cell/vesicle/proteoliposome, as seen for the vitamin B12 transporter from E. coll 
(Borths et al., 2005).
1.6 Major facilitator superfamily (MFS)
The largest class o f secondary transporters is the major facilitator superfamily 
(MFS) (Pao et al., 1998). The MFS is a huge family o f secondary transporters that 
have diverse substrate specificities despite sharing structural similarities and 
conserved sequence motifs (Pao et al., 1998). Members of the MFS are composed 
of a single polypeptide, the majority o f which are predicted to have 12 TMHs, 
although some are predicted to have 14. Hydropathy profile and sequence analysis 
revealed 2-fold pseudosymmetry in MFS members indicating that a gene 
duplication event of a 6 helical bundle resulted in the formation of the 12 TMHs 
observed. Structural analysis of three distinct MFS members (OxIT, GIpT and 
LacY) has confirmed this theory (Abramson et al., 2003, Hirai et al., 2003, Huang 
et al., 2003).
1.6.1 Lactose permease as a model secondary transporter
1.6.1.1 General features
The most comprehensively studied secondary transporter is lactose permease 
(LacY) from E. coll. Studies on this protein have been performed, to some degree, 
for almost 50 years starting with the work of Jacob and Monod (Jacob & Monod, 
1961) right up to modern day with the structural characterisation of the transporter 
in last decade (Abramson et al., 2003, Guan et al., 2007). 
lacY  is the second structural gene in the lacZYA operon and was the first gene 
encoding a transporter to be cloned, overexpressed (Teather et al., 1980), 
sequenced (Buchel et al., 1980), purified and functionally characterised in vitro 
(Newman et al., 1981, Viitanen et al., 1984). LacY is specific for a number of 
different a- and /?-galactosides, is known to transport mono-, di- and tri-saccharides 
and is a member of the oligosaccharide:H+ symporter (OHS) family in the MFS 
based on sequence identity (Pao et al., 1998).
The protein itself is 417 amino acids long, is -85%  alpha helical when measured 
using circular dichroism and is also predicted to have 12 TMHs using hydropathy
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analysis (Foster et al., 1983). The functional unit was experimentally determined to 
be a monomer (Guan et al., 2002, Sahin-Toth et al., 1992). All of these 
experimentally derived observations have been confirmed with the elucidation of 
high resolution crystal structures (Abramson et al., 2003, Guan et al., 2007).
Lactose permease utilises a downhill proton gradient (ApH+) to drive accumulation 
o f galactosides against their concentration gradient. Conversely, it has been 
observed that LacY can use a downhill galactoside gradient to accumulate H+ 
against its concentration gradient, thus forming a ApH+ (Kaback et al., 2001). A 
vast number of biochemical studies have been performed to ascertain the 
mechanism by which the movement of protons through the protein facilitates 
accumulation of substrate. One of the more powerful and informative techniques 
that has been used is cysteine-scanning mutagenesis, which can give both 
mechanistic and structural information (Frillingos et al., 1998, Kaback et al., 2001). 
Using this technique, all 8 of the native cysteine residues in LacY were mutated 
and then amino acids 2-402 were individually mutated to cysteine producing 401 
different mutants. One of the major findings from this study was that only 6 out of 
the 417 residues are absolutely required for transport of substrate (Frillingos et al., 
1998, Joshi et al., 1989). Each of these essential residues was predicted to have a 
particular role in the transporter cycle; Glu126 and Arg144 are vital for substrate 
binding as they have been shown to form a charged pair and Glu269 is involved in 
the coupling o f H+ translocation to substrate transport (Sahin-Toth et al., 1999, 
Weinglass et al., 2003). Residues Arg302, His322 and Glu325 are all involved in 
H+ translocation because it has been shown that mutations in these residues 
cannot catalyse ApH+-mediated accumulation o f substrate, but can catalyse 
exchange and counterflow (Kaback et al., 2001). However, these data could not be 
explained without a high resolution structure of the transporter.
1.6.1.2 High resolution structure of lactose permease
Two high resolution crystal structures of LacY have been solved. The original 
structure published in 2003 was of a mutant that could bind substrate but was not 
functional (Fig. 1.4a (Abramson et al., 2003)). Protein crystallography of LacY was 
difficult due to its inherent flexibility and so a conformationally constrained mutant 
was produced (Smirnova & Kaback, 2003). This structure was published
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Figure 1.4 H igh reso lu tion  crysta l s tructu res o f secondary transporters.
(a) High resolution crystal structure of lactose permease (modified from Abramson 
(2003)) showing bound substrate (black), (b) The glycerol-3-phosphate transporter, 
GIpT (modified from Huang (2003)). The cytoplasm and periplasm are indicated in 
each case.
36
concomitantly with a high resolution crystal structure of another MFS member, 
GIpT (Fig. 1.4b (Huang et al., 2003)). This secondary transporter catalyses the 
uptake of glycerol-3-phosphate into the cytoplasm in exchange for inorganic 
phosphate, therefore, it not only has a completely different substrate to LacY, but 
also has a different transport mechanism. However, there are many parallels 
between LacY and GIpT, which suggests that observations of structure and 
mechanism in LacY can be inferred for other members of the major facilitator 
superfamily. The second structure of LacY was published in 2007 and was solved 
using the wild-type protein which was made possible by advances in the field of 
integral membrane protein crystallography (Guan et al., 2007). The major insight 
taken from this study is that the conformationally constrained mutant LacY is not 
significantly different from the wild-type protein.
The high resolution structure o f the mutant LacY with bound /?-D-galactopyranosyl- 
1-thio-£-D-galactopyranoside (TDG) reveals that LacY is a monomer and is 
reported to be “heart-shaped” with a large internal, hydrophilic cavity (Fig. 1.4a). 
This internal cavity is open on the cytoplasmic face, but closed on the periplasmic 
face, representing the outside-closed conformation. Both structures that have been 
published of LacY are in this outside-closed conformation, as is the structure of 
GIpT, possibly indicating that this is the most conformationally stable intermediate 
in the transport cycle. The substrate, TDG, is in the centre of the molecule 
indicating that there is only one substrate binding site in the molecule (Fig. 1.4a).
The lactose permease structures reveal that there are indeed 12 cr-helices as 
predicted (Foster et al., 1983), which has 2-fold pseudosymmetry with the 
formation o f 2 helical bundles containing 6 helices each connected by a loop 
between helices VI and VII. The N- and C-terminal domains are superimposable 
with a root mean square deviation (RMSD) value of 2.2 A. These observations 
suggest that one of the domains in the functional unit emerged through gene 
duplication followed by divergence. A similar observation has been made for OxIT 
(Hirai et al., 2003) and for the crystal structure o f GIpT (Huang et al., 2003) 
indicating that this may be a feature of all MFS members.
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The substrate binding site is found in the hydrophilic cavity in the middle of the 
protein/membrane in the vicinity of the axis of pseudosymmetry. The binding site is 
composed of residues from both the N- and C-terminal domains which make a 
number of different contacts with the substrate including van der Waals 
interactions, hydrogen bonding, salt bridges and some possible interactions via 
water molecules (Fig. 1.5a). The essential residue Arg144 makes direct contacts 
with the ligand. Contrary to the biochemical data, Glu126 does not appear to 
interact with either the ligand or Arg144, however, it may be doing so via 
interactions with water molecules that are not discernable at this resolution (Fig. 
1.5a). Analysis of the transport activities of mutations of essential residues 
revealed that neutral substitutions o f Arg302, His322 and Glu325 can catalyse 
transport of substrate as long as it does not depend on H+ translocation (exchange 
reactions and counterflow (Kaback et al., 2001)). In the crystal structures, these 
residues are closely packed and form a complex salt bridge/hydrogen bonding 
network that is ~6 A  away from the substrate binding site (Fig. 1.5b and c). Even 
with the large amount of biochemical, biophysical and structural data, the exact 
nature of the communication between H+ translocation and substrate translocation 
cannot be inferred from this structure alone. More work is required to make definite 
assertions on the exact transport mechanism.
1.6.1.3 Proposed transport mechanism
The proposed mechanism of H+ gradient-dependent galactoside transport, and that 
of other members o f the MFS, is termed the “rocker switch” or the alternating 
access model (Fig. 1.6). In this model, it is proposed that upon binding substrate 
and counter ion to the outside-open conformation o f the protein, a conformational 
change occurs which closes the outer opening of the internal cavity and opens the 
inner opening, thus allowing release o f the substrate into the cytoplasm. The 
protein is then thought to reconfigure to the outside-open conformation upon 
release of the substrate. Unfortunately, there are no crystal structures that support 
this model, as both crystal structures of LacY and the crystal structure of GIpT are 
in the inwardly-open conformation. However, a recent study revealed that the 
binding of substrate to LacY induces conformational changes on both the
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(b)
Figure 1.5 Substrate b ind ing  site and H+ trans loca tion  channel o f lactose 
permease, (a) Substrate binding site of lactose permease showing interaction of 
protein residues with bound substrate, /?-D-galactopyranosyl-1-thio-£-D- 
galactopyranoside (TDG). (b) Residues in lactose permease forming a complex 
salt bridge/hydrogen bonding network proposed to be forming the H+ channel, (c) 
Close positioning of substrate binding site and H+ translocation channel (6 A) 
allows communication between the sites of substrate and H+ binding/translocation. 
Figure modified from Abramson (2003).
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Figure 1.6 C onform ational changes o f lactose permease during the proposed 
a lternating access model. Molecular modeling based on DEER measurements 
and the crystal structure of lactose permease, (a-c) are the secondary structure 
representations of lactose permease and (d-f) are the equivalent space filling 
representations, (a+d) represent an inside-open conformation prior to substrate 
binding, (b+e) represents a transition state, (c+f) represents an outside-open 
conformation with bound sugar. The cytoplasmic and periplasmic faces of the 
protein are indicated. The numbers are the distances between labelled residues 
measured by DEER. Figure modified from Smirnova (2007).
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cytoplasmic and periplasmic sides of the internal cavity (Smirnova et al., 2007). 
This study was performed using double electron-electron resonance (DEER) to 
measure the distances between specifically labelled helices allowing a model to be 
constructed which is in agreement with the alternating access model.
1.7 ATP-binding cassette (ABC) transporters
As discussed previously, there are a number of different types of primary 
transporters found in Nature. The most applicable system for comparison to 
secondary transporters and TRAP transporters is the ABC transporter superfamily.
1.7.1 ABC transporters: an introduction
ABC transporters are widespread transport systems with representatives in all 
three domains of life from bacteria to higher eukaryotes, including humans 
(Higgins, 2003). Indeed, ABC transporters have been implicated in a number of 
human diseases, including cystic fibrosis (Riordan et al., 1989), Tangiers disease 
and multidrug resistance in chemotherapeutic treatment (Cole et al., 1992).
ABC transporters perform active transport on a number of diverse substrates 
resulting in the formation of a high substrate gradient (up to 106:1 (Dippel & Boos, 
2005)). ABC transporters are primary transporters because it has been found that 
they couple the binding/hydrolysis of ATP forming ADP and P\ to the transport of 
the substrate across the membrane (Dean et al., 1989). Although the composition 
of ABC transporter components is quite variable, they can be generally divided into 
two categories; ABC importers and ABC exporters. ABC importers catalyse the 
unidirectional uptake of a wide range of substrates including sugars (maltose 
(Dean et al., 1989)), a number of amino acids (histidine (Yao et al., 1994), 
polypeptides (Tame et al., 1994), vitamins (vitamin B12 (Borths et al., 2005)) and 
metal-chelate complexes (Pinkett et al., 2007). ABC exporters catalyse the 
extrusion of virulence factors, for example, Haemolysin (Dinh et al., 1994) and 
hydrophobic compounds, the majority of which have anti-microbial action. The ABC 
importers are the most pertinent group to discuss in detail as they are most 
comparable to TRAP transporter, therefore, ABC exporters will not be described in 
any further detail.
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The core structure o f an ABC transporter contains two components; a hydrophobic 
integral membrane domain that forms the translocation channel, otherwise known 
as the transmembrane domain (TMD) and a soluble, cytoplasmic nucleotide 
binding domain (NBD, otherwise known as ATPase domain or the ABC protein) 
that binds and hydrolyses ATP. In the functional transporter, the TMD and the NBD 
are both dimeric and have been found in a number of configurations. Often the four 
domains are separate proteins. However, they have also been found to have one 
TMD and one ATPase domain fused into one polypeptide and the functional 
transporter composed of two of these so-called ‘half transporters’ (Dawson et al.t 
2007).
A  third structural component of ABC importers is an extracytoplasmic solute 
receptor (ESR, otherwise known as a solute binding protein or periplasmic binding 
protein). This component is found in the periplasm of Gram negative bacteria and 
attached to the cytoplasmic membrane by a lipid moiety in Gram positive bacteria 
(Gilson et a!., 1988). The ESR binds the substrate of the transporter with a high 
affinity (low pM) and presents it to the translocation machinery. The ESR is thought 
to confer the specificity to the transporter, the high affinity, and also 
unidirectionality (Doeven et al., 2004, Wilkinson, 2003).
1.7.2 A  short history of ABC transporters functional determination
There was a great deal of debate and controversy in the transport field when ABC 
transporters were first discovered, and it took almost three decades before the full 
picture emerged regarding the structural components and the energy utilisation of 
these transporters.
In the late 1970s and early 1980s transporters were originally separated on the 
basis of being either “shock sensitive" or “shock insensitive” permeases. This 
refers to the sensitivity of the transporter when the cell undergoes osmotic shock 
treatment (Neu & Heppel, 1965). This method compromises the integrity of the 
outer membrane using the metal-chelating agent, ethylenediaminetetraacetic acid 
(EDTA) and lysozyme while preventing cell lysis by maintaining the cells in high 
sucrose solution. In this way the periplasm is removed leaving sphaeroplasts. At 
the time, “shock insensitive” transporters were essentially all secondary
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transporters as they did not require any periplasmic components to facilitate 
transport. The “shock sensitive” transporters were what we now refer to as ABC 
importers that require a periplasmic ESR for function (ignoring for a moment the 
other ESR-dependent transporter that will be mentioned later). These initial 
classifications were obviously limited by all the studied organisms being Gram 
negative bacteria. The classifications have since been refined with the discovery of 
variations, for example, anchored ESRs, ABC exporters and other ESR-dependent 
transporters.
The term “ABC transporter” was not coined until 1990 (Hyde et al., 1990) and prior 
to this there was a great deal of ambiguity as to the energy coupling of substrate 
transport via ABC transporters. Some examples that led to this ambiguity and 
confusion include the E. coli glutamine ABC importer (now known as GlnHPQ), 
which was thought to require both ATP and the membrane potential in the 
transport mechanism (Plate, 1979). Another example o f literature that produced 
some ambiguity was that maltose uptake in E. coli (by MalEFGK2) was found not to 
require the PMF, but was also reported to be unaffected by depletion of 
intracellular ATP concentration (Ferenci et al., 1977). A particularly curious 
example is that transport of glutamine, histidine and methionine in E. coli was 
reported to be independent of the PMF, but dependent on acetyl phosphate (Hong 
et al., 1979). These experiments were performed in whole cells, which are complex 
environments where it is particularly difficult to determine accurate transport 
energetics (Poolman, 1994). It was also found that some of the inhibitors used in 
these experiments produced artifacts that would produce misleading data (Joshi et 
al., 1989). It was only with the use of a simplified vesicle system that the energy 
coupling of ABC transporters was resolved (Ames eta l., 1989, Dean et al., 1989).
1.7.3 E. co li maltose transport by MalEFGK2 as a model ABC system
The maltose ABC transporter in E. coll is arguably the most comprehensively 
studied ABC transporter in Nature. It is a member of the carbohydrate uptake 
transporter (CUT) family as defined by Saier (Saier, 2000) and has been shown to 
transport di- and oligo-saccharides. Homologues of the E. coli maltose ABC 
transporter are present in a number of bacteria dwelling in various environments. 
Bacteria obtain maltose from the amylase-mediated degradation of starch in the
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environment. In the case of soil and marine bacteria this is derived from plant 
matter and in the case of gut-dwelling organisms like E. coli, it is obtained from the 
human diet. The maltose ABC transporter can also transport maltodextrins, which 
are linear polymer of D-glucose molecules joined at the O-glycosidic bond,’ up to 
maltoheptaose (7 glucose molecules) (Wandersman eta l., 1979).
The maltose uptake system in E. coli is composed of an ESR, namely MalE (or 
MBP), a heterodimer of TMDs, MalF and MaIG and a homodimer of the ATPase 
domain, MalK.
1.7.3.1 The ESR domain -  MalE
MalE is a soluble, ~40 kDa protein that is found in the periplasm of Gram negative 
bacteria (Kellermann & Szmelcman, 1974) or anchored to the cytoplasmic 
membrane as a lipoprotein in Gram positive bacteria (Gilson et al., 1988). MalE, 
like most periplasmic proteins, is synthesized in the cytoplasm and then 
translocated to the periplasm by the Sec translocon that recognizes an N-terminal 
signal peptide. The signal peptide is cleaved off during the translocation process 
producing the mature protein.
MalE has been purified and characterised in vitro and found to bind maltose and 
maltodextrin with a high affinity (Kd of 1 pM (Kellermann & Szmelcman, 1974). 
Production of MalE is induced by maltose to high degrees and is present in the 
periplasm at high concentration (~1 mM (Dietzel et al., 1978)). The total number of 
molecules of each component of the MalEFGK2 ABC transporter have been 
calculated (Dietzel et al., 1978, Koman et al., 1979, Shuman & Silhavy, 1981) and 
it has been determined that MalE is in ~40-50x excess over the other components. 
However, a study has revealed that only ~20% of the MalE predicted to be present 
in the periplasm is required for normal transport rates (Manson et al., 1985). In this 
study, the MalE signal peptide was modified to modulate the total amount of MalE 
translocated to the periplasm. The levels were varied between 4-23% of normal 
MalE levels and transport rates of maltose were then determined, revealing that 
the MalE concentration is in great excess of what is required for transport. It is 
unknown why such a high concentration is present, however, MalE is also known 
to have been recruited for a use as a chemotaxis receptor (Springer et al., 1977). 
Maltose bound to MalE interacts with a chemotactic signal transducer, Tar (taxis to
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aspartate and some repellents), which generates a chemotactic response to 
maltose. E. coli requires approximately double the concentration MalE for wildtype 
chemotactic response compared to wildtype uptake rates (Manson et al., 1985), 
which may help in explaining the overabundance of MalE.
Studies using in vitro vesicle systems have shown that MalE stimulates ATPase 
activity and is locked onto the TMDs when an ATP transition state analogue is 
bound to the ATPase domain (Chen et al., 2001, Davidson et al., 1992). These two 
observations suggest that there is communication between the ESR and the 
ATPase domains, presumably mediated by conformational changes in the TMDs.
The high resolution structure o f MalE has been determined in both the liganded 
and unliganded states (Sharff et al., 1992, Spurlino et al., 1991). These structures 
revealed that MalE is composed o f two globular domains connected by a flexible 
hinge region (Fig. 1.7a). The ligand binding site is in the middle of the globular 
domains which is freely accessible to the solvent prior to binding the ligand. Upon 
binding ligand, the protein undergoes a large conformational change which results 
in complete occlusion of the ligand from the bulk solvent (Fig. 1.7b). Residues from 
both globular domains contribute to the formation of the binding site and make a 
number o f van der Waals interactions, two hydrogen bonding interactions and 
possibly more interactions that can not be seen at the 2.3 A resolution obtained.
The overall features of MalE as determined by the high resolution crystal structures 
are also found in other ABC transporter binding protein, including the 
leucine/isoleucine/valine binding protein (Olah eta l., 1993, Trakhanov eta!., 2005), 
the D-galactose/D-glucose binding protein (Vyas et al., 1991), the L-arabinose 
binding protein, and the vitamin B12 specific protein (Borths et al., 2002). What is 
remarkable about this observation is that these proteins share little sequence 
identity and yet have the same overall structural features and mode of action. The 
major difference found in the structures of ESRs is in the folding topology and how 
the two globular domains are connected. These are divided into two groups; type I 
and type II ESRs (Fig 1.7c).
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Figure 1.7 High reso lu tion  crysta l s tructu re  o f MalE and topo log ica l 
d ifferences between type I and type II ESRs. (a) High resolution structure of 
MalE with bound substrate from hyperthermophile T. lito ra lis  (Diez e t a l., 2001). (b) 
Crystal structures of the conformational changes of MalE from E. c o li in the 
presence (purple) and absence (blue) of bound substrate. Figure taken from 
Davidson (2008). (c) Difference in the core structure of type I and type II ESRs 
caused by domain dislocation. Taken from Fukami-Kobayashi (1999).
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1.7.3.2 ATPase domain (NBD) - MalK
MalK is the NBD subunit of the maltose ABC transporters and is the most 
comprehensively studied of all the ABC transporter subunits. A  large number of 
biochemical, biophysical and genetic studies have been performed on MalK in 
isolation and also in complex with the other subunits of the transporter. MalK was 
experimentally confirmed to be the ATPase subunit because when expressed and 
purified in isolation, MalK spontaneously hydrolyses ATP (Morbach et al., 1993, 
Walter et al., 1992), whereas, in the full transporter ATP hydrolysis is tightly 
coupled to the presence of the binding protein MalE (Davidson et al., 1992). The 
stoichiometry of subunits has also been determined using immunoprécipitation and 
found that two MalK subunits were present in a functional transporter along with 
one MalF and one MaIG (Davidson & Nikaido, 1991). It has been demonstrated in 
a reconstituted system that addition of liganded MalE stimulates ATPase activity, 
indicating that binding of liganded MalE transmits a signal through MalF and MaIG 
to MalK presumably through conformational changes. This signalling process 
depends on the protein:protein interactions in the transporter complex.
Mutational and phylogenetic analysis has determined that MalK, and indeed all 
NBDs, contain several conserved motifs, some of which are characteristic of all 
ATP-binding proteins and some are specific to NBD subunits from ABC 
transporters. The Walker A and Walker B motifs are found in a number of different 
nucleotide-binding proteins (Walker et al., 1982), and is proposed to be the 
nucleotide-binding fold. The W alker B motif is preceded by LSGGQ (or “ABC 
signature sequence" or the “linker peptide”) motif (Hyde et al., 1990). This motif is 
found in all NBD subunits in ABC transporters. The Walker A and B motifs are 
separated from the LSGGQ motif by a sequence containing a conserved glutamine 
and called the Q loop (otherwise known as the “helical domain" or the “lid”). The 
proposed functions o f these motifs and folds have been deduced from the 
observed phenotypes produced upon mutation o f residues within the motifs 
(extensively reviewed in Hunke (2000) and Schneider (2003)). This mutational 
analysis has shown that any variants of the Walker A  or Walker B motifs prevent 
ATP binding and/or hydrolysis and therefore also inhibit transport. The Q loop has
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been implicated in signaling between the NBD and the TMDs because mutations in 
this motif abolished transport, but left nucleotide binding unaffected. The postulate 
that the Q loop facilitates the interaction of the NBD with the TMD is further 
strengthened by the production of suppressor mutations in MalK that restore 
transport activity in response to mutation o f a conserved region of the TMD (Hunke 
et al., 2000, Mourez et al., 1997). Mutations in the LSGGQ motif have been found 
to abolish transport, but leave nucleotide binding unaffected indicating that this 
motif is also involved in signaling between the NBD and TMD.
To determine the mechanism of NBDs in ABC transporters it was necessary to 
elucidate the high resolution structure o f an NBD in complex with ATP, ADP and Pi 
and nucleotide free. There are a number of structures o f isolated NBDs from 
different transporters (Diederichs et al., 2000, Gaudet & Wiley, 2001, Hung et al., 
1998, Karpowich et al., 2001, Yuan et al., 2001). There are also a number of 
structures for complete ABC complexes determined (Hollenstein et al., 2007a).
The first structure of a MalK homologue was from the archaeon Thermococcus 
litoralis. This structure was determined to be non-physiological due the small dimer 
interface and peculiar arrangement o f sub-domains (Diederichs et al., 2000). More 
recent structures of MalK in isolation (Chen et al., 2003, Lu et al., 2005) and in 
complex with the rest of the MalEFGK2 complex (Oldham et al., 2007) from E. coli 
have been solved that are more consistent with the biochemical data for MalK.
The structure of MalK has revealed that it is composed of two domains, an 
ATPase domain and a regulatory domain (RD, Fig. 1.8a). MalK from E. coli is not a 
typical ABC transporter NBD for two reasons. Firstly, it contains an additional C- 
terminal domain present in MalK homologues, but not in other NBDs (Diederichs et 
al., 2000, Oldham et al., 2007) and secondly, MalK can be purified as a dimer in 
the presence and absence of nucleotide -  a feature not shared with other NBDs 
(Chen et al., 2003, Diederichs et al., 2000, Kennedy & Traxler, 1999). These 
characteristics are thought to be linked as the RDs from each protomer are thought 
to stabilize the dimer in the absence of nucleotide (Chen et al., 2003). MalK from 
E. coli has been crystallised in three different conformations; a closed, ATP bound 
form, and two open forms in the presence of ADP and without bound nucleotide
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Figure 1.8 Crystal s tructu re  and conform ationa l changes o f the ATPase 
dom ain, MalK. (a) Crystal structure of a MalK monomer showing the nucleotide 
binding domain (NBD), the regulatory domain (RD), LSGGQ motif, Q loop and 
WalkerA/B motifs. Substrate is shown interacting with the Walker A motif. Figure 
taken from Chen e t a l (2003). (b) Conformational changes during binding and 
hydrolysis of ATP. (i) In the absence of nucleotide, the dimer is in the resting state 
and primarily interacting through the RD. (ii) In the presence of nucleotide, the 
NBDs come together burying ATP and allowing hydrolysis to occur, (iii) The ADP- 
bound state after hydrolysis is in the open state allowing release of nucleotide and 
resetting back to resting state. Figure modified from Lu e t a l (2005).
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buried surface area. The contacts between the protomers principally come from the 
ATPase domains. However, the structure also reveals that the RDs from each 
protomer make contacts with the ATPase domains from the opposing protomer, 
presumably strengthening the dimer formation. The structure reveals that two ATP 
molecules are bound along the dimeric interface of the ATPase domains and in the 
closed form the ATP binding sites are buried, indicating that a conformational 
change must be required for ATP/ADP to enter/exit the binding site. As well as 
there being a number of contacts between the protomers, there are also a number 
o f contacts made between both subunits o f the dimer with each ATP molecule. 
Each ATP molecule interacts with the Walker A  motif from one protomer and the 
LSGGQ motif from the other protomer, explaining the requirement for a dimer. This 
“head-to-tail” formation has also been seen in other NBDs, for example, MJ0796 
(Yuan e ta l., 2001).
The open structures o f MalK without bound nucleotide reveal that the ATPase 
domains are not in close contact. The regulatory domains are superimposable in 
both the open and closed structures demonstrating that the conformational 
changes associated with binding ATP are limited to the ATPase domain. This 
suggests that if the regulatory domains were not present then MalK would not be a 
stable dimer in the absence of nucleotide, as seen with other NBDs.
These structures suggest a model where, in the absence of nucleotide, the dimer is 
open, with the only interactions coming from the RDs. Upon binding ATP the NBDs 
come together and allow hydrolysis of ATP. After hydrolysis has occurred, the 
NBDs open again to release the ADP and reset to the resting state (Fig. 1.8b).
1 .7.3.3 Transmembrane domains (TMD1 - MalFG
The transmembrane component of the maltose ABC transporter is composed of 
MalF and MaIG, two integral membrane proteins of unequal length. The topological 
models o f both proteins have been experimentally determined using alkaline 
phosphatase fusions (Boyd et al., 1993, Ehrmann et al., 1990). MaIG is predicted 
to be 32 kDa and have 6 TMHs and MalF is 57 kDa and has 8 TMHs.
Phylogenetic analysis of the amino acid sequence o f MaIG revealed a conserved 
motif in a hydrophilic, cytoplasmic loop that was also present in MalF and other 
ABC transporter TMDs (Dassa & Hofnung, 1985). The consensus sequence o f this
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motif is EAAX3GX9IXLP (where X is any amino acid), but is referred to as the EAA 
motif. Due to the conserved nature of the EAA motif it was theorised to be essential 
for functional transport and, because of its cytoplasmic location, was thought to 
interact with the ATPase domain. This theory was confirmed using site-specific 
chemical crosslinking (Hunke et al., 2000) and by mutagenising the most highly 
conserved residues in the EAA motif in MalF and/or MaIG (Mourez et al., 1997). 
This latter study revealed that mutation of the highly conserved residues leads to 
decreased or complete abolition of transport activity. In the mutants where 
transport was abolished, MalK was no longer membrane associated and was 
localized in the cytoplasm indicating that the EAA motif forms an interaction with 
MalK. This evidence was further strengthened by the isolation of suppressor 
mutations in MalK that regained functional activity with some of the more 
deleterious MalFG mutations. The suppressor mutations isolated in MalK were 
localized to the Q-loop motif, including residues Ala85 and Val117. These residues 
were also found to interact with residues in the EAA motif in the chemical 
crosslinking study (Hunke et al., 2000). This mutagenesis study o f the EAA motif 
also revealed that the EAA motifs of MaiF and MaIG do not act symmetrically and 
do not contribute to the definition o f the substrate specificity. The interaction o f the 
EAA motif with MalK has also been demonstrated in a more recent study 
monitoring the binding of synthetic peptides from a library derived from MalFG to 
MalK, and vice versa (Bluschke et al., 2007).
MalF has been extensively mutagenised throughout helices 3-8, which has 
revealed that substrate differentiation between maltose and maltodextrins was 
defined by TM5 and 6 (Ehrle et al., 1996, Steinke et al., 2001). This indicates that 
there is a substrate binding site in the transmembrane domain o f the maltose ABC 
transporter and could also be true for other ABC systems. This fact is not 
necessarily obvious when ligand specificity and high affinity is conferred by the 
ESR. Crosslinking studies have revealed that MalE interacts with MalF and MaIG 
in periplasmic loops 1 and 2 (Daus et al., 2007).
It has been established that a wild type maltose ABC transporter has an absolute 
requirement for the binding protein MalE in order to transport substrate (Shuman, 
1982). However, mutants have been isolated that can transport substrate in the
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absence of MalE and the mutations responsible have been localised to MalF and 
MaIG (Covitz et al., 1994, Treptow & Shuman, 1985). In these mutants there is a 
much lower affinity for maltose (Km of 2 mM as opposed to 1 pM in the wildtype 
transporter), the ATPase activity of the MalK dimer is higher (Davidson et al., 1992) 
and the addition of wildtype MalE actually inhibits transport by these mutants 
(Treptow & Shuman, 1985). The mutations were mapped to transmembrane 
helices 5-8 in MalF and 3 and 4 in MalG. The mutations are proposed to alter the 
character of the transmembrane helices such that the transporter is in the “MalE- 
triggered” state that has previously been shown to stimulate the ATPase activity of 
MalK2. The clustering of the mutations in helices 5-8 o f MalF correspond with the 
helices that were strongly implicated in forming the binding site/translocation 
channel in the mutagenesis studies (Ehrle et al., 1996).
1.7.3.4 High resolution structure of complete MalEFGK? complex 
There have recently been a number of high resolution crystal structures of intact 
ABC transporter complexes, including the binding protein-less Sav1866 multidrug 
exporter from Staphylococcus aureus (Dawson & Locher, 2006), BtuCD vitamin B12 
importer from E. coli (without its cognate binding protein BtuF (Locher et al., 
2002)), H11470/1 metal-chelate importer from H. influenzae (Pinkett et al., 2007) 
and ModBaCaA, the molybdate importer from Archeoglobus fulgidus (Hollenstein et 
al., 2007b). The most relevant structure to this introduction is the elucidation o f the 
intact MalEFGK2 complex from E. coli (Fig. 1 .9 (Oldham et al., 2007)).
The structure of MalEFGK2 was solved to a resolution o f 2.8 A. To obtain the intact 
structure it was necessary to introduce a single mutation into MalK (E159Q) that 
permitted binding of ATP but prevented its hydrolysis. An overview of the structure 
reveals that the MalK dimer is essentially identical to the crystal structure 
previously obtained (Chen et al., 2003). It is a closed dimer with two ATP 
molecules bound. The only difference between this structure and the structure of 
MalK2 crystallised on its own is that the Q loops are ordered into ^-strand 
structures. In the structure of MalK2 alone, this region was disordered, but in the 
structure o f the complete transporter the Q loops interact with the TMDs and form 
an ordered structure. MalF and MalG form the translocation channel and reveals 
that the topology modelling of these proteins was accurate. There is
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Figure 1.9 Crystal s truc tu re  o f the in tact MalEFGK2 com plex. Overall complex 
of the maltose ABC transporter. Each polypeptide is colour-coded and labelled 
accordingly on the left hand side. The structure is of a catalytic intermediate able to 
bind, but not hydrolyse ATP. In this structure, the ATPase domains are closed and 
bound to ATP. The ESR, MalE (MBP) is open and maltose is bound in the 
translocation channel of the TMD. MalF (P2) is the Ig-like domain of the integral 
membrane component that interacts with MalE. Figure taken from Oldham e t a l 
(2007).
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pseudosymmetry between helices 3-8 of MalF and 1-6 of MalG. The ESR, MalE is 
ligand-free with both globular domains forming extensive interactions with both 
MalF and MalG (Fig. 1.9).
As predicted from previous work, the EAA motif of the TMDs is prominent in the 
interaction face between the MalFG dimer and the MalK dimer (Fig. 1.10a). The 
EAA motifs from both MalF and MalG form 2 small helices with one o f these 
helices docking into a cleft of MalK. This MalK cleft consists of the helical 
subdomain, the Q loop and the helix after the W alker A motif. This supports the 
results obtained from the extensive biochemical and genetic studies previously 
performed.
The substrate binding pathway is the second region forming important interactions 
in this structure. This pathway is composed of MalF, MalG and MalE and at the 
intersection of these three proteins there is a large solvent-filled cavity that extends 
from the periplasmic side to the mid-point of the lipid bilayer (Fig. 1.10b i). This 
cavity is sufficiently large to accommodate the longest MalEFGK2 substrate, 
maltoheptaose. At the bottom of this cavity, which is at the mid-point of the lipid 
bilayer, a maltose molecule is observed making a number o f contacts with several 
residues from MalF, but none from MalG. The specific interactions made between 
protein and substrate, and previous biochemical evidence, suggests that this is a 
genuine interaction and not an artefact of purification or crystallization (Fig. 
1 .10b ii). This is the first structural evidence of a binding site in the TMD of an ABC 
transporter, and the overall architecture is analogous to the binding site at the mid­
point of the bilayer in LacY.
At the other end of this cavity, MalE is in its open conformation, cupping the top of 
the translocation channel. There is no maltose in the binding cleft of MalE, 
therefore binding to MalFG presumably stabilizes the open conformation allowing 
release o f maltose in to the MalFG binding pocket. One of the most striking 
features from this structure is the presence a periplasmic loop from MalG in the 
binding cleft of MalE (Fig. 1.10b iii). This so-called “scoop loop" either dislodges 
maltose from MalE and/or sterically hinders its re-entry therefore facilitating 
unidirectional transport. Another interesting and unexpected protein:protein 
interaction is the formation o f an Ig-like domain from second periplasmic loop of 
MalF that makes extensive contacts with the N-terminal globular domain o f MalE.
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Figure 1.10 Domain in te ractions in the MalEFGK2 com plex, (a) The conserved 
EAA loop of MalF and MaIG docking with a surface cleft in MalK. Position of the 
EAA motif from MalF (blue) and MaIG (yellow) are compared by superimposing the 
MalK monomers (red and green). The Q loop, Walker A (WA) and Walker B (WB) 
are shown, (b) (i) Cross-section of a space-filling model showing the open 
conformation of MalE (MBP), the solvent filled cavity and the positioning of maltose 
at the bottom, (ii) Maltose binding site within the TMD showing interactions 
between maltose and amino acids, (in) Insertion of the “scoop loop” from MaIG into 
the binding pocket of MalE. A maltose molecule has been modelled in to 
demonstrate the resultant steric hindrance. Figures taken from Oldham e t a l  
(2007).
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This Ig-like domain is not seen in any o f the other structures o f intact ABC 
transporters and whether it is absolutely essential for maltose transport is currently 
unknown.
The high resolution crystal structure of ModC2B2A, an intact ABC importer from 
A. fulgidis, has been solved. Comparison of this with MalEFGK2 gives insight into 
the transport mechanism because the ModC2B2A structure is in the open, 
nucleotide-free form with substrate bound in the binding cleft of the binding protein 
ModA (Holienstein et al., 2007b). The TMDs of ModC2B2A and MalEFGK2 have a 
very similar topology despite little sequence similarity and different numbers of 
transmembrane helices (MalFG have 8 and 6 TMs, respectively and ModB is a 
homodimer with 6 TMs each). The binding protein, ModA is bound to substrate and 
is interacting with ModB2. Contrary to the MalEFGK2 structure, the translocation 
channel is closed at the periplasmic end and is open at the cytoplasmic end and 
there is no evidence of substrate within the TMD. The nucleotide-free ATPase 
domain, ModC2, is in an open conformation and the interaction of the EAA motif of 
ModB2 is slightly different to that seen in the MalEFGK2 structure, corresponding to 
the different conformations of the transporter components.
1.7.4 Proposed mechanism of transport by ABC importers
The culmination o f the decades o f biochemical, genetic and more recent 
biophysical data has allowed the production of a model for transport by an ABC 
importer (Fig. 1.11). The protein complex of ATPase domain and TMDs starts in 
the resting state in which the translocation channel is closed to the periplasm and 
the ATPase domain is in the open, unliganded form. Substrate-bound ESR docks 
with the TMDs (this is observed in the ModC2B2A structure) which promotes the 
conformational change to the catalytic transition state (as seen in the MalEFGK2 
structure) in which the periplasmic side o f the TMD is open, stabilizing the open 
state of the ESR and release of substrate into the translocation channel (with help 
from the “scoop loop”, where available). ATP hydrolysis takes place, substrate-free 
binding protein is released, the ATPase dimer opens and the TMDs revert to the 
resting state. The transport cycle is then ready to begin again.
56
Binding •  Substrate
Figure 1.11 Proposed m echanism  fo r so lu te  transport by ABC uptake 
system . Substrate binds to the ESR and interacts with the TMD-NBD complex its 
resting state. Interaction of liganded ESR triggers conformational changes within 
the TMD resulting the opening of the periplasmic side of the TMD and release of 
substrate from the ESR. The NBD closes and hydrolysis of ATP occurs leading to 
opening of NBD and subsequent opening of the cytoplasmic side of the TMD 
releasing substrate into the cytoplasm. ADP+Pi are released resulting in the 
resetting to the resting state. Figure taken from Oldham e t a l  (2007).
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It is worth reiterating that the model suggests that it is the interaction of the 
liganded ESR with the TMDs and not binding of ATP that initiates the opening of 
the periplasmic side of the translocation channel and closing of the ATPase 
domain. ATP concentrations within the cytoplasm have been reported to be 
sufficiently high so that the ATPase domain is saturated at all times (Davidson et 
al., 1996, Oldham et al., 2007). It has also been demonstrated that introduction of 
liganded MalE stimulates ATPase activity in vitro, which further strengthens the 
proposed model (Davidson et al., 1992).
1.8 Tripartite ATP-independent periplasmic (TRAP) transporters
TRAP transporters are ESR-dependent secondary transporters that are 
widespread in bacteria and archaea, but not in eukaryotes (Kelly & Thomas, 2001). 
TRAP transporters consist of an ESR and two unequally sized integral membrane 
proteins, one of which is predicted to be the translocation channel and the other is 
of unknown, but essential function (Forward ef al., 1997).
Compared to ABC transporters and secondary transporters, there is little known 
about the structure and mechanism of TRAP transporters. Some comparisons can 
be drawn between TRAP, classical secondary and ABC transporters. TRAP 
transporters utilize an electrochemical gradient to power transport, therefore they 
are secondary transporters. This is combined with the presence of a high affinity 
ESR, characteristic of ABC transporters (Kelly & Thomas, 2001) (Fig. 1.12).
The first TRAP transporter to be identified was the C4-dicarboxylate (malate, 
succinate and fumarate)-specific DctPQM from Rhodobacter capsulatus (Forward 
e ta l., 1997).
1.8.1 Discovery of the first TRAP transporter: DctPQM from R. capsulatus
1 .8.1.1 Ci-dicarboxvlate transport in bacteria
C4-dicarboxylates (succinate, fumerate, malate) are transported into bacterial cells 
and metabolized in both aerobic and anaerobic conditions. A number o f different 
variations of secondary transporters are known to be used to transport C4- 
dicarboxylates into and out of the cell. Based on sequence similarity, structural 
components and energetic requirements these transporters can be split into a
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ABC Secondary TRAP
transporte r transporte r transporte r
Figure 1.12 C om position  o f archetypal ABC, secondary and TRAP 
transporte rs. Comparison of the structural composition of three types of 
transporter. ABC transporters, represented by MalEFGK2 (Oldham et al., 2007) are 
composed of an ESR, a transmembrane domain and a nucleotide binding domain. 
Secondary transporters, represented by lactose permease (Abramson et al., 2003) 
are composed of a transmembrane domain with no need of ancillary protein 
components. TRAP transporters are secondary transporters composed of a 
transmembrane domain and an ESR component. The ESR shown is SiaP (Muller 
et al., 2006). There is no structural information regarding TRAP transporter integral 
membrane components. Colour coding: ESR domains are red, transmembrane 
domains are blue and nucleotide binding domains are yellow.
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number of families. The first group is the DctA family of transporters that are 
expressed under aerobic conditions (Janausch et al., 2002) and are members of 
the dicarboxylate/amino acidxation symporter (DAACS) family (Paulsen et al., 
1998). DctA transporters are found in eukaryotes and prokaryotes and catalyse the 
symport o f C4-dicarboxylates and certain amino acids with H+ or Na+ (Janausch et 
al., 2002). The transporters in this family contain 10-12 TMHs and are classical 
secondary transporters, much like lactose permease. This family includes YdbH 
from Bacillus subtills (Asai et al., 2000) and DctA from E. coli (Davies et al., 1999).
The Dcu family of C4-dicarboxylate transporters, represented by DcuA, DcuB and 
DcuC, is more versatile, as members have been shown to perform symport of C4- 
dicarboxylates with H+, exchange (of succinate and fumarate) and efflux (symport 
with H+ or Na+) (Zientz et al., 1996). These transporters are predicted to contain 
approximately 12 TMHs, although DcuA has been shown to contain 10 TMHs with 
dcuA-blaM  fusions (Golby et al., 1998).
Members of the CitT transporter family are also predicted to possess 12 TMHs. 
This family has been shown to catalyse the exchange of succinate, fumarate or 
tartrate with citrate (the tricarboxylic acid) leading to uptake of citrate for 
fermentation (Pos et al., 1998).
The final group of C4-dicarboxylate transporters is the TRAP family of transporters. 
Although it is now known that TRAP transporter substrates are not limited to the 
C4-dicarboxylates, the first TRAP transporter identified was a C4-dicarboxylate 
transporter from R. capsulatus.
1.8.1.2 Ca-dicarboxvlate transport in Rhodobacter capsulatus 
R. capsulatus is a purple, photosynthetic bacterium that can grow in aerobic and 
anaerobic conditions, photo- and chemo-heterotrophically on various organic 
carbon sources (Madigan & Gest, 1979). The C4-dicarboxylate-specific TRAP 
transporter in R. capsulatus was initially identified during a transposon 
mutagenesis study (Hamblin et al., 1990). This study identified 5 separate 
mutations that resulted in the loss o f R. capsulatus growth on malate, succinate
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and fumarate as the sole carbon source in aerobic conditions in the absence of 
light. Using complementation from a library of cosmids, this study identified at least 
three closely associated genes that were required for uptake o f the C4- 
dicarboxylates into the cells and were located in the locus designated dct 
(dicarboxylate transporter, (Hamblin et al., 1990)).
The transport characteristics and substrate specificity of this transporter were 
studied using in vivo transport assays and it was confirmed to transport succinate, 
malate and fumarate (Shaw, 1991). This transporter, like certain ABC transporters, 
was found to be “shock sensitive” indicating that there was a role for an ESR 
during the transport cycle. The presence of an ESR was further indicated by a filter 
binding assay that revealed radiolabelled malate was sequestered by a protein in 
the periplasmic fraction prepared from R. capsulatus. However, unlike ABC 
transporters, a strong link between ApH, A*+* and malate transport was also 
observed (Shaw, 1991).
The utilisation o f an ESR was confirmed when it was purified and characterised in 
vitro (Shaw et al., 1991, Walmsley et al., 1992). The protein, named DctP, was 
found to be extremely abundant in the periplasm of wild-type R. capsulatus, but 
was absent from one o f the transposon insertion mutant strains, MJH28 (Hamblin 
et al., 1990). DctP was purified to homogeneity and filter binding assays 
determined that DctP bound malate with a high affinity (K<* o f 8.4 ± 1.49 pM) 
comparable to ABC transporter ESRs. Competition studies confirmed that 
succinate and fumarate were also substrates of DctP (Shaw et al., 1991). Steady- 
state fluorescence spectroscopy revealed that DctP bound the C4-dicarboxylates 
with different affinities. L-malate bound with the highest affinity (0.05 pM), followed 
by fumarate and succinate (0.255 and 0.17 pM, respectively) and finally D-malate 
(6.3 pM) (Walmsley et al., 1992). The substrate specificity of DctP in vitro reflected 
the substrate specificity o f the transporter in vivo further reinforcing that DctP was 
an ESR with a similar function in transport as ABC ESRs.
The pre-steady state binding kinetics o f ligand to ABC ESRs have been assessed 
using stopped-flow fluorescence spectroscopy for a number o f different proteins 
with different substrate specificities, for example, galactose, maltose, histidine and
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arabinose (Miller et a/., 1983, Miller et a/., 1980). In each example, the binding of 
protein (P) and ligand (L) were described as a rapid, 2nd order process with a 
simple association of ligand with a single binding site on the protein, i.e.;
P + L±=^P L
The binding kinetics of C4-dicarboxylates to DctP were found to be inconsistent 
with this kind o f simple association. Instead, the stopped-flow analysis suggested 
that DctP could be in four different states during the binding mechanism; closed- 
unliganded (P1), open-unliganded (P2), open-liganded (P2-L) and closed-liganded 
(P3-L);
P1 P 2  P 2 -L  ± = 5: P 3 -L
The data obtained suggested a slow isomerisation o f the protein between P1 and 
P2 with the ligand only binding to P2 (Kelly & Thomas, 2001, Walmsley et al., 
1992). These data indicate that the ABC ESRs studied are predominantly in the 
open state prior to ligand binding. DctP, on the other hand is predicted to have a 
more stable closed-unliganded conformation. This bias in the equilibrium between 
the two unliganded conformations o f DctP may depend on a number o f variables 
that were not investigated, such as the ionic strength or pH of the buffer (Walmsley 
et al., 1992). The same kinetic behaviour was observed for another TRAP ESR, 
RRC01191 also from R. capsulatus (Thomas et al., 2006). Curiously, analysis of 
the pre-steady state kinetics o f ligand binding to two other TRAP ESRs revealed 
kinetic behaviour similar to that seen by the ABC ESRs (Muller et al., 2006, 
Thomas et al., 2006). This demonstrates that this kinetic behaviour is not 
characteristic for all TRAP ESRs and may indicate a fundamental difference 
between ESRs within the TRAP family.
Sequencing o f the 3’ region downstream o f dctP  revealed two coding sequences 
(CDSs) of 681 and 1320 base pairs, named dctQ and dctM  respectively (Forward 
et al., 1997). Mutagenesis revealed that all three genes were required for growth 
on C^dicarboxylates (Forward et al., 1997).
The gene dctQ encodes a protein of 24.7 kDa. Hydropathy analysis of the residues 
predicted 4 TMHs (62% hydrophobic residues), which was later confirmed by dctQ-
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blaM  fusions (Wyborn et a!., 2001) (Fig. 1.13a, left panel and b). The gene dctM  
encodes a protein with a predicted molecular weight o f 46.8 kDa and 12 predicted 
TMHs (73% hydrophobic residues Fig. 1.13a, right panel) separated by a large 
hydrophilic sequence reminiscent o f the 2 x 6 configuration o f the 12 TMH 
secondary transporters such as OxIT, LacY and GIpT (Abramson et al.t 2003, Hirai 
et al., 2003, Huang et al., 2003). However, there is no sequence similarity between 
DctM and these secondary transporters; furthermore, there are none o f the 
distinguishing features o f ABC transporter, such the LSGGQ or EAA motifs 
(Forward et al., 1997). DctQ and DctM were confirmed to be integral inner 
membrane proteins by heterologously co-expressing the genes from a T7-inducible 
vector in E. coli, labelling proteins with [35S]-methionine and separating the inner 
and outer membranes with a sucrose density gradient. The proteins were visible 
using a fluorogram after 2 days exposure but were not visible on Coomassie- 
stained SDS-PAGE indicating very low abundance (Forward et al., 1997).
To determine whether dctPQM  encoded the complete transporter and to dispel the 
possibility that other components, like an ATP-binding cassette protein were 
encoded elsewhere on the genome, dctPQM  were heterologously expressed in a 
strain o f Sinorhizobium meli'loti with a disruption in the sole C4-dicarboxylate 
transporter, a DctA family member. Heterologous expression of dctPQM  in this 
strain led to uptake o f succinate, providing strong evidence that all 3 o f the 
proteins; DctP, DctQ and DctM are necessary and sufficient for the transport of C4- 
dicarboxylates (Forward et al., 1997).
1.8.1.3 Transport by DctPQM is dependent on and not ATP hydrolysis 
To determine the energy coupling mechanism for DctPQM in R. capsulatus, in vivo 
transport of radiolabelled succinate was measured in relation to intracellular ATP 
concentration and the membrane potential. A  decrease in succinate transport was 
observed upon dissipation of the membrane potential by titration with 3 different 
uncouplers; FCCP, SF6847 and 2,4-dinitrophenol. Intracellular ATP concentrations 
remained high during these assays indicating that the membrane potential, and not 
ATP hydrolysis, was responsible for succinate transport via DctPQM (Forward et 
al., 1997). To further ratify this observation, cells were treated with orthovanadate, 
which is known to be a potent inhibitor o f ABC transporters (Richarme et al., 1993).
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Figure 1.13 Topo logy m odeling o f DctQ and DctM from  R. sphaeroides. (a)
Hydropathy analysis of the amino acid composition of DctQ and DctM showing 
hydrophobic and hydrophilic residues. Transmembrane helices (TMHs) are 
indicated by black peaks. DctQ has 4 predicted TMHs and DctM has 12 predicted 
TMHs. A large hydrophilic loop is observed between helices 6 and 7 of DctM. 
Figure taken from (Forward et al., 1997) (b) Experimentally defined topology model 
of DctQ. Positively charged residues are shown in black. The locations of BlaM 
fusions used to define the model are labelled A-O. Figure taken from Wyborn e t a l 
(2001).
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Transport of C4-dicarboxylates via DctPQM was orthovanadate insensitive. The 
lactose permease control was also orthovanadate insensitive, whereas an alanine- 
specific ABC transporter was 80% inhibited. Combined, this evidence strongly 
suggested that the pmf, and not ATP binding and hydrolysis, was required for 
transport of C4-dicarboxylates by DctPQM.
Through this work on DctPQM, predominantly performed in Prof. David Kelly’s 
laboratory in Sheffield, a new class of transporter was identified that combined an 
ESR with the use o f an electrochemical gradient to power transport of substrate 
across the membrane. DctPQM was the first TRAP transporter described and 
characterised in detail. As such, all subsequently discovered TRAP transporters 
that were homologous to these proteins were placed in the DctP, DctQ or DctM 
families.
1.8.2 Phylogenetic analysis of the DctP, DctQ and DctM families of proteins
Phylogenetic analyses of the components DctPQM has provided a number of 
insights into the prevalence, genetic organisation and divergence of TRAP 
transporters in bacteria and archaea (Kelly & Thomas, 2001, Rabus ef at., 1999).
1.8.2.1 The DctP family of ESRs
Phylogenetic analysis of ESRs can be used to group the proteins into families 
based on their sequence similarity, where members o f a particular family will bind 
chemically similar ligands (Tam & Saier, 1993). This can be performed for dctP 
homologues and can be used in conjunction with the genome context to predict 
substrate specificities of TRAP systems. As an example of this, the YiaMNO TRAP 
transporter from E. coli is in an operon with the genes necessary for the utilization 
of 2 ,3-diketo-L-gulonate (2,3-DKG) and has been predicted to be a 2,3-DKG 
specific transporter (Yew & Gerlt, 2002). Although some literature implicated 
YiaMNO in L-xylulose transport (Plantinga et a!., 2004), the purified ESR, YiaO has 
been shown conclusively to bind 2,3-DKG and not L-xylulose using a number o f 
complementary biophysical techniques (Thomas et al., 2006). H. influenzae 
contains 3 complete TRAP transporters, one of the ESRs; HI0128 has high 
sequence similarity with YiaO, therefore one would predict that HI0128 also binds
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2,3-DKG (Kelly & Thomas, 2001). This high degree of sequence similarity of TRAP 
ESRs from different organisms, including archaea, indicates that these orthologues 
have arisen by vertical transfer and not horizontal transfer, i.e. from speciation. 
This indicates that TRAP transporters are ancient, and were present before the 
split between bacteria and archaea occurred (Rabus et al., 1999).
Multiple dctP  homologues have been found in some organisms, and have also 
been found to be highly divergent indicating that they bind structurally different 
substrates. There are also examples of paralogues having very high sequence 
similarity at the amino acid level (>70%), for example PA0884, PA4616 and 
PA5167 from P. aeruginosa, suggesting that they bind chemically similar 
substrates and arose from a recent gene duplication event (Kelly & Thomas, 2001). 
Phylogenetic analysis o f DctP has also revealed a TRAP ESR being used in a non­
transport related context. YdbE in B. subtilis is an orphan TRAP ESR and is not 
associated with dctQ or dctM  genes. B. subtilis does not contain any dctQ or dctM  
orthologues, strongly suggesting that YdbE is not part of a complete TRAP 
transporter (Kelly & Thomas, 2001). ydbE  is divergently transcribed from a 2 
partner sensor-regulator pair, ydbF  and ydbG, and a gene encoding a C4- 
dicarboxylate transporter o f the DcuA-family, ydbH. YdbE is an experimentally 
determined extracytoplasmic C4-dicarboxylate sensor that binds substrate and 
interacts with the 2 component sensor-regulator pair to activate transcription of 
ydbH  (Asai et al., 2000). This is analogous to MalE, which can work as either a 
transport associated ESR or as a sensor for chemotaxis (Springer et al., 1977). 
However, YdbE does not have cognate integral membrane components so acts
I
solely as a C4-dicarboxylate sensor.
1.8.2.2 The DctM family of integral membrane proteins
Phylogenetic analysis of the dctM  family has revealed that the nucleotide sequence 
of these genes has diverged least out of all TRAP genes, suggesting that it has a 
central role in transport and does not necessarily define the substrate specificity 
(Rabus e ta l., 1999).
Members o f the DctM family are ~350-450 amino acids long and possess 10-13 
TMHs that are separated by a centrally located hydrophilic sequence o f amino 
acids, similar to other secondary transporters that consist of 12 TMHs (Prakash et
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al., 2003). It has been proposed that DctM is the translocation channel through 
which the substrate passes to cross the membrane. Analysis of the amino acid 
sequence has revealed that DctM shares a sequence motif with DcuC -  a C 4 - 
dicarboxylate secondary transporter that does not require any auxiliary protein 
components to function -  indicating that DctM has a weak but significant 
relationship with classical secondary transporters (Prakash et al., 2003, Rabus et 
al., 1999).
DctM is a member of the ion transporter (IT) superfamily which consists of 
secondary transporters specific for anionic and cationic compounds (Prakash et al., 
2003). Other members o f this superfamily include the arsenite-antimonite (ArsB) 
efflux family, which can consist of 2 proteins ArsA, an ATPase domain and ArsB, a 
12 TMH translocation channel. In the presence o f ArsA the transporter is ATP- 
driven. However, in the absence of ArsA, ArsB uses the PMF to power transport 
(Dey & Rosen, 1995). This demonstrates that ArsB and DctM are translocation 
channels and are able to incorporate ancillary proteins to modify their transport 
mechanism.
Although it has not been explicitly demonstrated experimentally, these findings 
demonstrate that DctM is a very strong candidate to be the translocation channel 
for TRAP transporters.
1.8.2.3 The DctQ family of integral membrane proteins
Phylogenetic analysis reveals that DctQ is the most divergent o f the TRAP 
components and has no sequence similarity with any other family of proteins (Kelly 
& Thomas, 2001, Rabus et al., 1999). DctQ is o f unknown function, but has been 
shown to be essential for transport (Forward et al., 1997). It has been postulated 
that DctQ may be involved in coupling ESR recognition to the translocation 
channel. It has also been suggested that DctQ acts as a landing pad for the ESR, 
or DctQ may be involved in the folding/insertion of DctM into the membrane (Kelly 
& Thomas, 2001). Unfortunately, there is very little evidence for any o f these 
theories and more experimental work will be required to ascertain what role DctQ 
has in the transport cycle.
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1.8.3 Genetic arrangement of TRAP transporters
Phylogenetic analysis has revealed that the organization o f the genes encoding 
TRAP transporters varies considerably (Fig. 1.14 (Kelly & Thomas, 2001)). 
Operons have been discovered where the three proteins are expressed from 3 
separate genes, for example, DctPQM from R. capsulatus or YiaMNO from E. coli 
(Fig. 1.14). These two systems differ in the position o f the dctP  gene in relation to 
the dctQ  and dctM  genes. The former has dctP  upstream and latter has dctP  
downstream of the dctQ and dctM  positions.
The only example of a dctP-dctQ  fusion is from Rhizobium  sp. Strain NGR 234 
(Fig. 1.14).
Although DctQ and DctM have been treated as separate entities until now, there 
are a number o f examples o f dctQ-dctM  fusions, for example SiaQM from 
H. influenzae (Fig. 1.14). This is a commonly observed fusion in a number of 
different TRAP transporters, however, this organisation is not as common as 
encoding the 3 components from 3 different genes. Although fused, these fusion 
proteins have easily discernable DctQ and DctM domains. This fusion is found in 
TRAP transporters from a number of different bacteria, but curiously, all TRAP 
transporters in archaea have a DctQM fusion protein (Kelly & Thomas, 2001).
There is an example of a TRAP system with 2 dctP  genes associated with dctQ 
and dctM  in Trepomena pallidum  (Fig. 1.14) and examples of dctP genes 
divergently and convergently transcribed from the dctQ and dctM  genes from 
Actinobacillusactinomycetemcomitans and Rhodopseudomonas palustris, 
respectively (Fig. 1.14).
These observations reveal a number of insights into TRAP transporters. The 
example o f a dctP-dctQ fusion adds weight to the possibility that DctQ acts as a 
bridge between the ESR and the translocation channel. The phylogenetic analysis 
reveals that there are no examples where a dctM  gene is transcribed before a dctQ  
gene. This implies that dctQ must be transcribed/translated first, which suggests 
DctQ may be involved in the stability/insertion of DctM. To reinforce this postulate, 
it has also been noted that DctM can not be accumulated unless co-expressed with 
DctQ (Kelly & Thomas, 2001).
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Example
R. caps Hiatus DctP/DctQ/DctM
E. coll ViaMjYiaNA’iaO
Rhizobium  sp. strain NGR234 
Y4MM/Y4ML
H. in f lu e n za e  HI0I46/H10147 
T. p a llid u m  I P0956/IP0957/1 P09S8
A. actinomycetemcomitans
ORF942 ORF2353/ORI 1598
R. p a lu s tr is
ORF2Î87/ORF3I07/ORF2406
Figure 1.14 O rganisation o f genes encoding TRAP transporte rs  conta in ing 
DctP hom ologues. Genes encoding the integral membrane proteins, DctQ and 
DctM are coloured dark blue and light blue, respectively. In some of the cases, the 
d c tQ  and d c tM  genes are fused. The d c tP  homologues flanking the genes 
encoding DctQ and DctM are shown in red. It is unknown whether the gene 
coloured in pink in T. p d llid u m  is a true d c tP  homologue. Examples of organisms 
and genes where these different organizations can be observed are shown on the 
right. Figure modified from Kelly & Thomas (2001).
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1.8.4 Known and predicted substrates of TRAP transporters
Since their discovery, a number of TRAP transporter substrates have been 
identified. This has revealed that TRAP transporters are not limited to C4- 
dicarboxylate transport, but actually have a wide variety o f substrates. The 
following compounds are experimentally determined substrates o f TRAP 
transporters (Fig. 1.15a); C4-dicarboxylates (succinate, fumarate and malate) in 
R. capsulatus (Forward et al., 1997) and Wofinella succinogenes (Ullmann et al., 
2000), A/-acetylneuraminic acid (Neu5Ac) in H. influenzae (Allen et al., 2005, 
Seven et al., 2005), ectoine in Halomonas elongata (Grammann et al., 2002) and 
glutamate from Synechocystis sp. Strain PCC6903 (Quintero e t al., 2001). A  
glutamate specific, ESR-dependent secondary transporter has also been reported 
in Rhodobacter spheroides (Jacobs et al., 1996). However, the genes encoding the 
transporter were not identified and so cannot be confirmed as belonging to this 
family o f transporter.
The ESR component o f TRAP transporters is thought to confer the specificity to the 
transporter. There have been a number of TRAP ESRs characterised and the 
substrate specificities determined, including (Fig. 1.15b); 2,3-diketo-L-gulonate 
from E. coll and monocarboxylate keto-acids from R. sphaeroldes (Thomas et al., 
2006). Two ESRs from Bordetella pertussis have been crystallised and found to be 
bound to pyroglutamate (Rucktooa et al., 2007).
A study of transcriptional inducers o f the ESR components of TRAP transporters in 
Sinorhizobium meliloti has led to the prediction of a number of new substrates 
including (Fig. 1.15c); malonate, quinate, oxobutyrate, pyruvate and a number of 
sugars including mannose, raffinose, fucose, arabinose and lactose (Mauchline et 
al., 2006). These findings increase the range of possible TRAP transporter 
substrates considerably, but obviously need to be experimentally verified.
Finally, there are the substrates that are predicted from genome context and 
phylogenetic analysis, which includes (Fig. 1.15c); taurine from both R. capsulatus 
(Bruggemann et al., 2004) and R. sphaeroides 2.4.1 (Denger et al., 2006) and 4- 
chlorobenzoate from Pseudomonas sp. DJ-12 (Chae et al., 2000).
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Figure 1.15 Known and predicted TRAP transporte rs  substra tes, (a) TRAP 
transporter substrates experimentally defined using in vivo studies, (b) TRAP 
transporter susbtrates defined by in vitro characterization of purified ESR 
components, (c) TRAP transporter substrates predicted from phylogenetic and 
genome context analysis or from transcription induction studies.
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1.9 SiaPQM: an /V-acetylneuraminic acid TRAP transporter from H. influenzae
SiaPQM is a TRAP transporter from H. influenzae that has been shown to be 
essential for transport of the sialic acid, A/-acetylneuraminic acid (Neu5Ac) in vivo 
(Allen et al., 2005, Severi et al., 2005). This transporter consists o f an ESR, SiaP 
and a single integral membrane component, SiaQM.
1.9.1 An introduction to sialic acids
Sialic acids have been studied for over 40 years and were once said to be “not only 
the most interesting molecules in the world, but also the most important” (Vimr, 
1994), so it would be remiss to attempt to encapsulate the breadth o f sialic acid 
research into a few paragraphs. There are however, a number of excellent reviews 
on this subject that will cover the areas not discussed (Severi et al., 2007, Vimr et 
al., 2004).
The term sialic acid encompasses over 40 different naturally occurring 9-carbon 
sugar acids. The parent compound from which these compounds are derived, and 
the most common sialic acid, is A/-acetylneuraminic acid (Neu5Ac) (Angata & 
Varki, 2002). Throughout the course o f this section the terms sialic acid and 
Neu5Ac will be used interchangeably unless specifically stated otherwise.
A  feature of all higher metazoan cells is the presence of a sialic acid molecule as 
the outermost constituent on surface exposed glycoconjugates (glyco-proteins and 
-lip ids). On the eukaryotic cell surface, these sialylglycoconjugates have been 
shown to have a number o f important functions. They prevent complement 
activation and autoimmunity by interacting with innate immune response factors, 
can take part in cell-to-cell communication and adhesion, and they can act as 
chemical messengers, regulating receptor and membrane transport functions 
(Varki, 1993, Varki, 1997, V im r et al., 2004). Bearing in mind the importance and 
apparent abundance of these molecules, it is not surprising to find that 
microorganisms that interact with higher eukaryotic organisms have developed 
methods o f harnessing sialic acids for their own use, sometimes to the detriment of 
the host (Severi et al., 2007, Vimr et al., 2004). It has become apparent that a 
number o f human commensals and pathogenic bacteria are able to utilize sialic 
acid as a source o f carbon, nitrogen, energy and amino sugars for use in cell wall 
synthesis (Plumbridge & Vimr, 1999). Sialic acids are now well known to be
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virulence factors in a number o f pathogenic organisms that are able to sialylate 
their surface-exposed lipopolysaccharide (LPS) and masquerade as “se lf, thus 
circumventing the innate immune response o f the host (Bouchet et al., 2003, 
Figueira et al., 2007, Hood et al., 1999, Vimr et al., 2000). In some organisms there 
is a dual fate for sialic acid; acquired sialic acid is either catabolised and used for 
biosynthesis or it is used to decorate the outer surface of the organism for immune 
evasion tactics (Vimr et al., 2000).
1.9.2 Acquisition of sialic acid
There are two major methods by which bacteria acquire sialic acid; either by de 
novo synthesis or by scavenging from the environment (Vimr et al., 2004). 
Synthesis of sialic acid is performed by a number of organisms including £. coll K1, 
Neisseria meningitidis and Campylobacter je jun i (Vimr et al., 2004) using the cell 
wall synthesis precursor, CMP-GIcNAc, as a starting point. The actions of two 
enzymes, NeuC and NeuB, produce Neu5Ac via ManNAc (Vimr et al., 2004). 
Neu5Ac can then be catabolised or used to decorate the LPS. The second method 
o f obtaining sialic acid is from the environment, in the case of pathogens, this is the 
mammalian host. Although most o f the sialic acids will be bound to glyoconjugates, 
there is such an abundance o f sialogylcoconjugates on the cell surfaces of 
mammalian cells that even a conservative estimate of the percentage (0.05%) that 
is in the free form produces an appreciable amount of free sialic acid for bacteria to 
scavenge (Vimr et al., 2000). Certain bacteria, for example Vibrio cholerae also 
encode a neuraminidase (also known as a sialidase) that can be used to free sialic 
acid from the host glycoconjugate (Corfield, 1992). Neuraminidases can also be 
used to desialylate other bacteria to free sialic acid (Shakhnovich et al., 2002), or 
they can scavenge sialic acid freed from host sialidase action in response to 
inflammation (Sohanpal et al., 2004, Sohanpal et al., 2007).
1.9.3 Utilisation of sialic acid in bacteria
The enzymes that are involved in sialic acid catabolism have been identified in 
E. coli, and homologues of these enzymes are found in a number of other bacteria 
(Vimr et al., 2004). The first isolated mutants defective in Neu5Ac utilisation were 
designated nan mutants (for A/-acetylneuraminate) and were found to have
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disruptions in the genes, nanA and nanT  (Vimr & Troy, 1985a). These were found 
to encode the transporter NanT, and an aldolase NanA. A number of biochemical 
studies elucidated the pathway o f Neu5Ac catabolism (Fig. 1.16a); Neu5Ac is 
transported into the cytoplasm and broken down into ManNAc and pyruvate by the 
action of NanA (Vimr & Troy, 1985a, Vimr & Troy, 1985b). ManNAc is 
phosphorylated by the ATP-dependent enzyme NanK to produce ManNAc-6-P, 
which is then converted to GlcNAc-6-P by the actions of a reversible epimerase, 
NanE (Ringenberg et a!., 2003). GlcNAc-6-P is deacetylated by NagB producing 
GlcN-6-P which is deaminated to Fructose-6-P and can be used in glycolysis 
(Plumbridge & Vimr, 1999).
One of the more exciting aspects of sialic acid biology is the fact it has potentially 
two roles to play; it can be used for biosynthesis or can be used to decorate the 
bacterial cell surface where it has a number of functions including host immune 
response evasion and a role in adhesion/invasion to host cells (Karlsson, 1998, 
Vimr et al., 2000). There are a number o f different methods by which cell surface 
glycoconjugates are sialylated. The method most pertinent to this study is a 
process termed precursor scavenging, best described in H. influenzae, in which 
Neu5Ac is taken into the cytoplasm and activated by CMP-Neu5Ac synthetase 
(SiaB in H. influenzae or NeuA in E. coli) (Vimr et al., 2000). Activated Neu5Ac is 
then added to the lipooligosaccharide (LOS) by the actions of sialyltransferases, of 
which H. influenzae has 3; Lic3A, Lic3B and SiaA (Fox et al., 2006, Hood et al., 
2001) (Fig. 1.16a). The sialylated LOS is then presented on the cell surface using 
the normal LOS biosynthesis machinery (Bos et al., 2007).
1.9.4 Bacterial sialic acid (Neu5Ac) transporters
Whether scavenged from the environment or released by neuraminidase action, 
bacteria still need to transport Neu5Ac into the cytoplasm because it has been 
demonstrated that the catabolic enzymes and enzymes involved in LPS sialylation 
are cytoplasmic (Lilley et al., 1998, Vimr et al., 2000). To do this, bacteria have 
employed a number of different classes of transporter. The first bacterial Neu5Ac 
transporter identified and characterised was NanT from E. coli (Vimr & Troy, 
1985a). This is the sole uptake route for Neu5Ac in £. coll, a classical secondary
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Figure 1.16 (a) Dual function  o f Neu5Ac in H. influenzae  and (b) genetic 
arrangem ent o f s ia lom etabo lic  operon in H. influenzae  and related species.
(a) Catabolic pathway of Neu5Ac resulting in formation of fructose-6-phosphate 
(Fru-6-P) shaded orange. Pathway for LOS sialylation by Neu5Ac shaded green. 
Figure modified from Vimr e t a l (2000). X is the Neu5Ac specific transporter, which 
is SiaPQM in H. in flu e n za e , (b) Schematic of sialometabolic opérons from 5 
organisms containing genes for TRAP transporters (solid black, s/'aP and s ia Q M )  
and sialometabolic genes. Organisms include H. in flu e n z a e  (Hi), P. m u lto c id a  
(Pm), F u s o b a c te r iu m  n u c le a tu m  (Fn), V ib rio  c h o le ra e  (Vc), P h o to b a c te r iu m  
p ro fu n d u m  (Pp). Figure taken from Severi e t a l (2005).
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transporter and member of the sialate:H+ symporter subfamily (2.1.12) of the major 
facilitator superfamily (Pao et al., 1998, Vimr & Troy, 1985a, Vimr & Troy, 1985b). 
The sialic acid transporter from Haemophilus ducreyi has also been characterised 
and found to be an ABC transporter, SatABCD (Post et al., 2005). Finally, 
identification and characterisation o f the Neu5Ac transporters in P. multocida and
H. influenzae has revealed that TRAP transporters also perform this function (Allen 
et al., 2005, Severi et al., 2005, Steenbergen et al., 2005). Both the ABC 
transporter and TRAP transporter will have increased affinity over the classical 
secondary transporter and allow scavenging of low concentrations of Neu5Ac.
The importance of sialic acid in bacterial systems is reflected by the fact that there 
are at least three different families o f transporters have evolved to transport it. The 
use of different transporters for sialic acid uptake is likely influenced by 
environmental factors such as competition from other microbes and scarcity of 
substrate.
I .  9.5 Haem ophilus influenzae  and N-acetylneuraminic acid
H. influenzae is a common Gram negative nasopharyngeal commensal that is 
found in up to 80% of the population (Bouchet et al., 2003). It is also a human 
pathogen with encapsulated strains causing septicaemia and meningitis and 
capsule-deficient (nontypeable) strains causing otitis media (infection of the middle 
ear) and acute respiratory tract infections (Moxon, 2000).
H. influenzae contains all the genes necessary to enable it to utilise sialic acid as a 
carbon and nitrogen source (Vimr et al., 2000) and it has also been observed that a 
high proportion of H. influenzae strains, both capsule-deficient and capsular, 
contain sialic acid in their LPS (Hood et al., 1999). Disruptions of genes in the LPS 
sialylation pathway have demonstrated that sialylation o f the LPS in H. influenzae 
increases the resistance to the complement-mediated killing effect of normal 
human serum (Hood et al., 1999). Sialylation of the LPS has been shown to be an 
important virulence factor for H. influenzae mediated otitis media in chinchilla 
(Bouchet et al., 2003). In H. influenzae, the catabolic pathway and the sialylation of 
the LPS both require sialic acid to be in the cytoplasm. It is unknown how the 
utilization of sialic acid is regulated between these two separate pathways; 
however, it has been shown that disruption of the first gene in the catabolic
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pathway, nanA, leads to hypersialylation of the LPS and increased resistance to 
human serum (Vimr et al., 2000).
H. influenzae does not have the enzymes necessary to synthesize sialic acid de 
novo and has been shown to incorporate sialic acid into its LPS by scavenging 
Neu5Ac from its host (Bouchet et al., 2003).
The TRAP transporter SiaPQM was first implicated in sialic acid transport in
H. influenzae due to its close proximity to sialometabolic genes in the genome 
(Kolker et al., 2004, Severi et al., 2005, Steenbergen et al., 2005). The linkage of 
TRAP transporter and sialometabolic genes has also been observed in other 
organisms including Pasteurella muttocida, Vibrio cholerae, Photobacterium  
profundum  and Fusobacterium nucleatum  (Fig. 1.16b). In H. Influenzae, the siaP  
gene that encodes the ESR and the siaQM  gene, which encodes a fused integral 
membrane component are transcribed with HI0128 (a homologue o f nanM  (Severi 
et al., 2008)) and divergently transcribed from the sialometabolic genes nanE, 
nanK, nanA, nagB and nagA. This close association of transporter and metabolic 
genes strongly suggested that the substrate o f the transporter was Neu5Ac.
I .  9.6 Characterisation of SiaPQM from H. influenzae
1.9.6.1 Characterisation of SiaPQM in vivo
SiaPQM was confirmed to be Neu5Ac specific transporter in two separate, but 
complementary studies on the unencapsulated laboratory H. influenzae strain 
RW118 (Rd) and the nontypeable strain, 2019 (Allen et al., 2005, Severi et al., 
2005). Disruptions in either of the genes siaP  and siaQM  in H. influenzae 
prevented transport o f radiolabelled Neu5Ac into the cell, measured using in vivo 
transport assays (Allen et al., 2005, Severi et al., 2005). These same studies also 
showed that H11104, a homologue o f NanT from E. coll is not involved in transport 
o f Neu5Ac under these conditions in either strain o f H. influenzae.
A sialylated glycoform of LPS is easily differentiated from LPS lacking sialic acid 
using SDS-PAGE due to the differences in molecular weight imparted by sialylation 
(Hood et al., 2001, Hood et al., 1999). When the LPS profile o f siaP  and siaQM  
mutants were compared to the LPS profile from wildtype H. influenzae it was found 
to be significantly different, consistent with lack of sialylation of the LPS in the
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mutant strains. The LPS profile from wildtype H. influenzae cells was found to be 
sensitive to neuraminidase treatment which led to removal of Neu5Ac from LPS 
and a decrease In the molecular weight. The LPS profile of the siaP  and siaQM  
mutants was insensitive to neuraminidase treatment further confirming the absence 
o f sialylated LPS in the mutant strains (Allen et al., 2005, Severi et al., 2005). 
Sialylated LPS is known to confer resistance to human serum and consistent with 
SiaPQM being essential for Neu5Ac uptake and therefore sialylation of LPS, there 
was decreased survivability o f the siaP  and siaQM  mutants in normal human 
serum (Allen et al., 2005, Severi et al., 2005). These data show that SiaPQM is 
essential for the uptake o f Neu5Ac indicating that it is the sole uptake route for 
Neu5Ac in H. influenzae under these conditions.
1.9.6.2 In vitro characterisation of SiaP
It has been demonstrated for ABC transporters that it is the ESR component that 
confers the specificity to the transporter (Doeven et al., 2004, Wilkinson, 2003), 
therefore, the in vitro characteristics of SiaP were defined.
SiaP was purified to homogeneity in the absence of Neu5Ac and the ligand binding 
was characterised using electrospray ionization mass spectroscopy (ESI-MS), 
tyrosine fluorescence spectroscopy and stopped-flow fluorescence spectroscopy 
(Allen et al., 2005, Muller et al., 2006, Severi et al., 2005). The mass of SiaP in the 
presence and absence of Neu5Ac was determined using ESI-MS. Unliganded SiaP 
was revealed to have a mass of 34165 Da. Addition of Neu5Ac led to an increase 
o f 309 Da to 34473 Da indicating that SiaP was bound to a single molecule of 
Neu5Ac (Severi et al., 2005). The binding o f Neu5Ac to SiaP was confirmed with 
tyrosine fluorescence spectroscopy, which revealed that SiaP bound Neu5Ac with 
a high affinity of 120 nM (Severi et al., 2005). These two techniques were also 
used to determine that SiaP did not bind to other known TRAP transporter 
substrates such as C4-dicarboxylates, pyruvate or a-ketobutyrate (Severi et al., 
2005). The high affinity binding o f Neu5Ac to SiaP and the 1:1 stoichiometry was 
confirmed using isothermal titration calorimetry (ITC) with a calculated Kd of 28 nM 
(Johnston et al., 2008).
The pre-steady state kinetics of Neu5Ac binding to SiaP were established using 
stopped-flow fluorescence spectroscopy (Muller et al., 2006). The data obtained
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was consistent with a simple bimolecular interaction similar to that seen in ABC 
ESRs (Miller et al., 1983, Miller et al., 1980) and to another TRAP ESR, YiaO from 
E. coli (Thomas et al., 2006). The kinetic behaviour of SiaP and YiaO are not 
consistent with the kinetics measured for the’ TRAP ESRs, DctP and RRC01191 
both from R. capsulatus suggesting that there may be more than one kinetic 
mechanism used by TRAP ESRs.
1.9.6.3 High resolution crystal structure of SiaP
Two independent studies have produced high resolution crystal structures of SiaP 
in the presence and absence of bound ligand (Johnston et al., 2008, Muller et al., 
2006). The first structure to be solved was of SiaP as it is found in H. influenzae 
RW118 (Rd). This structure was solved with a resolution of 1.7 A in both the 
absence o f ligand and in the presence o f a Neu5Ac analogue, Neu5Ac2en (Fig. 
1.17a (Muller et al., 2006)) This analogue has been shown to have a binding 
affinity of 20 pM with SiaP, 167-fold lower than that of the true substrate, Neu5Ac 
(Severi et al., 2005). The second SiaP structure to be solved was the protein from 
H. influenzae strain 2019 to a 1.4 A resolution in the presence of Neu5Ac 
(Johnston et al., 2008). The two structures are predominantly the same except that 
the binding site interactions deviate slightly due to the difference in the bound 
substrates. Neu5Ac2en differs from Neu5Ac by having a double bond between 
carbons (C) 2 and 3 o f the sugar ring resulting in a partial flattening of the normal 
chair conformation and removal o f the hydroxyl group on C2 (Fig. 1.17c).
SiaP is composed of 2 globular alp  domains connected by 3 polypeptides 
segments forming a “hinge” region, one o f which is a long o-helix that is unique to 
this ESR structure. This structure is very similar to that seen for ABC ESRs. The 
glycine-betaine ABC ESR (PDB 19RL) and a number o f other ABC transporter 
ESRs were the most similar structures in a DALI search of the SiaP structure 
despite there being no sequence similarity (Muller et al., 2006). Thé structure of 
SiaP reveals that it is also a type II ESR as seen for ABC ESRs (Fukami- 
Kobayashi et al., 1999).
The structure of the ligand bound versions of SiaP reveal that it is closed with a 
single molecule of ligand in the binding site, confirming the previous ITC and ESI-
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Figure 1.17 Crystal s tructu re  o f SiaP in ligand-free and ligand-bound form s.
(a) Superimposition of ligand-free SiaP (yellow) and ligand-bound SiaP (blue) 
showing conformational changes induced upon ligand binding. Neu5Ac2en is 
present in the binding site (green), (b) Space filling model of ligand-bound SiaP 
showing almost complete envelopment of Neu5Ac2en (blue) by SiaP (light brown), 
(c) Structural differences between Neu5Ac and Neu5Ac2en. Dehydration of carbon 
2 in Neu5Ac leads to double bond formation and loss of hydroxyl group to form 
Neu5Ac2en. Figures modified from Muller e t a l (2006).
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MS results showing a 1:1 ratio of ligand to protein (Johnston et al., 2008, Seven et 
al., 2005). Comparison of the open unliganded form and the closed liganded form 
o f SiaP suggests a rigid body domain movement upon ligand binding (Fig. 1.17a). 
This movement brings the two globular domains together, kinks the long a-helix in 
the hinge region and reorients the residue Phe170 to form a stacking interaction 
with the sugar ring of Neu5Ac in the binding cleft (Muller et al., 2006).-
1.9.6.4 Ligand binding site and specificity determinants of SiaP:Neu5Ac interaction 
The crystal structures reveal that the binding site is formed by the 2 globular 
domains of the protein. The ligand is almost completely buried with only 32 A2 still 
solvent accessible from its total 435 A  surface area (Muller et al., 2006) (Fig. 
1.17b). Both published SiaP structures agree that the carboxylate group of Neu5Ac 
forms a salt bridge with Arg147 and polar interactions with Asn187 of SiaP (Fig. 
1.18a). The carboxylate group is also coordinated with a salt bridge interaction with 
Arg127 that is located in the hinge region of the protein. Glu67 hydrogen bonds 
with the glycerol group and Asn10 interacts with the N-acetyl group. The structure 
o f SiaP bound to Neu5Ac also reveals that the oxygen o f the hydroxyl group at C2 
interacts with Asn187 and Arg127 (Fig. 1.18b (Johnston et al., 2008)). This was not 
observed in the structure with Neu5Ac2en because Neu5Ac2en does not have the 
hydroxyl group at C2.
The importance o f these interactions was ascertained by two different approaches; 
by altering the nature o f the ligand by using Neu5Ac analogues (Fig. 1.19), or 
altering the nature of the protein by introducing mutations into the binding site 
(Johnston et al., 2008, Muller et al., 2006). In the first approach, ESI-MS and 
tyrosine fluorescence spectroscopy were used to measure binding of ligand to 
SiaP (Muller et al., 2006). In the second approach an in vivo phenotype of LPS 
sialylation (measured by whole cell ELISA assays and matrix-assisted laser 
desorption/ionization time-of-flight mass spectroscopy (MALDI-TOF MS)) was used 
to determine the effects of point mutations in the binding site of SiaP (Johnston et 
al., 2008).
It is clear from the structures that residue Arg147 forms a salt bridge with the 
carboxylate group in Neu5Ac. The binding affinity for sialyl amide (Fig. 1.19f), an
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Figure 1.18 B inding site in te ractions between Neu5Ac2en and SiaP. (a)
Interactions between binding site residues of SiaP and Neu5Ac2en. Figure taken 
from Muller.e t a l (2006). (b) Stereo diagram of SiaP binding site in the presence of 
Neu5Ac (blue) or Neu5Ac2en (red) showing almost identical binding site 
architecture. Figure taken from Johnston e t a l (2008).
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Figures 1.19 Neu5Ac o rtho logues used in the b iophys ica l analysis o f SiaP 
b ind ing  determ inants. Structures shown; A/-acetylneuraminic acid (Neu5Ac), N- 
glycolylneuraminic acid (Neu5Gc), Neu5Ac2en, dNeu5Ac, 2-keto-3-deoxy-D- 
glycero-D-galactonononic acid (KDN), sialyl amide and 4-acetylaminocyclohexane 
carboxylic acid. The binding affinity of each compound for SiaP is indicated on the 
right. Figure modified from Muller e t a l (2006).
83
analogue of Neu5Ac that has replaced the carboxylate with an amide group, is 
found to be 2000-fold lower affinity than the affinity for Neu5Ac (243 pM compared 
to 0.12 pM for Neu5Ac). Reciprocally, if Arg147 is mutated to an alanine or lysine 
then LPS sialylation is completely abolished indicative of no transporter function. 
The importance of Arg147 for binding was also shown by the inability of SiaP to 
bind /V-acetylglucosamine (GIcNAc) and A/-acetylmannosamine (ManNAc), two 
compounds closely related to Neu5Ac that do not possess the carboxylate group 
(Severi et al., 2005). This indicates that Arg147 is an important factor in the high 
affinity binding o f Neu5Ac.
The importance of the A/-acetyl group for Neu5Ac binding to SiaP was assessed 
using analogues that either replaced the A/-acetyl group for a glycolyl group (A/- 
glycolylneuraminic acid, Fig. 1.19b) or completely removed the A/-acetyl group 
(KDN) (Fig. 1.19 e (Severi et al., 2005)). Biophysical analysis revealed that the 
presence of the glycolyl group reduced the affinity 2-fold and removal of the N- 
acetyl group reduced the affinity 350-fold (Severi et al., 2005). The structures of 
SiaP reveal that the Asn10 residue interacts with the /V-acetyl group. However, 
mutation of this residue to alanine did not reduce the observable level of LPS 
sialylation in vivo (Johnston et al., 2008).
The contribution o f the hydroxyl group at C2 was assessed by measuring the 
binding affinity of the Neu5Ac analogue, dNeu5Ac (Fig. 1.19d). This compound 
does not have the hydroxyl group, but is otherwise identical to Neu5Ac. The Kd 
determined for the binding of this compound was 34 pM, which is similar to the 
binding affinity o f Neu5Ac2en (~20 pM, Fig. 1.19c (Severi et al., 2005)) indicating 
that the lower affinity of Neu5Ac2en is due to the absence o f the C2 hydroxyl group 
and not the partial flattening o f the sugar ring. The C2 hydroxyl group was shown 
to interact with Arg127 and Asn187 in the SiaP structure with Neu5Ac bound 
(Johnston et al., 2008). If Asn187 is mutated to a glutamine then LPS sialylation 
still occurs at wildtype levels. If Arg127 is mutated, then LPS sialylation is 
completely abolished. However, Arg127 also interacts with the carboxylate group 
so is likely to be a more important residue than Asn187. The binding of Neu5Ac to 
the SiaP R127A mutant was also assessed using ITC and no binding was 
detectable, reinforcing the importance of this residue in the binding mechanism 
(Johnston et al., 2008).
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To determine whether the carboxylate and amino groups of Neu5Ac alone were 
sufficient for binding to SiaP, the binding affinity of the compound, 4- 
acetylaminocyclohexane carboxylic acid was assessed using tyrosine fluorescence 
spectroscopy (Muller et al., 2006). This molecule is a 6 carbon ring with the amino 
and carboxylate groups in analogous positions to Neu5Ac, but with all other 
Neu5Ac functional groups missing (Fig, 1.19g). There was no measurable binding 
indicating that the carboxylate group and the amino group are essential but not 
sufficient for high affinity binding.
1.10 Other ESRs working with TRAP integral membrane components
1.10.1 TAXI-type TRAP transporters
During phylogenetic analysis of the TRAP transporters, a family of ESRs with no 
sequence similarity to the DctP family of ESR has been found to be associated 
with the TRAP transporter integral membrane components (Fig. 1.20a (Kelly & 
Thomas, 2001, Rabus et al., 1999)). The first example o f these proteins was a cell 
surface component of Brucella abortus and many, if not all genes encoding these 
proteins are annotated as ‘immunogenic proteins’ (Mayfield et al., 1988). These 
ESRs are associated with the membrane components of TRAP transporter, and 
with no DctP homologue also associated, these immunogenic proteins are the 
obvious candidate for the ESR role. They also have all the characteristics o f ESRs; 
hydrophilic proteins, 300-400 amino acids long and possessing an N-terminal 
signal sequence (Kelly & Thomas, 2001). With no functional information available 
on these proteins, they were termed IRAP-associated extracytoplasmic 
immunogenic proteins (TAXI). Phylogenetic analysis has revealed that they form a 
discrete family of ESRs and analysis o f the genome context o f TAXI genes has 
shown them to be associated only with dctQM  fusion genes (Fig. 1.20a (Kelly & 
Thomas, 2001)). Another curious observation is that TAXI-TRAP transporters are 
the only type o f TRAP transporter archaea possess, however, TAXI-TRAP and 
DctP-TRAP transporters are widespread in bacteria possibly indicating that the 
TAXI-TRAP ESRs are the older of the two (Kelly & Thomas, 2001).
The only published functional data on TAXI-type ESRs is from a high-throughput 
structural genomics project in which the high resolution structure of a TAXI ESR
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Figure 1.20 Other ESRs in te racting  w ith  TRAP integral membrane 
com ponents, (a) Organisation of genes encoding TRAP transporters associated 
with TAXI-type ESRs. DctQ and DctM homologues shaded in dark and light blue 
respectively. Genes encoding TAXI-type ESRs shaded in yellow. TRAP-linked 
genes (tig , white with spots) encode proteins of unknown function. The ABC-type 
ESR, GlnH, shaded in green. Examples of the genetic organizations shown are 
indicated. Figure taken from Kelly & Thomas (2001). (b) Crystal structure of TAXI- 
type ESR bound to L-glutamate or L-glutamine. Figure taken from Takahashi e t a l 
(2004).
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was solved, however, the authors did not identify this protein as such (Fig. 1.20b 
(Takahashi et al., 2004). The crystal structure solved is of TTHA1157 from 
Thermus thermophllus HB8 and is associated with a DctQM-type integral 
membrane protein (Muller et al., 2006). Structure was solved in the presence and 
absence of ligand and the bound ligand was identified as either L-glutamate or L- 
glutamine, which fits in with other known TRAP substrates as it is an organic anion. 
Like SiaP and ABC ESRs, this ESR is a type II ESR composed of two globular 
domains separated by a hinge region (Takahashi et al., 2004). Interestingly, the 
architecture o f the binding site is completely different to that seen in SiaP with the 
carboxylate groups of the ligand coordinated by interaction via water molecules 
and amino acid residues glutamine, serine, threonine.
1.10.2 ABC-type ESR working with TRAP integral membrane components
Phylogenetic analysis of TRAP transporters has also revealed an example of the 
genes for TRAP transporter integral membrane proteins associated with a gene 
encoding an ESR homologous to GlnH, an ABC ESR from a glutamate transporter 
(Fig. 1.20a (Kelly & Thomas, 2001, Quintero et al., 2001)). The genes SII1102 and 
sll1103 are homologous to dctQ  and dctM  from R. capsulatus, respectively. The 
gene sll1104 is homologous to glnH  from E. coli and with no other candidate ESR 
genes in the vicinity it is assumed they are co-regulated and form a functional 
transporter (Kelly & Thomas, 2001). When the genes fo r the integral membrane 
components (SII1102 and SII1103) or the putative ESR (SII1104) are disrupted 
separately, Na+-dependent transport of glutamate decreases to 70-80% of 
wildtype. This indicates that all three genes encode proteins involved glutamate 
transport. The background (the remaining 70-80%) glutamate transport is caused 
by a Na+-dependent secondary transporter homologous to GltS from E. coli 
(Quintero et al., 2001).
1.11 Other notable TRAP transporters
1.11.1 A  dimeric DctP-type ESR
The gene takP  encodes a DctP-type (20% identity with SiaP) ESR from 
R. sphaeroides (Gonin et al., 2007). TakP and an orthologue from R. capsulatus
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have both been characterised using tryptophan fluorescence spectroscopy and 
found to be specific for the a-keto acids, pyruvate, oxobutyrate and oxovalerate 
(Gonin et al., 2007, Thomas et al., 2006). The structure o f TakP was solved and 
was found to be a homodimer with intricate helix swapping between the protomers 
ruling out crystal contacts as the source of dimerisation (Fig. 1.21a and b (Gonin et 
al., 2007)). Dimer formation was confirmed in solution using analytical size 
exclusion chromatography (SEC) and protein cross-linking (Gonin et al., 2007). 
The protomers are in a back-to-back configuration with a number o f hydrogen 
bonds and salt bridges stabilizing the complex. The 55 A long kinked helices that 
are swapped from one protomer to another are conserved in 100 homologues of 
TakP, including RRC01191 from R. capsuslatus, but not DctP from R. capsualtus 
(Mulligan and Thomas, unpublished data). The structure was solved in complex 
with sodium pyruvate indicating that sodium plays an important role in binding (Fig. 
1.21c).
It is currently unknown whether this dimeric configuration is a common feature of 
TRAP ESRs homologous to TakP, if there are any advantages to a dimeric ESR, 
or indeed how a dimeric ESR would interact with the membrane components.
1.11.2 A glutamate specific ESR-dependent secondary transporter from  
R. sphaeroides
A strain of R. sphaeroides 2.4.1 was isolated that was unable grow on L-glutamate 
as the sole carbon and nitrogen source, however, upon addition o f Na+ growth was 
restored (Jacobs et al., 1996). In vivo transport assays revealed high affinity 
transport of glutamate that was Na+-stimulated, however, osmotic shock treatment 
abolished transport indicating the presence o f an ESR. Experiments also revealed 
that this transporter was inhibited by ionophores, valinomycin and nigericin, but 
insensitive to orthovanadate. The ESR was purified from the periplasmic fraction 
and was shown to bind glutamate with a high affinity (1.2 pM) and the binding o f 
glutamate was not stimulated by the addition of Na+ ions (Jacobs et al., 1996). 
Vesicles from R. sphaeroides were isolated and transport was characterised in 
vitro. Uptake o f radiolabelled glutamate was only observed in the presence o f high 
concentration of Na+ ions and the purified ESR and uptake activity was reduced in 
the presence of ionophores and uncouplers. Radiolabelled glutamate taken into the
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Original in Colour
F igure  1.21 C rysta l s tru c tu re  o f d im e ric  TRAP ESR in com p lex  w ith  
sod ium  pyruvate , (a) TakP monomer colour-coded to differentiate the 2 
globular domains (yellow and blue) and the dimer forming helix (red), (b) 
Dimeric form of TakP. The same colour scheme is used as in (a), (c) TakP 
binding site showing presence of pyruvate and sodium (purple sphere). Figures 
taken from Gonin e t a l (2007).
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vesicles was not released (exchanged) upon addition o f 500-fold excess non- 
radiolabelled substrate as is observed in classical secondary transporters, like 
lactose permease (Jacobs et al., 1996). Unfortunately, the identity o f this 
transporter is unknown and R. sphaeroides 2.4.1 has 13 predicted TRAP 
transporters, therefore it is not possible to confirm whether this ESR-dependent 
secondary transporter is a TRAP transporter or not.
1.12 Tripartite tricarboxylate transporter (TTT) family
Members o f the TTT family of transporters are ESR-dependent secondary 
transporters found to be encoded on a number of bacterial genomes (Winnen et 
at., 2003). Members o f the TTT fam ily have very sim ilar characteristics to TRAP 
transporter despite there being no sequence similarity between them. TTT 
systems consists o f an ESR, one integral membrane component predicted to 
have 4 TMHs and a large integral membrane component predicted to have 12 
THMs, remarkably sim ilar to TRAP transporters (Forward et al., 1997, W innen 
et al., 2003). The first TTT system to be identified and characterised was the 
TctABC system from Salmonella typhlmurium, which has been shown to 
transport fluorocitrate, citrate and isocitrate in a Na+-dependent manner 
(Widenhorn et at., 1988) The ESR o f this system has been purified and 
characterised revealing it to be a dimeric protein that requires Na+ ions for 
optimal substrate binding (Sweet et al., 1979). The TctABC-type systems have 
only been found in bacteria, however, it is thought that the large membrane 
component, TctA is found in archaea without its auxiliary proteins, which 
suggests it is functioning as a standalone secondary transporter (Winnen et al., 
2003).
79 genes encoding predicted ESR proteins have been identified in Bordetella 
pertussis. The majority o f these so-called Bordetella uptake genes (Bug) are 
orphan ESRs and not encoded with any translocation machinery (Antoine e t al., 
2003). These Bug  genes have also been identified in a number o f other 
bacteria, but the only other bacteria to have as many Bug genes as Bordetella 
pertussis are Bordetella parapertussis, Bordetella bronchiseptica  and Ralstonia 
metallidurans, suggesting that this enrichment is lineage-specific (Antoine et al., 
2003). TctC has been found to be orthologous to these Bug genes (Antoine et 
al., 2003). High resolution structures o f two Bug proteins, BugD and BugE, from
B. pertussis have been elucidated (Huvent et al., 2006b, Huvent et al., 2006a).
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Both ESRs were crystallised with bound ligand. BugD binds aspartate and 
BugE binds glutamate (or glutamine), however, the overall binding site 
architecture is very sim ilar with both proteins utilising two H20  molecules to 
coordinate the ligand.
1.13 Expression and purification of bacterial integral membrane proteins
It is predicted that 5-10% of bacterial genomes and 3% of the human genome 
are dedicated to encoding transport proteins (Paulsen e t al., 2000, Paulsen et 
al., 1998, Venter et al., 2001). However, there is a dearth o f structural and 
functional information on integral membrane proteins when compared to soluble 
proteins. To study transport proteins biochemically and biophysically, large 
amounts o f purified protein are required, which is the major bottleneck for this 
work.
There are a number o f difficulties involved in the production o f integral 
membrane protein that makes them challenging to work with. Generally, integral 
membrane transporters make up a very low proportion o f the membrane 
proteome (<0.1% in most cases). This means harvesting transporters at their 
natural abundance would be incredibly laborious and often unfruitful, thus 
necessitating the development o f overexpression systems for transport proteins. 
However, overexpressing integral membrane proteins brings its own problems. 
Integral membrane proteins are inherently insoluble and are often found to be 
unstable in solution. They also need to be correctly inserted into the membrane 
to  function properly, which is a process reliant on a host o f other proteins. It has 
been observed in a number of instances that integral membrane protein 
expression leads to growth perturbation and/or cell death (M iroux & Walker, 
1996). A  proteomic study o f the consequences o f integral membrane 
overexpression revealed that growth perturbation was caused, in part, by the 
saturation o f the cytoplasmic membrane protein translocation machinery 
(W agner et al., 2007). Saturation o f the translocation machinery leads to  build 
up of cytoplasmic aggregates that include the overexpressed proteins 
themselves, chaperones, proteases and precursors o f periplasmic and outer 
membrane proteins. There was also a significant decrease in the levels o f 
respiratory chain complexes in the membrane and activation o f less efficient 
forms o f ATP production, which would decrease cell processes significantly 
(W agner et al., 2007). A  further problem with the production o f integral
membrane proteins is that once the protein has been successfully inserted into 
the membrane, it must then be extracted using detergents for purification. 
These processes can often lead to inactivation and aggregation o f the 
transporters. To overcome these problems a number o f key variables can be 
altered, two o f the most important are; the expression strain and the expression 
vector used. However, the overriding message from the literature is that 
expression o f integral membrane proteins is very subjective. It is therefore often 
more fruitful to use a number o f approaches simultaneously in order to attain 
successful overexpression.
1,13.1 Choice of expression strain
For expression of bacterial integral membrane transporters, E. coll is the 
expression strain o f choice due to its low cost, high growth rate, well 
characterised genetics and plethora o f available cloning vectors. Probably the 
most common E. coli expression host is BL21 (DE3) (Novagen). This strain is 
fo r use with genes expressed from a T 7 RNA polymerase based system such 
as the pET series o f vectors from Novagen. The (DE3) designation denotes the 
presence o f a chromosomal copy o f the T7 RNA polymerase gene under the 
control o f the isopropyl-/?-D-thiogalactopyranoside (IPTG)-inducible lacUVS 
promoter (Studier et al., 1990). BL21 (DE3) is deficient in the proteases Ion and 
ompT, to prevent interference with overexpressed protein accumulation. C41 
(DE3) and C43 (DE3) are strains o f E. coli derived from BL21 (DE3) (Miroux & 
W alker, 1996). These strains were derived by selecting fo r BL21 (DE3) mutants 
with increased resistance o f expression-induced toxicity. The exact mutations in 
C41 (DE3) and C43 (DE3) that allow it to overcome the toxic effects o f integral 
membrane protein expression are not known. However, it is believed that the 
mutations help to prevent the uncoupling o f transcription and translation which 
is believed to contribute to  these toxic effects. MC1061 is another strain of 
E. coli that is used fo r protein expression. MC1061 is used primarily with the 
arabinose-inducible pBAD vectors because it has the region o f its genome that 
encodes the catabolic genes fo r arabinose deleted (Casadaban & Cohen, 
1980). This allows persistence o f arabinose in the cell and continued protein 
induction.
Aside from E. coll, there are a number o f expression hosts that have been used 
to express many proteins with different properties. However, the other
expression host most pertinent to study is Lactococcus lactis. L  Jactis is a Gram 
positive, aerotolerant, lactic acid bacterium that is reported to possess a number 
o f characteristics that make it ideal for membrane protein expression (Kunji et 
a/., 2003). L. lactis is able to grow rapidly and requires no aeration for growth. It 
has tightly controlled promoter systems making expression o f toxic proteins 
possible. L. lactis possesses a small genome and has only one membrane 
making membrane protein purification easier. There are now a number o f 
studies available on the expression o f eukaryotic membrane proteins, which are 
particularly difficult to express in bacteria (Kunji et al., 2005, Kunji et al., 2003, 
Monne et al., 2005). The most commonly used L. lactis expression strain is 
NZ9000 (Kunji et al., 2003). This strain is a derivative o f MG1363 and has the 
genes encoding NisR and NisK integrated in the chromosome for use with the 
nisin A  inducible expression vectors (see below).
1.13.2 Choice o f expression vector
The choice o f expression vector is another major consideration when 
expressing integral membrane proteins. There are a number o f desirable traits 
an expression vector should have fo r the expression o f membrane proteins. 
Expression should be tightly regulated, which prevents leaky expression that 
can lead to proteolysis and cell death. The promoter system should not be too 
strong to prevent the formation o f inclusion bodies. Ideally, the promoter should 
be tightly controlled so that expression can be modulated.
The series o f pET vectors offers a variety o f options (>30 variants) and has 
been used to express a number o f membrane proteins, however, they are not 
ideal candidates. Expression from pET vectors is controlled by the T7 promoter, 
which is not recognised by the E. co li RNA polymerase, so is in theory tightly 
regulated. However, the T7 promoter is very strong, which has been shown to 
lead to cell death (Miroux & Walker, 1996). The arabinose inducible pBAD 
vectors are a better choice as expression is highly repressed in the absence of 
inducer and induction can be varied linearly between 0.00002% and 0.2% 
arabinose (v/v) (Guzman e t al., 1995). The pTTQ18 vector is under the control 
o f the moderately strong tac promoter (Stark, 1987). Expression is not tightly 
repressed as leaky expression has been observed when cells enter stationary 
phase (Ward, 2000). However, this vector has been extremely efficacious in the 
expression o f a number o f integral membrane proteins (Liang et al., 2005,
Morrison et a/., 2003, Saidijam et al., 2005, Saidijam et al., 2003). The 
expression vectors most commonly used in L. lactis are pNZ8048 variants. 
Expression from pNZ8048 is under the control o f nisA  promoter and is induced 
by addition of nisin A to the medium. Alternatively, it has been demonstrated 
that expression can be induced by addition o f the culture supernatant o f 
NZ9700, which is a strain o f nisin A-producing L. lactis (Kuipers et al., 1993). 
The nisin expression system is composed of a sensor kinase, NisK and the 
response regulator, NisR, which are both integrated into the chromosome of 
strain NZ9000 (Kuipers et al., 1993). Expression from pNZ8048 is tightly 
regulated controllable between 100- 10000-fold dilutions of NZ9700 culture 
supernatants making it a good alternative for integral membrane protein 
expression (Kunji et al., 2003).
Aims of this investigation
The aim of this study was to investigate the structure and mechanism of TRAP 
transporters using biochemical techniques.
The first priority was to develop an overexpression system for the production o f 
the integral membrane proteins from the Escherichia coli TRAP transporter, 
YiaMNO and the Haemophilus influenzae TRAP transporter, SiaPQM. It was 
hoped that at least one o f these transporters would be reconstituted into 
liposomes and its transport mechanism characterised using in vitro transport 
assays. It was also hoped that these integral membrane proteins would be 
characterised in vitro using other biochemical and biophysical techniques in 
order to answer some fundamental questions regarding these transporters.
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Chapter 2
Materials 
and methods
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2.1 Suppliers
All chemicals, reagents and media were purchased from New England biolabs 
(NEB), Sigma-aldrich, GE Healthcare, Oxoid, Promega, Pierce, Merck, Avestin, 
Applied Biosystems, Bio-rad, Bioline, Fermentas, Invitrogen, Qiagen and Avanti 
Polar Lipids.
2.2 Table of primers
See table 2.1 for details of the oligonucleotides used during PCR for the 
amplification o f DNA fragments.
2.3 Strains and plasmids
See table 2.2 and 2.3 for details o f the plasmids and bacterial strains used.
2.4 Media and antibiotics
2.4.1 M9 minimal medium
M9 minimal salts contained 6 g Na2H P 04, 3 g K2H P 04, 0.5 g NaCI and 1 g 
NH4CI per litre. For growth o f E. coli, these salts were supplemented with 0.2% 
glucose, 1 mM M gS 04 and antibiotics, if required. The growth of E. co// strain 
MC1061 in M9 required the addition o f the following; 40 mg/ml L-leucine, 40 
mg/ml L-isoleucine, 50 mg/ml 4-methyl-5-(£-hydroxyethyl) thiazole (THZ), 2 
mg/ml thiamine, 50 mg/ml nicotinic acid 100 mM FeS 04.
2.4.2 Enhanced M9 minimal medium
Enhanced M9 minimal medium was composed o f the same components as M9 
minimal medium except all the weights, percentages and concentrations were 
doubled. In addition, the following supplements were added; 25 pg/ml 
FeS 04.7H20 , 1 pg/ml riboflavin, 1 pg/ml nicotinamide and 1 pg/ml thiamine.
2.4.3 Luria-Bertani (LB) medium
LB was composed o f 10 g tryptone, 5 g yeast extract and 10 g NaCI per litre.
2.4.4 M17 medium
M17 medium was made by dissolving 37.25 g o f M17 (Oxoid) into 1 L dH20  and 
autoclaving. In addition, 0.5% glucose was added for growth.
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Name o f P rim er Sequence o f p rim er (5’-* 3 ’)
R estric tion
s ite
YiaMF
CCG G AATTCGCATATGAAAAAAATACTCGA
ACGAATACTGG
EcoRI
YiaMR
AAAACTGCAGCAGCTCCTTGCGGTGGCGAC
GTTAG
Pstl
YiaNF
CCGG AATTCG CATATG G CTG TG CTG ATTTT
TCTGGGCTG
EcoRI
YiaNhisR
AAAACTG CAG CATTAATCCATTTCAAAG G G
AGGATG
Pstl
SiaQMpTTQHisF
CCG G AATTCG CATATG AAATATATTAATAA
GCTTGAGG
EcoRI
SiaQMpTTQHisR
AAAACTG CAG CTG G TATCAATAG ATTTG G C
ACAAATG TG
Pstl
SiaP_Nfor_minSP
ATG G TG AG AATTTATATTTTCAAG G TG CTG
ATTATG A C TTA A A A TTC G G
LIC
SiaP_Cfor
ATG G G TG G TG G ATTTG CTATG AAATTG ACA
A A A C TTTTC C TTG C C
LIC
SiaP_Nrev
TG G G AGGGTGGGATTTTCATTATGGATTAA
T T G C T T C A A T T T G T T T T A A
LIC
SiaP_Crev
TTG G A A G TA TA A A TTTTC TG G ATTA A TTG C
T T C A A T T T G T T T T A A
LIC
SiaQMJMfor
A TG G TG AG AATTTATATTTTCAAG G TAAG T
ATATTAATAAG CTTG AG G AA
LIC
SiaQM_Cfor
A TG G G TG G TG G ATTTG CTAAATATATTAAT
AAGCTTGAGGAATGG
LIC
SiaQM_Nrev
TGGGAGGGTGGGATTTTCATTATGGTGGTA
TCAATAG ATTTG G CACAAATG T
LIC
SiaQM_Crev
TTG G A A G TA TA A A TTTTC TG G TA TC A A TA G
A TTTG G CACAAATG T
LIC
Table  2.1 D eta ils o f o lig o n u c le o tid e  p rim e rs  used fo r  a m p lifica tio n  o f  DNA 
fragm en ts .
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P lasm id  name D escrip tion
pTTQ18 E. coli expression vector Ampr
pBADnLIC2005
pBAD vector (Invitrogen) modified with LIC 
cassette
Ampr
pBADcLIC2005
pBAD vector (Invitrogen) modified with LIC 
cassette
Ampr
pNZ8048 L  lactis expression vector Chlr
pERL
L. lactis vector containing the pNZ8048 
origin o f replication
Erythr
pRY11 pET20b containing gene VC1779 Ampr
pES7 pWSK30 vector containing E. coli nanT Ampr
pCM14 yiaM  in pTTQ18 with C-terminal RGSH6 Ampr
pCM19 YiaN \n pTTQ18 with C-terminal RGSH6 Ampr
pCM20
yiaM N  in pTTQ18 with C-terminal RGSH6 
y/aA/(G368D) mutant
Ampr
pCM22 yiaMN  in pTTQ18 with C-terminal RGSH6 Ampr
pCM23
siaQM  in pTTQ18 with C-terminal RGSH6 
s/aQM(D322Y) mutant
Ampr
pCM23.1 siaQM  in pTTQ18 with C-terminal RGSH6 Ampr
pBADnSiaQM siaQM  in pBAD with N-terminal H-io Ampr
pBADcSiaQM siaQM  in pBAD with C-terminai H 10 Ampr
pBADnSiaP siaQM  in pBAD with N-terminal H10 Ampr
pBADcSiaP siaQM  in pBAD with C-terminal H10 Ampr
pNZnSiaQM siaQM  in pNZ9000 with N-terminal H-io Chlr
pNZcSiaQM siaQM  in pNZ9000 with C-terminal H10 Chlr
Table 2.2 Details of plasmids created or used during this study.
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B acteria l s tra in Bacteria l
species
G enotype Source
BL21 (DE3) E. coli F -  o m p l hsdSB(rB~, 
m B -) gal dcm  (DE3)
Novagen
MC1061 E. coli araD139 A(ara-leu)7696  
AlacX74 galU  galK  
hsdR2 (rK. mK+) mcrB1 
rpsL (F-)
(Casadaban 
Cohen, 1980)
&
DH5a E. coli K-12 F' 08Od/acZAM15 
recA1 endA1 gyrA26 thi- 
1 hsdR17 supE44 relA1 
deoR A(lacZYA- 
argF)U169]
Invitrogen
NZ9000 L. lactis (Kuipers et 
1993)
al.,
NZ9700 L  lactis (Kuipers et 
1993)
al.,
BW 25113A/ianT E. coli A(araD-araB)567, 
A/acZ4787(::rrnB-3), 
lambda*, rph-1, AfrhaD- 
rhaB)568, hsdR514, 
AnanT
(Baba et 
2006)
al.,
Table 2.3 D eta ils o f bacte ria l s tra in s  used d u rin g  th is  s tudy .
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2.4.5 Solid media
Solid media were made by mixing liquid media with 1.5% (w/v) agar.
2.4.6 Antibiotics
Antibiotic stock solutions were made and filter sterilized. The antibiotics were 
added to liquid or solid media such that the final concentrations were; 100 pg/ml 
ampicillin, 50 pg/ml kanamycin and 30 pg/ml chloramphenicol.
2.5 Buffers and solutions
2.5.1 SDS-PAGE
10x running buffer was composed o f 30 g/L Tris, 140g/L glycine and 10 g/L 
SDS.
Coomassie Brilliant Blue (CBB) dye consisted o f 45% methanol, 10% acetic 
acid and 0.25% Coomassie brilliant blue dye.
2.5.2 Western blotting
TBST (10x) was composed o f 24.2 g/L Tris, 80 g/L NaCI and 10 ml/L Tween 20 
and adjusted to pH 7.6 with concentrated HCI.
Transfer buffer (1x) was composed o f 14.41 g/L glycine, 100 ml/L methanol and 
25 mM Tris, pH 8.3.
PBST (1x) was composed o f 1.088 g/L KH2P 0 4, 4.544 g/L Na2H P 04, 13.444 
g/L NaCI and 1% Tween 20.
TBSTT (1x) was composed o f 20 mM Tris pH 7.5, 500 mM NaCI, 0.05% (v/v) 
Tween 20 and 0.2% Triton X-100.
2.5.3 Agarose gel electrophoresis
TBE (1 Ox) was composed o f 108 g/L Tris, 55 g/L orthoboric acid and 9.3 g/L 
sodium EDTA (ethylenediaminetetraacetic acid). This solution was diluted 10- 
fold to produce a working solution fo r agarose gel electrophoresis o f DNA 
samples.
Agarose gels were constructed by dissolving 1% (w/v) agarose into 1x TBE 
buffer.
Sample buffer consisted o f 10% (v/v) glycerol, 0.025% (w/v) bromophenol blue 
in 10 mM Tris-HCI, pH 7.5, and 1 mM EDTA.
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2.6 General cloning techniques
2.6.1 Agarose gel electrophoresis
1 % (w/v) agarose gels were made by pouring molten agarose directly Into a 
horizontal electrophoresis tank, adding combs to produce appropriately sized 
wells and allowed to set. Solid agarose gels were submerged in TBE buffer 
(1x).
Samples were prepared by mixing 8 pi DNA sample with 5x stock o f sample 
buffer and loading into a well. 50pl of 10 mg/ml ethidium bromide solution was 
added to the TBE buffer at the anode end o f the electrophoresis tank and 
electrophoresis was performed fo r -4 5  minutes at a constant 80 V. DNA was 
visualized under UV light using a transillum inator (Syngene).
2.6.2 Polymerase chain reaction (PCR)
PCR was used for the amplification o f genes fo r cloning. High fidelity DNA 
polymerases were used throughout, fo r example, KOD Hotstart (Novagen). A 
standard PCR reaction consisted o f KOD PCR buffer (1x), 0.2 mM each dNTPs, 
1 mM MgS04, 0.5 pM 3’- and 5’-primers, 1 unit KOD polymerase and either 
genomic or plasmid DNA template. A  thermocycler (Techne) was used and the 
standard program was initial denaturation at 94°C for 5 minutes followed 30 
cycles o f 94°C for 30 seconds, 60°C for 60 seconds and 72°C for 6 minutes.
2.6.3 Preparation of DNA fragments for cloning
2-6.3.1 Preparation o f plasmid DNA
Plasmid DNA was prepared from bacterial strains using a Miniprep kit (Qiagen) 
that employs the alkaline lysis method fo r plasmid recovery. The manufacturers 
recommended protocol was used.
2-6.3.2 Gel extraction
This method was used when the target DNA fragment was contaminated with 
other DNA. The commercially available QIAquick gel extraction kit (Qiagen) was 
used. The manufacturers recommended protocol was used.
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2.6.3.3 PCR clean-up
This method was used to remove unwanted, non-DNA contaminants, such as 
PCR reaction components, from a pure DNA fragment. The commercially 
available QIAquick PCR clean-up kit (Qiagen) was used. The manufacturers 
recommended protocol was used.
2.6.4 L iga tion -dependen t c lon in g
This cloning method consisted o f treating vector DNA (“vector”) and the DNA 
fragment to be inserted (“insert”) with restriction enzymes and then ligating the 
insert and vector together. A  standard 35 pi restriction enzyme treatment 
consisted o f 15 pi DNA (either insert or vector), 1 pi o f restriction enzyme(s) o f 
choice, 3.5 pi compatible 10x buffer and made up to 35 pi with dH20 . The 
reaction is incubated for between 1 and 18 hours at 37°C. The DNA is then 
purified, either by gel extraction or PCR clean-up.
A standard 15 pi ligation reaction consisted o f an insert DNA to vector DNA 
molar ratio of at least 2 :1,1 pi £. coli ligase (NEB) or T4 DNA ligase (Promega), 
Ligase buffer and made up to 15 pi with dH20 . The reaction was incubated at 
room temperature overnight.
2.6.5 L iga tion -independen t c lon in g  (LIC)
This method was used in the cloning of SiaP and SiaQM into pBAD vectors; 
pBADnLIC2005 or pBADcLIC2005 (Geertsma & Poolman, 2007). These vectors 
are modified versions o f the commercially available pBAD vectors with the 
inclusion o f a LIC cassette at the site o f cloning (modified by Dr. Eric 
Geertsma).
Primers were designed such that a dedicated LIC tail was added to the PCR 
product, which was designed to be complementary to the LIC cassette in 
pBADnLIC2005 and pBADcLIC2005 (see Methods section 2.1 for Table of 
Primers). The gene o f interest was amplified using PCR and purified using gel 
extraction. The vector was prepared by digestion with Swal (1 pl/2.5 pg DNA) 
fo r 3 hours at 25°C. The linearised vector was purified by gel extraction.
Both the insert and vector DNA were treated with T4 DNA polymerase 
(Promega). The 3’-* 5 ’ exonuclease activity o f T4 DNA polymerase produces 
long, complementary overhangs on the vector and the insert. To do this, 200 ng 
o f linearised vector was made up to 10 pi with dH20  and treated with T4 DNA
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polymerase in the presence o f dCTP (1.5 pi 25 mM dCTP, 3 pi 5x buffer and 
0.5 pi T4 DNA polymerase). The reaction was Incubated at room temperature 
for 30 minutes, after which T4 DNA polymerase was deactivated by Incubation 
at 75°C for 20 minutes. A  volume of Insert DNA corresponding to a 1:1 molar 
ratio with vector was treated with T4 DNA polymerase but this, time in the 
presence o f dGTP. Both the “LlC-ready” Insert and vector can be stored stably 
at 4°C fo r several months.
The LlC-ready components were mixed in a 1:3 ratio of vector to insert and 3 pi 
o f this mixture was transformed into competent cells using standard methods.
2.6.6 Vector backbone exchange (VBEx) into L  lactis  pNZ8048 vector
(Geertsma & Poolman, 2007)
The cloning o f SiaQM Into the L. lactis vector pNZ8048 was achieved using 
vector backbone exchange (VBEx). This method was developed to avoid DNA 
manipulations In L  lactis. An intermediate vector was developed by fusing an 
E. coli vector with the region of the pNZ8048 vector (L  lactis  vector) relevant for 
cloning. All DNA manipulations, i.e. insertion of gene Into the vector, could then 
take place in E. coli. When the desired construct was achieved the pNZ8048 
region o f the vector could be excised and ligated into the L. lactis vector, pERL, 
which can then be transformed into L. lactis.
2.6.7 Transformations
2-6.7.1 Making chemically competent E. coli
To chemically induce competence in E. coli, a 10 ml LB culture o f the desired 
strain was incubated overnight. 1 ml o f this culture was diluted 10-fold and 
allowed to grow to an optical density (OD65o) o f 0.4-0.5 at which point the cells 
were kept on ice. The cells were separated into 1 ml aliquots in sterile 1.5 ml 
tubes. The cells were harvested by centrifugation at 5000 rpm for 10 minutes 
and then resuspended in 1 ml ice-cold 100 mM CaCI2. The cells were incubated 
on ice fo r 1 hour and then harvested by centrifugation at 5000 rpm for 10 
minutes. The aliquots o f cells were resuspended in 200 pi ice-cold 100 mM 
CaCI2 each and incubated on ice fo r 20 minutes. The chemically competent 
cells could be used immediately or, with the inclusion o f 20% glycerol in the final
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resuspension, could be snap frozen with liquid nitrogen or dry-ice/ethanol and 
stored at -80°C for future transformations.
2 .6 1 .2  Transformation of chemically competent cells: freeze-thaw method 
This transformation method was used solely fo r the movement o f plasmid DNA 
into a desired strain and not fo r transforming competent cells with a ligation 
reaction. A 5 ml culture o f the desired strain was grown overnight in LB and 
then refreshed in the morning by diluting 0.5 ml of the overnight culture with 4.5 
ml of LB. This culture was then grown aerobically for a further hour at 37°C. The 
cells were harvested by centrifugation at 5000 rpm fo r 10 minutes and the 
supernatant was discarded. The cell pellet was resuspended in 600 pi ice-cold 
50 mM CaCl2 and divided into 6 x 100 pi aliquots. These aliquots were kept on 
ice until they were required. 1-2 pi o f concentrated plasmid DNA was added to 
an aliquot o f cells, mixed by vortrexing and snap frozen using liquid nitrogen o r 
a dry-ice/ethanol bath. Once the mixture was frozen (-1  minute) it was quickly 
thawed by incubation at 37°C for no longer than 2 minutes. 1 ml o f LB was 
added to the mixture and then incubated fo r 1 hour at 37°C, after which, 100 pi 
o f the cell suspension was spread on a selective LB agar plate. The plates were 
incubated overnight at 37°C.
2.6.7.3 Transformation of chemically competent cells: heat shock method 
This method o f transformation can be used fo r the transformation o f the desired 
E. coli strain with both plasmid DNA or ligation products. This method required 
a stock of ready-made chemically competent cell (for details, see Methods 
section 2.6.7.1). An aliquot o f chemically competent cells was allowed to thaw 
on ice. 1 -2 pi of plasmid DNA or a volume of ligation reaction was added to the 
cells. The mixture was missed by vortexing and incubated on ice for a further 30 
minutes. The mixture was incubated fo r 1.5 minutes at 42°C, then had 1 ml o f 
LB added and was incubated at 37°C fo r 1 hour. A fter 1 hour, 100 pi o f the cell 
suspension was spread on a selective LB agar plate, the remaining cell 
suspension was harvested by centrifugation and resuspended in 100 pi LB and 
spread on a second selective LB agar plate. All plates were incubated at 37°C 
overnight.
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2.7 Growth of bacteria
2.7.1 Initial trial for expression from pTTQ18-derived vectors in E. co li
2 x 250 ml flasks containing 50 ml LB (supplemented with 20 mM glycerol and 
100 pg/ml o f ampicillin) were inoculated to an optical density (OD6so) of 0.1 from 
a 5 ml overnight culture of the particular E. coli expression strain. The cultures 
were grown to mid-log phase (OD65o o f 0.5) at 37°C with aeration, at which point 
one flask was induced with 0.5 mM IPTG and the other was left uninduced. The 
cultures were grown for a further 3 hours before being harvested by 
centrifugation.
2.7.2 Initial trial for expression from pBAD-derived vectors in E. coli
2 x 6 ml LB media (supplemented with 0.5% glycerol and 100 pg/ml ampicillin) 
were inoculated with 60 pi (1 % inoculum) o f a 2 ml overnight culture o f the 
particular E. coli expression strain. The culture was grown aerobically to mid-log 
phase (OD65o o f 0.5) at 37°C, at which point expression was induced by the 
addition o f 0.005% L-arabinose. The culture is grown for a further 2 hours 
before being harvested by centrifugation at 5000 rpm for 15 minutes.
2.7.3 Initial trial for expression from pNZ8048-derived vectors in L. lactis
10 ml of (M17 supplemented with 1% glucose and 50 pg/ml chloramphenicol) 
was inoculated with 200 pi (2% inoculum) o f a 2 ml overnight culture o f the 
particular L. lactis expression strain. The culture was grown anaerobically to 
mid-log phase (ODeoo o f 0.5) at 30°C, at which point expression was induced by 
the addition o f 1/5000 dilution o f culture supernatant from the nisin A  producing 
strain o f L. lactis NZ9700. The culture was grown fo r a further 2 hours before 
being harvested by centrifugation at 5000 rpm for 15 minutes.
2.7.4 Standard timecourse experiment for expression from pTTQ18 
derivatives
This protocol was used for the optimization of growth temperature, growth 
medium and harvest time for accumulation o f integral membrane proteins 
expressed from the pTTQ18 system.
650 ml LB (supplemented with 20 mM glycerol and 100 pg/ml o f either 
carbenicillin or ampicillin) or M9 minimal media (supplemented with 0.2%
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casamino acids and 100 |jg/m l of ampicillin) were inoculated to OD65o o f 0.1 
with overnight cultures o f the particular E. coH strain. Cultures were grown, with 
aeration, at 37°C or 25°C. All cultures were grown to mid-log phase and induced 
with 0.5 mM IPTG. Samples o f the cultures were taken every hour after 
induction for 4/5 hours. A  sample was also taken from the culture after overnight 
growth.
2.8 Preparation o f bacterial extracts
2.8.1 Preparation of total membrane extracts using the water lysis method
(W itholt & Boekhout, 1978)
This method was primarily used for the analysis o f membrane fraction content 
during expression optimization o f integral membrane proteins.
Bacterial cell culture is harvested by centrifugation at 5000 rpm for 15 minutes 
at 4°C (SLC6000 rotor in Sorvall Evolution centrifuge). The cell pellet was 
resuspended in 10 ml 200 mM Tris, pH 8, and incubated at room temperature 
for 20 minutes. After 20 minutes, 4.85 ml buffer containing 1 M sucrose, 200 
mM Tris, pH 8,1  mM EDTA was added and incubated fo r 1.5 minutes. 65 pi 10 
mg/ml lysozyme solution (prepared freshly in dH20 )  was added after 1.5 
minutes and incubated for a further 30 seconds, at which point 9.6 ml dH20  was 
added. The suspension was incubated at room temperature fo r 20 minutes.
The resultant sphaeroplasts were collected by centrifugation at 18000 rpm for 
20 minutes at 4°C (SS34 rotor in Sorvall Evolution centrifuge). The supernatant 
(periplasmic fraction) was discarded. The sphaeroplast pellet was resuspended 
in 15 ml dH20  and incubated at room temperature for 30 minutes. The 
membrane fraction was collected by centrifugation at 18000 rpm for 20 minutes 
at 4°C (SS34 rotor in Sorvall Evolution centrifuge). The supernatant 
(cytoplasmic fraction) was discarded. The membrane fraction was washed twice 
with 30 ml o f buffer containing 100 mM sodium phosphate, pH 7.2, and 1 mM 0- 
mercaptoethanol and then resuspended in a small volume o f this buffer 
(typically ~50-200 pi). Membrane fractions were stored at -20°C.
2.8.2 Preparation o f total membrane extracts using the a FastPrep 
machine
This method was used to prepare total membrane fractions from small bacterial
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cultures during expression test and expression optimization.
A  small volume bacterial culture (typically 5ml) o f bacterial culture was 
harvested by centrifugation and resuspended in 0.6 ml 50 mM potassium 
phosphate, pH 7, 10% glycerol, 10 mM M gS04 and 0.1 mg/ml DNase. 300 mg 
of glass beads were added to the cell suspension and the cells are ruptured 
using a Fastprep machine (Q-biogene) at force 6 setting for 20 seconds. 
Samples were cooled on ice for 5 minutes and 5 mM EDTA was added. 
Samples are centrifuged at 20000xg for 15 minutes at 4°C (Sigma 2-18K 
refrigerated centrifuge) and the supernatant is centrifuged again at 100000 rpm 
fo r 30 minutes at 4°C (TLA100.1 rotor in a Beckman Coulter TL100 
ultracentrifuge). The resultant pellet (the mixed membrane fraction) is 
resuspended in 1x SDS PAGE sample buffer and loaded onto an SDS-PAGE 
gel for analysis.
2.8.3 Preparation of total membrane extracts from E. co li and L. lactis
This method was used primarily fo r the preparation o f membrane extracts from 
large volume cultures.
Harvested E. coli cells were ruptured by at least 2 passes through a French 
pressure cell (Thermo) at 10000 psi in the presence of 100 pg/ml 
deoxyribonuclease I (Sigma) and 1 mM MgCI2. Lysate was incubated on ice for 
5 minutes and 5 mM EDTA, pH 7, was added.
Harvested L. lactis cells were ruptured by 30 minute incubation with 10 mg/ml 
lysozyme followed by at least 4 passes through a French pressure cell 
(Thermo) at 10000 psi in the presence o f 100 pg/ml deoxyribonuclease I 
(Sigma) and 1 mM MgCI2.
Cell lysate from both cultures were incubated on ice fo r 5 minutes and 5 mM 
EDTA, pH 7, was added. Unbroken cells and cell debris were removed by 
centrifugation at 13000 rpm for 20 minutes at 4°C (SS34 rotor in Sorvall 
Evolution centrifuge). The supernatant was centrifuged at 45000 rpm for 1 hour 
at 4°C (Ty70Ti rotor in a Beckman L7-65 ultracentrifuge) and the membrane 
pellets were resuspended in 50 mM KPi, pH 7. Mixed membrane vesicles were 
snap-frozen in liquid nitrogen and stored at -80°C.
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2.8.4  Separation o f E. c o li inne r and o u te r m em branes us ing  sucrose  
d e n s ity  g rad ien t
A  sucrose density gradient was prepared with percentages o f sucrose (in 20 
mM Tris pH 7.5) ranging from 30% to 55%, in 5% increments, in a 70 ml Ti45 
ultracentrifuge tube (Beckman Coulter) with the highest density sucrose solution 
at the bottom and the lowest density (30%) at the top.
E. coli mixed membrane vesicles were prepared (see Methods section 2.8.3) 
and were applied to the top of the sucrose density gradient. The gradient was 
centrifuged at 38000 rpm for 16 hours at 4°C (Ty45Ti in a Beckman L60 
ultracentrifuge). To maintain the integrity o f the gradient slow acceleration was 
used and no brakes were applied for deceleration.
A fter the 16 hour centrifugation step, the gold-coloured inner membrane (at 35- 
40%) was separated from the white outer membrane (45-50%) using a large 
needle. The inner and outer membrane fractions were diluted by at least 3-fold 
and placed into separate, clean Ty45Ti ultracentrifuge tubes. The membrane 
fractions were harvested by ultracentrifugation at 45000 rpm for 2 hours at 4°C 
(Ty45Ti in a Beckman L60 ultracentrifuge). The membrane fractions were finally 
resuspended in 20 mM Tris pH7.5 and snap frozen in liquid nitrogen or dry- 
ice/ethanol and stored at -80°C.
2.8.5 P e rip lasm ic  p repara tion  us ing  lysozym e trea tm en t (Neu & Heppel, 
1965)
The cells were harvested by centrifugation at 5000 rpm for 15 minutes 
(SLC6000 or SS34 rotor in Sorvall Evolution centrifuge). The subsequent pellet 
was resuspended in 15 ml ice-cold 50 mM KPi pH7.8 per litre o f cells in the 
original culture. The resuspended cells were centrifuged at 12000 rpm for 5 
minutes at 4°C (SS34 rotor in Sorvall Evolution centrifuge). A fter centrifugation, 
the supernatant was discarded and the cell pellet was resuspended in SET 
buffer (0.5 M sucrose, 5 mM EDTA, 50 mM KPi pH 7.8 and 600 pg/ml 
lysozyme) in a ratio o f 10 ml per litre o f cells in the original culture. This 
suspension was incubated for 1 hour at 30°C. The subsequent sphaeroplasts 
were harvested by centrifugation at 12000 rpm for 30 minutes (SS34 rotor in 
Sorvall Evolution centrifuge); the supernatant from this centrifugation was the 
periplasmic fraction.
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2.9 P ro te in  concen tra tion  de te rm ina tion
2.9.1 B rad fo rd  assay
A set o f protein standard was produced by serially diluting a stock solution of 
bovine serum albumin (BSA) from 400 pg/ml to 6.25 pg/ml. The protein o f 
unknown concentration was serially diluted by at least 6 times. 50 pi of each 
dilution o f BSA and unknown sample was added to 1 ml o f Bradford reagent 
(Bio-rad) in a cuvette. The absorbance was measured at 595 nm wavelength. A 
graph o f protein concentration versus absorbance (A595) was plotted and the 
concentrations o f the unknown samples calculated by comparison to the 
standard curve.
2.9.2 B ic in ch o n in ic  acid  (BCA) p ro te in  assay
A  commercial BCA assay (Pierce) was used. The assay was performed 
according to the manufacturer’s recommendations. Briefly, a BSA standard 
curve was produced ranging from 900 to 28.125 pg/ml. Protein samples o f 
unknown concentration were serially diluted 5x, 10x, 20x, 40x, 80x and 160x. 
W orking reagent was made by mixing 50 parts Reagent A (Bicinchoninic acid) 
w ith 1 part Reagent B (4% cupric sulphate). 20 pi o f each standard and sample 
was mixed with 180 pi working reagent in a 96-well plate and incubated at 37°C 
fo r 30 minutes. A plate reader was used to read the absorbance values at 562 
nm, a standard curve was plotted o f absorbance (A562) versus protein 
concentration and the concentrations o f the unknown samples was determined.
2.9.3 S chaffner-W eissm ann p ro te in  assay (Schaffner&  Weissmann, 1973)
A  number o f BSA standards were made ranging from 0-20 pg protein made up 
to a volume of 270 pi. The sample o f unknown concentration was diluted 10-fold 
and 4 pi was added to 266 pi dH20. Each sample was treated with 30pl o f 1M 
Tris, pH 7.5, 10% (w/v) SDS and vortexed. The protein in each sample was 
precipitated by addition o f 60 pi 60% (w/v) trichloroacetic acid (TCA). Using a 
vacuum manifold the sample was applied to filter paper (Type HA, 0.45 pm, 
Millipore). The filter paper was then washed with 2 x 2 ml 6% TCA.
The filte r paper w ith bound protein were stained fo r 3 minutes in a Petri dish 
containing 30 ml 0.1% Naphthalene Biack (Sigma-aldrich) in methanol, acetic 
acid and H20  (45:10:45 v/v). The filters were rinsed in dH20  and destained in
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30 ml methanol, acetic acid and dH20  (90:2:8 v/v). The Individual protein spots 
were excised and transferred to a 1.5 ml eppendorf tube. The stain was eluted 
with 1 ml 25 mM NaOH and 50 pM EDTA in 50% aqueous ethanol. The 
absorbance was measured at 630 nm, the standard curve o f absorbance versus 
concentration was plotted and the concentration o f the unknown sample was 
determined.
2.9.4 Using A28o/extinction coefficient
The molecular weight and the extinction coefficient o f purified proteins were 
calculated using the peptide property calculator tool on the Innovagen website 
(www.innovagen.se). Absorbance (A28o) o f protein solution was measured using 
either a Fluoromax-3 fluorimeter o r a Nanodrop ND-1000 Spectophotometer 
system. Protein concentration was determined using the Beer-Lambert law.
2.10 SDS-PAGE
2.10.1 Molecular weight markers
During this project a number o f different molecular weight markers have been 
used. Rainbow marker (GE Healthcare, #RPN756) was used for W estern blots 
performed in Leeds, "SDS-7 Dalton Mark V ll-L  for SDS gel electrophoresis" 
(Sigma-Aldrich) was used for Coomassie stained SDS PAGE gels in Leeds and 
Prestain protein marker, Broad range (New England Biolabs) was used for both 
Western blotting and Coomassie stained SDS PAGE gels in York. Prestained 
ladder (Fermentas) was used fo r W estern blots in Groningen and a low 
molecular weight ladder was used for Coomassie stained SDS PAGE gels.
2.10.2 Sample preparation for SDS-PAGE
The desired amount o f protein (pg) was mixed with dH20  and 4 x sample buffer 
consisting o f 200 mM Tris, pH 6.8, 8% (w/v) SDS, 0.4% (w/v) bromophenol 
blue, 40% glycerol and 50 pl/ml yff-mercaptoethanol.
Soluble protein samples (e.g. periplasmic binding proteins) were composed as 
above, boiled at 95°C fo r 5 minutes and centrifuged for 1 minute at 13000 rpm 
before being loaded onto the gel. Samples containing integral membrane 
proteins were composed as above, but were not boiled or centrifuged before 
loading.
I l l
2.10.3 Mini-SDS PAGE gels
Most applications of SDS-PAGE were performed with the Mini-PROTEAN 3 Cell 
system (Bio-rad) using 12% agarose resolving gels and 4% agarose stacking 
gels. The manufacturer’s guidelines were used fo r the assembly o f the SDS- 
PAGE apparatus. A 10 ml solution o f 12% resolving gel was made by mixing
3.4 ml dH20 , 4 ml Protogel (30% acrylamide, 0.8% bisacrylamide), 2.5 ml 1.5 M 
Tris, pH 8.8, 100 pi 10% SDS, 100 pi ammonium persulphate (APS) and finally 
10 pi N, N, N’, N-tetramethylethylenediamine (TEMED). A  10 ml solution o f 4% 
stacking gel was made by mixing 6.1 ml dH20 , 1.3 ml Protogel (30% 
acrylamide, 0.8% bisacrylamide), 2.5 ml 0.5 M Tris, pH 6.8, 100 pi 10% SDS, 
100 pi APS and finally 10 pi TEMED. The SDS-PAGE tank buffer consisted of 3 
g/L Tris, 14 g/L glycine and 1 g/L SDS. SDS-PAGE was performed at a 
constant 200 V  fo r ~45 minutes.
2.10.4 Large SDS-PAGE gels
The SDS-PAGE gels performed in Professor Peter Henderson’s laboratory in 
Leeds were large (~ 17 x 11 cm gels) 15% gels, however, a sim ilar protocol to 
that used for the Mini-PROTEAN 3 Cell system was applied with the following 
modifications; the 15% resolving gel consisted o f 4.22 ml 40% acrylamide, 0.49 
ml bisacrylamide, 2.81 ml 1.5 M Tris, pH 8.7, 100 pi 10% SDS, 3.48 ml dH20 , 
37 pi 10% APS and 12 pi TEMED. The 3% stacking gel consisted o f 0.77 ml 
40% acrylamide, 0.39 ml bisacrylamide, 0.75 ml 0.5 M Tris, pH 6.8, 50 pi 10% 
SDS, 3.2 ml dH20 , 30 pi 10% APS and 9 pi TEMED. Electrophoresis was 
perforemd at a constant 23 mA fo r approximately 2 hours.
2.10.5 Staining/destaining SDS-PAGE gels
Coomassie Brilliant Blue (CBB) dye was used to detect proteins on SDS-PAGE 
gels. CBB consists of 2.5 g Coomassie Brilliant Blue, 450 ml methanol, 450 ml 
dH20  and 100 ml acetic acid. Gels were removed from the SDS-PAGE 
apparatus and washed briefly with H20  to remove excess SDS. The gel was 
submersed in approximately 30-50 ml o f CBB dye and incubated fo r 5-10 
minutes with agitation. The excess CBB was then poured o ff and the gel was 
briefly rinsed with H20  to remove the residual dye. Approximately 100 ml o f 
destain containing 10% acetic acid and 10% ethanol was added and heated at
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full power in a 750 W  microwave for 30 seconds. The gel is left to destain with 
agitation overnight.
2.11 Western Blotting
Different Western blotting protocols were used in the three laboratories where 
the work was performed. Almost all o f the Western blotting for YiaM expression 
and purification was performed in Leeds using semi-dry transfer. Western 
blotting o f YiaN and SiaQM expressed from the pTTQ18 system were 
performed in York with wet transfer system. Western blotting o f SiaQM and 
SiaP produced from pBAD and pNZ8048 was performed in Groningen with a 
semi-dry transfer system. The following protocols detail the W estern blotting 
procedures used in each laboratory.
2.11.1 W et transfer of protein
W et transfer from SDS-PAGE gel to nitrocellulose membrane (GE Healthcare) 
was performed using a Mini Trans-Blot electrophoretic transfer cell (Bio-rad). 
Assembly o f the apparatus and protein transfer was performed according to the 
manufacturer’s guidelines. The wet transfer was performed at 350 mA for 1 
hour in the presence o f a cooling unit and constant stirring.
2.11.2 Semi-dry transfer of protein
Semi-dry transfer was performed using a Trans-Blot SD Semi-dry 
electrophoretic Transfer Cell (Bio-rad). Assembly of the apparatus and protein 
transfer was performed according to the manufacturer’s guidelines. In the Leeds 
laboratory, the transfer buffer was 0.5x SDS-PAGE running buffer and PVDF 
membrane (Pall) was used. In the Groningen and York laboratories and the 
transfer buffer consisted o f 5.82 g/L Tris, 2.93 g/L glycine and 200ml/L methanol 
and nitrocellulose membrane (GE Healthcare) was used. The transfer was 
performed at either 52 mA for 2 hours (in Leeds), 80 mA for 30 minutes (in 
Groningen) or 15 V for 30 minutes (in York).
2.11.3 Processing the membrane after protein transfer (York)
The post-transfer membrane is incubated with 10 ml Ponceau S stain (Sigma 
Aldrich) fo r 15 minutes at room temperature. A fter analysis o f the Ponceau S
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stained membrane, the stain was washed o ff with H20  and incubated in 20 ml 
blocking solution (20 ml TBST and 5% milk powder) for 30-60 minutes at room 
temperature. The blocking solution was removed and the membrane was 
washed with 20 ml TBST for 15 minutes followed by a further 2 x 5  minute 
washes. The membrane was incubated with 1° hybridization buffer (5 ml TBST, 
1% milk powder and a 1/2000 dilution o f anti-tetrahis (mouse) antibody 
(Qiagen)) overnight at 4°C. After incubation with the 1° hybridization buffer, the 
membrane was washed with TBST for 15 minutes followed by 3 washes at 5 
minute intervals at room temperature. The membrane was then incubated with 
2° hybridization buffer (20 ml TBST, 1% milk powder and 1/5000 dilution o f 
rabbit anti-mouse IgG (H+L) HRP conjugate (Zymax)) for 1 hour at room 
temperature. The membrane was washed with TBST for 15 minutes followed by 
6 washes at 5 minute intervals. The visualization of the histidine-tagged proteins 
took place in the dark room and was performed using either the Amersham ECL 
kit or the Pierce Supersignal ECL kit. Both were performed using the 
manufacturer's guidelines.
2.11.4 Processing the membrane after protein transfer (Groningen)
The membrane is blocked PBST and 0.2% l-Block (Applied Biosystems) 
overnight at 4°C. The rest of the protocol is performed by a home-made, 
automated Western blotting machine named “Blot-o-matic” . The protocol that is 
performed is as follows; the membrane is blocked for at least 60 minutes, but 
can be left as long as is necessary. The membrane is then incubated with a 
solution containing PBST, 0.1% l-block and 100 mM EDTA for 60 minutes. It is 
then washed 3 times with PBST containing 0.1% l-Block and then incubated 
with 1o hybridization solution. This solution contains 10 ml PBST containing 
0.1% l-block and a 1/3333 dilution o f 1° antibody. The membrane is then 
washed 3 times with PBST containing 0.1% l-block and incubated with 2° 
antibody solution which consists o f 10 ml PBST containing 0.1% l-block and a 
1/5000 dilution of 2° antibody. The membrane is then washed 3 more times with 
PBST containing 0.1% l-block.
The membrane is washed twice with assay buffer. This consists o f 5.62 g 
diethanolamine, 1 mM MgCI2 and 0.5 ml concentrated HCI in 500 ml ddH20 . 
The membrane is incubated for 5 minutes with Nitroblot solution which is 2 ml o f 
assay buffer and 200 pi Nitroblock (Applied Biosystems). The membranes are
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then washed twice with assay buffer with 5 minute intervals and the CSPD 
solution is added and incubated for 5 minutes. The CSPD solution contains 2 ml 
assay buffer and 10 pi CSPD (Applied Biosystems). The CSPD solution is 
poured off and the membrane is rinsed with assay buffer. The his-tagged 
proteins are visualized using a Fujifilm Intelligent Dark Box II.
2.11.5 Processing the membrane after protein transfer (Leeds)
After transfer the membrane is washed with TBSTT for 10 minutes and then 
incubated with blocking solution overnight at 4°C. The blocking solution consists 
o f 20 ml TBSTT and 3% BSA. The blocking solution is removed and the 
membrane is washed twice with 10 ml TBSTT after which the membrane is 
incubated with 1/5000 dilution (in TBSTT) o f INDIA Hisprobe-HRP (Pierce). The 
use o f this particular 1° antibody foregoes the need for a 2° antibody, so after an 
hour the antibody solution is discarded and the membrane is washed 4 times 
with 10 ml TBSTT with 10 minute intervals. A  Pierce supersignal ECL kit is used 
to visualize the his-tagged protein.
2.12 Tryptophan fluorescence spectroscopy
Tryptophan fluorescence spectroscopy was performed with the Fluoromax-3 
spectrophotometer (Jobin Yvon Horiba). Titrations were performed using time- 
based acquisition with an excitation wavelength of 295 nm, an emission 
wavelength of 328 nm and a slit width o f 5 nm. All reactions were performed 
with the ESR in 3 ml 50 mM Tris-HCI, pH 8, at 25°C. Increasing concentrations 
o f ligand was added to the ESR solution and the fluorescence change was 
measured. The cumulative fluorescence change was plotted against the 
cumulative concentration of ligand in SigmaPlot 10. The data was fitted to a 
single rectangular hyperbola and non-linear regression was used to solve the 
equation and produce values for the dissociation constant (K^).
2.13 Integral membrane protein detergent solubility screening
Inner membrane or mixed membrane samples were solubilised with several 
different detergents to determine which detergent the integral membrane 
proteins were most stable in. A standard 200 pi solubilisation reaction was 
composed o f 2 pg/pl membrane vesicles, 200 mM NaCI, 10% glycerol, 20 mM 
HEPES, pH 7, 1% detergent. The reaction was mixed for between 1 hour and
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overnight at 4°C. The reactions were centrifuged at WOOOOxg (TLA100 rotor, 
Beckman Coulter) for 1 hour to separate the soluble and insoluble protein. The 
200 pi soluble supernatant is removed, the insoluble pellet is resuspended in 
200 pi and the protein content o f each fraction is analysed using SDS-PAGE 
and Western blotting.
2.14 Protein purification techniques
2.14.1 Extraction o f integral membrane proteins for purification by DDM  
solubilisation
Prior to  chromatography-based purification procedures on integral membrane 
proteins, the protein o f interest must be extracted from the hydrophobic 
environment o f the membrane by solubilisation in detergent. n-dodecyl-^-D- 
maltoside (DDM) is a common detergent used in the solubilisation o f integral 
membrane proteins fo r purification.
Membrane vesicles containing overexpressed integral membrane protein were 
resuspended to a concentration o f 3.33 mg/ml and solubilised in solubilisation 
buffer (50 mM Potassium Pi, pH 7.8, 20% glycerol, 200 mM NaCI, 0.5% n- 
dodecyl-£,D-maltoside (DDM), 10 mM imidazole). The solubilisation reaction 
was mixed by inversion and incubated on ice for 30 minutes. Insoluble material 
was removed from the solution by centrifugation at 53000 rpm (using TLA100.3 
rotor, Beckman Coulter) for 20 minutes at 4°C. The supernatant from this 
centrifugation contains solubilised integral membrane protein and can now be 
applied to chromatographic apparatus.
2.14.2 Ni2+-NTA affinity chromatography using batch washing and 
disposable columns
The soluble fraction containing the integral membrane protein o f interest is 
incubated with equilibrated Ni2+-NTA superflow resin (Qiagen, 1.5 ml/10 mg 
protein) for 2 hours at 4°C on a rotating platform. A fter 2 hours the resin 
suspension is centrifuged at 1000xg for 1 minute (Sigma refrigerated benchtop 
centrifuge) and the supernatant is removed -  this contains protein that did not 
bind to the resin. The resin is resuspended in 10 ml wash buffer (20 mM Tris, 
pH 8, 10% glycerol, 300 mM NaCI, 20 mM imidazole and 0.05% DDM) and 
centrifuged as before. This is repeated 10 times. The resin is resuspended in 5
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ml wash buffer and applied to a disposable 2 ml polystryrene column (Bio-rad). 
Bound protein is eluted with elution buffer (20 mM Tris, pH 8 ,10%  glycerol, 200 
mM imidazole and 0.05% DDM) and collected in fractions o f 300 pi followed by 
5 x 750 pi fractions.
2.14.3 Column-based Ni2+ affinity chromatography
A  volume between 1-8 ml o f Ni2+-NTA superflow resin (Qiagen) is packed into 
an 8 ml C 10/10 column (GE Healthcare) and connected to a Biologic FPLC 
(Bio-rad) or a Peristaltic Pump P-1 (GE Healthcare). The resin is equilibrated 
with 5 column volumes o f equilibration buffer (20 mM Sodium Pi, pH 7.2, 10% 
glycerol, 200 mM NaCI, 0.05% DDM (w/v), 10 mM imidazole) and the soluble 
fraction after DDM solubilisation is applied at a flow rate o f 0.25-0.5 ml/min. The 
column flowthrough is collected fo r analysis. The resin is washed with 10 
column volumes of wash buffer (20 mM Sodium Pi, pH 7.2, 10% glycerol, 200 
mM NaCI, 0.05% DDM (w/v), 20 mM imidazole). Bound protein is eluted with 
elution buffer (20 mM Sodium Pi, pH 7.2, 10% glycerol, 200 mM NaCI, 0.05% 
DDM (w/v), 250 mM imidazole).
2.14.4 Ni2+ affinity chromatography using disposable gravity-flow columns
The soluble fraction containing the integral membrane protein o f interest is 
incubated with equilibrated Ni2+-NTA superflow resin (Qiagen, 0.1 ml/10 mg 
protein) for 1 hour in a disposable polystyrene column (Pierce). The resin is 
allowed to sediment and the flow-through Is collected. The resin is washed with 
20 column volumes o f DDM wash buffer (50 mM Potassium Pi, pH 7.8, 20% 
glycerol, 200 mM NaCI, 0.04% DDM (w/v), 40 mM imidazole). Bound protein is 
eluted with Elution buffer (50 mM Potassium Pi, pH 7.8, 20% glycerol, 200 mM 
NaCI, 0.04% DDM (w/v), 500 mM imidazole). 5 mM EDTA was added to the 
elution fractions.
2.14.5 Ni2+ affintly chromatography using HisTrap HP columns
The soluble fraction containing the protein o f interest is dialysed into 50 mM 
Tris, pH 8, 300 mM NaCI overnight and then applied to the 1 ml HisTrap column 
(GE Healthcare) using a Biologic FPLC (Bio-rad). The column is washed with 
wash buffer (50 mM Tris, pH 8, 300 mM NaCI, 20 mM imidazole) and protein is
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eluted using elution buffer (50 mM Tris, pH 8, 300 mM NaCI, 200 mM 
imidazole).
2.14.6 Anion exchange chromatography
Diethylaminoethanol (DEAE) resin (Sigma-Aldrich) is packed into a 8 ml column 
(GE Healthcare) and connected to a Biologic FPLC (Bio-rad). The resin is 
washed 10 CV dH20  and equilibrated with low salt buffer (20 mM Tris, pH8). 
The supernatant is applied to the resin, which is then washed with 3-5 column 
volumes of low salt buffer. The flow through is collected. A  linear gradient is 
applied over 20 column volumes from 0 to 500 mM NaCI with a flow rate o f ~0.5 
ml/minute. Fractions are collected throughout and the resulting A 280 spectrum is 
used to identify the location of the eluted protein.
2.14.7 Size exclusion chromatography (SEC)
SEC was performed using a Superdex 20 10/300 GL column (GE Healthcare) in 
combination with an AKTA HPLC (GE Healthcare). The column was 
equilibrated with filtered SEC buffer (50 mM potassium phosphate buffer, pH 
7.8, 200 mM NaCI, 0.04% (w/v) DDM). Protein sample was centrifuged at 
20000xg for 20 minutes at 4°C to remove any precipitants. Protein sample was 
loaded onto the column and 1.5 column volumes o f SEC buffer were applied at 
a rate o f 1 ml/min and 0.5 ml fractions were collected.
2.15 Reconstitution of integral membrane protein into liposomes
2.15.1 Purification of £ . coli lipid extract and production of liposomes
This method details the extraction o f total phospholipids from  total E. coli lipids 
(Avanti Polar lipids). The extracted phospholipids are then mixed with Egg 
phospatidylcholine (Egg-PC, Avanti Polar lipids) which compose the liposomes 
that will be used to reconstitute integral membrane proteins.
1 g o f total E. coli lipids in -3 0  ml chloroform is completely dried in a round- 
bottomed flask by rotary evaporation and then resolubilised in 5 ml of 
chloroform.
W hile stirring the mixture vigorously at 4°C in a stoppered conical flask, the 
phospholipid is added dropwise to 150 ml ice-cold acetone and 1 mM DTT -  a
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white precipitant should form. The conical flask is flushed with N2i the stopper is 
replaced and the mixture is allowed to stir overnight at 4°C in the dark.
The precipitant suspension is centrifuged at 6000 rpm for 10 minutes at 4°C 
(SS34 rotor in polypropylene copolymer (PPCO), Teflon (FEP) or glass 
centrifuge tubes). After centrifugation, the supernatant is discarded and the 
pellets are completely dried by a stream of N2. The pellets are then solubilised 
in 150 ml diethyl ether, transferred to a foil-wrapped conical flask and stirred for 
10-20 minutes at room temperature. This solution is then 6000 rpm for 10 
minutes at 4°C (SS34 rotor) and the supernatant is added to a pre-weighed 
round-bottomed flask and dried using rotary evaporation at 30°C. The pure, 
dried phospholipids are then dissolved in chloroform such that the final 
concentration o f phospholipids is 100 mg/ml.
The 100 mg/ml solution o f purified E. coli lipids is mixed with 20 mg/ml Egg-PC 
in a ratio o f 3:1 (w/w) and dried using a rotary evaporation a t 30°C. Once the 
phopholipid/Egg-PC mixture is dried, it is rinsed with 96% ethanol and dried 
again. The dried phospholipids/Egg-PC mixture is then resuspended in 50 mM 
potassium phosphate, pH 7, to a final concentration o f 20 mg/ml. The 
suspension undergoes 4-6 cycles o f sonication with a M isonix sonicator 3000 
(15 seconds on/45 seconds off with 4 pm intensity) in a N2 environment. The 
liposomes are separated into 1 ml aliquots, go through at least 3 freeze-thaw 
cycles and are finally snap frozen and stored at -80°C
2.15.2 Reconstitution of SiaQM into liposomes by the rapid dilution 
method
Integral membrane protein was solubilised in DDM and purified by Ni2+ affinity 
chromatography as previously described in section 2.14.4 with the following 
modifications; after ultracentrifugation, the solubilised protein sample is 
incubated with the Ni-NTA resin and then washed with 10 column volumes o f 
DDM wash buffer (50 mM Potassium Pi, pH 7.8, 20% glycerol, 200 mM NaCI, 
0.04% DDM (w/v), 40 mM imidazole) followed by 10 column volumes o f decyl- 
£,D-maltoside (DM) wash buffer (50 mM Potassium Pi, pH 7.8, 20% glycerol, 
200 mM NaCI, 0.1% DM (w/v), 40 mM imidazole). The bound protein is eluted 
with DM-containing elution buffer (50 mM Potassium Pi, pH 7.8, 20% glycerol, 
200 mM NaCI, 0.1% DM (w/v), 500 mM imidazole). 5 mM EDTA was added to 
the elution fractions.
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For the reconstitution of this DM-solubilised purified protein, liposomes were 
prepared as a 3:1 ratio of purified E. coli lipids and L-a-phosphatidylcholine from 
egg yolk (see Methods section 2.15.1). Purified membrane protein was added 
to liposomes in a 1:40 ratio (w/w) and incubated on ice for 10 minutes. The 
mixture was rapidly diluted by mixing with 80 ml 50 mM potassium phosphate, 
pH 7. Proteoliposomes were collected by centrifugation at 45000 rpm for 2 
hours at 4°C. Proteoliposomes were repeatedly freeze-thawed before used in in 
vitro transport assays.
2.15.3 R econstitu tion  b y  the  des tab ilized  liposom e m ethod (Knol et al., 
1996)
Integral membrane protein was solubilised in DDM and purified by Ni2+ affinity 
chromatography as described in Methods section 2.14.4. Liposomes were 
thawed to room temperature and extruded 11 times through 400 nm filters 
(Avestin). The liposomes were diluted to 4 mg/ml with 50 mM potassium 
phosphate, pH 7, and titrated with 10% (w/v) Triton X-100. Using a UV-visible 
spectrometer (Shimadzu UV-1601) the absorbance (A540) of the liposome 
solution was followed while Triton X-100 was slowly added. At the point o f 
liposome solubilisation, purified protein is added at a 100:1 lipid to protein ratio. 
The mixture is incubated at room temperature for 20 minutes, at which point 40 
mg Biobeads are added (SM2 -  Bio-rad) per 1 ml o f mixture. This is incubated 
at room temperature for 30 minutes. Another 40 mg/ml Biobeads are added and 
incubated fo r 1 hour at 4°C followed by a further 40 mg/ml addition o f Biobeads. 
The mixture is incubated overnight at 4°C. The Biobeads are removed from the 
mixture by filtration and the proteoliposomes are harvested by centrifugation at 
80000 rpm for 15 minutes at 4°C (Beckman TLA 100.1 rotor). The 
proteoliposomes are resuspended in 50 mM potassium phosphate, pH 7, snap 
frozen and stored at -80°C.
2.16 In  vitro  tra n sp o rt assays
For all transport assays, /V-acetylneuraminic acid was used, which was 
radiolabelled on carbon 6 and had a specific activity o f either 0.025 or 0.05 
mCi/ml.
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2.16.1 Preparation of proteoliposomes for in  vitro  [14C]-Neu5Ac transport 
assays
On the day o f the uptake assay, the proteoliposomes (at 400 pg/ml integral 
membrane protein concentration) were thawed on ice and collected by 
centrifugation at 50000 rpm for 20 minutes at 4°C. The proteoliposomes were 
resuspended in Inside buffer (100 mM KAc pH 7, 20 mM KPi and 2 mM M gS 04, 
unless stated otherwise) and extruded 11 times through a 400 nm filter 
(Avestin). The extruded proteoliposomes were collected by centrifugation at 
50000 rpm fo r 20 minutes at 15°C. The proteoliposomes were then 
resuspended in Inside buffer to a final concentration o f 4 pg/pl SiaQM.
2.16.2 Standard in  vitro  [14C]-Neu5Ac transport assay
The standard in vitro uptake assay was performed by incubating 60 pi of 
appropriate external buffer (see sections 2.16.3.1-2.16.3.5) for 1 min at 30°C 
and adding 5 pM [14C]-Neu5Ac. Electrochemical gradients are formed upon 
addition of 12 pi 4 pg/pl proteolipomes. 100 pi samples are taken at 20, 60,100, 
140 and 180 seconds and are then incubated for 10 seconds with 100 pi cold 
wash buffer (these buffers have the same constituents as the external buffers 
fo r each assay, except no SiaP is present and 1 mM Neu5Ac is included 
instead o f [14C]-Neu5Ac) and bound to filter paper (BA85, Schleicher and 
Schuell). Filters are washed with 2 ml 50 mM potassium phosphate buffer, pH 
7. The counts per minute (cpma) for each sample are evaluated using a liquid 
scintillation analyzer (Packard Tri-carb 2900TR). In vitro transport assays can 
also be performed with half the volumes o f all the solutions involved with 
minimal difference in transport activity and standard deviations.
2.16.3 External buffers for formation o f electrochemical gradients
2.16.3.1 Na* gradient alone fAuNa*l
Na+ gradient alone (ApNa+) was formed by dilution o f proteoliposomes 
containing inside buffer (see above) into buffer containing 100 mM Sodium 
acetate, 20 mM Sodium PIPES, pH 7, 2 mM M gS 04and 5 pM SiaP.
2.16.3.2 Na* gradient plus membrane potential (AuNa* + AMA
Na+ gradient plus membrane potential (ApNa+ + AH') was formed by dilution of
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proteoliposomes containing inside buffer into buffer containing 100 mM Sodium 
acetate, 20 mM Sodium PIPES, pH 7, 2 mM M gS 04, 2 pM Valinomycin and 5 
pM SiaP.
2.16.3.3 Na* gradient plus pH gradient fAuNa* + AoH l
Na+ gradient plus pH gradient (ApNa+ + ApH) was formed by dilution of 
proteotiposomes containing inside buffer into buffer containing 120 mM Sodium 
PIPES, pH 7, 2 mM M gS 04 and 5 pM SiaP.
2.16.3.4 Membrane potential alone (AM^
A  membrane potential (AM^) was formed by dilution o f proteoliposome 
containing inside buffer into buffer containing 100 mM A/-methyl glucamine 
acetate, pH 7, 20 mM N-methyl glucamine phosphate, pH 7, 2 mM M gS 04 and 
5 pM SiaP.
2.16.3.5 pH gradient alone (AdHI
A  pH gradient (ApH) was formed by dilution o f proteoliposomes containing 
inside buffer into buffer containing 120 mM potassium phosphate, pH7, 2 mM 
M gS 04 and 5 pM SiaP.
2.16.4 Solute counterflow assay
SiaQM-containing proteoliposomes are treated as described in section 2.16.1, 
except that the proteoliposomes are loaded with counterflow internal buffer (100 
mM KAc, pH7, 20 mM KPi, pH7, 10 mM NaPIPES and 1 mM Neu5Ac). The 
solute counterflow assay was performed by incubating 600 pi o f counterflow 
external buffer (100 mM KAc, pH7, 20 mM KPi, pH7, 10 mM NaPIPES, and 5 
pM SiaP (where applicable)) for 1 min at 30°C and adding 5 pM [u C]-Neu5Ac. 
Electrochemical gradients are formed upon addition o f 12 pi 4 pg/pl 
proteolipomes. 100 pi samples are taken at 30, 60, 120, 240 and 480 seconds 
and are then incubated fo r 10 seconds with 100 pi cold wash buffer (these 
buffers have the same constituents as the external buffers for each assay, 
except no SiaP is present and 1 mM Neu5Ac is included instead of [14C]- 
Neu5Ac) and bound to filter paper (BA85, Schleicher and Schuell). Filters are 
washed with 2 ml 50 mM potassium phosphate buffer, pH 7. The counts per
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minute (cpma) for each sample are evaluated using a liquid scintillation 
analyzer (Packard Tri-carb 2900TR).
2.17 In v ivo  transport assays
2.17.1 Preparation o f cells for in  v ivo  [14C]-Neu5Ac transport assay
2x20 ml o f LB (supplemented with 100 pg/ml amplicillin, where necessary) was 
inoculated with 0.2 ml (1% inoculum) from cultures of strains BW 25113AnanT 
pES7 and B\N25113AnanT  grown overnight. The 20 ml cultures were grown 
aerobically to mid-log phase (OD66o) at 37°C, induced with 1 mM IPTG and 
allowed to grow for a further 2 hours. Cells were harvested by centrifugation at 
8000 rpm fo r 8 minutes at 4°C (using SS34 rotor in Sorvall evolution centrifuge) 
and washed twice with 20 ml o f 50 mM KPi, pH 7, 2 mM M gS 04. The cells were 
finally resuspended in a small volume such that the OD66o would equal 120. 
Cells were stored on ice until required.
2.17.2 In  v ivo  [14C]-Neu5Ac transport assay: application of PMF (ApH+ and 
ApLi+)
600 pi o f external buffer (50 mM KPi, pH 7, 2 mM M gS 04 and 10 mM D-Li- 
lactate) was incubated for 1 min a t 30°C and 7.6 pi cell suspension 
(OD66o= 120) was added to attain a final OD660 o f 1.5. This was incubated at 
30°C fo r 2 minutes under continuous airflow (water-saturated), at which point 
8 pM Neu5Ac (a 50:50 mixture o f unlabelled Neu5Ac and [14C]-Neu5Ac) was 
added. 100 pi samples are taken at 0.5, 1, 2, 3 and 4 minutes and bound to 
filter paper (BA85, Schleicher and Schuell) Filters are washed with 2 ml 50 mM 
potassium phosphate buffer, pH 7. The counts per minute (cpma) for each 
sample are evaluated using a liquid scintillation analyzer (Packard Tri-carb 
2900TR).
2.17.3 In  v ivo  [14C]-Neu5Ac transport assay: application of SMF (ApNa+)
600 pi o f external buffer (50 mM KPi, pH 7, 2 mM M gS 04 and 20 mM NaCI) 
was incubated fo r 1 min at 30°C and 8 pM Neu5Ac (a 50:50 mixture of 
unlabelled Neu5Ac and [14C]-Neu5Ac) was added. This was incubated for 1 
minute at 30°C at which point 7.6 pi cell suspension (OD66o=120) was added to 
attain a final OD66o o f 1.5. 100 pi samples are taken at 0.5, 1, 2, 3 and 4
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minutes and bound to filter paper (BA85, Schleicher and Schuell) Filters are 
washed with 2 ml 50 mM potassium phosphate buffer, pH 7. The counts per 
minute (cpma) for each sample are evaluated using a liquid scintillation 
analyzer (Packard Tri-carb 2900TR).
2.17.4 In vivo  [14C]-Neu5Ac transport assay: application of ApLi*
Exactly the same protocol as 2.17.3, except 20 mM LiCI was in the external 
buffer, and not 20 mM NaCI.
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Chapter 3
Genome-wide analysis 
of TRAP transporter 
gene frequency and 
organisation
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3.1 The TRAPdb relational database
As more prokaryotic genome sequences have been published, it has become 
evident that TRAP transporters are widespread in both bacteria and archaea 
(Kelly & Thomas, 2001). W ith hundreds o f TRAP transporter gene sequences 
now known there is a need fo r a unified resource o f TRAP transporter data. 
TRAPdb (www.trapdb.org) was created to be this resource and to store data on 
all known TRAP transporters and make this data accessible in a user-friendly, 
intuitive fashion. The data collected for TRAPdb would not only be used to 
populate TRAPdb with data on individual systems, but could also be used to 
determine trends in frequency and distribution o f TRAP transporters in a wide 
variety o f prokaryotes.
TRAPdb was created using MySQL and the web interface was created using 
Macromedia Coldfusion software (by Peter Bryant, a bioinformatics MRes 
student) and was populated initially with 103 TRAP genes comprising 49 
separate systems from 23 different organisms, taken from the TRAP transporter 
review o f 2001 (Kelly & Thomas, 2001). Information can be retrieved from 
TRAPdb using either a text search function or by selecting search criteria from a 
number o f pull-down menus (Fig. 3.1a). These criteria include searching for 
transporters with the same substrate (predicted or experimentally determined), 
all TRAP transporters with a particular gene organisation (i.e. system type), all 
TRAP transporters within a particular organism and all genes o f a particular 
family, i.e. DctP, TAXI, DctQ, DctM, etc (Fig. 3.1a).
Once the target TRAP system has been selected, the information regarding that 
system is displayed, information such as; gene name, locus tag, accession 
number, sequence length and molecular weight. The amino acid sequence of 
one or more o f the genes within a particular system can also be displayed (Fig. 
3.1b). If searching by organism name then the number o f TRAP transporters in 
that particular organism is displayed. There are also a number o f external links 
available; such as the taxonomy o f the organism and the Swissprot/trEMBL 
webpage for the particular protein.
TRAPdb was further populated with amino acid sequences and TRAP protein 
data such as locus tag, length and molecular weight collected from NCBI using
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Figure  3.1 Screen cap tu res o f TRAPdb w eb in te rface, (a) TRAPdb front 
page showing input box for free text searching and pull-down menus, (b) 
TRAPdb record page showing SiaP and SiaQM from H a e m o p h ilu s  in flu e n z a e .
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BLAST searches to find homologues o f the ESR subunits that were already In 
TRAPdb. Details of TRAP systems that were missed in these searches were 
obtained from Interpro (www.ebi.ac.uk/interpro). A  complete TRAP transporter 
system was defined as the three TRAP component genes (dctP , dctQ  and 
dctM, whether fused or not) present in close proximity in the genome.
As o f February 2008, TRAPdb held information on 2412 TRAP, component 
genes that made up at least 770 different complete TRAP transporter systems 
spanning 243 prokaryotic genomes, providing a significant resource for 
analysis.
The TRAP transporter review in 2001 detailed a number o f varieties o f genetic 
organisation o f TRAP transporters (Kelly & Thomas, 2001). This extensive data- 
mining was an ideal opportunity to update the list o f known TRAP transporter 
organisation. To do this, a web-based application, The Seed (www.theseed.org) 
was used to analyse the genome context for the TRAP transporters collected. 
Analysis o f the flanking genes in conjunction with a multiple sequence 
alignment o f all DctP-type ESR amino acid sequences collected, using the 
program ClustalX, has also allowed some substrate predictions to be made.
3.2 Specific enrichment of TRAP transporters in marine bacteria
The extensive data mining that was performed allowed the frequency and 
distribution of TRAP transporters to be assessed for the first time. Analysis of 
the number o f DctP-type and TAXI-type TRAP transporters in certain organisms 
in conjunction with other data, fo r example, the phylum o f the organism, the 
genome length and the environment, could be used to investigate whether there 
are any TRAP transporter distribution trends.
Using the data collected fo r the compilation o f TRAPdb, the total number of 
complete systems were calculated fo r each organism. A  complete TRAP 
system was defined by having the gene for at least one ESR component in the 
same operon as the genes for the two integral membrane components. These 
systems were then divided into either a DctP-type system or a TAXI-type 
system.
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TRAP densities were calculated for 193 organisms by dividing the number o f 
complete TRAP transporters (DctP-type and TAXI-type) encoded by an 
organism by the size o f the genome (Mb). The number o f TRAP transporters in 
an organism was also normalised by the total number of transporters in the 
organism, where the data was available (data provided by Quingu Ren and Ian 
Paulsen from TransportDB). This was expressed in a percentage and was 
performed for 70 organisms.
The total number of complete TRAP transporters was defined for 193 
organisms. The phylum and environment o f the organism were also collected 
and the list o f organisms was ordered by TRAP density, with the top 17 being 
presented (Table 3.1). Table 1 also contains other organisms mentioned in the 
text plus E. coli and Streptomyces coelicolor A3 (2). Streptomyces coelicolor A3 
(2) is included as it has a large genome, but is devoid o f TRAP transporters 
indicating the size of genome is not directly proportional to the number o f TRAP 
transporters. E. co li was included as a baseline because it is a common species 
w ith an average genome size, but only 1 TRAP transporter. There were 4 
organisms with a TRAP density greater than 5, and fo r S ilidbacter pomeroyi 
DSS-3 and Jannaschia sp. CCS1 data were available from TransportDB, 
revealing that TRAP transporters make up 10 and 9.13% of the total tranporters 
in these organisms. For the 70 organisms where data were available on 
TransportDB, the average percentage contribution o f TRAP transporters to the 
total number of transporters was calculated. The average was found to  be 2.05, 
indicating that Silicibacter pom eroyi DSS-3 and Jannaschia  sp. CCS1 have 5 
fold higher than average TRAP density. The four organisms with the highest 
TRAP densities and a number o f other organisms with above average TRAP 
densities were defined as marine dwelling organisms, i.e were all found in high 
NaCI concentrations. These organisms were not lim ited to one phylum, 
therefore this increased use o f TRAP transporters was not lineage-dependent 
expansion. Indeed, there are examples where closely related organisms have 
vastly different numbers o f TRAP transporters, which is proposed to be due to 
different environments and a requirement for NaCI in the growth media for one 
o f the organisms. For example, Bacillus subtilis is soil-dwelling and has no
129
Organism name Phylum Environment TRAP systems 
(DctP/TAXI)
Genome 
length (Mbp)
TRAP
density
Total no. of 
transporters
% of total 
transporters
A ura n tim o n a s  sp. SI85-9A1 a-proteobacteria Aquatic 27 (22/5) 4.33 6.24 - -
S ilic ib a c te r p o m eroy i DSS-3 o-proteobacteria Aquatic 28 (24/4) 4.60 6.09 280 10
C h rom o h a lo ba c tc r sa lex igens  DSM 3043 K-proteobacteria Aquatic 21 (17/4) 3.70 5.68 - -
Ja n n asch la  sp. CCS1 o-proteobacteria Aquatic 23 (19/4) 4.40 5.22 252 9.13
B orde te lla  b ronch isep tica  RB50 NCTC-1325 /J-proteobacteria Host 25 (23/2) 5.34 4.68 332 7.53
B o rd e te lla  pa rape rtuss is  12822 NCTC-1325 /9-proteobacteria Host 21 (19/2) 4.77 4.40 290 7.24
S ilic ib a c te r  sp. TM1040 o-proteobacteria Aquatic 15(14/1) 4.15 3.61 - -
P a ste u re lla  m u ltoc ida  Pm70 K-proteobacteria Host 8 (6/2) 2.26 3.54 167 4.79
A ctin o b a c illu s  succ inogenes  130Z K-proteobacteria Host 7(6/1) 2.05 3.42 - -
P a ra  co ccu s  den itrificans  PD 1222 o-proteobacteria Multiple 17(16/1) 5.16 3.28 - -
P o la ro m o n a s  sp. JS666 //-proteobacteria Multiple 18(17/1) 5.90 3.05 - -
M esorh izob ium  sp. BNC1 o-proteobacteria Multiple 15(11/4) 4.94 3.04 - -
O cean ico la  g ranu losus  HTCC2516 o-proteobacteria Aquatic 12(11/1) 4.04 2.97 - -
B orde te lla  p e rtuss is  Toham a  I NCTC-13251 0-proteobacteria Host 12(10/2) 4.09 2.94 231 5.19
O ceanosp irillum  sp. MED92 K-proteobacteria Aquatic 11 (8/3) 3.87 2.84 - -
Therm us the rm oph ilus  HB27 Deinococcus-Thermus Aquatic 6 (4/2) 2.13 2.82 108 5.56
R h o d o b a c te r sphaero ides  2.4.1 o-proteobacteria Multiple 12(10/2) 4.45 2.70 224 5.36
A rch a e og lo b u s  fu lg idus  DSM 4304 Euryarchaeota Aquatic 3 (3/0) 2.18 1.38 104 2.88
E sche rich ia  co li K12 K-proteobacteria Host 1 (1/0) 4.64 0.22 383 0.26
B a c illus  subtilis Firmicutes Terrestrial 0 (0/0) 4.21 0 297 0
S trep tom yces  co e lico lo r A3(2) Actinobacteria Multiple 0 (0/0) 9.34 0 442 0
Tab le  3.1 O rgan ism s co n ta in in g  h igh  frequenc ies  o f TRAP tra n sp o rte rs  o rdered by th e ir  TRAP density.
Seventeen organisms with a TRAP density over 2.5 are presented, with additional statistics for four genomes mentioned 
in the text.
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TRAP transporters, whereas its relative, the alkaliphilic Bacillus halodurans has 
8, which is proposed to be due to the requirement for high NaCI concentrations 
for growth (Takami et al., 2000). This difference was also observed for 
Rhodobacter capsulatus and Rhodobacter sphaeroldes, which have 4 and 12 
complete TRAP transporters, respectively. It has been shown that Na+ is 
essential fo r growth o f R. sphaeroides (Sistrom, 1960). The data strongly 
suggest that marine-dwelling organisms generally have high numbers o f TRAP 
transporters. A  possible reason for this is that TRAP transporters function better 
in high NaCI environments.
As well as this lineage-independent correlation, this analysis has also revealed 
an example of lineage-dependent expansion of TRAP transporters. The 
organisms, Bordetella bronchlseptica RB50 NCTC-1325, Bordetelta 
parapertussis 12822 NCTC-1325 and Bordetella pertussis Tomaha I NCTC- 
13251 all have above average TRAP densities. These pathogens are also 
massively enriched fo r ESRs from the TTT transporter fam ily (Antoine et al., 
2003). B. pertussis Tomaha I NCTC-13251 has 91 ORFs for TTT ESRs, the 
majority of which are orphan ESRs and not associated with transport 
machinery. The exact reason why there is massive amplification o f ESRs is 
unknown, however, it has been suggested that there is a correlation in this 
branch o f the ^ -proteobacteria between soil-dwelling bacteria and high numbers 
o f TTT ESRs (Antoine et al., 2003).
Analysis of the frequency of TAXI-type systems and DctP-type systems 
revealed that in contrast to the enrichment o f DctP-type TRAP transporters, the 
TAXI-type TRAP transporters are much more limited in number. Aurantimonas 
sp. SI85-9A1 was found to have the highest number o f TAXI-type TRAP 
transporters with 5 systems, whereas most other prokaryotes encode a 
maximum of 2 TAXI-type systems. Archeoglobus fulgidus was found to be the 
archaeon with the most TRAP transporters with a total of 3, all o f which are 
TAXI-type systems. Indeed, TAXI-type systems are the only TRAP transporters 
to  be found in archaea.
3.3 Genetic arrangement of dctQ  and dctM  genes
Prior to this extensive data mining exercise, all TRAP transporter operons 
encoding membrane components had the small membrane component (dctQ) 
encoded upstream o f the large subunit (dctM). In the TRAP systems with a
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single ORF encoding the fused small and large integral membrane components 
(dctQM), the dctQ  component domain was always encoded first. There are 
currently 627 different DctP-type systems with these gene organisations in 
TRAPdb. This led to the hypothesis that the dctQ  subunit had to be expressed 
first as the protein DctQ was involved in the stability or insertion o f DctM into the 
membrane. As a consequence o f the data mining there are now 4 examples 
where the dctM  gene is encoded upstream o f the dctQ  gene (Fig. 3.2, 
Roseovarius sp. 217). This is only 0.64% of all the DctP-type TRAP systems in 
TRAPdb, but these new observations suggest that the ordering o f dctQ  
upstream o f dctM  is not as essential as previously thought.
3.4 TRAP transporter systems with multiple ESR components
ABC transporter opérons have been discovered with multiple ESR components, 
fo r example, GInPQ, the four ESR containing glutamine/glutamate transporter 
from  Lactococcus Jadis has four ESR components associated with it 
(Schuurman-Wolters & Poolman, 2005). The data held within TRAPdb was 
used to determine whether there are examples o f TRAP transporters with 
multiple ESR components. In total, 14 DctP-type TRAP systems with multiple 
ESR components were discovered.
A  DctP-type TRAP system in Mannheimia succinoproducens was found to 
encode a dctQM  gene with two downstream d d P  genes, MS0049 and MS0050 
(Fig. 3.2, M. succiniciproducens MBEL55E). Analysis o f the genome context of 
this system revealed that the operon contained the same genes as the operon 
containing yiaMNO, the 2,3-diketo-L-gulonate TRAP transporter o f E. coli. 
Phylogenetic analysis o f the DctP-type ESR components contained within 
TRAPdb revealed that MS0049, MS0050 and YiaO clustered together in the 
same clade in the phylogenetic tree (data not shown). This information and the 
genome context data strongly suggest that this transporter is specific for 2,3- 
diketo-L-gulonate, however, the reason fo r having two separate ESRs is 
unknown.
Another DctP-type TRAP system with two d d P  genes, this time associated with 
a dctQM  gene was found in Polaromonas sp. JS666. In this system, the ORFs 
fo r the ESRs are flanking the dctQM  gene, one upstream and one downstream 
(Fig. 3.2, Polaromonas sp. JS666 Bpro_2838-2841). Curiously, phylogenetic
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F igu re  3.2 G enetic o rgan iza tion  o f se lected  TRAP tra n sp o rte rs  con ta ined  
w ith in  TRAPDb. The layout o f TRAP genes is centered on the dctP  (black 
arrow [P]), dctQ  (white arrow [Q]) and dctM  (grey arrow [M]) genes of the 
R. capsulatus dctPQM  operon. All DctP homologues are indicated by solid 
black lines, while TAXI ESRs are shaded in checkerboard [TAXI]. The malonyl- 
CoA decarboxylase domain fused to DctM is shaded with vertical stripes, while 
the malonyl-CoA synthase is shaded in dark grey with white spots. The small 
gene encoding a UspA homologue is shaded with diagonal checks. TRAP- 
linked genes (tig -  see (Kelly & Thomas, 2001)) are shaded with small black 
spots with a white background. The glnH  gene, an ABC ESR, is shaded with 
grey horizontal lines. The DctRS two-component system and dicarboxylate 
transporter in B. subtilis are shaded with diagonal black stripes and horizontal 
black stripes, respectively. The fused helix-turn-helix domain is shaded with 
black horizontal waves, while the kinase fusion to a TAXI ESR is shaded with 
grey and small white spots. Finally, the potential ABC transporter in an operon 
with a DctP ESR is shaded with a grey checkerboard pattern. Other 
abbreviation- for species names used are E. coli - Escherichia coli K12; H. 
influenzae - Haemophilus influenzae RD KW20; M. succiniciproducens - 
Mannheimia succiniciproducens MBEL55E; D. hafniense - Desulfitobacterium  
hafniense  Y51; A. actinomycetemcomitans - Actinobacillus 
actinomycetemcomitans; S. meliloti 1021 - Sinorhizobium meliloti 1021; A. 
fulgidus - Archaeoglobus fulgidus DSM 4304; P. aeruginosa PA01 - 
Pseudomonas aeruginosa PA01; B. halodurans - Bacillus halodurans C-125; A. 
succinogenes 130Z - Actinobacillus succinogenes 130Z; B. subtilis -  Bacillus 
subtilis-, M. lo ti - Mesorhizobium loti MAFF303099; R. baltica SH1 - 
Rhodopirellula baltica SH 1 and M. magneticum  AMB-1 - Magnetospirillum  
magneticum  AMB-1.
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analysis o f these ESRs revealed that they clustered in the same clade as YiaO, 
MS0049 and MS0050, therefore could possibly also bind 2, 3-diketo-L-gulonate. 
The third example o f a TRAP system with multiple ESR genes was again 
discovered in Poiaromonas sp. JS666. This system contained 3 dctP  genes 
separated from the dctQ  and dctM  genes by a gene encoding a protein of 
unknown function (Fig. 3.2, Poiaromonas sp. JS666 Bpro_1753-1748). The 
ESRs in this system have very high sequence identity with each other, which 
means they probably bind the same unknown substrate and are the product of 
relatively recent gene duplication.
Analysis o f the data held within TRAPdb revealed several TRAP systems with 
multiple ESR components. The multiple ESRs appear to be the product of 
recent gene duplication. The exact reason for multiple ESRs is unknown. 
However, it may be that the ESRs bind a similar, but not identical compound; 
therefore this duplication is a method by which to increase the repertoire of 
substrates.
3.5 Recruitment of TRAP ESR domains for non-transport functions
ABC transporter ESR domains are known to have been recruited for functions 
other than transport, for example the Lacl/GaIR family o f repressors are 
proteins that have a DNA-binding helix-turn-helix domain N-terminally fused to 
an ABC ESR domain (Fukami-Kobayashi et a/., 2003). The data within TRAPdb 
was analysed to determine whether there are any examples o f TRAP ESRs 
being recruited for purposes other than transport.
A  DctP-type TRAP, transporter system was discovered in Desulfitobacterium  
hafniense  Y51 that contained two ESR genes upstream of dctQ  and dctM  
genes. Phylogenetic analyses o f these ESR genes revealed that they were both 
predicted to bind C4-dicarboxylates, however, the gene DSY4256 clustered with 
ESRs from characterised TRAP transporters and DSY2457 clustered with YdbE 
(DctB), a characterised protein from B. subtilis  shown to regulate C4- 
dicarboxylate transport (see Introduction section 1.8.2.1 (Asai et al., 2000)). 
This suggests that this TRAP system is using the ESR-fold for two different 
functions; transport and regulation o f gene expression.
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A TAXI ESR gene was discovered in Rhodopirellula baltica  SH 1 with an N- 
terminal serine/threonine kinase fusion (Fig. 3.2, R. baltica SH 1). Analysis of 
the genome context revealed that the genes for the membrane components 
were not present in the same operon. When analysed using the web-based 
application, SignalP, no signal peptide is detected, indicating that it is a 
cytoplasmic protein. These properties imply that this orphan ESR no longer 
participates in transport and functions in signal transduction instead.
A  DctP-type ESR has been discovered in Mesorhizobium loti that has a C- 
terminal fusion to a helix-turn-helix DNA binding domain (Fig. 3.2, M. loti). This 
is also an orphan ESR and not associated with any genes encoding DctQ or 
DctM, therefore, it is possible that this protein acts as a transcription factor in 
response to ligand binding. This is analogous to the previously mentioned 
Lacl/GaIR fam ily o f repressors that contain ABC ESR domains fused to a DNA 
binding domain; however, this is the first incidence o f a TRAP ESR being 
employed in this manner.
Three examples of TRAP ESRs possibly being recruited for purposes other 
than transport have been discovered. This is a phenomenon also seen with 
ABC ESRs. Indeed, these proteins are well-suited for such activities as they 
bind ligands with high affinity which also induces a conformational change 
which could be recruited for a signalling function. Sequencing o f more 
prokaryotic genomes will no doubt reveal more examples o f this kind of 
recruitment.
3.6 UspA gene linked to TAXI TRAP transporter genes
Analysis o f the genome context o f TRAP transport systems held within TRAPdb 
has revealed genes that are regularly found in close proxim ity to TRAP 
transporters. These genes are often genes fo r enzymes that catabolise the 
substrate that the TRAP system transports into the cell, in this way, substrate 
specificities can be predicted like, for example, A/-acetylneuraminic acid-specific 
SiaPQM  from Haemophilus influenzae (Severi et al., 2005). Some genes, for 
example, the TRAPlinked genes {tig) have been found in the same operons as 
TRAP transporters in many organisms with no discernable function (Kelly &
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Thomas, 2001). Analysis of the TAXI TRAP systems has revealed a linkage to a 
gene fo r a universal stress protein A -like  protein (UspA).
A TAXI TRAP system was discovered in Actinobacillus succinogenes 130Z with 
two genes for TAXI ESRs with the gene for the permease component (Fig. 3.2, 
A. succinogenes 130Z). The two ESRs were found to flank dctQM  with the 
downstream ESR gene separated from the permease by a gene encoding a 
UspA-like protein.
Genes encoding the UspA protein have been found in the same operon as a 
number o f TRAP transporters from various species, however, the reason for the 
correlation is unknown. This is not the first time UspA have been associated 
with a transporter. UspA domains have also been discovered fused to a cationic 
amino acid transporter from the APC (amino acid-polyamine-organocation) 
superfam ily (Kvint et al., 2003). This particular transporter has 2 UspA domains 
fused to it, however, the exact function o f this fusion is not known. Studies on 
UspA have determined that its expression is induced by DNA damage under a 
number o f conditions including starvation, UV light treatment and high salt 
concentration (Kvint et al., 2003). The crystal structure o f UspA from 
H. influenzae has been elucidated and revealed to be a homodimer (Sousa & 
McKay, 2001); however, the true function o f UspA remains unknown.
3.7 A  TRAP ESR functioning with an ABC transporter?
High resolution crystal structures are now available for a number o f ABC ESRs, 
DctP-type TRAP ESRs and one TAXI-type TRAP ESR (see Introduction). 
These three families o f ESRs share no sequence similarity, but have been 
shown to have a sim ilar overall topology. This similarity o f topology possibly 
suggests a shared ancestry between TRAP ESRs and ABC ESRs (Muller et al., 
2006). In light o f this shared ancestry, it is possible that TRAP ESRs can 
functionally interact with ABC translocation machinery, and vice versa. There is 
an example in the literature of a glutamate-specific TRAP transporter in 
Synechocystis that uses a GlnH-like ABC ESR (Quintero et al., 2001). This 
example and the fact that DctP-type ESRs and TAXI-type ESRs have no 
sequence similarity, but functionally interact w ith closely related homologues o f 
the TRAP translocation machinery (DctQ and DctM) demonstrates that ESR 
promiscuity is not an unreasonable assumption.
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Analysis o f the genome context o f a DctP-type TRAP ESR from 
M. magneticum  AMB-1 revealed this gene to be in an operon with genes for an 
ABC transporter permease and ATPase subunits. In the absence o f an ABC 
ESR gene, this suggests that this TRAP ESR may function with ABC 
transporter translocation machinery.
3.8 A TRAP transporter for malonate
Sinorhizobium m eliloti 1021 is a symbiotic organism that resides within root 
nodules of the leguminous alfalfa plant (Medicago sativa) and has 15 predicted 
TRAP transporters. Curiously, one has been found to have a malonyl-CoA 
decarboxylase (MCD) enzyme fused to  the C-terminus o f the DctM component. 
The operon contains a DctP-type ESR gene, a dctQ  component gene, the 
aforementioned dcffl/f-MCD fusion gene and a gene encoding a putative 
malonyl-CoA synthetase. Analysis o f closely related organisms revealed 
conservation o f the association o f the MCD and malonyl-CoA synthetase genes 
with TRAP transporter genes, although none o f the other examples have this 
fusion protein (Fig. 3.3). One orthologous TRAP system in Dechloromonas 
aromatica RCB has a variation in that it is linked to a multisubunit MCD sim ilar 
to that seen in Pseudomonas putida  (Chohnan et al., 1999), but structurally 
unrelated to the MCDs found with orthologous TRAP transporters. This is 
significant, as it demonstrates a close linkage o f the TRAP transporter to a 
completely different type of MCD enzyme. There is also an example in 
Rhizobium irifoHi where the MCD and the malonyl-CoA synthetase genes are 
associated with a dicarboxylate transporter (Fig. 3.3, MatC) from the Dcu family 
(An & Kim, 1998). Strengthening the linkage between the presence o f a 
transporter gene and malonate catabolic genes.
Malonate is a major organic acid in the cytoplasm o f the alfalfa plant cells, the 
bacteroids and the roots o f the plants. It is thought to be an important carbon 
source for the bacteroids and disruption o f the malonate catabolic genes has 
been shown to disrupt the formation of mature root nodules (An et al., 2002). 
W hen taken into the bacteroid, malonate is firs t converted to  malonyl-CoA 
through the action o f malonyl-CoA synthetase and can then be incorporated into 
central metabolism as acetyl-CoA through the action o f malonyl-CoA 
decarboxylase (An & Kim, 1998). Malonate is known to  be a competitive
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F igu re  3.3 O rgan isa tion  o f genes p red ic ted  to  encode a TRAP tra n sp o rte r 
fo r  m alonate  and re la ted m alonate m etabo lism -re la ted  genes. The TRAP 
subunits are shaded as in Fig. 3.2 with the transcriptional repressor (m a tR ) 
shaded in grey with white spots. The malonyl-CoA decarboxylase fused to DctM 
in S in o rh iz o b iu m  m e li lo t i 1021 is shaded with diagonal stripes and the malonyl- 
CoA synthetase with vertical stripes. In R h iz o b iu m  le g u m in o s a ru m  b io va r. t r ifo lii 
the m a te  gene that encodes a Dcu-type transporter is shaded with a 
checkerboard pattern. The multiple subunits of the alternative malonate 
decarboxylase seen linked to the orthologus TRAP system in D e c h lo ro m o n a s  
a ro m a tic a  RCB is shaded with a horizontal wave pattern. Other species 
abbreviations used are: R  n u b in h ib e n s  ISM - R o s e o v a r iu s  n u b in h ib e n s  ISM; L  
v e s tfo ld e n s is  SKA53 - L o k ta n e lla  v e s tfo ld e n s is  SKA53.
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inhibitor o f succinate dehydrogenase, and so will need to be metabolised 
quickly to  avoid any deleterious effects. It is therefore tempting to speculate that 
the TRAP transporter is malonate specific, but because o f the potential toxicity 
o f malonate it has to be processed quickly, necessitating the fusion o f MCD to 
the transporter. However, one would have to wonder w hy the synthetase gene 
was not fused as it encodes the first enzyme in the catabolic pathway. 
Subsequent to this finding, a study was performed which demonstrated that 
malonate could induce the expression o f the ESR o f this system (Mauchline et 
al., 2006), further strengthening the case that this is a malonate specific TRAP 
transporter.
3.9 Chapter summary
This results chapter details the compilation o f a TRAP transporter-specific 
relational database, TRAPdb. Analysis of the data collected has provided a 
number of new insights. Analysis o f the distribution o f TRAP transporters 
throughout 243 different prokaryotic organisms revealed that marine-dwelling 
organisms have a propensity to have higher than average numbers o f TRAP 
transporters. Where data was available fo r an organism (from TransportDB), the 
overall contribution of TRAP transporters to the total number of transporters 
was calculated. In the marine-dwelling organisms enriched fo r TRAP 
transporters this was as high as 10%.
Analysis of the data collected for TRAPdb also revealed a number o f new TRAP 
gene organisations including the hitherto unseen positioning o f the dctM  gene 
upstream o f the dctQ  gene and the dctQ  and dctM  genes associated with up to 
3 dctP  genes. A  number o f TRAP ESR genes with the potential for non­
transport functions have been identified such as a ybdE-tike gene and a dctP  
gene fused to a serine/threonine kinase, both possibly participating in signalling 
processes instead o f transport.
A  dctP  gene has been found associated with the genes encoding the 
transmembrane domains and nucleotide-binding domains o f an ABC 
transporter, suggesting that this ESR can form a functional transporter with ABC 
transporter machinery.
Analysis o f phylogenetic and genome context data has led to the prediction that 
a TRAP transporter from S. m eliloti is specific fo r malonate. The dctM  gene in
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this system has also been found to be fused to 
enzyme, further strengthening this association.
a malonate decarboxylase
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Chapter 4
Expression and 
purification of YiaM 
and YiaN from E. coli
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4.1 Cloning and expression trial of the yiaM N  genes using pTTQ18
To characterise functionally the integral membrane proteins from the E. coli 
TRAP transporter YiaMNO, it was necessary to clone the genes yiaM  and yiaN  
into a plasmid vector suited for overexpression o f integral membrane proteins. 
The pTTQ18 expression vector was chosen as this has been used to 
overexpress a number of different integral membrane proteins, including other 
secondary transporters (Morrison et al., 2003, Saidijam et al., 2005, Saidijam et 
al., 2003, Ward, 2000).
The function o f the small subunit YiaM is unknown and may be necessary for 
the correct folding/insertion o f the large subunit, YiaN, into the membrane. To 
take this possibility into consideration, three different expression constructs 
were produced; yiaM  alone, yiaN  alone and the co-expression o f the yiaM N  
genes.
Regions of the E. coli K-12 genome were amplified by PCR using primers 
YiaMF and YiaMR for yiaM  amplification, YiaNF and YiaNhisR for yiaN  
amplification and YiaMF and YiaNhisR for yiaM N  amplification. These were 
cloned into pTTQ18-RGSH6 on an EcoR\-Pst\ fragment so that the coding 
sequences were in frame with the 3’-nucleotide sequence encoding the amino 
acids arginine, glycine serine and 6 histidines (RGSH6). The chosen clones 
were named; pCM14 (YiaM alone), pCM19 (YiaN alone) and pCM20 (YiaMN 
co-expressed). All expression vectors were then transformed into the E. coli 
expression strain BL21 (DE3) and used in initial expression trials (Methods 
section 2.7.1).
A  growth curve o f induced and uninduced BL21 (DE3) pCM14 cultures 
indicated that there was a marked decrease in the growth rate when inducer 
was added compared to where inducer is omitted (Fig. 4.1). It is known that the 
overexpression o f integral membrane proteins can lead to decreased growth 
rates and this is often a good indication o f whether overexpression is occurring 
(Miroux & Walker, 1996).
Analysis o f the steady-state levels o f YiaM from the samples taken during the 
initial expression trial using W estern blotting indicated that in the presence o f
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F igu re  4.1, E ffects  o f induc tion  w ith  IPTG on the  g ro w th  o f BL21 (DE3) 
pCM14. Optical densities (OD65o) o f two BL21 (DE3) pCM14 cultures grown 
aerobically in LB (supplemented with 20 mM glycerol and 100 pg/ml 
carbenicillin) to mid-log phase (OD650 of 0.4-0.6) and either induced with 0.5 mM 
IPTG (closed circles) or left uninduced (open circles) over a period o f ~3.5 
hours.
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IPTG induction an immunoreactive protein with an apparent molecular weight of 
-16 -18  kDa is produced from the strain BL21 (DE3) pCM14 (YiaM) (Fig. 4.2a 
and b). This is in range o f the predicted molecular weight o f YiaM (18 kDa). This 
immunoreactive species was not present in the membrane sample from the 
uninduced culture.
A  -3 4  kDa immunoreactive species was present in the membrane fractions o f 
the strains BL21 (DE3) pCM19 (YiaN alone) and BL21 (DE3) pCM20 (YiaMN), 
in the presence o f inducer (Fig. 4.2d). This molecular weight is slightly smaller 
than the size predicted fo r YiaN (45.4 kDa), however it is commonly observed 
that membrane proteins migrate aberrantly fast in SDS-PAGE gels. There are 2 
key differences observed between YiaN expressed on its own and YiaN co­
expressed with YiaM. There are higher steady-state levels o f YiaN 
accumulation after 3 hours growth when co-expressed with YiaM and there is 
also a -2 7  kDa species detected when YiaM and YiaN are co-expressed which 
is not detected otherwise. However, the absence of this second band may be a 
consequence o f the generally low expression from BL21 (DE3) pCM19.
It was subsequently discovered that the YiaMN construct (pCM20) used in this 
experiment had a mutation in yiaN. This mutation changed a small neutral 
glycine in the tenth predicted transmembrane helix into a bulkier charged 
aspartate residue. A wildtype YiaMN construct was subsequently produced 
(pCM22) and a parallel expression trial was performed on both the G-* D YiaMN 
mutant and the wildtype YiaMN. Western blot analysis showed that the Western 
signal fo r the wildtype protein was significantly more intense than the signal for 
the G-* D mutant (Fig. 4.2e). This result indicates that the difference in steady- 
state levels o f YiaN in the presence or absence o f YiaM co-expression is even 
more pronounced than previously presented (Fig. 4.2d).
These initial expression trials have shown that the pTTQ18 expression system 
is sufficient for the expression o f YiaM and YiaN to detectable levels. YiaM, 
when expressed alone, produces a 16-18 kDa immunoreactive species and at 
longer exposure levels, higher molecular weight species are detectable, the 
most pronounced o f which is around 30 kDa, the approximate size o f a YiaM 
dimer. These higher molecular weight species may be the result o f aggregation 
o f YiaM protein due to the high expression levels or may be genuine oligomer 
formations.
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Figure  4.2 Express ion  o f YiaM and YiaN from  pTTQ18 based express ion  
co n s tru c ts  in the presence (+) and absence (-) o f IPTG induc tion .
(a) Coomassie stained SDS-PAGE and (b) Western blot with anti His-tag 
antibody of YiaM expression from BL21 (DE3) pCM14. The identity of YiaM 
confirmed by peptide mass fingerprinting (red arrow), (c) Coomassie stained gel 
and (d) Western blot of YiaM expression from BL21 (DE3) pCM14, YiaN 
expression from BL21 (DE3) pCM19 and YiaMN expression from BL21 (DE3) 
pCM20. (e) Western blot of YiaMN expression from BL21 (DE3) pCM20 
(“YiaMN mutant”) and BL21 (DE3) pCM22 (“W T”). Molecular weight (MW) 
shown in kDa.
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An immunoreactive species of approximately the predicted size o f YiaN is 
produced when yiaN  is expressed alone or when co-expressed with yiaM. The 
W estern blot indicates that there are higher steady-state levels o f YiaN in the 
membrane after 3 hours growth when co-expressed with YiaM. Possible 
explanations of this observation include YiaM increasing the stability o f YiaN or 
increasing the efficiency o f YiaN insertion into the membrane. When YiaM and 
YiaN are expressed simultaneously there is also the appearance o f a ~27 kDa 
species. This could be a breakdown product of YiaN due to  specific peptidase 
activity, o r it could be a protein non-specifically interacting with the Western 
antibody.
Another question not addressed in this experiment is the fate o f YiaM when co­
expressed with YiaN. In this construct YiaM is untagged and undetectable in 
Western blots and due to low expression is also undetectable in SDS-PAGE.
The most significant conclusion from this experiment is that both YiaM and YiaN 
were expressed to detectable levels by the pTTQ18 expression system. Due to 
the low levels o f expression o f YiaN when expressed alone, only the YiaM alone 
(pCM14) and the YiaMN (pCM22) expressing constructs will be optimised 
further.
4.2 Optimisation o f growth and induction conditions for YiaM and YiaMN  
expression
To maximize the amount o f integral membrane protein produced it is often 
important to optim ise the growth and induction conditions. A  number o f common 
parameters are taken into account, these include: the concentration o f inducer 
used, the growth temperature, the growth medium and the length o f time after 
induction that the cells are harvested. Each o f these parameters was varied 
individually for the strains expressing YiaM alone or co-expressing YiaMN.
4.2.1 IPTG concentration optimisation
To assess the affect of varying the inducer concentrations on the expression of 
YiaM and YiaN, 6x50 ml bacterial cultures o f the strains BL21 (DE3) pCM14 
and BL21 (DE3) pCM22 were grown as in the initial expression trials (Methods 
section 2.7.1) except that various concentrations o f IPTG were added; 0 mM, 
0.1 mM, 0.25 mM, 0.5 mM, 0.75 mM and 1 mM.
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Analysis o f the steady-state levels o f YiaM (Fig. 4.3a) and YiaN (Fig. 4.3b) 
using W estern blotting indicated that varying the concentration o f IPTG between 
0.1 mM and 1 mM did not lead to any significant variation in the total amount o f 
YiaM or YiaN in the membrane fractions after 3 hours o f growth. There is no 
signal on the Western blot in the absence o f inducer.
The results o f this experiment reveal that any concentration between 0.1 and 1 
mM IPTG will produce approximately the same amount o f protein. Induction 
from the lactose promoter is not regarded as particularly tunable when 
compared to other promoters like the arabinose-inducible pBAD system. There 
is evidence in the literature that varying the concentration o f IPTG can alter 
expression levels (Londer e t a!., 2006); however, there was no dramatic 
difference in expression levels in the concentration range that was tested here. 
Increasing this range may have produced some differences in expression 
levels. The Western blot shows no accumulation in the absence o f inducer 
indicating that the promoter does not have a background level o f constitutive 
activity. This is advantageous when expressing membrane proteins as even a 
small amount of expression can lead to decreased growth rate or cell death. 
Subsequent optimisation experiments will use a concentration o f 0.5 mM IPTG 
fo r both expression strains being tested.
4.2.2 Growth medium, temperature of growth and harvest time
The growth medium and the length o f time after induction that the cells were 
harvested were the next parameters to be optimised. The initial expression trial 
indicated that accumulation o f YiaN was lower than YiaM (Fig. 4.2d and e); 
therefore, in an attempt to increase the accumulation o f YiaN, the temperature 
o f growth was also optimised. This parameter was varied simultaneously with 
medium and harvest time fo r BL21 (DE3) pCM22. A  combination o f the signal 
produced by the Western blot and the optical density at the time o f harvesting 
was used to determine the optimal growth conditions.
A  standard timecourse experiment was performed fo r BL21 (DE3) pCM14, at 
37°C, and two were performed fo r BL21 (DE3) pCM22, one at 37°C and the 
other at 25 C (Methods section 2.7.4). Mixed membrane fractions were 
prepared using the water lysis method and the accumulation o f protein was
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F igure  4.3 E ffect o f va ry ing  IPTG concen tra tion  on the  accum ula tion  o f 
YiaM and YiaN a fte r 3 hours  g row th . Western blot with anti His-tag antibody 
of (a) YiaM accumulation from BL21 (DE3) pCM14 and, (b) YiaN accumulation 
from BL21 (DE3) pCM22 in the presence of increasing concentrations of IPTG. 
Each culture was grown in LB, induced at mid-log phase with IPTG and 
harvested after a further 3 hours growth. 5 pg of protein was used in the 
Western blots. Molecular weight (MW) shown in kDa.
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analysed using W estern blotting. Protein samples were also analysed on SDS- 
PAGE gels to ensure that samples had equal amounts o f protein loaded (data 
not shown).
Analysis o f the steady-state levels o f YiaM using W estern blotting indicated that 
accumulation o f YiaM was approximately 2-fold higher in M9 minimal medium 
than LB and in both media the signals on the W estern blots peaked at 3 hours 
after induction (Fig. 4.4a). A t 3 hours after induction the OD65o o f the M9 culture 
was 0.882, whereas the LB culture reached an OD650 of 1.310. Although the 
highest ODeso was achieved by the LB culture grown overnight, this sample had 
a relatively weak signal on the Western blot, indicating that harvesting overnight 
culture would not result in the highest yield o f YiaM attainable. These 
observations indicated growth on LB and harvesting after 3 hours was optimal 
fo r YiaM production.
Analysis o f the steady-state levels o f YiaN in the samples taken from the BL21 
(DE3) pCM22 cultures using Western blotting indicated that there were very low 
levels o f YiaN in the M9 cultures grown at 37°C (Fig. 4.4bi), and no Western 
blot signal was visible in samples from the LB cultures grown at 37°C (Fig. 
4.4bii). These two Western blots signify that 37°C should not be used as the 
temperature for growth.
Analysis o f the steady-state levels o f YiaN when BL21 (DE3) pCM22 was grown 
in M9 at 25°C indicated YiaN accumulation peaked after 2 hours and then 
decreased steadily. There is no W estern blot signal for YiaN in the sample 
taken after overnight growth (Fig. 4.4biii). When grown in LB at 25°C, YiaN 
accumulation reached its peak after 3 hours at which point the steady-state 
amount levelled out resulting in the samples taken at 3, 4 and 5 hours after 
induction having sim ilar W estern blot signal intensity (Fig. 4.4iv). The intensity 
o f W estern blot signals in these samples were higher than the intensity o f the 
peak signal in the samples from the M9 culture and the optical densities were 
almost double, therefore, growing BL21 (DE3) pCM22 in LB at 25°C was 
identified as the growth conditions that would result in the highest accumulation 
o f YiaN.
These experiments have highlighted the subjective nature o f membrane protein 
expression conditions. YiaM is expressed well in M9 and LB at 37°C, however,
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Figure 4.4 O p tim isa tion  o f tim e  o f ha rvest a fte r induc tion , m edium  used 
and tem pera tu re  o f g row th  fo r  the p roduc tion  o f YiaM and YiaN. Western 
blots of membrane fractions from samples harvested at hourly intervals after 
induction, (a) YiaM accumulation in BL21 (DE3) pCM14 when grown in LB and 
M9 at 37°C. (b) (i) YiaN accumulation from BL21 (DE3) pCM22 when grown in 
(i) M9 at 25°C, (ii) LB and 25°C, (iii) M9 at 37°C and (iv) LB at 37°C. 5 pg of 
protein was used for all samples in the Western blots. Molecular weight (MW) 
shown in kDa.
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YiaN does not accumulate in the membrane to very high levels in LB or M9 at 
37°C. Only when the temperature Is lowered to 25°C does YiaN accumulation 
become detectable in the membrane fractions.
The expression timecourses for both YiaM and YiaN have shown that 
membrane protein overexpression from pTTQ18 peaks after only a couple of 
hours, after which the steady-state levels decrease quite rapidly. These 
experiments have both shown that steady-state levels o f YiaM and YiaM are 
relatively low after overnight growth; this is in stark contrast to the 
overexpression o f soluble proteins where 24 hour growth after induction is 
common practise.
A  problem that arises from the lethal effects o f integral membrane protein 
expression combined with the membrane proteins apparent instability is that the 
optical densities o f the cultures when harvested are generally low. One 
parameter that was not investigated was the optical density at which the 
cultures were induced. All the experiments described were with cultures that 
were induced between OD650 o f 0.3 and 0.5. Higher protein yields may have 
been obtained if the cultures had been induced later at, say, OD6so o f 1.
4.3 C om para tive  exp ress ion  tim e co u rse  o f YiaN fro m  pCM22 in  3 d iffe re n t 
exp ress ion  s tra in s ; BL21 (DE3), C41 (DE3) and C43 (DE3).
To overcome the toxicity associated with the overexpression o f integral 
membrane proteins, BL21 (DE3) mutants with higher tolerance fo r membrane 
protein expression have been discovered and developed. C41 (DE3) and C43 
(DE3) were derived from BL21 (DE3) by selecting for lower susceptibility to the 
toxic effects o f integral membrane protein expression (M iroux & Walker, 1996). 
These strains have been used a number of times in parallel w ith BL21 (DE3), 
usually in high throughput approaches, to try and increase the yield o f integral 
membrane protein expression with varying degrees o f success (Dumon- 
Seignovert et a/., 2004). Parallel timecourse experiments were performed to see 
if these strains could increase the yield o f YiaN beyond that obtained with BL21 
(DE3).
The plasmid pCM22 was transformed into C41 (DE3) and C43 (DE3) and 
standard timecourse experiments (Methods section 2.7.4) were performed for 
all 3 strains using the optimised conditions for accumulation o f YiaN from BL21
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(DE3) pCM22 as determined previously. Membrane fractions were prepared 
using the water lysis method.
Analysis o f YiaN accumulation using Western blotting indicated that YiaN is 
expressed in all three expression strains; BL21 (DE3), C41 (DE3) and C43 
(DE3). The accumulation o f YiaN in BL21 (DE3) pCM22 peaked 2 hours after 
induction with an optical density o f 0.804 (Fig. 4.5a), this follows the same 
pattern as seen in the optimisation experiment (Fig. 4.3 and 4.4). Accumulation 
o f YiaN in C41 (DE3) pCM22 and C43 (DE3) pCM22 reached its maximum after 
one hour and the signal remained almost constant in the subsequent timepoints 
(Fig. 4.5b and c). The Western blot signals from the C43 (DE3) pCM22 samples 
were less intense than the signal obtained from BL21 (DE3) and C41 (DE3) 
samples indicating lower levels o f accumulation. There is also an aberrant 
signal in the W estern blot fo r the C43 (DE3) samples that cannot be explained; 
however, it is unlikely to be a genuine signal from the sample because the 
signal is not aligned with a lane in the gel (Fig. 4.5c).
A lthough the peak W estern blot signals in the BL21 (DE3) andC41 (DE3) 
timecourse are of sim ilar intensity, the highest optical density o f C41 (DE3) 
pCM22 is achieved 4 hours after induction but is only 0.744, compared to an 
ODeso o f 0.804 after only 2 hours growth o f BL21 (DE3) pCM22. C43 (DE3) 
pCM22 has the highest optical densities o f all 3 strains, reaching 1.902 4 hours 
after induction it also has the least intense signals on the W estern blots.
Using C41 (DE3) and C43 (DE3) to try  and increase the steady state levels o f 
integral membrane proteins has been used in a number of different studies with 
varying degrees o f success. The comparative expression timecourses shown 
here indicate that accumulation o f YiaN is not significantly increased over that 
observed from BL21 (DE3) pCM22. As the growth and induction conditions fo r 
YiaN production have already been optimised for BL21 (DE3) pCM22 this strain 
will continue to be used. YiaN appears to be more stable in C41 (DE3) as the 
signal does not decrease during the timecourse, whereas, evidence o f 
decreasing YiaN levels is seen after 3 hours in BL21 (DE3). Unfortunately, 
overnight samples from these cultures were not collected as it was assumed 
that steady-state levels would be low as seen previously. It would be interesting
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Figure  4.5 C om parative  tim e co u rse s  o f YiaN exp ress ion  from  BL21 (DE3) 
pCM22, C41 (DE3) pCM22 and C43 (DE3) pCM22. Western blot of membrane 
fractions prepared from samples taken hourly after induction from the strains (a) 
BL21 (DE3) pCM22, (b) C41 (DE3) pCM22 and (c) C43 (DE3) pCM22. Cultures 
were grown at 25°C in LB. 5 pg of protein was used for all samples in the 
Western blots. Molecular weight (MW) shown in kDa.
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to see whether this apparent increase in the stability of YiaN when expressed in 
C41 (DE3) continued into higher optical densities. If this were the case then 
perhaps higher yields o f YiaN would be possible by using C41 (DE3) as the 
expression strain.
4.4 Determination of YiaM and YiaN subcellular location by separation of 
E. co li membrane fractions
As a means to confirm that YiaM and YiaN are localized to the inner membrane 
and also as a prelim inary purification step, the inner and outer membranes were 
separated by a sucrose density gradient.
A  larger volume, typically 5 L, o f BL21 (DE3) pCM14 and BL21 (DE3) pCM22 
cultures were grown and induced according to the optimised conditions 
mentioned previously. The mixed membrane fraction was prepared and applied 
to the sucrose density gradient as detailed in Methods section 2.8.4. The 
protein content of the mixed membranes, inner membrane and outer membrane 
fractions were analysed on SDS-PAGE and Western blots.
The Coomassie stained SDS-PAGE of the mixed, inner and outer membrane 
fractions for both of the cultures indicate significant difference in the protein 
content between the 3 different samples (Fig. 4.6a and c) demonstrating good 
separation o f the inner and outer membrane. The Western blots o f the same 
samples show signals fo r YiaM o r YiaN in each o f the membrane preparations; 
however, the signal in the inner membrane sample is the most intense 
indicating enrichment o f the proteins (Fig. 4.6b and d). There is also a Western 
signal for YiaM and YiaN in the outer membrane fraction samples; this is most 
likely due to cross-contamination with inner membrane during the separation 
process.
Separating the inner and outer membranes has led to the confirmation that 
YiaM and YiaN are indeed localized to the inner membrane in E. coli. It has also 
revealed itself to  be a method by which the inner membrane containing 
overexpressed protein can be separated from a lot o f potential contaminants 
shown in the outer membrane lanes in the SDS-PAGE gels (Fig. 4.6a and c).
155
Original in Colour
(a) (b)
MW MM IM OM MW MM IM OM
(c) (d)
MW MM JM_ OM MW MM IM OM 
175— W  175—
F igure  4.6 C om parison YiaM and YiaN con te n t o f m ixed, inne r and ou te r 
m em brane fra c tio n s  prepared fro m  BL21 (DE3) pCM14 o r BL21 (DE3) 
pCM22 cu ltu res, (a) Coomassie stained gel and (b) Western blot of mixed 
(MM), inner (IM) and outer (OM) membranes produced from a culture of BL21 
(DE3) pCM14 grown in LB to mid-log phase, induced with 0.5 mM IPTG and 
harvested after a further 3 hours growth, (c) Coomassie stained gel and (d) 
Western blot of mixed (MM), inner (IM) and outer (OM) membranes produced 
from a culture of BL21 (DE3) pCM22 grown in LB to mid-log phase, induced 
with 0.5 mM IPTG and harvested after a further 2 hours growth. 20 pg of protein 
is applied to the Coomassie stained SDS-PAGE gels (except for the OM lane in 
(b) which was too dilute and had the maximum volume possible loaded) and 5 
pg of protein is applied to the Western blots. Molecular weight (MW) shown in 
kDa.
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4.5 Differential solubilisation of YiaM and YiaN by a variety of detergents
One o f the most important considerations in the expression o f integral 
membrane proteins for biophysical and biochemical analysis is the choice of 
detergent used for solubilisation. There are a wide variety o f detergents 
available that solubilise integral membrane proteins to varying degrees while 
maintaining protein function. The choice o f detergent also becomes more 
important if the target protein is to be reconstituted into liposomes fo r in vitro 
uptake studies or used for crystallisation trials. Unfortunately, whether or not a 
detergent solubilises a particular protein and retains protein function has to be 
determined empirically.
To assess which detergents solubilise YiaM and YiaN most effectively, solubility 
trials were performed with a number o f different detergents from the zwitterionic, 
alkyl glucoside and PEP (polyoxoethylenes, monodisperse and polydisperse) 
fam ilies o f detergents.
Cultures o f BL21 (DE3) pCM14 and BL21 (DE3) pCM22 were grown and 
induced using the optimised conditions previously elucidated. The inner 
membrane fractions were then purified with sucrose density gradients (Methods 
section 2.8.4). The detergents used in the YiaM detergent trial were; CHAPS, 
THESIT (C12E9), n-nonyl-jff-maltoside (NM), n-nonyl-/?-D-glucopyranoside (NG), 
dodecyl-yff-D-maltoside (DDM), /?-octyl glucoside (£-OG), lauryldimethylamine 
oxide (LDAO), Zwittergent 3-08, Triton X100 and Zwittergent 3-16. The 
solubilisation trial for YiaN was performed with the following detergents; 
CHAPS, NM, THESIT, NG, DDM, £-OG, LDAO, Zwittergent 3-08, Triton X-100 
and CsEs. The detergent solubility screen protocol was used (Methods section 
2.13).
Analysis o f the soluble and insoluble fractions after solubilisation using 
Coomassie stained SDS-PAGE gels and W estern blotting revealed that DDM, 
NM, Triton X-100 and THESIT were capable o f solubilising YiaM (Fig. 4.7) to a 
satisfactory degree, whereas the other detergents tested did not. A  sim ilar 
pattern was observed for the YiaN solubilisation trial. In this case only NM, DDM 
and Triton X-100 showed satisfactory solubilisation (Fig. 4.8). DDM was 
particularly efficacious in the solubilisation o f both YiaM and YiaN and was far 
superior to any other detergent tested.
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Figure 4.7 S o lub ilisa tion  tria l o f YiaM w ith  10 d iffe re n t de tergents. SDS- 
PAGE (a, c and e) and Western blots (b, d and f) of the soluble (s) and insoluble 
(p) fractions after solubilisation with various detergents. The detergents used 
were CHAPS, THESIT (C i 2 E9), Nonyl maltoside (NM), n-nonyl-/?-D- 
glucopyranoside (NG), dodecyl-/?-D-maltoside (DDM), £-octyl glucoside (/?-OG), 
Lauryldimethylamine oxide (LDAO), Zwittergent 3-08, Triton X-100 and 
Zwittergent 3-16. Molecular weight (MW) shown in kDa.
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Figure  4.8 S o lub ilisa tion  tria l o f YiaN w ith  10 d iffe re n t de tergents. SDS- 
PAGE (a and c) and Western blots (b and d) of the soluble (s) and insoluble (p) 
fractions after solubilisation with various detergents. The detergents used were 
CHAPS, THESIT (C1 2E9 ), Nonyl maltoside (NM), n-nonyl-/?-D-glucopyranoside 
(NG), dodecyl-A-D-maltoside (DDM), 0-octyl glucoside (/?-OG), 
Lauryldimethylamine oxide (LDAO), Zwittergent 3-08, Triton X-100 and C8 E5. 
Molecular weight (MW) shown in kDa.
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The results obtained from both solubilisation trials indicate that a number of 
detergents could potentially be used to solubilise both YiaM and YiaN, however, 
DDM is by far the best at not only solubilising YiaM and YiaN, but also 
solubilising almost the entirety of the E. coll membrane proteome (Fig. 4.7c 
DDM lane). DDM has been the detergent o f choice in many studies in the 
literature and is used for the solubilisation o f integral membrane proteins for 
reconstitution and crystallisation (Curnow et al., 2004, Murakami et al., 2002, 
Screpanti et al., 2006); indicating that DDM retains the function o f the integral 
membrane proteins in question. Unfortunately there is no current functional 
assay for YiaMN, and so, it is unknown how any o f these detergents are 
affecting the functionality o f YiaM and YiaN, this could only be assessed after 
reconstitution into liposomes. Knowledge o f which detergents can or cannot 
solubilise YiaM or YiaN could also potentially be used in the purification 
process, for example, a detergent could be used to selectively solubilise 
contaminants and separate the target protein making purification more effective.
4.6 Purification of YiaM and YiaN by immobilized metal affinity 
chromatography (IMAC)
Most integral membrane proteins, even when overexpressed, are not abundant 
and are unstable when extracted with detergents so need to be separated from 
the rest o f the membrane proteome as quickly as possible, i.e. in one step. 
There is also a need to purify integral membrane proteins in one step as it has 
been observed that the delipidation o f membrane proteins over time can 
negatively affect their crystallisation and reconstitution into liposomes. To 
overcome these problems IMAC purification is used. This method relies on the 
high affinity interaction o f the IMAC resin with the hexahistidine tag on the target 
protein, which is then used to purify and enrich the protein o f interest.
YiaM was purified from the inner membrane fraction prepared from BL21 (DE3) 
pCM14 by first extracting the protein from the membrane with DDM using the 
standard protocol (Methods section 2.14.1), except that 2 mg/ml (final 
concentration) inner membrane protein was solubilised overnight at 4°C in a 5 
ml solubilisation reaction consisting of 20 mM HEPES, 10% glycerol, 300 mM 
NaCI and 1% DDM (w/v). YiaM was purified using a batch washing protocol with 
disposable columns (Methods section 2.14.2). YiaN was extracted from mixed
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membranes prepared from BL21 (DE3) pCM22 using the standard protocol 
(Methods section 2.14.1), except that 2 mg/ml (final concentration) mixed 
membrane protein was solubilised overnight at 4°C in a 15 ml solubilisation 
reaction consisting o f 20 mM HEPES, 10% glycerol, 300 mM NaCI and 1% 
DDM (w/v). YiaN was purified using a column and a peristaltic pump following 
the standard protocol (Methods section 2.14.3), except that the buffers used 
were the same as fo r the YiaM purification.
Analysis of the SDS-PAGE and W estern blot o f the YiaM purification fractions 
revealed a Western blot signal for YiaM in the inner membrane fraction and 
soluble fraction after detergent extraction and centrifugation, but not in the 
flowthrough or insoluble fractions. This indicates that almost all the YiaM is 
being solubilised by DDM and the soluble YiaM is binding to the Ni2+-NTA resin 
(Fig. 4.9b). SDS-PAGE o f the elution fractions reveals the major band to be -1 8  
kDa -  the molecular weight expected fo r YiaM (Fig. 4.9a). The W estern blot of 
the elution fractions reveals the predominant signal to be at -1 8  kDa, and also 
reveals signals fo r higher molecular weight species at regular and discreet 
intervals possibly signifying the formation o f YiaM oligomers (Fig. 4.9b). The 
immunoreactive species at -1 8  and -2 8  kDa were confirmed to be YiaM by 
tandem mass spectroscopy. YiaM is estimated to be >95% pure after IMAC 
purification and a yield of 0.75 mg/L culture.
W estern blot analysis o f the YiaN purification fractions indicates that it is 
present in the mixed membrane fraction and soluble fraction after solubilisation 
and centrifugation. As with the YiaM purification there is no Western blot signal 
in either the insoluble fraction or in the flowthrough indicating that YiaN was 
successfully solubilised and it was completely bound to the Ni2+-NTA resin (Fig. 
4.9d). The Western blot indicates that there is an immunoreactive species in the 
second elution fraction with a molecular weight of -31  kDa; which was 
confirmed to be YiaN by peptide mass fingerprinting. There is also a higher 
molecular weight immunoreactive species visible in the W este rn . blot at -6 3  
kDa, o f which the identity is unknown (Fig. 4.9d). A  number o f low intensity 
bands are visible in the second elution fraction on the Coomassie stained SDS- 
PAGE gel with the most abundant at -8 3  kDa (Fig. 4.9c). To identify what these 
contaminants were, the second elution fraction was concentrated using a 5000 
MWCO centrifugal concentrators (Vivascience) and analysed by SDS-PAGE
161
Original in Colour
( a )
MW IM
Elution fractions
sol. UB 1 2 3 4 Insol.
(b )
MW IM sol. UB
Elution fractions 
1 2 3 4 insol.
(M
66—  »  ;
1 | j |  — 66 —
45— |
45 —
3 6 - —  2
on 30 —
IT  * *
20— « a -  M
14 2 "—
20.1— .T|| - -
14.3 —
( c )
MW IM
Elution fractions 
sol insol. UB 1 2 3 4
( d )
MW IM sol insol. UB
Elution fractions 
1 2  3 4
175---------
o o ______ I
•■
175—
OO mmm
6 2 ---------
83 —  
62 —
4 7 .5 — —" . -jl— «Z» 47 .5—
3 2 .5 - — I 32.5—
2 5 —» 2 5 —
1 6 .5 -— 16.5—
(e )
M W Y iaN Y iaM
175--------
Q Q ___________ 1 -----
6 2 ---------
47.5 —  
32.5— -
25—
16.5—
6 .5 ---------
Figure  4.9 IMAC p u rifica tio n  o f YiaM and YiaN from  inne r m em brane.
(a) SDS-PAGE and (b) Western blot of YiaM purification and (c) SDS-PAGE 
and (d) Western blot of YiaN purification. SDS-PAGE and Western blots show 
the following purification samples; inner membrane fraction (IM) or mixed 
membrane fraction (MM), the soluble fractions (sol) and insoluble fractions 
(insol) after detergent extraction and centrifugation, the flowthrough (UB) and 
the elution fractions, (e) SDS-PAGE of concentrated elution fractions from YiaM 
and YiaN IMAC purifications. Proteins identified by peptide mass fingerprinting 
as 1 AcrB, 2 GlgA and 3 YiaN. Molecular weight (MW) shown in kDa.
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along with YiaM elution fraction and the 3 most intense bands were excised and 
identified by peptide mass fingerprinting (Fig. 4.9e). The most intense band at 
~83 kDa was identified as AcrB which has been observed as a common 
contaminant in other laboratories using the pTTQ18 system and IMAC 
purification (Peter Henderson, unpublished data), the ~47 kDa species was 
identified as glycogen synthase (GlgA) and the species at ~31 kDa was 
confirmed to be YiaN.
«
The purification o f YiaM from the inner membrane fraction yielded a ladder of 
bands on the Coomassie stained SDS-PAGE and W estern blot (Fig 4.9a, b and 
e). The bands that make up the ladder are discreet and have approximate 
molecular weights that correspond with them being oligomers o f YiaM. Indeed, 
the monomeric species (at ~18 kDa) and potential dim er species (at ~28 kDa) 
have both been confirmed to be YiaM using tandem mass spectroscopy. This is 
the first overexpression and purification o f an integral membrane component 
from any TRAP transporter and due to the scarcity o f structural and functional 
knowledge o f the integral membrane components it is unknown whether these 
potential oligomeric states are o f functional significance or an artefact o f the 
purification procedure. YiaM has separate polypeptides for its integral 
membrane components, but many TRAP transporters have the integral 
membrane components fused into one polypeptide thus suggesting that the 
integral membrane components are in a 1:1 ratio. If this is the case and the 
functional YiaM component is a multimer then one would expect YiaN to also be 
a multimer when co-expressed with YiaM.
The W estern blot o f the purification o f YiaN revealed 2 signals; one at ~30 kDa 
and the second at ~62 kDa. The species at 30 kDa was confirmed to be YiaN, 
and although the higher molecular weight species has not been identified the 
molecular weight is the approximate size one would predict for a dimeric YiaN. 
The construct used to express YiaN also should also produce an untagged 
YiaM that will not be visible on the W estern blot, but may be discernable on the 
SDS-PAGE gel. The SDS-PAGE o f the elution fractions revealed very weak 
bands indicating dilute levels of protein in the eluate. To analyse the protein 
content more thoroughly the second elution fraction was concentrated and
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analysed again on SDS-PAGE (Fig. 4.9e). This revealed a number o f proteins 
that were not apparent previously but could be identified by tandem mass 
spectroscopy. The most intense band was identified as AcrB with a molecular 
weight o f 83 kDa (Fig. 4.9e). AcrB is a component o f the E. coli acridine efflux 
pump and has been found to be a common contaminant in other laboratories 
using the pTTQ18 system and IMAC purification (Peter Henderson, unpublished 
data); the second most intense was YiaN at ~30 kDa (Fig. 4.9e) and the third 
most intense was E. coli glycogen synthase (GlgA) at ~47 kDa (Fig. 4.9e). 
Glycogen synthase is a natural metal-binding protein and is reported to be a 
common contaminant o f IMAC purifications (Bolanos-Garcia & Davies, 2006). 
GlgA has a higher affinity for Mg2+ than Ni2+ so including some Mg2+ in the 
washing stages may be a method by which this contaminant could be removed. 
There are a number o f reasons that the YiaN purification is not as successful as 
the YiaM purification. The first is that the resin volume used to purify YiaN was 
too large and therefore did not specifically select fo r the highest affinity motifs, 
i.e. the hexahistidine tag. This allowed a higher capacity for lower affinity 
interactions to occur. Unlike the YiaM purification protocol, the solubilised 
membrane proteins were not incubated with the resin fo r a prolonged period o f 
time which may help the resin bind affin ity tags that may be buried o r less 
accessible. YiaM was purified from inner membrane, whereas YiaN was purified 
from mixed membranes; however, the major contaminants identified were all 
inner membrane proteins so the retention o f the outer membrane was not 
detrimental to the overall purity. The purification o f YiaN could be made more 
effective by the optimisation o f purification conditions or the inclusion o f a 
secondary purification step, for example ion exchange chromatography or size 
exclusion chromatography.
4.7 Treatment o f purified YiaM with heat denaturation and reducing agent
Purification o f YiaM by IMAC yielded a ladder o f immunoreactive species o f 
which the 2 lowest molecular weight species were confirmed as YiaM using 
tandem mass spectroscopy. YiaM has 3 cysteine residues that are predicted to 
be at the centre o f transmembrane helices I, II and IV (using TMHMM) and it is 
unknown whether these contribute to  oligomer formation.
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To demonstrate that these higher molecular weight species were indeed 
oligomers of YiaM an experiment was designed in which purified YiaM was 
treated with boiling and the reducing agent £-mercaptoethanol to  try  and obtain 
only the monomeric species.
YiaM was purified using IMAC and treated with combinations o f 0%, 5% o r 20% 
^-mercaptoethanol with no boiling, 1 minute boiling or 5 minute boiling at 95°C.
In the presence o f no 0-mercaptoethanol (0%) there are 4 major species at -1 8 , 
-2 8 , -4 6  and -1 0 0  kDa on the Coomassie stained SDS-PAGE and W estern 
blot (Fig 4.10a and b). The predominant species is the 28 kDa “dimer” species 
in the SDS-PAGE and boiling for 0 ,1  or 5 minutes does not significantly change 
the appearance o f the ladder. W ith the addition o f 5% /?-mercaptoethanol the 
-1 0 0  kDa species is no longer visible on the W estern blot and the -1 8  kDa 
species becomes the predominant species in both the SDS-PAGE and the 
W estern blot. After 5 minutes boiling the only species visible on the Western 
blot were the monomer and the dimer. The monomer was the predominant 
species after the addition of 20% /?-mercaptoethanol with no boiling. After 
boiling for 1 minute, the monomer is visible and a very weak signal for the 
dimer, there is also evidence o f aggregation where the protein did not leave the 
wells and are visible at the top o f the stacking gel in the W estern blot (Fig. 
4.10b). A fter 5 minutes boiling in the presence of 20% /?-mercaptoethanol there 
were no immunoreactive species as seen in the previous lanes, there was 
however evidence o f aggregate in the stacking gel, suggesting that this 
treatm ent was too harsh and the protein completely aggregated/degraded.
Treatment o f the YiaM ladder with £-mercaptoethanol leads to a reduction in the 
number and intensity o f high molecular weight species. /?-mercaptoethanol 
treatment in combination with heat denaturation led to  a further decrease in the 
number o f higher molecular weight species. A t the more extreme conditions 
w ith 20% /?-mercaptoethanol and boiling fo r 1 or 5 minutes significant 
aggregation o f protein was observed. These observations and the fact that the 2 
lowest molecular weight species o f the ladder were identified as YiaM suggest 
that YiaM is forming higher order oligomers. This does not mean that the
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F igure  4.10 E ffect o f /?-m ercaptoethanol trea tm en t and heat dena tu ra tion  
on the  apparent YiaM ladder a fte r IMAC p u rifica tio n , (a) SDS-PAGE and (b) 
Western blot of the effects of the addition of 0%, 5% or 20% /?-mercaptoethanol 
in combination with no boiling, 1 minute or 5 minute boiling. The stacking gel is 
indicated in (b). The sample for 5% £-mercaptoethanol with 5 minutes boiling 
was not loaded in (a). Molecular weight (MW) shown in kDa.
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oligomers formed are functionally significant and they may just be a purification 
artefact with the cysteine residues interacting aberrantly. More experiments 
would be required to assess whether these oligomers are functionally relevant 
such as analytical ultracentrifugation (AUC) or in vivo crosslinking.
4.8 Chapter summary
This chapter describes the homologous expression and purification o f the 
integral membrane proteins YiaM and YiaN from E. coli. Both proteins were 
successfully expressed using the pTTQ18 expression, vector. A  number o f 
growth/induction conditions known to affect integral membrane accumulation 
were optimised including; the concentration of inducer, the length o f time after 
induction before harvesting the cells and the medium of growth.
YiaM was found to accumulate to high levels when expressed alone. It was 
found that co-expression o f YiaM with YiaN led to higher accumulation of YiaN 
than when YiaN is expressed alone. This indicates a possible function of YiaM 
in the stability/insertion o f YiaN.
The cellular location o f YiaM and YiaN was confirmed to be the inner membrane 
using sucrose density gradients to separate the inner and outer membranes. 
IMAC purification of YiaM revealed a ladder of distinct YiaM species with 
increasing sizes corresponding with the size o f the YiaM monomer. This 
suggests that YiaM can form higher oligomeric complexes. Due to the existence 
o f fusions between the two TRAP integral membrane proteins in certain 
systems it is assumed that they are in a 1:1 stoichiometry. The apparent 
oligomers of YiaM would therefore mean YiaN forms oliogmeric structures. 
When yiaM  and yiaN  were co-expressed and purified using the hexa-histidine 
tag on the YiaN subunit, a ladder o f YiaN species was not observed and a band 
fo r YiaM was not identified, so it is currently unknown what the subunit 
stoichiometry is. The exact nature o f the apparent YiaM complexes in solution is 
not known and may be an artefact o f the expression and purification 
procedures.
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Chapter 5
Expression and 
purification of SiaQM 
from H. influenzae
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5.1 Cloning and expression trial o f the siaQ M  genes using pTTQ18
To characterise the integral membrane protein from the H. influenzae TRAP 
transporter SiaPQM, the gene encoding this protein, SiaQM, was cloned into 
the pTTQ18-RGSH6 expression vector fo r overexpression and purification. To 
do this the region o f the H. influenzae  Rd KW20 genome encoding siaQ M  was 
amplified by PCR using primers SiaQMpTTQHisF and SiaQMpTTQHisR and 
cloned into pTTQ18-RGSH6 on an EcoRI-Psfl fragment so that the coding 
sequence was in frame with the 3 ’-nucleotide sequence encoding the amino 
acids arginine, glycine, serine and 6 histidines (RGSH6). The chosen clone was 
named pCM23.1. This expression vector was transformed into E. coli BL21 
(DE3) and used in expression trials (Methods section 2.7.1). The initial 
expression trial was performed in both LB and M9 minimal media. As observed 
in the expression optimisation o f BL21 (DE3) pCM22 (Chapter 4), growth at 
37°C can have deleterious effects on the steady state levels o f overexpressed 
membrane proteins. It was therefore decided to perform the initial expression 
trial at 25°C.
As observed for the expression o f YiaM and YiaN in pTTQ18-RGSH6, the 
overexpression o f SiaQM in pTTQ18 caused a significant decrease in the 
growth rate when inducer was added compared to  the absence o f inducer (data 
not shown) suggesting expression o f an integral membrane protein. Analysis of 
the steady-state levels o f SiaQM using Western blotting revealed that two 
immunoreactive proteins were produced from BL21 (DE3) pCM23.1 in the 
presence o f IPTG when grown in either LB o r M9 (Fig. 5.1). The 
immunoreactive species have apparent molecular weights o f ~50 kDa and -2 8  
kDa and were not present in the membrane samples from the uninduced 
cultures. The predicted molecular weight o f SiaQM is ~76 kDa and taking into 
account the aberrant migration o f integral membrane proteins in SDS-PAGE, 
the ~50 kDa species was predicted to be SiaQM. The identity o f the 
immunoreactive species at ~28 kDa was unknown. This -2 8  kDa species may 
be a breakdown product o f SiaQM or may be caused by the binding o f the anti 
His-tag antibodies to an E. coli protein. Therefore, this initial expression 
experiment has shown that the pTTQ18 expression system is sufficient fo r the 
expression o f SiaQM to detectable levels.
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Figure 5.1 E xpress ion  o f SiaQM from  pTTQ18 based express ion  
co n s tru c ts  in the presence (+) and absence (-) o f IPTG induc tion .
Coomassie stained SDS-PAGE (a) and Western blot (b) with anti His-tag 
antibody of SiaQM expression from BL21 (DE3) pCM23.1 grown in either LB or 
M9 minimal media to mid-log phase, induced with 0.5 mM IPTG and harvested 
after a further 2  hours growth. 20 pg of protein was applied to the Coomassie 
stained SDS-PAGE and 5 pg was applied to the Western blots. Molecular 
weight (MW) shown in kDa.
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5.2 Optimisation of growth and induction conditions for SiaQM expression
As with YiaM and YiaN expression, it was important to optim ise the growth and 
induction conditions for the production o f SiaQM. A number o f common 
parameters were taken into account, including the growth temperature, the 
growth medium and the length o f time after induction that the cells are 
harvested. Each o f these parameters was varied for the strain expressing 
SiaQM.
The growth medium, time o f harvesting after induction and the temperature of 
growth were optimised simultaneously. A  combination o f the signal intensity 
produced by the W estern blot and the optical density (OD65o) o f the culture at 
the time o f harvesting was used to determine which growth conditions were 
optimal.
Standard timecourse experiments (Methods section 2.7.4) were performed for 
BL21 (DE3) pCM23.1 grown on either LB or M9 at 25°C or 37°C, producing 4 
cultures in total. Mixed membrane fractions were prepared using the water lysis 
method and the accumulation o f SiaQM was analysed using Western blotting. 
Protein samples were also analysed on SDS-PAGE gels to ensure that samples 
had equal amounts of protein loaded (data not shown).
Analysis o f steady-state levels o f SiaQM using W estern blotting indicated that 
SiaQM was produced by BL21 (DE3) pCM23.1 in all 4 o f the different conditions 
(Fig. 5.2a-d). When grown at 37°C in M9 the peak signal was achieved after 1 
hour o f growth post-induction, the steady-state levels then gradually decreased 
until only a very weak signal remained on the W estern blot. There was no 
visible Western blot signal in the sample taken from bacteria grown overnight 
(Fig. 5.2a). When grown at 37°C in LB, the signal increased and peaked after 5 
hours growth and there was no W estern signal from the sample taken after 
overnight growth (Fig. 5.2b).
Samples taken from BL21 (DE3) pCM23.1 grown at 25°C in M9 had the most 
intense W estern blot signals o f all the conditions tested (Fig. 5.2c). The 
accumulation o f SiaQM did not peak in these conditions until after 6 hours
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F igure  5.2 O ptim isa tion  o f tim e o f ha rvest a fte r induc tion , g row th  m edium  
used and tem perature  o f g row th  fo r  the p rodu c tio n  o f SiaQM. Western 
blots with anti His-tag antibody of membrane fractions from BL21 (DE3) 
pCM23.1 samples harvested at hourly intervals after induction. BL21 (DE3) 
pCM23.1 grown in M9 at 37°C (a), LB at 37°C (b), M9 at 25°C (c) and LB at 
25°C (d). All samples were induced at mid-log phase with 0.5 mM IPTG. 5 pg of 
protein was used for all samples in the Western blots. Molecular weight (MW) 
shown in kDa.
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growth and, unlike the cultures grown at 37°C, there was also significant 
Western blot signal in the sample taken from culture grown overnight. A  sim ilar 
accumulation pattern was observed for samples taken from  cells grown in LB at 
25°C; the peak accumulation occurred after 6 hours growth and significant 
levels o f SiaQM were observed in the sample taken after overnight growth (Fig. 
5.2d). Even though the Western blot signals are more intense in the samples 
taken from cultures grown at 25°C in M9, the cells grown at 25°C in LB have 
significantly higher optical densities (OD65o) o f 6.7, -1 0  fold higher than any of 
the other samples.
Using the intensity o f the W estern blot signals in combination with the optical 
densities obtained for the samples, the optimal conditions for the accumulation 
o f SiaQM are growth at 25°C in LB and harvested after overnight growth.
5.3 Determination o f SiaQM cellular sublocation by separation o f E. co li 
m embrane fractions
As a means to confirm that SiaQM was localized to the inner membrane and 
also as a preliminary purification step, the inner and outer membranes were 
separated by a sucrose density gradient. A larger volume, typically 5 L, o f BL21 
(DE3) pCM23.1 culture was grown and induced according to the optimised 
conditions mentioned previously. The mixed membrane fraction was prepared 
and applied to the sucrose density gradient as detailed in Methods section 
2.8.4. The protein contents o f the mixed membranes, inner membrane and 
outer membrane fractions were analysed on SDS-PAGE and W estern blots.
Analysis o f the protein content o f the inner and the outer membrane fractions by 
SDS-PAGE indicated some differences in the protein content between the 3 
different samples (Fig. 5.3a) demonstrating that there had been some 
separation o f the inner and outer membrane. The W estern blot o f the same 
samples shows a signal fo r SiaQM in each o f the membrane preparations, 
however, the signal in the inner membrane sample is the most intense 
indicating enrichment of the protein in this fraction (Fig. 5.3b). There is also a 
very weak W estern blot signal fo r SiaQM in the outer membrane fraction 
samples; this is most likely due to  cross-contamination with inner membrane 
during the separation process.
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Figure  5.3 C om parison SiaQM con ten t o f m ixed, inne r and ou te r 
m em brane fra c tio n s  prepared from  BL21 (DE3) pCM23.1. Coomassie 
stained SDS-PAGE (a) and Western blot (b) of mixed (MM), inner (IM) and 
outer (OM) membranes produced from a culture of BL21 (DE3) pCM23.1 grown 
in LB to mid-log phase, induced with 0.5 mM IPTG and harvested after 
overnight growth. 20 pg of protein was applied to the Coomassie stained SDS- 
PAGE and 5 pg of protein is applied to the Western blots. Molecular weight 
(MW) shown in kDa.
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Separating the inner membrane and the outer membrane has led to the 
confirmation that SiaQM is indeed localised to the inner membrane in £  coli. It 
has also revealed itself to be a method by which the inner membrane containing 
overexpressed protein can be separated from a lot o f potentially contaminating 
protein shown in the outer membrane lanes in the SDS-PAGE gels (Fig. 5.3a).
5.4 Differential solubilisation of SiaQM by a variety of detergents
As with the optimisation o f expression and purification o f YiaM and YiaN 
(Chapter 4), it is important to choose the correct detergent to extract SiaQM 
from the E. coli membrane. A  solubilisation screen is performed with different 
detergents to assess their efficacy fo r the extraction o f SiaQM from the 
membrane. 10 detergents from the zwitterionic, alkyl glucoside and PEP 
(polyoxoethylenes, monodisperse and polydisperse) fam ilies are included in the 
screen. Cultures o f BL21 (DE3) pCM23.1 were grown and induced using the 
optim ised conditions previously elucidated. The inner membrane fractions were 
then purified with sucrose density gradients. A  solubilisation screen was 
performed (Methods section 2.13) using the detergents; dodecyl-/0-D-maltoside 
(DDM), CHAPS, THESIT (C12E9), n-nonyl-£-maltoside (NM), £-octyl glucoside 
(fi-OG), lauryldimethylamine oxide (LDAO), Zwittergent 3-08, Triton X-100, 
C8E5, C-13E10 and octyl-0-D-thioglucopyranoside (OTG).
Analysis o f the soluble and insoluble fractions after solubilisation using 
Coomassie stained SDS-PAGE gels and W estern blotting revealed that DDM, 
NM,/?-OG were capable of solubilising SiaQM to a satisfactory degree, whereas 
the other detergents tested did not (Fig. 5.4). As seen in the detergent trial for 
YiaM and YiaN, DDM was particularly efficacious in the solubilisation of SiaQM 
and was fa r superior to any other detergent tested.
The results obtained from this solubilisation trial indicated that a number o f 
detergents could potentially be used to solubilise SiaQM, however, as seen fo r 
YiaM and YiaN, DDM was by fa r the best. Knowledge o f which detergents can 
or cannot solubilise SiaQM could also be used potentially in the purification 
process, for example, a detergent could be used to selectively solubilise 
contaminants and separate the target protein making purification more effective.
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Figure  5.4 S o lub ilisa tion  tr ia l o f SiaQM w ith  10 d iffe re n t detergents.
Coomassie stained SDS-PAGE (a, c and e) and Western blots (b, d and f) of 
the soluble (s) and insoluble (p) fractions after solubilisation with various 
detergents. The detergents used were dodecyl-£-D-maltoside (DDM), CHAPS, 
THESIT (C1 2E9 ), n - nonyl-/?-maltoside (NM), £-octyl glucoside (0-OG), 
lauryldimethylamine (LDAO), Zwittergent 3-08, Triton X-100, C8 E5, C1 3 E10 and 
octyl-yff-D-thioglucopyranoside (OTG). Molecular weight (MW) shown in kDa.
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5.5 Purification o f SiaQM by immobilized meta! affinity chromatography 
(IMAC)
Most integral membrane proteins, even when overexpressed, are not abundant 
and are unstable when extracted with detergents so need to be purified as well 
as possible preferably in one step. There is also a need to purify integral 
membrane proteins quickly as it has been observed that the delipidation o f 
membrane proteins over time can negatively affect their crystallisation and 
reconstitution into liposomes. To overcome these problems IMAC purification is 
used. This method relies on the high affinity interaction o f the IMAC resin with 
the hexahistidine tag on the target protein, which is then used to purify and 
enrich the protein o f interest.
SiaQM was purified from the inner membrane fraction by firs t extracting the 
protein with DDM using the standard protocol (Methods section 2.14.1), except 
that 7 mg/ml (final concentration) o f inner membrane prepared from BL21 (DE3) 
pCM23.1 was solubilised fo r 1 hour at 4°C in a 9 ml solubilisation reaction 
consisting o f 20 mM HEPES, 10% glycerol, 300 mM NaCI and 1% DDM. SiaQM 
was purified using the batch washing method (Methods section 2.14.2), except 
that, after the batch washing stage, the resin was applied to a non-disposable 
column and eluted according to Methods section 2.14.3 with the following 
elution buffer; 10 mM NaPi, pH 8, 10% glycerol, 250 mM imidazole, pH 8, and 
0.05% DDM.
Analysis of the SiaQM purification fractions with Coomassie-stained SDS-PAGE 
and W estern blotting revealed that a strong signal on the W estern blot was 
visible in the inner membrane and supernatant fractions, and a very weak signal 
was present in the flowthrough and insoluble fractions (Fig. 5.5a and b). The 
weak signal in the insoluble fraction may be due to  the membrane fraction not 
being fully solubilised or could be a contamination o f the soluble fraction. The 
nature o f batch washing means that a small amount of resin (bound to  protein) 
is invariably still suspended after centrifugation and this leads to the “unbound 
fraction”, which should be devoid o f any SiaQM and resin, containing a small 
am ount o f both, which causes the signal in the W estern blot. Regardless o f
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Figure 5.5 IMAC p u rifica tio n  o f SiaQM from  inne r m em brane. Coomassie 
stained SDS-PAGE (a) and Western blot (b) of IMAC purification of SiaQM from 
inner membrane prepared from BL21 (DE3) pCM23.1. The following purification 
samples were analysed; inner membrane fraction (IM), the soluble fraction (sol) 
and insoluble fraction (insol) after detergent extraction and centrifugation, the 
flowthrough (UB) and the elution fractions. Proteins identified by peptide mass 
fingerprinting as 1) AcrB, 2) GlgA, 3) SiaQM and 4) ZitB. Molecular weight (MW) 
shown in kDa.
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these technicalities, the Western blot indicates that the majority o f SiaQM is 
solubilised and is bound to the resin.
Analysis o f the elution fractions with Coomassie-stained SDS-PAGE revealed 
several bands o f equal intensity indicating that the IMAC purification was not 
entirely successful (Fig. 5.5a). To aid in rationally designing further purification 
methods and to assess whether SiaQM was in the eluate, a number o f the 
bands in the elution fraction were identified using peptide mass fingerprinting. 
The band at ~90 kDa was identified as AcrB, the band at ~50 kDa was identified 
as glycogen synthase (GlgA) and the band at -  45 kDa was identified as SiaQM 
(Fig. 5.5a and b). The W estern blot o f the elution fractions indicates that there 
are two strongly immunoreactive proteins; one that corresponds to the 
molecular weight expected fo r SiaQM and a lower molecular weight species at 
~30 kDa o f unknown identity. Inspection o f the SDS-PAGE gel revealed a 
strong band at ~30 kDa which was identified as the E. coli zinc transporter ZitB. 
The contaminant at ~10 kDa was not identified.
Analysis o f the prelim inary purification o f SiaQM using SDS-PAGE revealed that 
in the conditions used it was not possible to purify SiaQM to  homogeneity. 
Using a combination o f Western blotting and peptide mass fingerprinting 
however, it was confirmed that SiaQM was bound by the Ni2+-NTA resin and 
was a major constituent o f the eluate. In an effort to design a purification 
protocol that would result in homogeneous SiaQM, the contaminants were 
identified. Two o f the contaminants identified, AcrB and GlgA, were also major 
contaminants o f the YiaN purification by IMAC (Chapter 4). The same resin was 
used in both and so it is likely that these proteins are weakly bound by non­
specific interactions with the resin. G lgA is a common contaminant o f IMAC 
because it is a natural metal binding protein (Bolanos-Garcia & Davies, 2006).
Analysis of the amino acid sequence of AcrB revealed the C-terminus to be 
histidine rich with 4 out o f the 8 terminal residues being histidines. Analysis o f 
the amino acid sequence o f the contaminant ZitB revealed that it is a histidine- 
rich protein with a sequence o f H-S-H-H-H-H at the C-terminus, forming a 
functional, native histidine tag. This histidine tag is the cause o f the ~30 kDa 
immunoreactive species in the W estern blot and facilitates ZitB binding to  the
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Ni2+-NTA resin. There are a number o f methods available to purify SiaQM 
further including increasing the imidazole concentration o f the washing steps or 
implementing an imidazole gradient to elute the more weakly associated 
contaminants. ZitB does not have a full hexahistidine tag unlike SiaQM so may 
bind more weakly. It may also be necessary to use another purification 
technique such as size exclusion chromatography or anion exchange 
chromatography to remove ZitB.
5.6 Further purification of SiaQM from inner membrane using anion 
exchange chromatography followed by IMAC
Following the identification o f the IMAC purification contaminants, a number of 
modifications to the IMAC purification protocol were implemented to try and 
remove the contaminants. The imidazole concentration in the washing step was 
increased from 20 mM to 50 mM followed by elution with 250 mM imidazole. 
This resulted in SiaQM eluting from the column during the washing step and 
ZitB eluting in the 250 mM elution step. This indicated that ZitB actually has a 
higher affinity for the Ni2+-NTA than SiaQM. It was considered, however, it may 
still be possible to purify SiaQM by washing at a lower concentration o f 
im idazole to remove all contaminants except ZitB and then increase the 
imidazole concentration and elute SiaQM without eluting ZitB. To assess 
whether this was possible, a step gradient o f imidazole from 10-50 mM in 10 
mM increments followed by elution at 250 mM imidazole was implemented. This 
revealed that SiaQM eluted at ~30 mM imidazole, but still unfortunately 
contained unacceptably high levels of ZitB. The detergent trial was revisited to 
see if ZitB could be selectively solubilised and separated from SiaQM, but the 
appearance o f the ZitB signal in the detergent trial is not consistent even after 
long exposure times (Fig. 5.4) making conclusions difficult to draw. It was finally 
decided that anion exchange chromatography would be used as a w ay o f 
separating SiaQM from ZitB. Preliminary anion exchange chromatography 
revealed that SiaQM and ZitB had different elution profiles over a linear gradient 
o f NaCI between 5-200 mM. Elution o f SiaQM was observed to occur between 
~56-130 mM NaCI and ZitB eluted between 110-130 mM (data not shown). 
Using these data, the anion exchange protocol was refined and the fractions 
containing only SiaQM could be purified further using IMAC.
180
Using the preliminary anion exchange data, the standard anion exchange 
protocol (Methods section 2.14.6) was refined so that a shallower gradient was 
applied over the NaCI concentration range SiaQM and ZitB eluted. SiaQM was 
extracted from the inner membrane fraction using the standard protocol 
(Methods section 2.14.1), except that 6.9 mg/ml (final concentration) o f inner 
membrane prepared from BL21 (DE3) pCM23.1 was solubilised for 1 hour at 
4°C in a 12 ml solubilisation reaction consisting o f 20 mM HEPES, 10% 
glycerol, 5 mM NaCI and 1% DDM. The refined anion exchange protocol 
involved a steep linear gradient from 5-30 mM o f NaCI over 2 column volumes 
followed by a shallow linear gradient from 30-130 mM over 16 column volumes 
collected in multiple small fractions. This was followed by a linear gradient from 
130-200 mM over 4 column volumes. SiaQM was further purified from the anion 
exchange eluate using 7 ml Ni2+-NTA resin (Qiagen) with a non-disposable 
column using the standard protocol (Methods section 2.14.3).
The absorbance (A2so) trace o f the elution profile revealed a number o f small 
contaminant elution peaks during the 0-30 mM NaCI wash. The trace also 
revealed a large elution peak between 56 and 103 mM NaCI, during the shallow 
NaCI gradient, followed by a steady elution o f protein throughout the 130-200 
mM NaCI gradient (Fig. 5.6). Analysis o f the protein content o f these fractions 
using Western blotting revealed a signal for SiaQM in elution fractions 30-50 
which corresponded to between 60 and 100 mM NaCI (Fig. 5.7). The samples 
on the Western blot that contained a SiaQM signal did not contain a signal for 
ZitB, which was expected because the prelim inary anion exchange purification 
revealed that ZitB eluted between 110-130 mM NaCI. Analysis o f the protein 
content o f the elution fractions using SDS-PAGE revealed a large proportion o f 
contaminants eluted before and after the SiaQM elution peak (Fig. 5.7a and c), 
however a W estern blot signal for ZitB was not visible (Fig. 5.7d) but this may 
be due to dilution o f the protein. The elution fractions containing a signal for 
SiaQM on the Western blot (Fig. 5.7c and d, fractions 22-44) were collated and 
applied to IMAC resin.
Analysis o f the IMAC purification samples using W estern blotting revealed a
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Figure 5.6 A n ion  exchange ch rom a tog raphy  o f SiaQM from  inner 
m em brane. Elution profile from DEAE sepharose resin (Sigma) monitored by 
absorbance (A28o) of the inner membrane fraction prepared from BL21 (DE3) 
pCM23.1 grown in LB to mid-log phase, induced with 0.5 mM IPTG and 
harvested after overnight growth. SiaQM peak indicated as identified from 
Western blotting (Fig. 7). A28o (blue line), conductance (red line) and percentage 
of 200 mM NaCI buffer (black line).
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Figure  5.7 A na lys is  o f fra c tio n s  from  anion exchange ch rom a tog raphy o f 
SiaQM from  inne r m em brane. Coomassie stained SDS-PAGE (a and c) and 
Western blot (b and d) of the purification of SiaQM with anion exchange 
chromatography. The samples included are the inner membrane fraction, the 
flowthrough from the column, the initial 5 mM wash and the numbered elution 
fractions. 20 pg of protein was applied to the Coomassie stained SDS-PAGE 
and 5 pg of protein is applied to the Western blots. Molecular weight (MW) 
shown in kDa.
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signal for SiaQM in the anion exchange eluate and in elution fraction 2 and 3 
(Fig. 5.8b). There were no signals for SiaQM in the flowthrough or the 20 mM 
wash fractions indicating that SiaQM was binding to the resin and remained 
bound during the washing step (Fig. 5.8b). The most intense signal in the 
elution fractions corresponds to SiaQM; there is also evidence o f degradation. 
There are two more signals fo r lower molecular weight species; one 
corresponding to the molecular weight o f ZitB and the other unknown (Fig. 
5.8b). The Coomassie stained SDS-PAGE reveals only two bands in the elution 
fractions; an intense band corresponding to SiaQM and a very weak band 
probably corresponding to ZitB (Fig. 5.8a).
The combination o f anion exchange chromatography and IMAC to purify SiaQM 
was relatively successful resulting in a preparation that contains SiaQM as the 
dominant species and ZitB as a very m inor contaminant. Despite the successful 
purification of SiaQM, quantification o f the protein content o f the elution 
fractions revealed that the overall yield o f SiaQM was low at ~0.15% of total 
inner membrane (0.12 mg/L culture).
5.7 Cloning and expression trials o f the s iaQ M  genes using the arabinose 
inducible pBAD vector in E. co li and the nisin inducible pNZ8048 vector in 
L. lactis.
One of the major reasons for the overexpression and purification o f SiaQM was 
to reconstitute SiaQM into liposomes and characterise the transport w ith in vitro 
A/-acetylneuraminic acid uptake assays (in collaboration with Professor Bert 
Poolman’s laboratory in Groningen). Unfortunately, there were problems 
associated with the production o f SiaQM from BL21 (DE3) pCM23.1 that were 
insurmountable in the timeframe o f this project. The overall yield of SiaQM was 
low, which meant that a large volume o f culture was required to obtain sufficient 
amounts o f protein. Another obstacle was that when integral membrane 
proteins were extracted from the native membrane with detergents, delipidation 
occurs over time. This process, where the native lipids are stripped away as a 
function o f time is thought to negatively affect the function/stability o f integral 
membrane proteins (E.R. Geertsma, personal communication), therefore, the 
requirement for two purification techniques to obtain homogeneous SiaQM took
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Figure 5.8 IMAC p u rifica tio n  o f SiaQM from  anion exchange eluate.
Coomassie stained SDS-PAGE (a) and Western blot (b) of IMAC purification of 
SiaQM from anion exchange eluate. The following purification samples were 
analysed; anion exchange (AE) eluate, the flowthrough, the 20 mM wash 
fraction and the elution fractions. 20 pg of protein was applied to the Coomassie 
stained SDS-PAGE and 5 pg of protein is applied to the Western blots. 
Molecular weight (MW) shown in kDa.
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too much time. Another setback was that the purification protocol could not be 
reproduced during my research visit to Groningen.
These reasons led to trying to express SiaQM using 2 more expression vectors; 
the arabinose inducible pBAD in an E. coll expression strain and the nisin 
inducible pNZ8048-derived vector in a L  lactis expression strain. SiaQM was 
cloned into these 2 expression vectors and the level o f expression was tested in 
initial expression trials.
The region o f the H. influenzae genome encoding siaQM  was amplified by PCR 
using primers SiaQM_Nfor with SiaQM_Nrev and SiaQM_Cfor with 
SiaQM_Crev and cloned into pBAD and pNZ8048-derivative using ligation 
independent cloning (LIC) so that the gene sequence was in-frame with a 5 ’- or 
3 ’-nucleotide sequence encoding a decahistidine tag (Methods section 2.6.5 
and 2.6.6). This resulted in 4 different expression vectors expressing an N- or 
C-terminally decahistidine tagged SiaQM from the pBAD and pNZ8048 vectors. 
The vectors were transformed into the expression strains E. coli MC1061 or 
L. lactis NZ9000. Three clones fo r each expression vector were included in 
initial expression trials (except for nLIC-QM where only 2 were selected).
The initial expression trials for SiaQM accumulation from MC1061 pBADnQM 
and MC1061 pBADcQM were performed as in Methods section 2.7.2. The initial 
expression trial fo r the accumulation o f SiaQM from NZ9000 pNZnQM and 
NZ9000 pNZcQM were performed as in Methods sections 2.7.3. The 
membranes from all expression tria ls were prepared using the Fastprep method 
(Methods section 2.8.2) and the resultant mixed membrane preparations were 
analysed using W estern blotting.
Analysis o f SiaQM accumulation in the three clones o f MC1061 pBADcQM and 
MC1061 pBADnQM using W estern blotting revealed the presence o f an 
immunoreactive species at the predicted molecular weight o f SiaQM (-50-60  
kDa) in two o f the pBADcQM clones and in all three pBADnQM clones (Fig. 
5.9a). There is a strong W estern blot signal in the membrane fraction prepared 
from  the MC1061 pBADcQM 1 culture compared to  a much weaker signal from 
the MC1061 pBADcQM 2 culture (Fig. 5.9a). There is no SiaQM W estern blot 
signal in the sample prepared from MC1061 pBADcQM 3 culture. The intensity
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Figure 5.9 Express ion  o f SiaQM from  the  E. c o l i  pBAD exp ress ion  vec to r 
and L . la c t is  pNZ8048 exp ress ion  vecto r, (a) Western blot of SiaQM 
accumulation from 3 independent clones of MC1061 pBADcQM and MC1061 
pBADnQM. Cultures were grown to mid-log phase at 37°C, induced with 
0.005% L-arabinose and harvested after a further 2 hours growth, (b) Western 
blot of SiaQM accumulation from 3 independent clones of NZ9000 pNZcQM 
and 2 independent clones of NZ9000 pNZnQM. Cultures were grown to mid-log 
phase at 30°C, induced with 1/5000 dilution of nisin and harvested after a 
further 2 hours growth. Equal amounts of protein were added for each sample 
by normalising by the optical density when harvesting the cells. Molecular 
weight (MW) shown in kDa.
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o f the SiaQM signal also differs in intensity between the MC1061 pBADnQM 
clones with the third one being the most intense; however, with the more 
intense signal more degradation is apparent (Fig. 5.9a).
Analysis o f SiaQM accumulation in the NZ9000 pNZnQM and NZ9000 pNZcQM 
clones by Western blotting revealed all the clones tested produced an 
immunoreactive species at the molecular weight expected SiaQM (Fig. 5.9b). In 
this case, the first NZ9000 pNZcQM clone accumulated less SiaQM than the 
second or third, which are approximately equal in intensity. The two pNZnQM 
clones that were tested both produced a very intense signal on the Western blot 
and evidence o f degradation (Fig. 5.9b).
The Western blots indicate that SiaQM can be expressed to measurable 
amounts using all 4 vectors; pBADnQM, pBADcQM, pNZnQM and pNZcQM. A 
number o f different clones were tested for their expression levels 
simultaneously and this revealed that clones within the same transformation 
reaction had differing levels o f accumulation. By testing more than one clone, 
the most effective producer of SiaQM can be selected. The W estern blots also 
indicated that, especially in the pNZnQM and pNZcQM trials, there was more 
accumulation o f N-terminally tagged SiaQM than when the tag is at the C- 
terminus.
The clones chosen from the initial expression trial were pBADnQM 3, 
pBADcQM 1, pNZcQM 3 and pNZnQM 2.
5.8 Optimisation o f growth and induction conditions for SiaQM expression 
from MC1061 pBADcQM and MC1061 pBADnQM
The optimisation o f growth and induction conditions fo r the expression o f SiaQM 
from MC1061 pBADnQM and MC1061 pBADcQM was performed to maximize 
the overall accumulation of SiaQM whilst minimising degradation.
Using the observed accumulation levels in the initial expression trials and 
previous studies with these expression vectors (Geertsma, 2005) the 
temperature o f growth, the concentration o f inducer and the optical density 
(ODeeo) o f induction were varied.
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SiaQM accumulation was optimised in MC1061 pBADnQM and MC1061 
pBADcQM by growing the cultures as in the initial expression trials in 
combinations o f the following conditions; at either 37°C or room temperature, 
induced with either 0.005 or 0.0005 % L-arabinose at optical densities (OD66o) 
o f 0.5 or 1.
Analysis of SiaQM accumulation in the membrane fractions prepared from 
cultures o f MC1061 pBADcQM using W estern blotting revealed very low levels 
o f immunoreactive material. A t the highest exposure, faint bands were present 
at the estimated molecular weight for SiaQM in only 2 lanes; the sample from 
cells grown at 37°C, induced at ODeeo o f 0.5 with 0.005% L-arabinose and the 
sample from cells grown at 37°C induced at ODeeo o f 1 with 0.005% L-arabinose 
(Fig. 5.10a). In contrast to this, a strong SiaQM W estern blot signal is present in 
each o f the membrane fractions prepared from cultures o f MC1061 pBADnQM. 
The SiaQM W estern blot signals were o f sim ilar intensity for membrane 
fractions prepared from cells grown at 37°C and induced with either 0.005 or 
0.0005% L-arabinose at an OD66o of 0.5 (Fig. 5.10b). The OD660 of these 
samples when harvested were 0.584 and 0.804, respectively. The most intense 
signal was obtained from the membrane fraction prepared from cells grown at 
37°C to an OD660 of 1 and induced with 0.005% L-arabinose, this had a final 
OD660 o f 1-028. In the same conditions, but with a lower concentration o f L- 
arabinose there is a distinctly lower intensity in the SiaQM signal and a higher 
OD660 o f 1.236. Samples from cells grown at room  temperature and induced 
with either 0.005% or 0.0005%  L-arabinose at an ODeeo o f 0.5 had the lowest 
OD660 values at 0.324 and 0.396, respectively. These optical densities were so 
low that there was not enough o f the sample to load normalised amounts o f 
protein on the gel, and so there is actually approximately ha lf the amount o f 
protein loaded compared to the other fractions on the gel. This was confirmed 
when the gel was stained after transfer during W estern blotting. If the same 
amount o f protein was added then the cells grown at room temperature would 
probably have higher Western blot signal intensity, but would still have very low 
optical densities, so would not be as effective at SiaQM production as growing 
the cells at 37°C and inducing them at an OD66o o f 1.
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F igu re  5.10 O p tim isa tion  o f tem pera tu re  o f g row th , ind u ce r concen tra tion  
and op tica l d ens ity  (OD66o) o f ind u c tio n  fo r  the  p ro du c tio n  o f SiaQM from  
MC1061 pBADcQM and MC1061 pBADnQM . Western blots with anti His-tag 
antibody of membrane fractions from 5 ml MC1061 pBADcQM (a) and MC1061 
pBADnQM (b) cultures grown at either room temperature or 37°C and induced 
at either OD6 6 o of 0.5 or 1 with either 0.005% ( 1 0 '3) or 0.0005% (10'4) L- 
arabinose. All samples were harvested after a further 2 hours growth after 
induction. Equal amounts of protein were added for each sample, except for the 
last two lanes in (b) which have approx, half the amount of protein. Molecular 
weight (MW) shown in kDa.
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The optimisation of SiaQM accumulation in MC1061 pBADnQM and MC1061 
pBADcQM has revealed that N-terminally tagged SiaQM accumulates to  a 
higher degree than the C-terminally tagged version. This is not just a SiaQM- 
specific observation as this difference in expression levels has been observed 
for other proteins expressed in the pBAD system (Geertsma E.R., personal 
communication); however, the reason for this is unknown. This observation 
indicated that MC1061 pBADnQM should be used for the production SiaQM in 
E. coli. A  number o f conditions were varied to maximise the output o f SiaQM 
from MC1061 pBADnQM while at the same time minimising degradation. The 
optimal conditions were identified to be growth a t 37°C and induction at an 
OD660 o f 1 with 0.005% L-arabinose.
5.9 Optimisation o f growth and induction conditions for SiaQM expression 
from NZ9000 pNZcQM and NZ9000 pNZnQM
The optimisation o f the growth and induction conditions for the expression o f 
SiaQM from L. Idctis NZ9000 pNZnQM and NZ9000 pNZcQM was performed in 
an attempt to maximise the overall accumulation of SiaQM whilst minimising 
degradation.
Using the observed accumulation levels in the initial expression trials the 
concentration o f inducer was varied fo r the L. iactis pNZ8048-derived vectors.
SiaQM accumulation was optimised in NZ9000 pNZnQM and NZ9000 pNZcQM 
by growing cultures as in the initial expression trials (Methods section 2.7.3) and 
inducing NZ9000 pNZnQM with 1/5000, 1/10000, 1/20000 or 1/50000 dilution o f 
nisin and inducing NZ9000 pNZcQM with either 1/1000 o r 1/5000 dilution o f 
nisin.
Analysis o f the steady-state levels o f SiaQM from cultures o f NZ9000 pNZnQM 
using W estern blotting revealed that when NZ9000 pNZnQM is treated with a 
nisin dilution o f 1/5000 there is an intense SiaQM W estern blot signal and some 
degradation, but as the dilution gets larger to 1/10000, 1/20000 and 1/50000, 
the SiaQM signal intensity decreases along with the appearance o f degradation 
products (Fig. 5.11). In addition, there is an increase in the OD60o values fo r 
each culture corresponding to  the decreasing amount o f induction and
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Figure  5.11 O p tim isa tion  o f induce r concen tra tion  fo r  the p rodu c tio n  o f 
SiaQM from  NZ9000 pNZcQM and NZ9000 pNZnQM. Western blot with anti 
His-tag antibody of membrane fractions from 10 ml NZ9000 pNZcQM and 
NZ9000 pNZnQM cultures grown at 30°C and induced at OD60o of 0.5 with nisin 
dilutions of 1/1000, 1/5000, 1/10000, 1/20000 and 1/50000. All samples were 
harvested after a further 2  hours growth after induction.
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subsequent low er steady-state levels o f SlaQM (Fig. 5.11). The steady-state 
levels o f SiaQM from  cultures o f NZ9000 pNZcQM did not d iffe r so greatly 
between 1/1000 and 1/5000 dilution o f nisin (Fig. 5.11).
This experim ent confirmed tha t the accum ulation o f N -term inally tagged SiaQM 
is fa r greater than the C -term inally tagged variant as orig ina lly seen in the in itia l 
expression tria l.
The optim isation o f SiaQM accum ulation in the pNZ8048 system  in L. lactis 
revealed that N -term inal tagged SiaQM accum ulates to a higher degree than 
the C -term inally tagged variant as was seen fo r SiaQM expression from  the 
pBAD system in E  co li (Fig. 5.10). As a consequence o f th is, production o f 
SiaQM from  L  lactis w ill be perform ed w ith the strain NZ9000 pNZnQM. The 
on ly condition to  be varied in the optim isation o f SiaQM accum ulation from  
NZ9000 pNZnQM was the inducer concentration. It was revealed that 
decreasing the am ount o f inducer decreased the am ount o f SiaQM produced, 
and also increased the optical density. This phenomenon was also observed in 
the pBAD system and clearly indicates tha t it is the production o f the integral 
m embrane protein that is decreasing bacterial growth rate.
The optim al conditions were identified as 30°C growth and induction at an 
OD600 o f 0.5 w ith a 1/20000 d ilution o f nisin. This particular d ilution was selected 
as it is a com prom ise between SiaQM production and low degradation.
Analysis o f steady-state levels o f SiaQM from  cultures o f NZ9000 pNZcQM and 
NZ9000 pNZnQM with d ifferent levels o f induction revealed decreasing the 
concentration o f inducer decreased the level o f SiaQM accum ulation and the 
appearance o f degradation products.
5.10 Purification o f N -term inally decahistidine tagged SiaQM by 
im m obilised m etal affin ity chrom atography (IM AC) and size exclusion  
chrom atography (SEC)
IMAC is the purification m ethod o f choice fo r m em brane proteins as it typ ica lly 
purifies target proteins to >95%  hom ogeneity and is a re la tive ly short procedure 
com pared to  other purification techniques. SEC w ill be used to  purify SiaQM to 
hom ogeneity and the elution profile w ill be used to  assess the m onodispersity o f
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the protein produced. M onodisperse SiaQM w ill have a sym m etrical elution 
peak that is greater in magnitude than any aggregate elution peak that is 
form ed.
Larger scale cultures o f MC1061 pBADnQM and NZ9000 pNZnQM, typ ica lly 2- 
5 L, w ere grown and induced according to  the optim ised conditions previously 
established. SiaQM was purified from  m ixed membrane preparations from  each 
culture by firs t extracting SiaQM from  the membranes w ith DDM using the 
standard conditions (Methods 2.14.1). SiaQM was purified using Ni2+-affin ity 
chrom atography using disposable gravity-flow  colum ns (M ethods section
2.14.4). S ize exclusion chrom atography w as perform ed using Superdex 20 
10/300 GL colum n (M ethods section 2.14.7).
Analysis o f the fractions taken during the IMAC purification o f SiaQM from  
E. coli vesicles using Coomassie stained SDS-PAGE revealed a m ajor band in 
e lution fraction 2 w ith an apparent m olecular w eight estim ated fo r SiaQM (-4 7 - 
50 kDa) (Fig. 5.12a). SiaQM is not abundant enough to be visib le  in the SDS- 
PAGE o f the mixed membrane sam ple o r the soluble fraction after detergent 
extraction and ultracentrifugation (Fig. 5.12a). There are a num ber o f m inor 
contam inants in the elution fraction, but the band at -4 7 -5 0  kDa is the m ost 
abundant.
Hom ogeneous SiaQM was attained by applying elution fraction 2 to a Superdex 
20 10/300 GL size exclusion chrom atography (SEC) colum n. The A 280 elution 
profile  o f the SEC purification revealed a m inor peak eluting im m ediately after 
the void volum e which was presumed to  be aggregate (Fig. 5.12b). A  m ajor 
peak over fractions 10 and 11 w as evident which, when analysed using SDS- 
PAGE was revealed to be the -4 7 -5 0  kDa band tha t is presum ed to  be SiaQM 
(Fig. 5.12b and c). The SDS-PAGE shows SiaQM to  be hom ogeneous and 
abundant in fractions 10 and 11 (Fig. 5.12c).
A nalysis o f the SDS-PAGE and elution profile  fo r the purification o f SiaQM from  
L  lactis  vesicles revealed tha t the purification proceeds alm ost exactly as the 
purification from  E. co li vesicles (Fig. 5.13a, b and c). There were some 
differences between the tw o purifications; the IMAC elution fraction from  the 
purification o f SiaQM expressed in L. lactis contained less contam inants and the 
SiaQM  band was more intense than the IMAC elution from  the purification o f
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F ig u re  5.12 IMAC fo llo w e d  by SEC o f SiaQM fro m  m em brane p repa ra tion  
fro m  MC1061 pBADnQ M . (a) Coomassie stained SDS-PAGE of SiaQM 
purification with IMAC showing membrane fraction (M), the soluble fraction (sol) 
and insoluble fraction (insol) after detergent extraction and centrifugation, the 
flowthrough (UB) and the elution fractions, (b) Elution profile of SEC purification 
of SiaQM from IMAC elution fraction 2 monitored by absorbance (a 280). (c) 
Coomassie stained SDS-PAGE of the fractions taken from SEC purification of 
SiaQM from IMAC elution fraction 2. Molecular weight (MW) shown in kDa
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F igure  5.13 IMAC fo llo w e d  by SEC o f SiaQM fro m  m em brane p repa ra tion  
fro m  NZ9000 pNZnQM . (a) Coomassie stained SDS-PAGE of SiaQM 
purification with IMAC showing membrane fraction (M), the soluble fraction (sol) 
and insoluble fraction (insol) after detergent extraction and centrifugation, the 
flowthrough (UB) and the elution fractions, (b) Elution profile of SEC purification 
of SiaQM from IMAC elution fraction 2 monitored by absorbance (A28o). (c) 
Coomassie stained SDS-PAGE of the fractions taken from SEC purification of 
SiaQM from IMAC elution fraction 2. Molecular weight (MW) shown in kDa
196
SiaQM expressed in E. coli (Fig. 5.13a). The SEC purification elution profiles 
monitored by absorbance (A28o) revealed that SiaQM produced by the two 
expression strains were very sim ilar, except that the peak fo r SiaQM purified 
from  L. lactis was slightly more sym m etrical and there was no evidence o f 
aggregate form ation, as was seen in the E. coli purification (Fig. 5.13b). 
Purification o f IMAC elution fraction 2 w ith SEC revealed hom ogeneous SiaQM 
in fractions 9, 10 and 11 (Fig. 5.13c). The overall yield o f pure SiaQM from  both 
E. coli and L  lactis vesicles was 2-3% tota l m ixed membrane
Analysis o f the purification o f SiaQM from  the membrane fractions o f MC1061 
pBADnQM and NZ9000 pNZnQM culture using SDS-PAGE revealed that 
SiaQM accumulated to  high levels in both the E. coli and L. lactis expression 
system s. The purification by IMAC and SEC revealed tha t both proteins are 
abundant, corresponding to  -3 %  o f the total mem brane proteom e, which 
equates to ~1.5 mg/L culture. This is approxim ately 10 fold higher accum ulation 
o f SiaQM than in the pTTQ18 system , although it is not entire ly fa ir to  com pare 
expression from  pTTQ18 w ith pBAD and pNZ8048 as there are a number o f 
differences between these vectors, not least of all is the location o f the histidine 
tag. SEC purification o f SiaQM from  L. lactis and E. coli also revealed that both 
proteins are monodisperse.
Aside from  the advantages o f using L. lactis as an expression strain (as 
m entioned in Introduction section 1.13.1), NZ9000 pNZnQM could be argued to 
be a better system fo r the production o f SiaQM than MC1061 pBADnQM 
because it has a slightly h igher yield and there is no aggregate form ation, unlike 
the E. co li system . However, e ither system  produces adequate am ounts o f 
SiaQM fo r use in in vitro A/-acetylneuram inic acid uptake assays and other 
biophysical analysis, such as crystallographic tria ls.
5.11 Chapter sum m ary
This chapter docum ents the heterologous expression and purification o f the 
integral m embrane protein, SiaQM, from  the sia lic  acid specific TRAP 
transporter from  H. influ&nzaa. SiaQM is a fusion o f the norm ally separate large 
and sm all TRAP membrane com ponents. Expression o f SiaQM was firs t
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observed using the pTTQ18 expression system in E. coli. Growth and induction 
conditions fo r the accum ulation o f SiaQM w ith a C-term inal hexa-histidine tag 
were optim ised. The growth medium, tim e o f harvesting after induction and the 
tem perature o f growth were varied sim ultaneously and optim al expression 
conditions were defined. SiaQM was found to be localised in the inner 
m em brane o f E. coli, as predicted and IMAC purification was used to  purify 
SiaQM facilita ted by the hexa-histidine tag. Unfortunately, expression from  th is 
system  had a number o f problems; the overall yield o f SiaQM was low  (0.15%  
o f total inner membrane), there was low affin ity between the IMAC resin and the 
hexahistidine tag and SiaQM was co-expressed w ith a hisitid ine tag-containing 
contam inant.
To overcom e these problem s, accum ulation o f SiaQM was m onitored when 
expressed from  two different expression systems; the arabinose-inducible 
pBAD vector in E. coli or the nisin-inducible pNZ8048 vector in L  lactis. In both 
o f these expression system s N- and C-term inal deca-histidine tagged variants 
were produced. The expression and induction conditions were optim ised fo r 
both o f these system s, which revealed that C -term inally tagged SiaQM 
accum ulated to a much low er degree than the N -term inally tagged variant. 
IMAC purification o f N -term inally tagged SiaQM revealed tha t the overall yield 
was between 2-3% o f total membrane protein, fa r superior to the yield obtained 
from  the pTTQ18 system . This yield equates to ~1.5 mg/L culture, which is high 
enough to facilita te  the biochem ical and biophysical characterisation o f SiaQM.
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Chapter 6
Reconstitution of 
SiaPQM and 
characterisation of 
W-acetylneuraminic acid 
transport mechanism
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6.1 In  vivo  A/-acetylneuram inic acid transport by SiaPQM
Although the overall goal o f th is project was to purify the com ponents o f 
SiaPQM and reconstitute the transporter fo r characterisation in vitro, there was 
also very little  known about the transport properties in vivo. Roughly 
characterising the in vivo transport properties o f SiaPQM would give insight into 
its  transport activ ity and also define in itia l in vitro transport assay conditions to 
te s t fo r successful reconstitution o f SiaPQM, i.e. to  provide conditions that are 
known to energise Neu5Ac transport by SiaPQM.
The in vivo transport assays were perform ed using a previously established 
com plem entation system (developed by Dr. Emmanuele Severi) where SiaPQM 
was expressed from  a low copy number, IPTG -inducible plasm id (pES7) in an 
E. coli m utant, BW251 AZAnanT, which had the E. co li Neu5Ac transporter gene, 
nanT, deleted (Baba et a l., 2006). The in itia l in  vivo transport assay was 
designed to  m onitor transport o f radiolabelled Neu5Ac in the presence o f a 
proton m otive force (PMF), a Na+ gradient and a Li+ gradient. The Li+ gradient 
w as included as it has been found in other transport system s that L i" and Na+ 
can be used interchangeably due to the ir s im ilar size and charge (Pourcher et 
a l., 1995).
The in vivo transport assays were perform ed using standard m ethods (M ethods 
section 2.17). B riefly, 20 ml cultures o f B W 251134nanr and BW 251132\nan7 
pES7 were grown in LB (supplem ented w ith 100 pg/m l am picillin) to  m id-log 
phase and induced w ith 1 mM IPTG. Cultures were grown fo r a fu rther 2 hours 
and then harvested. The PMF, Na+ gradient and L i+ gradient were established 
using standard methods (M ethods section 2.17.2-2.17.4).
M onitoring the uptake o f radiolabelled Neu5Ac in these d ifferent conditions 
revealed that transport activ ity is on ly observed in the stra in BW 25113AnanT  
pES7 in the presence o f a Na+ gradient (Fig. 6.1, closed triangles). The sam e 
strain in the presence o f a PMF or Li+ gradient did not show any uptake o f 
radiolabelled substrate into the cells (Fig. 6.1, closed circles and closed 
squares, respectively). The strain BW 25113dnanT, which was not 
com plem ented w ith pES7, showed no transport activ ity in a ll three o f the 
energised transport conditions w ith a basal Neu5Ac accum ulation o f
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Figure 6.1 In  v ivo  N .V lr iv e n  transport o f (»CJ-NeuSAc by SlaPQM  
expressed In B c c l l  strain BW 25113Anan r . Uptake of I ,4C]-Neu5Ac was 
monitored Into E. coff strain BW25113ZSnanr and BW 251132lnanr pES7 In the 
presence o f the PMF (BW 25113dnan7 pES7-dosed circles. BW2S113Anan7- 
open circles), a sodium gradient (BW 25113dnan7 pES7-closed triangles, 
8W 25113drranr-cpen triangles) or a lithium gradient (BW 25113,3nanr pES7- 
dosed squares. BW 25113dr>an7<pen squares). 20 ml cultures of 
BW 25113dnanT and B W 2 51 1 lin a n 7  pES7 were grown in LB (supplemented 
with 100 uo’ml ampidllin) to mid-log phase and induced with 1 mM IPTG  
Cultures were grown for a  further 2  hours and harvested. The PMF was created 
by © uting cells into buffer containing 50 mM KPi, pH 7 .2  mM MgSO, and 10 
mM IK W actate  and incubated in continuous airflow for 2  minutes. A  Na* 
gradient was created by diluting cells into 50 mM KPi. pH 7 .2  mM M gSO , and 
20 mM N a a  and a U * gradient was created by diluting cells into buffer 
containing 50 mM KPi. pH 7. 2  mM M gSO, and 20 mM UCI. All transport 
assays were performed with 8 pM Neu5Ac at 30°C with constant stirring Equal 
amount of cell suspension was added to each assay. A single data set is 
presented, but the experiment has been performed multiple times.
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-0 .0 5  nmol/mg (Fig. 6 .1. open symbols). The basal Neu5Ac accumulation in 
BW25113A nanT  pES7 in the presence of PM F or a Li* gradient where no 
transport was observed was -0 .3  nmol/mg. This is significantly higher than the 
BW 25113dnanT cultures and most likely due to SiaP in the periplasm of 
BW 25113dnanT pES7 binding radiolabelled Neu5Ac. but not able to 
accumulate it in the cell due to the presence of inappropriate electrochemical 
gradients.
Although previous transport assays with this in  vivo system had shown that it 
complements for NeuSAc transport (E. Seven, personal communication), 
individual electrochemical gradients had not been applied and the counter-ion 
for transport was unknown. This preliminary in vivo transport assay has shown 
the first strong evidence that Neu5Ac transport via SiaPQM is powered by a Na* 
gradient Although this finding in itself is noteworthy, the reason for doing this 
experiment was to choose conditions for the initial in vitro experiments to 
assess the success of reconstitution, which has been fulfilled.
6.2 C loning, expression trials and expression optim isation o f the s iaP  
gene using the arabinose inducible pBAD vector in E. c o li 
To  characterise functionally the in vitro transport properties of SiaPQM it was 
necessary to express and purify both components. SiaP and SiaQM, to an 
adequate level. The expression and purification of SiaQM has been 
demonstrated and optimised previously (Chapter 5). Wild-type SiaP has been 
purified, biochemically and biophysically characterised, resulting in the 
publication of the high resolution crystal structure (Muller et a!., 2006). 
Unfortunately, wild-type SiaP from these studies could not be expressed or 
purified to the levels required for the in vitro characterisation of SiaPQM  
transport
To Improve the yield and ease of purification of SiaP. the gene siaP  was cloned 
into the arabinose inducible pBAD vector. The region of the H. influenzae 
genome encoding siaP  was amplified by PCR using primers SiaP_Nfor minSP 
With S iaP .N rev and SiaP .C for with SiaP_Crev and doned into pBAD using LIC  
so that the gene sequence was in-frame with a  5 -  or 3'-nudeotide sequence 
encoding a decahistidine tag (Methods section 2.6.5). Expression trials were
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performed in E  coli strain MC1061 using standard methods (Method section
2.7 .2) Accumulation of both C - and N-terminally tagged SiaP was observed 
(data not shown) and the expressing clones selected from the initial expression 
trial were named MC1061 pBADnP and MC1061 pBADcP. The optimisation of 
growth and induction conditions for the expression of SiaP from MC1061 
pBADnP and MC1061 pBADcP was performed to maximise the overall 
accumulation of SiaP whilst minimising degradation. Using the observed 
accumulation levels in the initial expression trials and previous studies with 
these expression vectors (Geertsma, 2005) the temperature of growth, the 
concentration of inducer and the optical density (O D ^ ) of induction were 
varied.
SiaP accumulation was optimised in MC1061 pBADcP by growing the cultures 
as in the initial expression trials at 37°C, induced with 0.005%  L-arabinose at an 
optical density (OD^c) of either 0.5 or 1. SiaP accumulation was optimised in 
MC1061 pBADnP by growing the cultures as in the initial expression trials at 
either 37°C or room temperature, induced with either 0.005%  or 0.0005%  L- 
arabinose at OD«o of 0.5. All cultures were harvested 2 hours after induction 
and whole cell lysates were prepared using the protocol in Methods section 
2.8 .2 . except that the whole cell lysates were obtained by collecting the samples 
after the 20000xg centrifugation.
Analysis of SiaP accumulation in the whole cell lysate prepared from cultures of 
MC1061 pBADcP and MC1061 pBADnP using Western blotting revealed that 
N-terminally tagged SiaP accumulated to higher levels than the C-termina!Iy 
tagged variant (Fig. 6.2).
The ODesa of induction was the only parameter to be varied for MC1061 
pBADcP and revealed that there was no difference in accumulation levels when 
the culture was induced at either ODeeo of 0.5 or 1. however, there are two 
bands visible when the culture was induced at an ODsso of 0 .5 compared to a 
single band when induced at 0D «3  of 1 (Fig. 6.2). The two bands correspond to 
the full length SiaP. including the signal peptide and probably localised to the
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F igu re  6.2 O p tim isa tion  o f tem pera tu re  o f g ro w th , in d u ce r co n ce n tra tio n  
and o p tica l d e n s ity  (OD660) o f in d u c tio n  fo r the p ro d u c tio n  o f SiaP from  
MC1061 pBADcP and MC1061 pBAD nP. Western blots with anti His-tag 
antibody of whole cell lysates from 5 ml MC1061 pBADcP and MC1061 
pBADnP cultures grown at either room temperature or 37°C and induced at 
either ODseo of 0.5 or 1 with either 0.005% (10'3) or 0.0005% (10‘4) L-arabinose. 
All samples were harvested after a further 2 hours growth after induction. Equal 
amounts of protein were added for each sample. Molecular weight (MW) shown 
in kDa.
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cytoplasm , and processed SiaP localised to  the periplasm  w ithout a signal 
peptide.
The initial expression tria l fo r the accum ulation o f N -term inally tagged SiaP from  
MC1061 pBADnP revealed tha t accum ulation was very high, as was 
degradation. In an attem pt to  decrease the am ount o f degradation, the culture 
was grown a t room tem perature and induced w ith e ither 0.005%  o r 0.0005%  L- 
arabinose. Analysis o f S iaP accum ulation using W estern blotting revealed that 
decreasing the tem perature to  room tem perature greatly decreased the 
accum ulation and also the degradation, when both the tem perature o f growth 
and the fina l concentration o f L-arabinose were decreased sim ultaneously on ly 
a very weak W estern b lo t signal was visib le.
The results o f the optim isation experim ent revealed tha t N -term inally tagged 
S iaP  accum ulates to  a h igher level than the C -term inally tagged variant. M ost 
prote ins destined fo r the periplasm  in E. coii and other Gram negative bacteria 
contain a deavable N-term inal signal peptide which directs the protein to  the 
Sec translocon, which active ly transports the protein to  the periplasm  a t which 
po in t the signal peptide is deaved (M artoglio & Dobberstein, 1998). C -term inally 
tagged SiaP was expressed w ith its cognate signal peptide and was localised to 
the  periplasm , whereas N -term inally tagged S iaP did not have a signal peptide 
and w as localised to  the cytoplasm . Analysis o f the w hole cell lysate from  
M C I061 pBADcP grown a t 37°C and induced w ith 0.005%  L-arabinose at 
ODeeo o f 0.5 using W estern blotting revealed tw o sim ilarly-sized im m unoreactive 
species (Fig. 6.2). These speaes m ost like ly  correspond to  the processed 
(signal peptide deaved) SiaP from  the periplasm  and the unprocessed SiaP 
from  the cytoplasm . This phenomenon was not observed in MC1061 pBADnP 
cultures as a ll o f the SiaP was localised to  the cytoplasm . The extra level of 
processing required fo r correct localisation o f the C -term inally tagged variant 
and the higher capad ty o f the cytoplasm  over the periplasm  fo r recom binant 
proteins m ay have contributed to  the difference in observed accum ulation 
leve ls. It may. however, be caused by the position o f the a ffin ity tag as the same 
d ifference in expression levels was seen fo r N - o r C -term inally tagged SiaQM 
(C hapter 5).
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These observations indicate that MC1061 pBADnP should be used for the 
production of SiaP. Decreasing the growth temperature reduced degradation in 
MC1061 pBADnP, but also greatly reduced the extent of N-terminally tagged 
SiaP accumulation; therefore, the optimal conditions for SiaP accumulation 
were 37°C growth, induced at an OD«» of 0.4-0.5 with 0.005%  L-arabinose.
6.3 Purification o f ligand-free N -term inally decahistidine tagged SiaP by 
im m obilised m etal affin ity chrom atography (IMAC) and anion exchange 
chrom atography
LB medium contains casein which is a highly sialylated protein (Kim et at.,
2005), therefore sialic adds, induding the substrate of SiaPQM, N - 
acetylneuraminic add (Neu5Ac) are present in the medium. It has been 
observed that due to the high affinity interaction between SiaP and Neu5Ac, 
SiaP produced from cultures grown in LB result in a high percentage of SiaP 
being pre-bound to NeuSAc (Seven et al., 2005). The in vitro Neu5Ac transport 
activity of SiaQM is monitored using (14C]-labelled Neu5Ac, therefore it was 
necessary to produce a ligand-free version of SiaP, otherwise there would be a 
large concentration of unlabelled. Neu5Ac being transported which may affect 
the observed transport activity. E  co// can not produce Neu5Ac de novo (Vimr & 
Troy, 1985a); therefore, growing MC1061 pBADnP in a defined minimal 
m edium  devoid of Neu5Ac would mean that the SiaP produced would be 100%  
ligand-free.
A  larger scale culture of MC1061 pBADnP, typically 2-5 L, was grown In 
enhanced M 9 minimal medium and induced according to the optimised 
conditions previously established. SiaP was purified from whole cell lysate 
preparations, which was prepared by rupturing the cells with 2 passes through a 
French pressure cell (Thermo) at 10000 psi in the presence o f 100 pg/ml 
deoxyribonuclease I (Sigma) and 1 mM MgCfe. Cell lysate was incubated on Ice 
for 5  minutes and 5  mM EOTA. PH7 was added. The sample was darifed  by 
centrifugation at 18000 rpm for 20 minutes at 4°C  (SS34 rotor in Sorvall 
Evolution centrifuge). SiaP was purified with a  gravity flow column using the 
standard method (Methods section 2.14.3). except that none of the buffers 
contained the detergent. DDM. Anion exchange chromatography was
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perform ed w ith DEAE sepharose using the standard protocol (M ethods section
2.14.4).
A nalysis o f the fractions taken during the IMAC purification o f SiaQM from  
E. co li whole cell lysate using Coom assie-stained SDS-PAGE revealed an 
intense band in elution fraction 2 tha t corresponded to  the estim ated m olecular 
w eight o f SiaPHio (36.5 kDa, Fig. 6.3). A  band was present in the w hole cell 
lysate fraction, which was not present in  the flow through from  the colum n, 
indicating  tha t th is  band was SiaPH10 and w as abundant enough to  be is visib le 
in  the  w hole ce ll lysate (F ig. 6.3). There was a second intense band in the 
e lu tion fraction at -2 5  kDa that was identified as YodA, which has been found to  
be a com m on contam inant o f IMAC purification (Bolanos-G arcia &  Davies,
2006). YodA is  an E. coti m etal-binding lipocalin , is im portant in response to  
cadm ium  and has been shown to  have a high a ffin ity  fo r Ni2* ions. This 
contam inant was not present when S iaPH 10 was produced from  cells grown in 
LB (data not shown), therefore, its production is  a consequence o f growing the 
cu lture  in  m inim al medium. YodA is known to  be under the control o f fe rric  
uptake regulation (Fur) which is a repressor protein that em ploys ferrous iron as 
a co-repressor (Puskarova et af., 2002). M9 m inim al medium does not contain a 
source o f ferrous iron and so the addition o f FeS 04 to  the m edium could 
repress the expression o f YodA. This experim ent w as perform ed and in the 
presence o f FeSO« there was no reduction in  the YodA contam ination (data not 
shown).
A nion exchange chrom atography o f the IMAC eluate was found to  result in 
hom ogeneous S iaP w ith a high yield (Fig. 6.4). The absorbance (A 28o) trace o f 
the elution profile revealed 2 m ajor peaks during the linear gradient from  0-500 
m M  NaCI (F ig. 6.4a). Analysis o f the fractions spanning these peaks by SDS- 
PAGE revealed that the firs t peak consisted o f the species at approxim ately the 
m olecular w eight expected fo r S iaPH10 (36.5 kDa) and the second peak 
corresponded to  YodA (Fig. 6.4b). Analysis o f the protein content o f each 
fraction revealed tha t there was a sm all overlap between the SiaPHio and YodA 
peaks, but there were a sufficient num ber o f fractions tha t contained only
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F ig u re  6.3 IMAC p u rifica tio n  o f SiaP from  c la rifie d  w ho le  ce ll lysa te  from  
MC1061 pBADnP. Coomassie-stamed SDS-PAGE o f SiaP purification with 
IMAC showing danfied whole cell lysate (W CL). the flowthrough (UB). the 40 
mM im idazole washing step (W ) and the elution fractions. M olecular weight 
(M W ) shown m kO t.
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SiaPHio. The to ta l yield o f homogeneous, ligand-free S iaPHio was 2.56 m g/L 
culture. SiaPHio is  a robust protein that can be concentrated to  high levels (up 
to  1.2 m M ) and dialysed into dH20 .
6.4 In itia l re c o n s titu tio n  o f SiaPQM u s in g  d iffe re n t re c o n s titu tio n  m e thods 
The protein com ponents o f the SiaPQM TRAP transporter can be expressed 
and purified w ith a high yield. This achievem ent now perm its the biochem ical 
and biophysical study o f these purified com ponents, however, the main goal o f 
the expression and purification was to  reconstitute the integral membrane 
com ponent, SiaQM into liposom es, add purified SiaP and characterise transport 
o f (14C]-Neu5Ac in  vitro.
A  num ber o f d ifferent reconstitution methods have been developed and it is 
apparent tha t successful reconstitution is subjective and reconstitution 
conditions have had to  be optim ised fo r particular system s (Knol, 1999). It is 
a lso  apparent tha t the transport activ ity  o f a particular transporter in  vitro may 
be on ly a sm all percentage o f the activ ity observed in vivo (Knol, 1999). The 
m ost w ide ly used reconstitution m ethod is solubilising the integral m embrane 
protein in  a high CMC detergent like  DM o r /S-OG and rap id ly d ilu ting the 
protein/detergent m ix below the CMC in  the presence o f pre-form ed liposom es 
(Baron & Thom pson, 1975). A  second reconstitution method tha t w ill be tested 
involves the solubilisation o f m embrane protein in  the detergent o f choice, fo r 
exam ple, DDM, and then m ixing w ith detergent-destabilised liposom es (using 
T riton  X100, although other detergent have been used previously) follow ed by 
rem oval o f the detergents by polystyrene beads. This m ethod has a lso been 
subject to  rigorous optim isation fo r other proteins (Knol e t a l., 1996).
The prelim inary in  vivo uptake assays strongly indicated Na+ is the counter ion 
fo r NeuSAc transport, therefore in  the prelim inary in  vitro uptake assays an 
inw ardly directed Na* gradient w ill be the on ly electrochem ical gradient applied.
S iaQM  w as purified as detailed previously (C hapter 5) and reconstituted using 
e ither the detergent-destabilised liposom e m ethod (M ethods section 2.15.3) 
w ith  SiaQM solubilised in DDM o r the rapid d ilu tion m ethod (M ethods section
2.15.2) w ith SiaQM in the presence o f DM o r OG.
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Standard in vitro NeuSAc transport assays were performed (Methods section
2.161 and 2.16.2) in the presence of an inwardly directed Na+ Qradient
(Methods section 2.16.3.1). A  control of empty liposomes, i.e. liposomes with no 
protein reconstituted, was included.
Analysis of the transport activity of the proteoliposon.es prepared by three 
different methods revealed th a t upon creation of an inwardly directed Na* 
gradient there was increased uptake of radiolabelled NeuSAc into the 
proteoliposon.es created using the rapid dilution method with SiaQM solubilised 
in DM (Fig- 6.5a, closed triangles). The substrate accumulation increased from 
700 cpm to 1150 in 80 seconds at which point the uptake rate decreased and 
the cpm levelled off. Under the same conditions, the proteoliposomes created 
using the rapid dilution method with SiaQM in the presence of the fi-O G  (Fig. 
6.5a. open triangles) and the proteoliposomes created using the detergent 
destabilised liposome method (Fig. 6.5a. open circles) did not show any 
significant increase in radiolabel influx. There was a general upward trend 
indicating very slow rate of influx; however, this was also observed for the 
empty liposome control (Fig. 6.5a. closed circles). This suggests that the 
observed radioactivity increase in these two samples is caused by the gradual
diffusion of the [ '4C]-Neu5Ac across the liposome bilayer irrespective of the 
presence of SiaPQM.
Analysis of the protein content of the proteoliposomes prepared using the rapid
dilution method with SiaQM in DM by SDS-PAGE revealed that SiaQM is the 
major species present (Fig. 6.5b).
As in the expression of membrane proteins, the reconstitution of integral 
membrane proteins is subjective. As in the case o f protein expression the 
reconstitution method that will work best can not be determined a priori
therefore each method must be tested, and possibly optimised, to determine ita 
efficacy of reconstitution.
This preliminary in vitro transport assay was designed to determine which if 
any. of the three reconstitution methods would result in successful reconstitution 
Of SiaQM. Successful functional reconstitution was assessed by the abilitv of 
me reconstituted system to transport ("C]-Neu5Ac into the lumen of the
211
(a) 1200
E
S
1100 H
1000
▼
o
~  900Q.3
O<m3O
2
800
O  700
600
▼
a
500
20 40
(b)
175-  
83 
6 2 -  
47  5 -
3 2 5 -
25 -
1 6 5 -
A
A
60 80 100 120
Time (s)
mw 1 2.5 5
140 160 180
F igu re  6.5 N a '-d rive n  tra n sp o rt o f [»CJ-NeuSAc by SiaPQM re co n s titu te d  
by th ree  d iffe re n t m ethods, (a) Uptake o f [ ’ ‘ CJ-NeuSAc into SiaQM -containing 
proteoliposom es in the presence o f SiaP and an inw ardly directed Na* gradient 
(ApNa*). SiaQM was reconstituted using the destabilised liposom e method and 
SiaQM  solubilised in DDM (open circles) and the rapid dilution method with 
SiaQM  solubilised in e ither DM (closed triangles) or /f-O G  (open triangles) 
Em pty Irposomes were included as a control (closed circles). S iaQM -containing 
proteoliposom es (and the em pty liposom es) loaded w ith 100 mM potassium  
acetate. pH 7. and 20 mM potassium phosphate. pH 7. were diluted into buffer 
containing 100 mM sodium acetate. pH 7, 20 mM sodium  PIPES pH 7 to 
produce the sodium gradient. A ll reactions included 4 pM [’ 4C ]-Neu5Ac 4 uM 
NeuSAc and 5 pM SiaP. (b) Coom assie-stained SDS-PAGE o f 1 pi 2 5 p| and 5 
pi o f pro.eoliposom e suspension produced from  the rapid dilution me.hod^with 
SiaQM  solubilised in DM. S ingle experim ents were perform ed for the purposes 
o f experim ental optim isation only. M olecular w eight (MW ) shown in kDa
proteoliposom e in  the presence o f an inw ardly d irected Na* gradient and the 
ESR, SiaP.
The transport assay result indicated tha t the  rapid d ilution m ethod w ith SiaQM 
solubilised in DM w as the on ly m ethod o f the th ree  to  produce functionally 
active  proteoliposom es. Even the seem ingly sm all a lteration o f using SiaQM 
solubilised in £-OG ra ther than DM resulted in  no observable transport activity. 
The m ain objective o f th is  experim ent has been achieved: a method has been 
defined w hich results in  functionally reconstituted SiaPQM . These 
proteoliposom es can now be used to  dissect the energetic requirem ents o f 
N eu5Ac transport by SiaPQM.
6.5  C ha ra c te risa tio n  o f th e  e n e rg e tic  re q u ire m en ts  fo r  N -a ce ty ln e u ra m in ic  
a c id  tra n s p o rt b y  SiaPQM
R econstitution o f transporters into liposom es and characterisation in vitro allows 
very specific  dissection o f the energetic requirem ents fo r transport because 
specific  gradients can be applied across the mem brane w ithout fe a r o f 
com plications arising from  the presence o f o ther proteins (as in vesicles) o r 
o the r residual electrochem ical gradients (as in whole cells).
The in itia l in  vivo transport assays revealed tha t on ly the creation o f a Na* 
gradien t across the mem brane could power transport o f Neu5Ac. The ab ility  o f 
a  N a* gradient to  power transport was also shown in the in itia l in  vitro  transport 
assays. This, however, does not preclude other electrochem ical gradients, such 
as a H* (ApH) gradient o r membrane potential (AMO from  being able to  power 
transport o f Neu5Ac via  SiaPQM. Transport assays w ith proteoliposom es can 
determ ine the effects o f these  o ther gradients when applied ind ividually and in 
com bination.
S iaQ M  was expressed and purified as detailed previously and reconstituted 
using the rapid d ilu tion m ethod w ith SiaQM solubilised In DM. S tandard in  vitro 
transport assays w ere perform ed (M ethods section 2.16.1 and 2.16.2) w ith  
d iffe ren t com binations o f electrochem ical gradients created by d ilu ting  the 
proteoliposom es In specific buffers (detailed in  M ethod sctions 2  16 3 1- 
2.16.3.5). The fo llow ing electrochem ical gradients w ere created; Na* gradient
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alone (ApNa*), Na* gradient and membrane potential combined (ApNa* + AH'), 
Na* gradient and pH gradient combined (ApNa* + ApH), membrane potential 
alone (AH') and a pH gradient alone (ApH). An empty liposome control was 
included which had a ApNa* alone applied across the membrane. 5 pM SiaP  
and 5  pM (’*CJ-Neu5Ac were used in each assay. Each assay was performed in 
triplicate (except for Na* gradient alone, which was performed in duplicate) and 
the average of the three data sets was plotted.
Analysis of the transport data revealed that there was no transport activity when 
a  At» or ApH are applied individually (Fig. 6.6, open triangles and closed 
squares, respectively). Linear uptake into the  proteoliposomes is observed 
when the ApNa*. the ApNa* ♦  ApH and the ApNa* + a h ' were applie<J across 
the membrane, but all three have different transport rates (Fig. 6.6, closed 
circles, closed triangles and open circles, respectively). When the ApNa* was 
applied, the rate of transport was 20 nmol/mg/mln. The addition of ApH to make 
ApNa* ♦  ApH caused inhibition of the transport rate to - 8  nmol/mg/min. The 
inclusion of the AH' to make ApNa* + AH' had the opposite effect and increased 
the rate to 28 nmol/mg/min.
These in vitro transport assays have shown that transport of Neu5Ac can not be 
powered by a pH gradient of membrane potential alone. These electrochemical 
gradients do, however, have an impact on the rate of transport when in the 
presence of a Na* gradient Monitoring transport activity when a sodium 
gradient was applied in conjunction with the membrane potential revealed that 
the membrane potential has a synergistic affect with the Na*-gradient and 
increased the transport rate. A  molecule of Neu5Ac has one negative charge 
and if it is assumed that only one Neu5Ac is transported at a  time by SiaPQM  
then the observation that the inclusion of the membrane potential has a 
synergistic effect on Na* driven transport implies that SiaPQM Is an electrogenlc 
transporter. If, in contrast, SiaPQM was an electroneutral transporter then the 
inclusion of a (negative inside) membrane potential would have no effect on the 
transport rate. This observed positive effect of the (negative inside) membrane 
potential on transport of Neu5Ac implied that there are more than one Na* ions 
involved in the transport of one NeuSAc molecule. Further experiments will be
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Figure 6.6 Energetic requirem ent fo r [,4C]-Neu5Ac by SiaQM containing  
proteoliposom es. Uptake of [u C]-Neu5Ac into SiaQM-containing 
proteoliposomes in the presence of SiaP and different energetic conditions. 
SiaQM-containing proteoliposomes loaded with 100 mM potassium acetate pH 
7 . and 20 mM potassium phosphate. pH 7, were diluted into the following 
buffers; 100 mM sodium acetate, pH 7 , 20 mM sodium PIPES, pH 7 , 2 pM 
valinomycin to produce a  sodium gradient and membrane potential combined 
(ApNa* -  Am. open circles). 100 mM sodium acetate, pH 7 . 20  mM sodium 
PIPES. pH 7 , to produce a sodium gradient (ApNa*. dosed circles), 120 mM  
sodium PIPES, pH 7 , to produce a  sodium gradient and pH gradient combined 
(ApNa* ♦  ApH. closed triangles), 100 mM N-methyl glucamine (NM G ) acetate 
pH 7 .2 0  mM NMG phosphate, pH 7. to make a membrane potential (Am open 
triangles), 120 mM potassium phosphate, pH 7, to m ake a  pH gradient’(ApH 
closed squares). All reactions induded 5  pM [,4C]-Neu5Ac and 5 pM SiaP The 
average of triplicate data sets is shown, except for ApNa*. where the average of 
duplicate data sets is shown. Error bars shown are the standard deviations from 
the mean, exept for A p N a \ in which the range is shown (n=2)
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required to  define the stoichiom etry o f counter-ion to  substrate (see 
D iscussion).
The reasons fo r the inhibition o f N a'-driven transport by the addition o f a pH 
gradient (a lkaline inside) are unknown. It is unknown w hether the pH gradient 
affected transport or w hether the pH change w ithin the lum en o f the 
proteoliposom e changed the properties o f the protein.
6.6 R equ irem ent o f a Na* g ra d ie n t o ve r ju s t th e  p resence  o f N a* fo r  th e  
tra n s p o rt o f AA acetylneuram in ic a c id  v ia  SiaPQM
It has been dem onstrated that SiaPQM can transport Neu5Ac in the presence 
o f a Na* gradient, however, it is not c lear w hether it  is  the N a* gradient o r sim ply 
the presence o f Na* tha t is  im portant fo r transport If, fo r exam ple, Na* is  on ly 
required fo r the interaction o f S iaP w ith  Neu5Ac (like  in  TakP (G onin e t a!., 
2007)) o r the interaction between SiaP, Neu5Ac and SiaQM  then the gradient 
w ould not be necessary. To tes t w hether it is the Na* gradient tha t is im portant 
and not ju s t presence o f Na*. a  transport assay was perform ed in which the 
transport activ ity o f S iaQM -containing proteoliposom es w ere com pared when a 
N a* gradient and membrane potential was applied o r when equim olar 
concentrations o f Na* w ere present on both the outside and inside o f the 
proteoliposom es and a membrane potential was applied.
A  standard in  vitro transport assay (M ethods section 2.16.1 and 2.16.2) was 
perform ed w ith the follow ing m odifications; S iaQM -containing proteoliposom es 
loaded w ith  60 mM potassium  acetate, pH 7. and 60 mM sodium  PIPES, pH 7 
w ere  d ilu ted into  buffer containing 60 mM W-methyl glucam ine phosphate 
(N M G -P i). pH 7, 60 mM sodium  PIPES, pH 7. 2  pM valinom ycin to  create a 
s ituation where equim olar concentrations o f Na* w ere present on both the 
inside and outside the proteoliposom e. To produce a ApN a* + * q i,  S iaQM- 
conta in ing proteoliposom es loaded w ith 60 mM potassium  acetate, pH 7 and' 
60  mM NMG-Pi. pH 7. were diluted in to  the sam e outside bu ffe r as  above. A ll 
reactions included 5 pM S iaP and 5 pM [14C]-Neu5Ac.
A nalysis o f the transport activ ity o f S iaQ M -containing proteoliposom es in the 
presence o f S iaP  and a Na* gradient w ith a mem brane potential (negative
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inside) revealed rapid transport of the [” C]-Neu5Ac into the lumen of the 
proteoliposomes reaching -4 .8  nmol/mg after 180 s (Fig. 6.7, open circles). The 
transport activity of proteoliposomes in the presence of a membrane potential 
and equimolar concentrations of Na* was negligible in comparison (Fig. 6.7, 
closed circles). There is a slight increase during the assay indicating slow 
transport into the proteoliposome. This is unlikely to be due to Na*-gradient 
independent transport and could be a consequence of a small Na* gradient 
being established due to the electrostatic attraction of Na* to the negatively 
charged lumen (relative to the outside) formed by the membrane potential. 
Monitoring the transport activity in these two different conditions revealed that it 
is indeed a  Na* gradient that is required for transport and not the mere 
presence of Na*.
6 .7  Investigation into W -acetylneuram inic acid transport by SiaQM and 
SiaP orthologue, VC1779
The process of transporting a substrate through an ESR-dependent transporter 
like SiaPQM consists of multiple steps. The ESR, SiaP, has to bind Neu5Ac. 
and then interact with the translocation machinery SiaQM. The binding of 
substrate to ESR has been studied in depth for ABC transporters as well as a 
number o f TRAP ESRs (See Introduction section 1.7.3.1 and 1.8.1.2) The 
interaction of the ESR with ABC transporter integral membrane protein has also 
been studied using mutagenesis and more recently using cocrystallisation 
(Locher et a l.. 2002, Oldham et a!., 2007). These studies have revealed that 
surface charge is the major driving force for the interaction between ESR and 
integral membrane protein. It is unknown, however, how the liganded (or 
unliganded) TRAP ESRs interact with their cognate integral membrane proteins. 
A  possible method to determine which regions of S iaP confer specificity to 
SiaOM  would be to determine whether a close orthologue of SiaP can form a 
functional transporter with SiaQM. VC1779 from V,brio choleras is known to 
bind Neu5Ac with a high affinity and has -5 1  % identity to SiaP. If this ESR can 
interact functional!y with SiaQM then conserved, solvent exposed regions of the 
two ESRs would be good targets for the region o f interaction. Conversely if 
VC 1779 cannot interact functionally with SiaQM then solvent exposed regions 
«mere these very similar proteins differ could be Investigated as the possible
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F ig u re  6.7 T ra n sp o rt o f [14C ]-N eu5Ac in  th e  presence and absence o f a Na* 
g ra d ie n t. Uptake o f [  C]-Neu5Ac into SiaQM -containing proteoliposom es in the 
presence o f S iaP and an inw ardly-directed Na* gradient and membrane 
potentia l (ApNa* + AH', open circles) o r in the absence o f a Na+ gradient but 
w ith  equim olar Na* on both sides o f the mem brane and a m em brane potential 
(closed circles). S iaQM -containing proteoliposom es loaded w ith 60 mM 
potassium  acetate. pH 7. and 60 mM sodium  PIPES, pH 7, w ere dilu ted into 
b u ffe r containing 60 mM NMG-Pi, pH 7, 60 mM sodium  PIPES, pH 7, 2 pM 
va linom ydn to  create a situation where equim olar concentrations o f Na+ were 
present on both the inside and outside the proteoliposom e. To produce the 
ApN a* ♦ A ^ . S iaQM -containing proteoliposom es loaded w ith 60 mM potassium  
acetate, pH 7, and 60 mM NMG-Pi, pH 7, were d ilu ted into the sam e outside 
bu ffe r as above. A ll reactions included 5 pM SiaP and 5 pM [u C]-Neu5Ac. The 
average o f trip licate data is presented and error bars shown are the standard 
devia tions from  the mean.
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region o f interaction. To perform  th is experim ent, VC1779 had to  be purified and 
tested fo r its  ab ility  to  bind Neu5Ac w ith a high a ffin ity  before it could be 
included in an in vitro uptake assay.
A  m ore thorough investigation into the differences between S iaP  and VC1779 is 
possible because the high resolution crystal structures are available fo r both 
((M u lle r e t a l., 2006) and S. Ramaswamy, unpublished data).
The expression strain BL21 (DE3) plysS pRY11 w as used to  produce ligand- 
free  V C 1779 .6  L o f double M 9 m inim al m edium  was inoculated to  an ODko  o f 
0.1 from  an overnight culture o f BL21 (DE3) PR Y1 1 . The culture was grown a t 
25°C  to  an ODbo o f 0.4-0.5 and expression was induced w ith 0 .5  mM IPTG 
T he  ce lls  w ere harvested a fte r overnight grow th. Perip lasm ic fraction was 
prepared (M ethod section 2 .8 .5) and ligand-free VC1779 w as purified using a 
H isT rap colum n (GE Healthcare) and standard m ethods (M ethods section
2.14.4).
Tryptophan fluorescence spectroscopy was perform ed using a Fluorom ax 3 
w ith  an excitation wavelength o f 295 nm and an em ission w avelength o f 328 
nm . A  25 nM solution o f VC1779 dilu ted in to  50 mM Tris. pH 8  was used. A  
tim e-based acquisition was perform ed in w hich increasing concentrations o f 
N eu5Ac w ere added every 30 seconds up to  a fina l concentration o f 8 pM The 
cum ulative fluorescence change (AF) was plotted against concentration o f 
N eu5Ac and the K , was calculated by fitting  the  curve to  a single rectangular 
hyperbola.
A  standard uptake assay was perform ed (M ethods section 2.16.1 and 2.16.2) 
w ith  a ApN a* ♦ A V  applied across the m embrane (M ethods section 2.16.3.2) in 
presence o f 5 pM SiaP o r 5 pM VC1779.
A nalysis o f the SiaP (PDB code: 2CEY) and VC1779 (S . Ramaswamy. 
unpublished data) structures was perform ed using the program  CCP4MG.
VC 1779 is expressed in-fram e w ith a C -term inal hexahistid ine tag  and it is 
expressed to  a high degree in  the expression stra in  BL21 (D E3) PRY11 grown 
¡n M9 m inim al m edia, therefore, it is  purified in its  ligand-free form  The 
expression is  from  the pET20b plasm id (N ovagen) and the protein is  d irected to  
m e periplasm  by fusion to  the E. co// PelB signal peptide. Preparation o f the
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periplasm  can be considered the firs t purification step as the contents o f the 
cytoplasm  are not release during the procedure. VC1779 is purified to -99%  
hom ogeneity in one IMAC purification step (Fig. 6.8, inset). VC1779 was 
dia lysed in to  50 mM KPi, pH 7, as it has been found to  be less stable than SiaP 
and it  w as unknown w hether it would be soluble in  dH20  (E. Seven, personal 
com m unication).
Tryptophan fluorescence spectroscopy revealed tha t at an em ission wavelength 
o f 328 nm the binding o f Neu5Ac causes a -3 0 %  quench in the fluorescence 
signal (data not shown). The binding a ffin ity (Kd) can be determ ined by titra ting 
the  extent o f fluorescence quenching w ith increasing concentrations o f Neu5Ac 
(F ig. 6.8). The affin ity o f Neu5Ac fo r VC1779 was calculated to  be 0.113 pM ± 
0.002 (an average o f three experim ents). This indicates tha t the VC1779 
purified was active and was able to  bind Neu5Ac w ith a high affin ity. A  second 
experim ent was performed to determ ine the affects o f the presence and 
absence o f Na+ on the binding a ffin ity  o f Neu5Ac to VC1779. Purified VC1779 
w as dialysed into N aV ree  buffer and a fluorescence titra tion  was perform ed as 
before, e ither in the absence o f Na+ o r in the presence o f 120 mM NaCI. The 
a ffin ity  o f Neu5Ac fo r VC1779 in the absence o f Na+ was calculated to  be 0.111 
pM  ± 0.037 (an average o f fou r experim ents, data not shown). In the presence 
o f 120 mM NaCI the affin ity was calculated to  be 0.347 pM ± 0.113 (an average 
o f fo u r experim ents, data not shown). This data suggests that Na+ is not integral 
to  the binding mechanism  o f VC1779.
The in  vitro transport assays revealed th a t there w as no transport activ ity when 
VC1779 was included in the outside buffer (Fig. 6.9. closed circles), however, 
the  sam e experim ent perform ed w ith SiaP w ith  the sam e proteoliposom es 
revealed uptake o f radiolabelled Neu5Ac (Fig. 6.9, open circles). This indicated 
tha t, although V C 1779 can bind Neu5Ac w ith a high a ffin ity, it is not capable o f 
interacting functionally w ith SiaQM to  transport Neu5Ac.
H igh resolution crystal structures have been elucidated fo r ABC transporter 
in tegra l m embrane com ponents in com plex w ith th e ir cognate ESRs fo r the 
m altose transporter (O ldham et a!., 2007) and the m olybdate
transporter(H ol!enstein e t a!., 2007b). The structures have shown th a t the ESR 
is positioned on the integral membrane com ponent so tha t the mouth o f the 
b ind ing c le ft is in-line w ith the opening o f the translocation channel. These
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F ig u re  6.8 Neu5Ac co n cen tra tio n -d ep e n d en t flu o re sce n ce  change in 
VC1779. Fluorescence changes measured at 328 nm upon addition of 
increasing concentrations of Neu5Ac. Data were fitted to a single rectangular 
hyperbola. Inset: Coomassie-stained SDS-PAGE gel of VC1779 purified by Ni2* 
affinity chromatography. Triplicate data sets were collected. Molecular weight 
(MW) shown in kDa.
221
Figure 6.9 Uptake of [” C]-Neu5Ac by SiaQM in the presence of ApNa ♦ AV 
and either SiaP or VC1779. Uptake of f 4C]-Neu5Ac into SiaQM-containing 
proteoliposomes in the presence of SiaP (open circles) or VC1779 (dosed 
drdes) and an inwardly directed Na* gradient plus negative-inside membrane 
potential (ApNa* ♦ AV). SiaQM-containing proteoliposomes loaded with 100 
mM potassium acetate, pH 7, and 20 mM potassium phosphate, pH 7 were 
diluted into buffer containing 100 mM sodium acetate, pH 7. 20 mM sodium 
PIPES, pH 7 .2 pM valinomydn. All readions included 5 pM [MC]-Neu5Ac The 
average of duplicate data sets is presented. Error bars shown indicate the 
range  between the two sets of data (n=2).
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structures and other studies on ABC transporter ESRs (P rossnitz 1991 
Sebulsky e t a/.. 2003) have revealed that the interaction between the ESR and 
the integral membrane com ponents is driven prim arily by charged interactions 
between the  proteins. It has been dem onstrated tha t VC1779 cannot form  a 
functional transporter w ith SiaQM and so the te rtia ry structure o f S iaP and 
VC1779 were com pared. This revealed tha t the backbone architecture was 
a lm ost Identical, which is  rem arkable considering the proteins are on ly 50 % 
identica l a t the am ino acid level (Fig. 6.10a). Analysis o f the surface exposed 
e lectrostatic properties o f these tw o proteins on the protein face predicted to  
in teract w ith the membrane com ponents revealed a num ber o f differences in 
charge d istribution over th is area (Fig. 6.10b and c). The conserved surface 
exposed region previously identified (M uller e t a l„  2006) is essentia lly identical 
in  both proteins (Fig. 6.10b and c). Unfortunately, w ithout experim ental 
evidence it would be extrem ely d ifficu lt to  predict which residues on th is 
in terface d ifferentiate SiaP from  VC1779.
VC 1779 is  a close orthologue o f S iaP and is part o f a TRAP transporter in 
V. cholerae. In vitro transport assays have revealed tha t VC1779 can not form  a 
functional transporter w ith  SiaQM. The reason VC1779 can not function w ith 
S iaQ M  is like ly due to variations In residues and e lectrostatic properties in
reg ions o f VC1779 that sterically o r e lectrostatica lly h inder interaction w ith the 
reciprocal in te racton  patch on SiaQM.
6.8 Directionality of W-acetyl neuraminic acid transport by SiaPQM
O ne o f the characteristics o f secondary transporters is the ab ility  to  transport 
substrate reversibly, tha t is. depending on the d irection o f the substrate and 
counter-ion gradient, the substrate can be transported in e ither d irection (See 
Introduction section 1.5.4). A lthough TRAP transporters are  ESR-dependent 
they are still secondary transporters and m ay have som e residual seconds™  
transporter characteristics. The ESR in the TRAP transporter confers a h igher 
a ffin ity  to  TRAP transporters than is found in  secondary transporters and ESRs 
a lso  define the d irection o f transport, however, th is  does not mean it is not 
possib le fo r the TRAP transporter to  w ork reversibly. To assess th is tw o rh vitro
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Original in Colour
F ig u re  6.10 C ontparison  o f ,he  te rtia ry  s tru c tu re  and su rfa ce  exposed 
e le c tro s ta tic  ch a ra c te ris tics  o , S iaP and VC1779. <„ S u p e r im p o s iL  of 
carbon backbone of S iaP  (green) and V C , 779 (biue). Electrostatic 
characteristics of the face of (b) VC1779 and (c) S iaP  predicted to interact with 
the integral membrane protein c o n s e n t s .  The c o n so le d , surface exposed 
region pred.cted to be the interaction patch (Mulier e, a,.. 2006, is outlined
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transport assays were performed; a counterflow assay and a cold substrate 
chase.
The two transport assays; counterflow and cold chase are both a way of 
measuring exchange of substrate between the lumen to the outside of the 
proteoliposome, and wee versa. In the cold chase experiment, a standard 
transport assay is performed, except that at a specified point during the assay a 
large excess of cold substrate is added. If the transporter can transport 
substrate reversibly there will be an exchange of cold substrate on the outside 
for radiolabelled substrate on the inside. This will manifest itself with a decrease 
in the observed radiolabelled substrate within the proteoliposomes. If the 
transporter can not transport substrate reversibly then transport will level out 
with no decrease and no further increase due to dilution of the radiolabelled 
substrate on the outside.
A  counterflow assay is an in vitro transport assay in which the proteoliposomes 
are pre-loaded with excess cold substrate (1 mM) and no electrochemical 
gradients are applied. A comparatively small concentration of radiolabelled 
substrate is added to the outside of the proteoliposome. If the transport is 
reversible, addition of the pre-loaded proteoliposomes to the outside buffer 
leads to rapid uptake of the radiolabelled substrate as it is exchanged for the 
cold substrate being effluxed down the substrate gradient. Eventually, the 
internalised radiolabelled substrate will start to efflux as the radiolabelled and 
non-radiolabelled substrate reach equilibrium.
The chase experiment was performed like a standard transport assay (Methods 
section 2.16.1 and 2.16.2) with a ApNa* + A4> applied (Methods section
2.16.3 .2) except using a 600 pi reaction volume and taking 50 pi samples. 
Either dH20  or 1 mM cold Neu5Ac was added at 100 seconds (as indicated in 
the figure).
The counterflow experiment (Methods section 2.16.4) was performed in the 
presence and absence of 5 pM SiaP. Empty liposome controls were added for 
experiments in the presence and absence of SiaP.
There was no significant difference between the transport activities for assays
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where a 1 mM Neu5Ac chase or dH20  was added (Fig. 6.11). In both assays 
transport of NeuSAc increased quickly, and after 60 seconds the transport rate 
levelled off. After 150 seconds there was a slight decrease in the Neu5Ac 
uptake indicating efflux of substrate from the proteoliposomes This 
phenomenon is observed for both the experiment where 1 mM NeuSAc is 
added and the control experiment where dH20  is added, therefore this is not a 
consequence of the 1 mM cold NeuSAc chase. After this slight decrease in 
uptake, the rate levels off again and decreases no further (Fig. 6.11)
The counterflow assay was performed in the presence of Na* as it has been 
shown that N a* is required for transport, however, this was not a Na* gradient 
as Counterflow assays are performed in the absence of electrochemical 
gradients. The experiments were also performed in the presence and absence 
of SiaP. To give a reference point for the transport activity data, the counterflow 
assays were plotted with the data from the cold chase control in which only 
dH20  was added. The resultant graph revealed that there was no transport 
activity in the counterflow assay in the presence (Fig. 6.12a) or absence fFio 
6.12b) of SiaP. v y ‘
The results obtained t a n  the counterflow and cold chase experiments strongly 
suggest that SiaPQM is unidirectional in the conditions used. A positive control 
for these expenments would have made this assertion more robust for 
example, reconstituted NanT from e  call, which is a classical secondary 
NeuSAc transporter and would have shown bi-directional transport 
Unfortunately, this positive control was not available; however, the counterflow 
assay and the cold chase experiments are well established and have been used 
on a number of occasions with other transporters in vitro and in vivo Indeed 
the cold chase experiment has been performed on SiaPQM in vivo with NanT 
as a control, both expressed in £ . coli. The results indicated that although 
bidirectional transport could be observed for NanT. it could not be observed for 
SiaPQM. (Dr. Emmanuele Seven', personal communication). This reflects the 
result from the in vitro experiment presented and adds weight to the assertion 
that SiaPQM can only transport Neu5Ac unidirectionally.
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Original in Colour
F ig u re  6.11 E ffec t on the accum ula ted  ieve ls  o f [«q-NeuSAc upon 
a d d ,t,o n  o f excess co id  Neu5Ac to  assess the  d ire c tio n a lity  o f SiaQM.
Uptake of [ C]-Neu5Ac into S.aQM-containing proteoliposomes in the presence
of SiaP and an inwardly directed Na* gradient plus (negative-inside) membrane
potential (ApNa ♦ AM», with the addition of either 1 mM NeuSAc (open circles)
or dH20  (closed circles, a, 100s. The ApNa* ♦ AM- was created by loading
SiaQM-contaming proteoliposomes with 100 mM potassium acetate nH 7  „ „ h
20 mM potassium phosphate. pH 7, and diluting them into buffer containing 100
mM sodium acetate, pH 7, 20 mM sodium PIPES, pH 7, 2 pM valinomycin All
transport assays included 5 pM SiaP and 5 pM [«q-N eu5A c. Duplicate data
sets were collected. Error bars shown indicate the range between the two sets
of data (n=2). Red arrow indicates time at which excess cold substrate (or 
dH 2 0 ) was added. P ira te  (or
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(a)
Figure 6.12 Counterflow  assays in the presence and absence o f SiaP.
SiadM-containing proteoliposomes loaded with 100 mM KAc, pH7, 20 mM KPi 
pH7, 10 mM NaPIPES and 1 mM Neu5Ac were diluted into the same buffer 
buffer devoid of NeuSAc, but containing 5 pM l” C]-Neu5Ac and either (a) 5 uM
SiaP or (b , no SiaP (closed circles). A  control experiment was included in which 
SiaPQM was energised by ApNa* ♦ Am (0pe„ cirdes). An
control was added and treated in the same way with and without SiaP The 
values for the counterflow were calculated by subtracting the empty liposome
control values. The average of duplicate data sets is presented E r l  bars 
shown indicate the range between the two sets of data (n=2 )
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6.9 E ffect o f increasing concentrations o f S iaP on W -acetylneuram inic acid 
transport by SiaPQM in  vitro
SiaPQM is a secondary transporter, and the large subunit of the integral 
membrane components is a member of the IT (ion transport) superfamily and is 
thought to be related to classical secondary transporters that transport substrate 
with no need of an ESR (Prakash et a l, 2003). It has been shown in vivo that 
deletion of either SlaP or SlaQM results in the Inability to transport the NeuSAc 
Into the bacteria (Seven et al.. 2005). however, the ability of SlaQM to transport 
Neu5Ac without SiaP has not been assessed in vitro.
An experiment was designed to determine whether SlaQM could transport 
NeuSAc in the absence of SiaP. This experiment was then extended to assess 
the effects increasing the concentration of SiaP In the in vitro transport assay.
A  standard in vitro transport assay (Methods section 2.16.1 and 2 16 2 ) was 
performed with a ApNa* + A V  applied across the membrane (Methods section 
2.16 .3 .1 ) except that the concentration of SiaP In the outside buffer was 0 2 5 
5, 10 or 20 pM. An empty liposome control was also Included which had the 
standard SiaP concentration of 5 pM.
Analysis of the transport activity In the presence of different concentrations of 
SiaP revealed that In the conditions tested, there was no transport activity In the 
absence of SiaP (Fig. 6.13, closed circles). In the presence of 5 pM SiaP, rapid 
uptake was observed up to -11  nmol/mg, at which point the transport rate’levels 
off (Fig. 6.13, closed tnangles). In the presence of 2 .5  pM SiaP, a  slower 
transport rate was observed compared to transport in the presence of 5 pM 
SiaP and the value at the end of the assay was also lower at - 9  nmol/mg (Fig 
6.13, open circles). In the presence of 10 pM SiaP, the transport rate was lower 
and reached its peak at -100  seconds at which point the uptake started to 
decrease, l.e. substrate was being effluxed from the proteollposome (Fig 6 1 3  
open triangles). A  similar transport activity was seen In the presence of 20 pM 
SiaP. except that the uptake peaked after only 60 seconds and there was 
markedly Increased efflux from the proteofiposome resulting in a value of -4  
nmol/mg at the end of the assay (Fig. 6.13, closed squares).
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Figure 6.13 Transport activity of SiaQM in the presence of increasing 
concentrations of SiaP with a fixed f ‘ C]-Neu5Ac concentration
Uptake of [14C]-Neu5Ac into SiaQM-containing proteoliposomes in the presence 
o f an inwardly directed Na* gradient plus (negative-inside) membrane potential 
(ApNa* + A>F) and SiaP in concentrations of 0 pM  (closed circles) 2  5 uM  
(open circles). 5 p M  (closed triangles). 10 pM  (open triangles) or 20 pM  (closed 
squares). The ApNa* ♦ A-P was created by loading SiaQM-containing 
proteoliposomes with 100 mM potassium acetate, pH 7, and 20 mM potassium 
phosphate. pH 7. and diluting them into buffer containing 100 mM sodium 
acetate, pH 7, 20 mM sodium PIPES, pH 7, 2  pM valinomycin. All transport 
assays included 5 pM [»C]-Neu5Ac. Duplicate data sets were collected Error 
bars shown indicate the range between the two sets of data (n=2)
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The results of this experiment have shown that SiaQM cannot transport Neu5Ac 
in the absence of SiaP in the conditions used. It is possible that SiaQM is 
capable of transporting Neu5Ac in the absence of SiaP, but the affinity of 
SiaQM for NeuSAc is very low. Perhaps if the concentration of Neu5Ac was 
increased then some transport activity would be observed.
Increasing the concentration of SiaP to 2.5, 5, 10 and 20 pM led to different 
transport activities. The results suggest that at 2.5 and 5 pM SiaP, Neu5Ac was 
transported into the proteoliposome and was stably retained within the lifetime 
of the assay. When the concentration of SiaP was increased to 10 and 20 pM, 
the uptake rate of Neu5Ac Into the proteoliposomes was comparatively lower 
and a Vm„  was reached followed by efflux of Neu5Ac from the proteoliposome 
This was SiaP concentration-dependent efflux as there was a more pronounced 
phenotype with the higher concentrations of SiaP. If this is Indeed efflux of 
Neu5Ac from the proteoliposomes, then the obvious gate would be SiaQM as 
there Is no evidence that NeuSAc can permeate the lipid bilayer of the 
proteoliposome. This unexpected conclusion is contrary to the results of the 
counterflow assay and the cold chase experiment, which suggested that 
transport through SiaPQM was unidirectional.
6.10 Effects o f excess SiaP chase on N-acetylneuram lnic acid transport 
and accum ulation in  vitro
The previous experiment revealed that if Increased amounts of SiaP were used 
In the in vitro transport assays a phenomenon occurred in which Neu5Ac was 
transported Into the proteoliposomes, but then exited the proteoliposomes 
presumably via SiaQM. To determine whether this phenomenon Is directly 
linked to increasing the concentration of SiaP, an experiment was designed in 
which a standard transport assay was performed with 2.5 pM SiaP and a ApNa*
+ ^  applied across ,he ™ rt*ra n e . At 180 seconds into the assay excess 
SiaP (17.5 |iM> was added and the effects on transportfefflux of NeuSAc were 
monitored.
A standard in vitro transport assay (Methods section 2 16 1 and 2 16 2) 
performed with a ApNa* ♦  A4, applied across the membrane (Methods s e c Z  
2.16.3.1 ) except that the concentration of SiaP in the outside buffer was 2 5 pM
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Samples were taken at intervals and 17.5 pM SiaP was added at 180 seconds.
A control was included where dH20  was added instead of SiaP. Duplicate data 
sets were recorded for both experiments.
Upon application of the ApNa* + A V  and addition of radiolabelled Neu5Ac, 
similar transport rates were observed for both transport assays, reaching 
between -1 6  and 18 nmol/mg at 180 seconds (Fig. 6.14).
The Neu5Ac accum ulation levels continue to  increase and level o ff at -21
nmol/mg when dH20  was added, however, accumulated levels of NeuSAc
rapidly decreased upon addition of 17.5 pM SiaP, reaching - 5  nmol/mg by the 
end of the assay.
This experiment was designed to confirm whether it is the addition of excess 
SiaP that is causing the efflux of NeuSAc from the proteoliposomes The 
transport activity observed revealed ¿hat addition of excess SiaP led to efflux of 
Neu5Ac, whereas adding the same volume of dH20  did not. This was an 
unexpected result considering the results of the counterflow assay and cold
chase expenment, which demonstrated that transport through SiaPQM was 
unidirectional.
There are a number of possible reasons for this excess SiaP-dependent 
NeuSAc efflux; for example, ligand-free SiaP could be binding to SiaQM and 
dunng the natural oscillations of the ligand-bound SiaQM translocation channel 
the ligand binds to SiaP and is carried out of the proteoliposome. This is unlikely 
because there will be a large excess of ESR over translocation channel in vivo 
so if this was the reason for this phenomenon then Neu5Ac would never 
accumulate In the cell. A  second scenario is that ligand-free SiaP is binding all 
NeuSAc outside the proteoliposomes and forming a large pseudo-substrate 
gradient that is greater than the combined magnitude of the Na* gradient 
(ApNa*) and membrane potential (A-P). It would be difficult to assess whether 
the first scenano Is occurring, the second scenario, however could be examined 
with further experiments.
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Original in Colour
F ig u re  6.14 E ffect o f a d d itio n  o f excess ^ ia P  nn
,  s b,aP on accumulated NeuSAr
Accumulation of , CJ-NeuSAc in SiaQM-con,aining proteoliposomes in £
presence of 2.5 mM S,aP and an inwardly directed Na* gradient plus (nega.ive- 
inside) membrane potential (ApNa* ♦ A *>  followed by the addition (red arrow) 
of 17.5 mM Slap (closed circles) or dH20 (open circles,. The ApNa + ^  wa 
created by loading SiaQM-containing pro.eoliposomes with 1 0 0  mM potassium
acetate. pH 7, and 20 mM potassium phosphate, pH 7, and diluting them Into
buffer containing 100 mM sodium acetatP nH 7  onum acetate, pH 7, 20 mM sodium PIPES nH 7  2
PM valinomycin. Both transport assays included 5 pM [’ ‘ cj-NeuSA The
average of dup ,cate data sets are presented. Error bars shown indicate
range between the two sets of data (n=21 Thn „  6
0 . „  1 £ ) ' rhe red arrow indicates the time at
which excess SiaP (or dH2 0 ) was added. 6  at
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6.11 Com parison o f effects o f SiaP chase and VC1779 chase on N - 
acetylneuram inic acid transport and accum ulation in  vitro
The previous experiments have revealed that addition of excess SiaP can 
cause efflux of Neu5Ac from the proteoliposomes. To determine whether this 
observed efflux is due to a specific interaction between SiaP and SiaQM or 
whether it is simply due to the formation of a pseudo-substrate gradient, the 
following experiment has been designed. This experiment takes advantage of 
the fact that VC1779, a high affinity Neu5Ac binding protein and SiaP  
orthologue, is available and is known not to interact functionally with SiaQM. An 
experiment will be performed which is a repeat of the experiment performed in
section 6 .10, but will include an excess VC1779 chase as well as the excess 
SiaP chase.
A  standard in wire transport assay was performed (Methods section 2  16 1 and 
2.16 .2) with a ApNa* ♦ A *  applied across the membrane (Methods section 
2.16.3 .1) except that the concentration of SiaP in the outside buffer was 2 5 uM 
Samples were taken at intervals and at 100 seconds 17.5 pM SiaP or 17 5 uM 
VC1779 (both in 50 mM KPi, pH 7) were added. A  control was included where
50  mM KPi, pH7  was added instead of ESR. The average of duplicate data sets 
for each experiment is presented.
Upon application of ApNa* + A V  in the presence of 2 .5 pM and 5 pM 
radiolabelled NeuSAc, a high rate of uptake was observed reaching -2 0  
nmol/mg after 60 seconds (Fig. 6.15). Upon addition of 17.5 pM SiaP a 
decrease in the accumulated levels of radiolabelled NeuSAc reaching -5  5 
nmol/mg by the end of the assay (Fig. 6.15, open circles). However upon 
addition of 17.5 pM VC1779 (Fig. 6.15, closed triangles) or 50 mM KPi’ pH 7 
(Fig. 6.15. closed circles), no such decrease in the accumulated levels of 
NeuSAc was observed. A  general downward trend is observed in the VC1779  
chase data, but this is also observed in the control data where 50 mM KPi pH 
7, was added, indicating that this is not a consequence of adding VC1779. ’
This experiment and the previous experiment in section 6.10 have shown that 
efflux of radiolabelled NeuSAc from the proteoliposomes after addition of ,7 5
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F ig u re  6.15 E ffect o f a d d itio n  o f excess
cess SiaP and excess VC 177Q nn 
a ccu m u la te d  Neu5Ac. Accumulation of r14C l • *■
. . .. 1 J Neu5Ac in SiaQM-containina
proteoliposomes the presence of 2.5 pM SiaP and an inwardly directed J
gradient p.us (negative-inside, membrane potential (ApNa* + Am , followed bv
the addition o, ,7.5 pM SiaP (open circ.es), ,7.5 pM V C ,779 (closed triangles
or 50 mM KPi, PH 7 (C losed c irc le s )  a, ,00  s e c o n d s . The ApNa* ♦ A m t
created by loading SiaQM-containing pro.eo.iposomes with 100 mM potassium
acetate. pH 7, and 20 mM potassium phosphate. pH 7, and diluting them into
buffer containing 100 mM sodium acetate nH 7  onceiate, pH 7, 20 mM sodium PIPES d H 7 9
pM vallnomycin. 5 pM [ ' ‘ C-NeuSAc was used in each transport assay The
average of dup cate data sets are presented. Error bars shown indicate the
range between the two sets of data (n = 2 ) Thn ^
h red arrow indicates the time * t 
which excess ESR (or 50 mM KPi, pH 7) was added.
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pM SiaP is a consequence of specific interaction between SiaP and SiaQM  
Efflux was not induced by the addition of 17.5 pM VC1779, a SiaP orthologue 
that has been shown to being Neu5Ac with a  similar affinity to SiaP. This is an 
unexpected result as it suggests that excess SiaP can make SiaQM work
bidirectionally resulting in the movement of Neu5Ac in the opposite direction to 
the Na+ gradient and AH'.
The exact reasons for this SiaP-induced efflux are unknown, but it could be 
suggesting that unliganded SiaP can interact with SiaQM and somehow w  
the substrate back through SiaQM. One possibility is that prior to the docking of 
SiaP onto SraQM. S.aQM is in a conformation such that the periplasmic side of 
the translocation channel is closed, and the cytoplasmic side is open (if we 
assume that the alternating access model applies to TRAP transporters) The 
high concentration of NeuSAc in the lumen of the proteoliposome could mean 
that the binding site within SiaQM is saturated, if the docking of unliganded 
SiaP induces a conformational change within SiaQM that closes the 
cytoplasmic side and opens the periplasmic side then the NeuSAc in the binding 
site of SiaQM could possibly bind to SiaP resulting in efflux of substrate This 
however, is just conjecture and a number of experiments will have to be 
performed to determine the reasons for this observation.
6 .12  C h ap ter sum m ary
Using SiaQM that was purified as documented in Chapter 5, the whole NeuSAc 
specific TRAP transporter was reconstituted into liposomes. This chanter 
documents the first demonstrafion of TRAP transporter activity in an in vitro 
reconstituted system. Using this reconstituted system, the energetics of Neu5Ac 
transport by SiaPQM were probed. This has revealed that SiaPQM utilises a 
A pN a- to power transport of NeuSAc. This was conoborated by vivo NeuSAc 
transport assays in whole cells expressing SiaPQM.
Transport assays on the reconstituted SiaPQM system revealed that it can no, 
use a ApH or the A *  to transport NeuSAc. A  ApNa* in combination with a AoH 
was found to decrease the rate of transport, whemas the application of a ApNa* 
in combination With a A *  increased the transport rate above that of ApNa* 
alone. It was demonstrated that it was the Na+ n r a r w  w . P 
presence of Na* that drove transport of NeuSAc. I, was
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the interaction of the ESR, SiaP with SiaQM is specific as the close orthologue 
of SiaP, VC1779 could not form a functional transporter with SiaQM.
TRAP transporters are secondary transporters, however, it was shown that 
SiaPQM does not demonstrate characteristic secondary transporter behaviour 
SiaPQ M  did not show any solute counterflow activity or exchange activity in a 
“cold chase” experiment. Contrary to these findings, the addition of excess 
unliganded SiaP resulted in efflux of Neu5Ac from the proteoliposomes, 
demonstrating that, under these non-physiological conditions, SiaQM could 
work reversibly. This was shown to be a result of a specific interaction between 
SiaP and SiaQM as VC1779 could not induce this reversible characteristic.
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Chapter 7
Discussion
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7.1 D istribution and diversity of TRAP transporters  
As part of this body of work, the relational database TRAPdb was populated 
with data descnbing the characteristics of thousands of TRAP transporter 
genes. Collection of this data has dearly shown the extent of TRAP transporter 
distribution in prokaryotes, with 243 different organisms containing at least one 
component of a TRAP transporter. This data was correct as of February 2008 
and has no doubt increased greatly since then. The last analysis of this kind 
was performed in 200t (Kelly & Thomas, 2001) which identified approximatelv 
10% of the total TRAP transporter genes that can now be found in TRAPdb 
During this data-mining exercise a number of novel organisations of TRAP 
genes were found that extend the already variable repertoire of TRAP 
transporter genetic organisation (Chapter 3). This analysis also identified a 
number of motifs, such as a serine/threonine kinase and a helix-tum-helix DNA 
binding domain, fused to TRAP transporter ESR genes, potentially rendering 
them able to perform non-transport related functions (discussed in Chapter 3) 
Although these findings clearly need to be experimentally verified, they extend 
the  potential uses for TRAP transporter components
The most interesting finding from this data-mining was the high numbers of 
TRAP transporters found in bacteria whose environment contains high Na* 
concentrations (Chapter 3). A list of organisms with the highest numbers of 
TRAP transporters was compiled from the data collected. This analysis 
revealed that some organisms had up to 28 separate TRAP transporters 
encoded on their genomes, which in some cases accounted for - 10% of the 
total number of transporters. Further analysis revealed that a large proportion of 
organisms with a high number of TRAP transporters were marine-dwelling 
bacteria (Chapter 3). It has been shown that the bioenergetics of most marine 
bacteria depends on a Na* circuit as opposed to a H* circuit found in bacteria 
such as £  coll (Kogure, 1998). The sodium motive force (smf) is known to be 
used for a number of different processes such as transport and flagellar 
movement in a number of different bacteria (Hirota & Imae, 1983, Lanyi 1979) 
This correlation alone is not sufficient to declare that all TRAP transporters 
utilise a Na* gradient, but it does add to a growing litany of research linkim  Ma" 
to TRAP transporters. The first unequivocal demonstration that N a* is reauimd 
for the transport mechanism by TRAP transporters is shown In this thesis bv Z  
transport of Neu5Ac by SiaPQM (Chapter 6). y the
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The most powerful and useful application of the data collected for TRAPdb is In 
the prediction of substrate specificity. It Is assumed that TRAP transporter 
ESRs, like ABC transporter ESRs, confer the substrate specificity to the 
transporter (Doeven e t al., 2004, Wilkinson, 2003). ESRs can be grouped by 
the,r sequence similarity and it has been demonstrated that groups of ESRs 
bind the same or similar compounds (Tam & Saier. 1993). This Is powerful tool 
because If the substrate specificity of one protein in the group is known then the 
specificity of the rest of the group can be inferred (but would obviously need 
experimental verification). Another method that can be used to predict the 
substrate specificity of a TRAP transporter is to analyse its genome context. If 
the transporter is surrounded by genes that encode enzymes that catabolise a 
particular compound then it is likely that that particular compound is transported 
by the encoded TRAP system. This method has been demonstrated for a 
number of TRAP transporters including SiaPQM and YiaMNO (Sever! ef a/. 
2005, Thomas ef af„ 2006). Analysis of the data from TRAPdb revealed a’ 
TRAP transporter from Sinorhizobium meWoti whose larçe membrane 
component (M M ) Is fused to a malonyl-CoA decarboxylase enzyme Closer 
Inspection of the genome context revealed that it is also in an operon with a 
gene encoding malonyl-CoA synthetase. Analysis of the genomes of closely 
related organisms revealed a similar linkage of a TRAP transporter to these two 
enzymes (although they were not fused), and one example of a TRAP 
transporter linked to a multisubunit malonyl-CoA decarboxylase which is 
structurally different, but performs the same function. This strongly suggests 
that this TRAP transporter (and orthologues in related species) is specific for 
malonate. This was reinforced by a study that demonstrated malonate could 
induce the expression of the ESR of this system (Mauchline ef at 2006) To 
confirm this specificity, the ESR could be purified and characterised or in  vivo 
transport assays could be performed. It would be especially interesting to 
determine whether the TRAP transporter membrane component is actually 
fused to the malonyl-CoA decarboxylase enzyme. y
There are now a number of predicted and experimentally defined substrates for 
TRAP transporters (see Introduction section 1 8 4 \ All ^  *u
defined substrates share a common feature- they all on 9 eXpenmenta,ly
iney an possess at least nno
carboxylate group. Crystal structures of TRAP transporter ESRs have shown
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that a carboxylate group of the ligand is coordinated by an arginine residue 
(A rg t47 in SiaP) ,n the binding site of the protein (Gonin ef a/., 2007 Johnston 
ef a/ 2008. Muller ef a/., 2006, Rucktooa ef a/., 2007). Phylogenetic analysis 
revealed that this arginine ,s conserved in 98% of TRAP ESRs (from 248 
sequences), implyng tha, this interaction is very important in th'e ™  
mechanism of TRAP transporters (Muller et al.. 2006). This also correlates wen 
with the fact that all experimentally defined TRAP transporter substrates contain 
at .east one carbox^ate group. There are, however, a number of predicted 
substrates of TRAP transporters tha, do no, possess a carboxylate group For 
example, taurine does no, possess a carboxyiate group and is predicted to be a 
TRAP transporter substrate from genome context analysis (Bruggemann ef a/ 
2004, Oenger ef a ,  2006). Taurine contains a su,phone,e group, wh"ch h i t  
chemical properties similar to carboxylate so it is likely that it could be a TRAP 
transporter substrate. Other predicted TRAP transporter substrates are not as 
straight forward. A  number of sugars, including raffinose, lactose and arabinose 
are predicted to be TRAP transporter substrates. These compounds were 
shown to induce the transcription of a TRAP transporter ESR from s  me, w  
and are therefore predicted to be the substrates (Mauchline et al 2006) These 
sugars do no, possess any acidic functional groups so it is unknown whether 
they are truly TRAP transporter substra,es. ABC transporters are able to bind 
and transport a number of compounds with different chemical properties 
including sugars and amino acids, so there should be no limitations p a rs e  in 
what TRAP transporters can transport. Experimental verification will be required 
to determine whether these are true TRAP transporters substrates.
7.2 Expression and purification of TRAP integral membrane proteins
In order to study the biochemical and energetic characteristics of TRAP 
transporters in more detail, the protein components need to be overexpressed 
and purified. Production of large quantities of ESR proteins „  now fa|
and a number of different TRAP ESRs have been expressed and purified to 
homogeneity (Gonin et al„ 2007, Johnston e, al„ 2008. Muller et al 2006
Rucktooa et al.. 2007, Thomas et al„ 2006). I, is the production of the inteqrai 
membrane components that has proved most challenging.
During the course of this investigation, 3 integral membrane proteins h »  „ 
expressed; YiaM (4 TMHs). ViaN (,2  TMHs), both from E. coli and ^  ^
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TM Hs) from H. inftuanzaa. Three different expression vectors have been used-
PTTQ18 (C-terminal RGSHe tag), two pBAD vectors (either N- or C-terminal H ’
tag) and two pNZ8048 d e r iv e s  (either N- or C-termina, H „  tag). Four E  col
expression strains have been utilised (BL21 (DE3), C41 (DE3) C43 ÎD E3I
M C1061) and one L. lactts strain (NZ9000). Varying facto'rs such as the
expression vector and strain and optimisations of expression conditions has
resulted in the overexpression o f all three proteins. Unfortunately, the sam ple
size and number of variables changed are not large enough to make general
statements about the relative merits of each expression system in the
overexpression of integral membrane proteins. However, a number of the
param eters that contributed to  the successful expression o f these TRAP
transporter membrane components have also been observed to contribute to
the successful expression of other integral membrane proteins in the literature
As a preface to th is section o f the discussion, a fte r review ing the literature on
th e  subject, it is apparent that expression o f integral mem brane proteins is 
overa ll very subjective. K ,s
All three proteins, YiaM, YiaN and SiaQM were expressed using the pTTQ18 
vector, which has previously been used to overexpress a number of integral 
membrane proteins (Morrison ef a i,  2003, Saidijam ef a/., 2003, Saidijam at at. 
2005, W ard, 2000). Expression from this vector is tightly regulated and under 
the control of the moderately-strong fac promoter. A protein produced from this 
vector possesses a C-terminal RGSH* tag. Expression of YiaM from this vector 
resulted in a yield of -0 .7  mg/L culture, whereas expression of SiaQM In the 
PTTQ18 vector resulted in a yield of -0 .1 2  mg/L culture. Unfortunately YiaN 
was not purified to homogeneity, therefore a yield can not be calculated A  
number of conditions were optimised for the expression of each protein 
including inducer concentration, temperature of growth, post-induction
incubation time and the medium of growth (Chapter 5 and 6). The importance of 
optimising culture conditions is emphasised by studies showing that
optimisation can lead to a 3-5 fold increase in protein production (Li ef at 20m  
Auer e t a i ,  2001). , u l-
In order to increase the overall yield of YiaN, the expression of YiaN was 
compared in three different strains of E. co//, BL21 (DE3) C41
(D E3). C41 and C43 are derivatives of BL21 that were derived by s e le a J T r  
tower susceptibility to the toxic effects of integra, membrane protein expression
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(Miroux & Walker, 1996). Comparing steady state levels of YlaN using Western 
blotting revealed that BL21 (DE3) accumulates the most YiaN after 2 hours, the 
signal then decreased in subsequent timepoints. YiaN accumulation in C43 
(DE3) peaked after 1 hour, but was lower than that observed for BL21 (DE3I 
Accumulation in C41 (DE3) peaked after 1 hour, and attained similar 
accumulation levels to BL21 (DE3). There appeared to be higher stability of 
YiaN in C41 (DE3) as there was no decrease in signal during the timecourse as 
seen for BL21 (DE3). A study was performed comparing expression levels 
plasmid stability and toxicity from a number of different vectors in BL21 C41 
and C43 (Dumon-Seignovert ef a/., 2004). This study revealed that C41 and 
C 43 had higher plasmid stability, lower toxicity and higher percentage of 
expression (percentages of expressing plasmids were 54%, 86% and 81% for 
BL21, C41 and C43, respectively), however, the relative levels of expression 
were not reported (Dumon-Seignovert ef a/., 2004). Another study this time 
working with only one protein, MexY, detected no accumulation o i MexY in 
BL21 <DE3>- However' “ f» n  switching to C43 (DE3) a yield of up to 5 ma/L 
culture was obtained (Mokhonova ef a/.. 2005). In a high throughput study of 49 
different integral membrane proteins, comparative expression in BL21 C41 and 
C43 was performed (Eshaghi ef at. 2005). Out of the 49 targets, 51% were 
expressed from BL21, 49% from C41 and 45% from C43. There were veiy few  
differences in which targets were expressed by each strain, however there 
were several targets where the relative expression levels were quite different for 
each strain. These studies and the findings from Chapter 4 of this thesis 
suggest that BL21, C41 and C43 will all express the same proteins, with some 
exceptions. However, the relative levels of expression may be quite different
Therefore, it would be beneficial to screen all 3 strains for expression of the 
target membrane protein.
SiaQM was the major target for study and this H . influenzae protein was 
heterologously expressed from pTTQ18 and pBAD vectors in E  coli The 
protein produced from the PTTQ18 vector had a C-terminal RGSH« tag 
whereas SiaQM was produced with either an N- or C-terminal H,0 tag from the 
pBAD vectors. The variable that made the biggest difference in expression 
levels was the location of the affinity tag. SiaQM expressed from pTTQ18 had 
an overall yield of 0.12mg/L, whereas, N-terminally tagged SiaQM from the 
pBAD vector had an overall yield of 1.5 mg/L. The C-termina„y tagged version
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of SiaQM expressed from a pBAD vector was never purified so an overal. yield 
was not calculated. However, expression trials and optimisation suggest that It 
was significantly lower than the yield of N-termlnally tagged SiaQM expressed 
from PBAD and was more in the range of the yield of SiaQM from S  
(Chapter 6). A study on how accumulation of aquaporin was affected by 
histidine tag length and location has been performed that corroborates this 
finding (Mohanty & Wiener, 2004). Aquaporin from E. co// was expressed by a 
PET vector (T7  promoter) with either a hexa- or deca-histidlne tag at the N- or 
C - terminus. This study revealed that for this protein, the longer the affinity taq 
the lower the accumulation, and having the affinity tag at the N-terminus results 
in higher accumulation. A much wider study on the expression optimisation of 
36 P-type ATPases from 11 different bacteria also revealed .ha, positioning of 
the affinity tag at the N-terminus resulted in higher accumulation of protein 
(Lewinson ef a/.. 2008). This study was performed In both pET vectors and 
pBAD vectors with the same overall result in each. As mentioned previously 
membrane protein expression is very subjective and this is reflected in the fact 
that approximately 1/3 of the P-type ATPases in this study accumulated to a 
higher degree with a C-terminal affinity tag. This higher accumulation of the N 
terminally tagged variant compared to the C-terminally tagged variant was also 
obseived for SiaQM expressed in L. lactis and for SiaP expressed from the 
pBAD vectors in E  co// (Chapter 6). The mason for the different levels of 
accumulation of Integral membrane proteins according to the position of the
affinity tag Is not known, but these studies clearly show that it is a variable that 
requires significant consideration.
A  study that directly compared the heterologous expression of 37 targets from 3 
different bacteria from pTTQ18 and pBAD in E  co// showed that pTTQ18 was 
able to express the highest number of proteins (68% compared to 65% from 
pBAD), however, there was higher accumulation of protein from the pBAD 
vector (Surade ef a/., 2006). The study concludes that there is no single 
expression vector that is best for every protein, therefore using multiple vectors 
(even just two) will undoubtedly increase success rate of membrane pmtein
expression.
As well as expression in E. coli, SiaQM was also expressed in L  lactis with a C- 
or N-terminal decahistidine tag (Chapter 6). Expression of SiaQM from the nisin
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inducible PNZ8048 vector in L  lactis resulted in a higher overall yield of protein 
than expression from pBAD in E. coli. This difference in accumulation was quite 
small with SiaQM making up 2-3%  of the total membrane protein in each strain 
The previously mentioned study that compared the accumulation of 37 fac ets  
from 3 different bacteria expressed from different vectors also compared the 
accumulation of these targets in E  cofffrom the pTTQ18 and pBAD vectors with 
expression in L  lactis from the PNZ8048 expression vector (Surade et al 
2006). The study showed that 84% of targets were successfully expressed in 
E  coli (from at least one of three vectors) compared to just 40%  in L lactis 
(utilising only one expression vector). It was shown that each Individual E  coli 
expression vector used in this study (pTTQ18, pBAD and pQE) outperformed 
the L  lactis expression vector (pNZ8048). It was also revealed that there were 
no targets expressed by L. lactis that were not expressed by at least one of the 
E  coli vectors with approximately the same level of accumulation (Surade et al 
2006). This may suggest that expression in L. lactis is not worthwhile; however,’ 
as is apparent from all these studies, expression of membrane proteins is very 
subjective so varying the expression species is an excellent idea if expression 
in E  coll is not ideal. As an example of this, L. lactis has been shown to be 
effective in the overexpression of a number of eukaryotic membrane proteins 
(Kunji e t al., 2003, Monne et al., 2005, Kunji et al., 2005).
7 .3 B asic structural requirem ents o f TRAP transporters
7.3.1 ESR com ponent
It has been demonstrated unequivocally in two separate TRAP systems 
DctPQM and SiaPQM, that the membrane component (whether fused or 
encoded by two separate genes) and the ESR component are essential for 
transport activity In vivo (Forward et al., 1997, Severi et al., 2005). This 
dependence on the presence of SiaP has also been demonstrated in vitro in the 
purified, reconstituted system (Chapter 6). In the presence of SiaP, SiaQ M - 
containing proteoliposomes and a ApNa* + A V . transport of Neu5Ac into the 
lumen of the proteoliposomes is observed. However, under the same 
conditions, with the same batch of proteoliposomes, but in the absence of SiaP  
no transport activity was observed (Chapter 6). This phenotype is also observed 
in ABC transporters. ABC transporters were first differentiated from secondary
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transporters by their osmotic shock sensitivity, a process in which the 
periplasm, and all periplasmic components, is removed (Neu &  Heppel 1965) 
ABC transporters require an ESR for transport and are therefore osmotic shock 
sensitive. Secondary transporters that require no periplasmic components are 
osmotic shock insensitive. TRAP transporters, however, are not ABC 
transporters, and it has been postulated that the likely translocation domain, 
D °tM  was °hce a standalone secondary transporter that recruited the accessory 
proteins, the small integral membrane component, DctQ and an ESR (Rabus e l 
a /., 1999). It is therefore not beyond the realms of possibility that the integral 
membrane component can still work independently of the ESR component but 
with a very low affinity for substrate. In the rh vitro transport assay where SiaP  
w as not present, 5 pM Neu5Ac was added to the transport mixture, and It is 
possible that this concentration may be too low to observe any transport. A  
simple experiment to determine whether this were true would be to increase the 
concentration of Neu5Ac and monitor transport activity in the absence of ESR.
A  potentral function for the small membrane component in TRAP transporters is 
the ability to recruit the ESR domain. It may also function as a clamp to prevent 
backflow through the large membrane component, which is why the counterflow 
and the substrate exchange phenomena are not observed (Chapter 6) If the 
DctM component was purified in the absence of the DctQ component, phrhaps 
bidirectional and ESR-independent transport could be observed.
Due to the scarcity of structural information on TRAP transporters, derived 
either biochemically or biophysically, a number of vital characteristics are 
unknown. One of these characteristics is the position at which the ESR Interacts 
with the membrane components. In the high resolution structure of SiaP, a  
potential site of interaction is observed that is conserved in members of the 
sialic acid dade, but not outside of it (Muller et al„ 2006). It was proposed that 
this surface exposed conserved patch interacted with the integral membrane 
components and would allow promiscuity o f the ESRs from these transporters 
between the transporters In the sialic acid-specific grouping. In  vltn, transport 
assays in the presence of SiaQM-containing proteoliposomes and VC1779 the 
SiaP orthologue from I/, choferae, showed no transport activity, thus disprovino 
this theory (Chapter 6). 9
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The positions at which SiaP and SiaQM interact with each other remain 
unknown. This interaction has been shown to be specific, therefore it is likely 
that the sites of interaction on each protein have evolved synchronously The 
question of where SiaP and SiaQM interact could be answered using a number 
o f different experiments. The complex of the integral membrane component and 
the ESR could be crystallised. This is not a trivial feat as Integral membrane 
proteins are particularly difficult to crystallise and a number of reviews have 
been published on the subject (Wiener, 2004). One of the major problems Is the 
highly dynamic nature of transporters, especially secondary transporters The 
elucidation of the high resolution crystal structure of lactose permease was only 
possible at first by using a conformationally constrained mutant (Abramson ef 
a/., 2003). However, recent advances have allowed the wild type structure to be 
crystallised (Guan ef a/., 2007). The third major limitation in the elucidation of a  
high resolution crystal structure of a complete TRAP transporter complex is 
stably trapping the ESR onto the membrane components, This was only 
possible for the maltose ABC transporter structure by using a mutation in the 
ATPase domain that could bind ATP, but could not hydrolyse it (Oldham ef af.
2007). Unfortunately, no inhibitors that can trap a transition state in the transport 
cycle of TRAP transporters are currently available. One route to circumvent this 
would be to use chemical crosslinking to covalently attach the membrane 
component to the ESR. However, one would have to question the physiological 
relevance of a complex trapped ¡n this way.
The interaction between the ESR and membrane components could be mapped 
using specific chemical crosslinking. A cysteine-free SiaQM could be 
constructed and monitored for activity (SiaP is naturally cysteine-free). A  
number of single cysteine mutations In each protein component could be 
Introduced onto the surface of SiaP proposed to Interaction with SiaQM and the 
periplasmlc loops of SiaQM predicted from hydropathy analysis. This would 
allow the mapping of the site of interaction as the cysteine residues would have 
to be very close to form a disulphide bond. A  more accurate topology model for 
SiaQM  would be required first, which could be produced using cysteine 
scanning mutagenesis and hydrophilic thiol-reactive agents, as seen for lactose 
permease (Frillingos ef a t , 1998), or PhoAtf-lactamase fusions, as used with 
DctQ and MalFG (Boyd ef a t , 1993, Ehrmann ef a t , 1990, Wyborn a t a t  2001)
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An issue that has not been addressed for TRAP transporters is whether the 
uniiganded ESR interacts with the integral membrane components or whether it 
is only after ligand binding that the ESR and membrane components interact 
This is a contentious issue in ABC transporters as it has been demonstrated 
that it is only the ligand bound form that interacts with the integral membrane 
components in at least one well characterised ABC transporter, OppABCDF 
(Doeven ef a/., 2008). In this case, interaction was only observed between 
llganded ESR OppA and the membrane components using fluorescence cross 
correlation spectroscopy (FCCS) Ligand-free OppA was shown not to interact 
(Doeven e t al., 2008). In vitro transport studies on the vitamin B ,2 ABC 
transporter suggested that In the absence of ATP radiolabelled substrate was 
trapped in between the ESR and membrane components. This trapped 
radiolabelled substrate could be slowly displaced with unlabelled substrate 
leading to the proposition that the ESR is in constant contact with the 
membrane components throughout the transport cycle (Borths ef a l 2005) It 
has also been shown that the ESR and membrane components of thè BtuCDF 
system form a very stable complex in vitro (Borths e f al., 2002). There is also 
evidence that the uniiganded maltose-specific ESR MalE from £ . coli and 
histidine specific ESR HisJ from S. typhm urium  interact with their cognate 
membrane components with a similar affinity to when they have ligand bound 
(Ames ef a /., 1996, Austermuhle ef al., 2004). This was demonstrated for the 
maltose system using site directed spin labelling followed by electron 
paramegnetic resonance (EPR) and for the histidine ABC system using 
chemical crosslinking.
It is unknown at this time which of these mechanisms TRAP transporters 
employ. However, this could be addressed using a number of different methods 
such as those mentioned above for the maltose and histidine ABC systems as 
well as ITC or surface plasmon resonance (SPR). Both o f the latter methods 
can be used to detect prateimprotein interactions and could be used to 
determine whether uniiganded or liganded ESR can interact with detergent 
solubilised membrane components.
7 .3.2 DctQ  and DctM com ponents
Due to the aforementioned problems with Integral membrane protein expression 
and purification, the DctQ and DctM (and fusions of the two) are by far the least
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studied components of TRAP transporters.
There are many fundamental questions that remain to be answered regarding 
these proteins and now with the high yield production of a number o f these 
proteins, we are able to study them in more detail. One aspect that remains to 
be answered is the topology of the large integral membrane subunit, DctM and 
fused integral membrane proteins, DctQM. Another fundamental question that 
has not been addressed is the subunit stoichiometry required to form a 
functional transporter.
Expression and purification of the hexahistidine-tagged DctQ subunit YiaM  
from the £  coli TRAP transporter revealed a ladder of immunoreactive species’ 
The species with apparent molecular weights corresponding to a monomer and 
dim er of YiaM were confirmed to be YiaM using peptide mass fingerprinting 
(Chapter 4). This ladder of Immunoreactive species Is composed of discreet 
bands that have apparent molecular weights that approximately correlate with 
the consecutive addition of YiaM protomers. The highest oligomeric structure 
observed by Western blotting corresponds approximately with a complex of five 
YiaM  subunits. There is reason to believe that all of these species are YiaM  
complexes because the monomer and dimer were confirmed by peptide mass 
fingerprinting and the higher oligomeric species are sensitive to boiling and 
treatm ent with the reducing agent, 0-mercaptoethanol. The actual oligomeric 
state of YiaM In solution is not known and it is also unknown whether any of 
these apparent complexes are physiologically relevant.
There are now known to be many examples of a fusion between the DctQ and 
DctM subunits. Unless there are unforeseen structural and mechanistic 
differences between TRAP systems composed of two separate membrane 
components or one a single membrane component, this would suggest that the 
DctQ and DctM subunits in TRAP transporters are In a 1:1 stoichiometry with 
each other. This Implies that if the YiaM (DctQ subunit) Is forming oligomeric 
structures then its cognate DctM subunit, YiaN is forming equivalent oligomeric 
structures. However, when hexahistidine-tagged YiaN was co-expressed with 
untagged YiaM, two immunoreactive species were observed; one at the size 
predicted for a monomer and one at the size approximately predicted f o H  
dimer. Unfortunately, the purification was not very efficacious and the elution 
fraction contained a number of contaminants so It could not be determined 
whether the potential dimeric YiaN species was actually YiaN A rotei
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corresponding to YiaM was not identified in this elution fraction, however it may 
have been masked by the high abundance of contaminants. It would be 
interesting to discover whether YiaM is still accumulated when co-expressed 
with YiaN and whether YiaM and YiaN form a complex in the membrane
Answering these fundamental questions would help to determine the function of 
YiaM . onor
The stoichiometry of the integral membrane components in a functional 
transporter is still unknown. Classical secondary transporter integral membrane 
components (MFS members) are Invariably composed of -12 -14  TMHs (Pao et 
a l.. 1998) and ABC transporter membrane components have on average -1 2  
TM Hs (a dimer of proteins with 6 TMHs each (Davidson et al. 2008)) The 
average TRAP DctM subunit (or DctM domain in fused membrane 
components), which is considered to form the translocation channel, consists of 
a predicted -1 2  TMHs (Rabus et al„ 1999). Unless there are huge differences 
between TRAP transporters and these other families of transporters then one 
would predict that 12 TMHs in the DctM domain is sufficient for a single 
transporter. This reasoning would suggest that the stoichiometry of the DctM 
component in a single TRAP transporter is 1. If a model had to be made from 
the current body of evidence, one DctQ and one DctM would be predicted for a 
single TRAP transporter. However, further work is required to confirm this.
There are several potential functions suggested for the DctQ component in the 
literature. These include; a role in mediating the interaction between the DctP 
and DctM components, as a chaperone to maintain the stability of DctM or in 
the assembly of DctM in the membrane. It is also speculated that DctQ may be 
involved in electrochemical energy coupling to substrate transport (Kelly & 
Thomas, 2001). The first of these possibilities was initially corroborated by the 
identification of a DctP-DctQ fusion. However, this is the only example of this 
type of fusion, despite the comprehensive data mining required for the 
compilation of TRAPdb and is therefore considered to be a sequencing error 
The possibility of DctQ acting as an assembly factor or as a chaperone is 
reinforced slightly by the observations that YiaN from £ . coll and DctM from 
R . capsulatus are accumulated to a much higher degree in the presence of their 
cognate DctQ subunits, * a M  and DctQ, respectively (Chapter 4 and (Kellv 8 
Thomas, 2001)). However, this apparent instability of the DctM c o m p o n e n t
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the absence of the DctQ subunit may simply be due to DctQ interacting with 
DctM and burying protease cleavage sites or ordering disordered polypeptide 
that is prone to degradation, and not that it is directly involved in insertion or 
assembly of DctM.
There is currently no evidence to suggest that DctQ is involved in coupling the 
electrochemical energy to solute transport. There is strong evidence in the 
maltose ABC transporter system that the ESR, MalE, interacting with the 
periplasmic side of the integral membrane proteins, MalFG, induces a 
conformational change that results in the stimulation of ATPase activity 
(Davidson e ta l., 1992). The model for maltose transport by this ABC transporter 
suggests that interaction of the liganded MalE with MalFG induces a 
conformational change which opens the periplasmic side of the transmembrane 
channel, opening the ESR and releasing the ligand into the membrane 
component (Oldham et al., 2007). It is possible that in TRAP transporters the 
DctQ subunit is responsible for inducing this conformational change upon 
interaction with liganded DctP subunit. Whilst phylogenetic analysis indicates 
the DctM component was likely a standalone secondary transporter in its 
evolutionary past. DctQ homologues are not found associated with any other 
protein and may have been recruited to facilitate the use of an ESR component 
with the translocation machinery.
Much work will be required to define the role of DctQ in the transport cycle. A 
number of approaches for this would be possible. Structural studies are an 
obvious avenue of investigation and the major bottleneck with membrane 
protein crystallography is producing enough protein for the screening process. 
This is not a problem for YiaM or SiaQM, as expression systems have been 
developed produce a high yield of protein (Chapter 4 and 5). Another approach 
is to determine how much of the DctQ subunit is required for transport by 
truncating the protein. It would also be interesting to determine whether the 
DctM component alone is sufficient for transport, which could be assessed 
using in vitro transport assays.
The stoichiometry of the integral membrane components could be assessed 
using chemical crosslinking. This is not an ideal solution as there is no way to 
prove whether the oligomeric state defined is relevant in solution. A more 
accurate method would be to use analytical ultracentrifugation (AUC). However, 
this method is not without its problems. AUC can be used to calculate the
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m olecular w eight and overall size o f the protein. The problem  w ith  integral 
m em brane proteins is that the detergent m icelle is required to keep the protein 
so lub le. The m icelle w ill increase the size o f the particle m assively and unless 
the  contribution o f the detergent can be determ ined there is no w ay to  m easure 
the  s ize  o f the protein alone. To determ ine the detergent contribution, 
rad io labelled detergent can be used as fo r AmtB from  E. coli (B lakey et a/., 
2002). One o f the m ost commonly used detergents, DDM (and DM fo r that 
m atte r) have a m altoside headgroup and there are colorom etric assays 
ava ilab le  to  determ ine the concentration o f detergent in a given sam ple (Lau & 
Bow ie, 1997)- This information can be used to  determ ine the contribution o f 
de tergent and thus subtracting it from  the to ta l mass, therefore gleaning w hat 
th e  actual mass o f the protein is. The ideal solution to th is problem  is to use 
neu tra lly  buoyant detergents such as C8E5 (Flem ing et al., 1997). These 
detergents do not contribute to  the sedim entation during AUC and are 
essentia lly  ignored. The m ajor problem  w ith th is  m ethod is solubilising enough 
o f the  integral membrane protein in the detergent to  get a good signal in the 
AU C .
7 4  Energetic requirem ents and characteristics o f Neu5Ac transport via  
SiaPQ M
The firs t TRAP transporter to  be reconstituted and exam ined in vitro has been 
reported (C hapter 6). Assessm ent o f the energetic requirem ents fo r transporter 
b y  reconstituted SiaPQM revealed tha t transport o f Neu5Ac into the lum en o f 
th e  proteoliposom es was dependent on the presence o f an inwardly-directed 
A pN a+ Application o f specific gradients across the m embrane revealed tha t a 
A pH  o r a AH* alone could not support transport o f Neu5Ac. This dependence o f 
N a+ is  supported by data from  a num ber o f d iffe rent sources. It has been shown 
th a t there is a strong correlation between high num bers o f TRAP transporters 
and environm ents w ith high Na+ concentrations (C hapter 3). M arine-dwelling 
bacteria  appear to  have a propensity fo r TRAP transporter above bacteria found 
¡n o ther environm ents. A  more d irect line o f evidence tha t TRAP transporters 
a re  Na+-dependent transporters is that whole cell transport assays revealed an 
gSR -dependent transporter in R. sphaeroides, assum ed to  be a TRAP 
transporte r, which w as found to  be Na+-dependent (Jacobs et al., 1996). 
A no ther exam ple sim ilar to  th is is that Na+-dependent glutam ate transport in
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Synecocystis w as found to  be mediated by an atypical TRAP transporter tha t 
u tilised  an ABC transporter ESR (homologous to GlnH (Q uintero et a/., 2001)). 
The high resolution structure o f a TRAP ESR from  R. sphaeroides has been 
solved in com plex w ith a pyruvate molecule and a Na+ ion in the  binding site. 
T h is  sodium  ion interacts w ith both the protein and the ligand indicating tha t it is 
in tegra l to  the binding process. This does not appear to be the case fo r all 
TR AP transporter ESRs as it has been shown tha t the binding a ffin ity o f 
N eu5Ac to  VC1779 in Na+-free buffer is  not sign ificantly d iffe rent to  when 120 
m M  NaCI is added (Chapter 6). The same observation was made fo r the ESR 
from  the presumed glutam ate-specific TRAP transporter from  R. sphaeroides 
(Jacobs e t a l., 1996). This indicates in these tw o cases tha t Na+ is not required
for high a ffin ity  binding o f ligand.
In the  case o f SiaPQM, Na+ does not appear play a role in facilita ting binding o f 
the  ligand to  the ESR. It has been observed tha t a gradient o f Na+ is required 
fo r transport and not sim ply the presence o f Na+ in the buffer (C hapter 6). 
U nfortunately, it was not possible to  assess the effects o f Na+ ions on the 
b ind ing a ffin ity  o f Neu5Ac fo r SiaP using tryptophan fluorescence spectroscopy. 
S iaP  has a very low  fluorescence signal due to  the lack o f tryptophan residues, 
w h ich  makes assessing the im portance o f Na+ in ligand binding very d ifficu lt 
and potentia lly unreliable. A  method to  circum vent th is problem  would be to  
isotherm al titra tion  calorim etry (ITC).
A lthough the effects o f Na+ on Neu5Ac binding to  SiaP have not been assessed 
d irectly , the  evidence would suggest that the contribution o f Na+ to  the transport 
m echanism  is not in the coordination o f the ligand in the ESR com ponent. 
H ow ever, th is characteristic does not necessarily extend itse lf to all TRAP 
transporters.
T he application o f d ifferent com binations o f electrochem ical gradients across 
th e  m em brane was perform ed on SiaQM -containing proteoliposom es (C hapter 
6 ) Aside from  the separate application o f a ApN a+, a ApH and a AH' across the 
m em brane, com binations o f ApNa+ + ApH and ApN a+ + AH' w ere also applied. 
T ransport measured under these conditions revealed tha t upon application o f 
A pN a* + ApH there was a decrease in the transport rate when com pared to 
A pN a* alone. There are a num ber o f ways the internal pH, external pH and the 
ApH  across the membrane can affect transport by secondary transporters
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(review ed in  (Poolm an e f a/., 1987)). The pH can affect transport by ABC 
transporters, secondary transporters and group translocators (Poolm an 1994)
It Is easy to  envisage how the change in pH m ay a ffect secondary transporters 
th a t use ApH  as a driving force as th is could interfere w ith d iscreet 
(de)protonatlon steps Integral to  the transport m echanism  (Poolm an e t al 
1987). However, it  Is less obvious how the ApH could affect a ApN a* driven’ 
transporte r like  SiaPQM. There is o f course the e ffect o f pH on the  Ion ic sta te  o f 
th e  substra te  o r Its affects on the  transporter itse lf, which m ay a ffect critical 
residues th a t would result in decreased transport. The m agnitude o f the Internal 
pH  has a lso been im plicated In a llosteric effects fo r certa in  transporters 
(Poolm an e t a l.. 1987). However, the reason fo r the  observed decrease in 
transport ra te  via SiaPQM when a ApN a* + ApH are applied is  not known and 
fu rthe r investigations would be required to  draw  any conclusions.
A pp lica tion  o f a com bination o f ApNa* + AW led to an increase in  the  transport 
ra te  com pared to  application o f ApN a* alone. NeuSAc contains a carboxylate 
g roup  and is negatively charged a t physiological pH (pKa = 2.6). The AW tha t is 
app lied  produces a charge separation across the  m em brane w ith  the inside 
negative com pared to outside. The fact tha t Neu5Ac Is negatively charged and 
th e  addition o f a AW Increases transport rate despite it m aking the Inside o f the  
proteoliposom e negative compared to the outside suggests tha t m ore than one 
N a* ion is  transported per m olecule o f NeuSAc. The exact sto ichiom etry o f 
NeuSAc to  Na* Is not known, however. It Is an Im portant deta il to  establish w ith 
regard  to  the mechanism  o f transport. A  num ber o f m ethods are  available to  
de term ine  the  stoichiom etry o f H* and substrate fo r o ther transporters, m ost o f 
w h ich  can also be applied to determ ining the Na*:Neu5Ac stoichiom etry in 
S iaPQ M . O ne method is to  include pH probe in the transport assay and 
determ ine the  change In pH as transport proceeds. Sym port o f substrate w ith 
H * w ill lead to  acid ification o f the proteoliposom e lum en and an increase In pH 
va lue  In the  external buffer, which can be converted Into the num ber o f H* 
transported  (Z ilberstein e ta l.. 1979). I f  a  parallel transport assay is  perform ed in 
w h ich  transport rate o f substrate is  m easured then the  tw o values can be 
com bined and a stoichiom etry established. N a*-specific probes are available  
the re fo re  th is  m ethod can be d irectly applied to  SiaPQM . Another m ethod is  to  
load  the  lum en o f the veside/proteollposom e w ith  a dye such as 2 ' T  bis (2 
carboxyethyl)-5(6)roarboxyfluoresceln (BCECF) tha t a lters its  e m is s io n 'p ro fl'
254
upon acid ification o f the lumen (Graves e f a/., 2008). A  dye that reacts to  the 
presence o f Na+ is also available and could be used to determ ine the  rate o f 
Na+ transport into the proteoliposome (Lo et al., 2006).
A s deta iled in section 1.5.4 o f the introduction, classical secondary transporters 
share common characteristics under certain experim ental conditions Solute 
counterflow  and exchange ("cold chase ') reactions are characteristic o f 
secondary transporters and are on ly possible because o f the bidirectional 
na ture  o f transport by secondary transporters. TRAP transporters are 
secondary active transporters, but utilise an ESR com ponent, w hich makes 
them  inherently unidirectional. To assess w hether SiaQM could transport 
NeuSAc bidirectionally, solute counterflow  and exchange reactions were 
perform ed on SiaQM -containing proteoliposom es. These experim ents revealed 
th a t SiaQM  (in the presence and absence o f 5 pM SlaP) could not catalyse 
b id irectiona l m ovem ent o f substrate (C hapter 6). In an ideal situation these 
experim ents would have been accompanied by a positive contro l fo r 
counterflow  and exchange. The perfect control fo r these experim ents would 
have  been the  classical secondary transporter NanT from  £  co ll and the perfect 
nega tive  control would have been the ABC transporter SatABCD from  
H. ducreyi. Both o f these systems are specific fo r NeuSAc, but ne ither system  
had been reconstituted into liposom es fo r use in these types o f experim ents.
A n  experim ent was performed to  assess the effects o f varying the concentration 
o f S iaP  w hilst m aintaining the same concentration o f SiaQM and Neu5Ac 
(C hap te r 6). The Neu5Ac concentration was m aintained a t 5 pM and SiaP was 
va ried  between 0  pM, 2 .5  pM, 5 pM, 10 pM and 20 pM. W ith no SiaP present 
th e re  w as no transport indicating tha t transport o f Neu5Ac by SiaQM is 
dependent on the presence o f SiaP. The transport rates in the presence o f 2 5 
pM  o r 5 pM SiaP were alm ost indistinguishable from  each other. The presence 
o f 10 pM S iaP  facilita ted uptake o f NeuSAc, but unexpectedly eventually led to 
e fflu x  o f the substrate. This was also observed in the presence o f 20  pM but 
N eu5Ac was efduxed to higher degree, suggesting tha t th is  efflux w as facilita ted 
b y  SiaP.
T o  c la rify  w hether th is efflux was a d irect e ffect o f excess SiaP, a transport 
assay was perform ed In the presence o f 5 pM Neu5Ac and 2 .5  pM S iaP  A t 100
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seconds, a S iaP  -chase’  was added m aking the fina l concentration o f S iaP 20 
m m . T h is resulted in rapid efflux o f NeuSAc. A n experim ent was perform ed to  
determ ine  w hether th is efflux was caused by a specific interaction between 
S iaP  and SiaQM  o r whether it  was a consequence o f th e  excess S iaP binding 
a ll o f the  free  NeuSAc in the external buffer and form ing a pseudo-substrate 
g rad ien t th a t was higher in  m agnitude tha t the ApNa* and A>F com bined. The 
expenm ent perform ed to ascertain which o f these possib ilities was correct took 
advantage o f the  availability o f VC1T79, a high a ffin ity  NeuSAc ESR th a t was 
know n not to  functionally interact w ith SiaQM. If a VC1779 -chase" experim ent 
produced the sam e efflux as the SiaP chase then it would suggest th a t efflux is 
no t due to  a specific interaction between S iaP and SiaQM. This w ould indicate 
th a t the re  is  a d ifferent reason fo r the efflux, possib ly the  form ation o f a pseudo­
substra te  gradient as mentioned above. The results showed tha t e fflux was not 
fa c ilita ted  by a VC1779 chase as it was fo r a SiaP chase indicating tha t a 
specific  interaction between SiaP and SiaQM caused th is efflux.
W h ils t th is is  an interesting observation, th is situation is un like ly to  occur in  vivo  
a s  th e  transporter and catabolic genes are co-regulated. Upon transport o f 
N eu5Ac in to  the cytoplasm , the  substrate would be catabolised m aking e fflux o f 
N eu5Ac im possible. By using an artific ia l system , it has been dem onstrated tha t 
u nde r certa in non-physiological conditions SiaPQM is ab le to  perform  
b id irectiona l transport.
7 .5  Proposed model fo r TRAP transporters
U sing  w hat is  now  known fo r TRAP transporters and w hat has been defined fo r 
c lassica l secondary transporters and ABC  transporters, a m echanism  o f 
transport can be proposed fo r TRAP transporters. The m odel w ill be a general 
TR A P  transporter m odel so the  d iffe rent protein subunits w ill be referred to  as 
D d P , DctQ  and DctM. The transport mechanism  begins w ith  binding o f ligand to  
th e  ESR dom ain. DctP (Fig. 7.1a). The ESR docks w ith the integral m em brane 
com ponents DctQM in the ir assumed resting state. Th is interaction has been 
show n to  be specific as VC1779 cannot form  a functional transporter w ith  
SraQM in  vitro  (Chapter 6). It is  currently unknown w hether D ctP  interacts w ith  
D ctQ  o r DctM  o r both and it is also unknown w hether unllganded DctP can 
in te ract w ith  the membrane components. The resting state o f DctM  w hich Is the 
com ponent predicted to  form  the translocation channel, is  assum ed to  be such
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that the periplasmic opening is closed (outside-closed). This assumption is made 
because the structures of LacY and GIpT are both in the outside-closed 
conformation, therefore it is predicted to be the most stable conformational state 
(Abramson et al., 2003, Huang et a i,  2003).
The binding and transport of an unknown number of Na+ ions across the 
membrane through DctQ induces a conformational change in DctM which opens 
the periplasmic entrance to the translocation channel in DctM and also prises open 
the DctP component releasing the substrate into the translocation channel. The 
substrate may interact with specific residues in the translocation channel as seen 
for the maltose ABC transporter (Oldham et al., 2007). However, there is currently 
no evidence for the presence of a binding site in the membrane components. It is 
currently unknown whether there are separate translocation channels for the 
substrate and Na+ ion in the integral membrane subunits, as determined for 
galactoside:H+ in LacY (Abramson et al., 2003), or whether they go through the 
same channel in the membrane component. The suggestion that DctQ functions as 
the component that couples the ApNa+ to conformational changes in the DctM 
component is pure speculation at this stage. The DctQ subunit is poorly conserved 
and it seems unlikely that such an important function as this would not have 
conserved residues. Upon release of substrate into the translocation channel the 
DctM collapses back to its more favourable resting state (outside-closed), which 
releases the DctP component and opens the cytoplasmic entrance of the DctM 
component allowing release of the substrate into the cytoplasm.
Another model could be proposed with a different role for DctQ (Fig. 7.1b). In this 
alternate model, liganded DctP interacts with DctQ. DctM alone forms the 
translocation channel for the substrate and  Na+ ion. The argument in favour of this 
is that DctQ is not conserved enough for such an important function as forming the 
Na+ channel. Furthermore, standalone secondary transporters are able to couple 
transport of substrate and counter ion without the need for auxiliary proteins like 
DctQ, so there is no reason why DctM could not. DctP and DctQ have a lot more 
sequence divergence than DctM so it possible they have diverged together thus 
conferring specificity of ESR on each transporter.
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The models so far suggested do not take into account the apparent efflux of 
substrate observed upon addition of excess unliganded ESR (Chapter 6). Although 
this result is difficult to explain without further experiments, the results obtained in 
Chapter 6 allow for some speculation. The following explanation of the results from 
Chapter 6 will be assumed to be true for the benefit of this model, however, the 
validity of this explanation Is still to be confirmed. Prior to any interaction with the 
DctP component, Dct(Q)M is in Its resting state, which is assumed to be an 
outside-closed conformation, which Is also assumed for LacY and GIpT (Abramson 
et al., 2003, Huang et al., 2003). Due to the high concentration of substrate In the 
lumen of the proteollposome, the binding site within DctM is saturated. Upon 
interaction with the excess unliganded DctP component, the conformation of DctM 
changes to outside-open. At this point, DctP either detaches and substrate diffuses 
out or DctP binds substrate and detaches In a liganded form. The latter option is 
possible as it has been shown that Neu5Ac makes the majority o f contacts with 
only one globular domain of SlaP (Muller et al., 2006). The model that could be 
suggested from this is that llganded DctP docks with DctM and Induces a 
conformational change in DctM. This is analogous to the model suggested for the 
maltose ABC transporter (Oldham et al., 2007). This conformational change opens 
DctP releasing the substrate, which enters the translocation channel of DctM, 
possibly interacting with specific residues within the channel. The binding and 
transport of Na+ could then induce the outside-closed conformation, breaking the 
interaction with DctP and releasing substrate into the cytoplasm. There are clearly 
several problems with this model, such as, what is stopping the unliganded DctP 
from rebinding to DctM In its resting state? Also, if the outside-closed conformation 
is the resting state of DctM, there is presumably no energetic requirement (from 
ApNa+) to return to that conformation. Would it not be more likely that the opening 
of DctP and the Induction of the outside-open conformation is the energy -  
dependent step in the transport cycle?
Clearly, there are a number of potential models that could be proposed. This large 
number of possibilities Is due to the lack of experimental evidence regarding the 
structure and mechanism of TRAP transporters.
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An important question to consider is: why does a secondary transporter require an 
ESR component? The recruitment of an ESR by a secondary transporter is 
probably a way to increase the affinity of the transporter to enable scavenging of 
low concentrations of substrate from the environment. In organisms containing 
TRAP transporters it is presumably less energetically expensive to use a ApNa+ to 
transport a particular substrate than to synthesise ATP to drive transport. This 
correlation is clearly observed in the propensity for marine-dwelling bacteria to 
have high numbers of TRAP transporters (Chapter 3). However, these organisms 
still require the presence of high affinity transport via ABC transporters. The reason 
why an organism requires both ABC and TRAP transporters may be due to the 
substrate range of TRAP transporters being confined to organic anions, whereas 
ABC transporters can transport a plethora of different substrates. The reason for 
this limitation of substrate range is not immediately obvious as TRAP transporters 
are assumed to be an ancient family o f transporters and will have had time to 
diversify, like ABC transporters (Rabus et al., 1999). However, the very nature of 
the substrate may have profound implications on the mechanism of transport by 
TRAP transporters that we do not know about yet.
Other questions that still remain unanswered, but are pivotal for the understanding 
of TRAP transporters are; what is the function of the DctQ component? How does 
the ESR component interact with the membrane components? Can the DctM 
subunit function on its own as a standalone secondary transporter? Are all TRAP 
transporters limited to the transport of organic anionic substrates? Do all TRAP 
transporters utilise a ApNa+ for driving transport? More experiments, using these 
proposed models as a basis, will lead to a deeper understanding of the functions 
and interactions o f TRAP transporter subunits which will shed more light on the 
mechanism of transport.
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